-- Table structure for table `gif_ads`
--

CREATE TABLE `gif_ads` (
  `id` bigint(20) UNSIGNED NOT NULL,
  `gif_no` varchar(255) NOT NULL,
  `title` varchar(255) NOT NULL,
  `image` varchar(255) NOT NULL,
  `created_at` timestamp NULL DEFAULT NULL,
  `updated_at` timestamp NULL DEFAULT NULL
) ENGINE=InnoDB DEFAULT CHARSET=utf8mb4 COLLATE=utf8mb4_unicode_ci;

--
-- Dumping data for table `gif_ads`
--

INSERT INTO `gif_ads` (`id`, `gif_no`, `title`, `image`, `created_at`, `updated_at`) VALUES
(1, 'Gif Ad 1', 'Healthcare', '394543280.gif', NULL, '2022-02-18 06:28:36'),
(2, 'Gif Ad 2', '+ health coverd', '937325771.gif', NULL, '2022-02-18 06:29:46'),
(3, 'Gif Ad 3', 'Be Kind', '966034509.gif', NULL, '2022-02-18 07:14:40'),
(4, 'Gif Ad 4', 'Progress', '219615920.gif', NULL, '2022-02-18 06:20:08');

-- --------------------------------------------------------

--
-- Table structure for table `hospital_clinics`
--

CREATE TABLE `hospital_clinics` (
  `id` int(10) UNSIGNED NOT NULL,
  `institution_name` varchar(255) CHARACTER SET utf8mb4 COLLATE utf8mb4_unicode_ci NOT NULL,
  `institution_type` varchar(255) CHARACTER SET utf8mb4 COLLATE utf8mb4_unicode_ci NOT NULL,
  `institution_address` text CHARACTER SET utf8mb4 COLLATE utf8mb4_unicode_ci DEFAULT NULL,
  `district` varchar(255) CHARACTER SET utf8mb4 COLLATE utf8mb4_unicode_ci DEFAULT NULL,
  `phone_no` varchar(255) CHARACTER SET utf8mb4 COLLATE utf8mb4_unicode_ci DEFAULT NULL,
  `email_address` varchar(255) CHARACTER SET utf8mb4 COLLATE utf8mb4_unicode_ci DEFAULT NULL,
  `website` varchar(255) CHARACTER SET utf8mb4 COLLATE utf8mb4_unicode_ci DEFAULT NULL,
  `created_at` timestamp NULL DEFAULT NULL,
  `updated_at` timestamp NULL DEFAULT NULL
) ENGINE=MyISAM DEFAULT CHARSET=latin1 COLLATE=latin1_swedish_ci;

--
-- Dumping data for table `hospital_clinics`
--

INSERT INTO `hospital_clinics` (`id`, `institution_name`, `institution_type`, `institution_address`, `district`, `phone_no`, `email_address`, `website`, `created_at`, `updated_at`) VALUES
(12, 'Dhaka Medical College Hospital', 'Govt. Hospital', 'Secretariat Road , Shahbagh, Dhaka-1000', 'Dhaka', '02-55165001', 'dmch@hospi.dghs.gov.bd', 'www.dmc.gov.bd', '2022-07-06 17:01:02', '2022-07-07 05:28:23'),
(11, 'Sir Salimullah Medical College & Mitford Hospital', 'Govt. Hospital', 'Mitford Rd, Dhaka 1206', 'Dhaka', '02-7319002-5', 'mitford@hospi.dghs.gov.bd', 'ssmcbd.net', '2022-07-06 17:00:45', '2022-07-07 05:45:29');

-- --------------------------------------------------------

--
-- Table structure for table `inter_national_health_days`
--

CREATE TABLE `inter_national_health_days` (
  `id` bigint(20) UNSIGNED NOT NULL,
  `title` varchar(255) NOT NULL,
  `image` varchar(255) NOT NULL,
  `description` longtext NOT NULL,
  `h_date` varchar(255) NOT NULL,
  `created_at` timestamp NULL DEFAULT NULL,
  `updated_at` timestamp NULL DEFAULT NULL
) ENGINE=InnoDB DEFAULT CHARSET=utf8mb4 COLLATE=utf8mb4_unicode_ci;

--
-- Dumping data for table `inter_national_health_days`
--

INSERT INTO `inter_national_health_days` (`id`, `title`, `image`, `description`, `h_date`, `created_at`, `updated_at`) VALUES
(2, 'World Down Syndrome Day', '936000097.jpg', '<p><strong>World Down Syndrome Day</strong>&nbsp;(<strong>WDSD</strong>) is marked each year on March 21 beginning in 2006. The 21st day of March (the 3rd month of the year) was selected to signify the uniqueness of the triplication (trisomy) of the 21st chromosome which causes&nbsp;Down syndrome.</p>\r\n\r\n<p>Every year on March 21,&nbsp;<strong>World Down Syndrome Day</strong>&nbsp;is observed to create awareness about Down syndrome. It is a condition in which a child is born with an extra 21st&nbsp;chromosome.</p>\r\n\r\n<p>source: internet&nbsp;</p>', 'March 21, 2022', '2022-01-27 08:21:02', '2022-02-19 07:17:29'),
(3, 'World Kidney Day', '1676878080.png', '<p>World Kidney Day aims to raise awareness of the importance of our kidneys to our overall health and to reduce the frequency and impact of kidney disease and its associated health problems</p>', 'March 14, 2022', '2022-01-27 08:21:02', '2022-02-19 07:20:04'),
(4, 'World Epilepsy Day', '1089779259.jpg', '<p>International Epilepsy Day has been celebrated on the second Monday of February since 2015. It provides a platform for people with epilepsy to share their experience and stories from around the world. This year is rather special as it falls on the 14th of February &ndash; St. Valentine&rsquo;s Day. So, we are hoping that many people from around the world will be able to reach out and share a heart and a smile with someone they know in their family, at their school, or in their community who lives with epilepsy.</p>\r\n\r\n<p>Perhaps you know someone, but perhaps you don&rsquo;t. Despite the fact that 1 in 22 of us will have a seizure at some point in our lives you may not actually know someone with epilepsy. This is because seizures and epilepsy are often hidden away. There is a lot of misunderstanding about epilepsy all around the world, and many people with epilepsy suffer from isolation and discrimination.</p>', 'February 8, 2022', '2022-01-27 08:21:02', '2022-02-19 07:22:22'),
(5, 'World Cancer Day', '188165552.jpg', '<p>World Cancer Day was born on 4 February 2000 at the World Summit Against Cancer for the New Millennium in Paris. The Paris Charter aims to promote research, prevent cancer, improve patient services, raise awareness and mobilize the global community to make progress against cancer, and includes the adoption of World Cancer Day.<br />\r\n<br />\r\nWorld Cancer Day is an initiative of the Union for International Cancer Control (UICC), the largest and oldest international cancer organization dedicated to taking the lead in convening, capacity building and advocacy initiatives that unite the cancer community to reduce the global cancer burden, promote greater equity, and integrate cancer control into the world health and development agenda.<br />\r\n<br />\r\nWe believe that access to life-saving cancer diagnosis, treatment and care should be equal for all &ndash; no matter where you live, what your income, your ethnicity or gender.&nbsp;&nbsp;<br />\r\n<br />\r\nWe believe that governments must be accountable and national leadership on policies, legislations, investment and innovation is key to accelerated progress. We believe that individuals together can create change.</p>', 'February 4, 2022', '2022-01-27 08:21:02', '2022-02-19 07:26:54'),
(6, 'World Leprosy Awareness Day', '561474321.jpg', '<p>World Leprosy Day is observed internationally every year on the last Sunday of January to increase the public awareness of leprosy or Hansen&#39;s Disease. This date was chosen by French humanitarian Raoul Follereau as a tribute to the life of Mahatma Gandhi who had compassion for people afflicted with leprosy.</p>', 'January 30, 2022', '2022-01-27 08:21:02', '2022-02-19 07:29:47'),
(7, 'World Leprosy Day', '996362012.jpg', '<p>World Leprosy Day is observed internationally every year on the last Sunday of January to increase the public awareness of leprosy or Hansen&#39;s Disease. This date was chosen by French humanitarian Raoul Follereau as a tribute to the life of Mahatma Gandhi who had compassion for people afflicted with leprosy.</p>', 'January 24, 2022', '2022-01-27 08:21:02', '2022-02-19 07:28:39'),
(8, 'World Braille Day', '1473199614.jpg', '<p>World Braille Day is celebrated January 4, 2022</p>', 'January 4, 2022', '2022-01-27 08:21:02', '2022-06-06 05:47:54'),
(9, 'World TB Day', '1265237859.png', '<p>World TB Day, March 25,2022</p>', 'March 25, 2022', '2022-02-10 19:53:06', '2022-06-06 05:42:36'),
(10, 'World Autism Awareness Day', '978870239.jpg', '<p>World Autism Awareness Day, April 2, 2022</p>', 'April 2, 2022', '2022-02-10 19:55:14', '2022-06-06 05:40:05'),
(11, 'World Health Day', '1009433718.jpg', '<p>World Health Day, April 7, 2022</p>', 'April 7, 2022', '2022-02-10 19:56:01', '2022-06-06 05:38:22'),
(12, 'World Hemophilia Day', '861413111.jpg', '<p>World Hemophilia Day, April 17, 2022</p>', 'April 17, 2022', '2022-02-10 19:56:40', '2022-06-06 05:35:59'),
(13, 'World Immunization Week', '1580411914.jpg', '<p>World Immunization Week, Last Week April-2022</p>', 'Last Week April', '2022-02-10 19:57:25', '2022-06-06 05:33:40'),
(14, 'World Malaria Day', '1005082570.jpg', '<p>World Malaria Day, April 25, 2022</p>', 'April 25, 2022', '2022-02-10 19:58:03', '2022-06-06 05:32:30'),
(15, 'World Day for Safety and Health at Work', '344029508.jpg', '<p>World Day for Safety and Health at Work</p>\r\n\r\n<p>April 28, 2022</p>', 'April 28, 2022', '2022-02-10 19:58:35', '2022-06-06 05:30:50'),
(16, 'World Hand Hygiene Day', '587020488.jpg', '<p>World Hand Hygiene Day</p>\r\n\r\n<p>May 5, 2022</p>', 'May 5, 2022', '2022-02-10 19:59:15', '2022-06-06 05:29:35'),
(17, 'International No Diet Day', '701300315.jpg', '<p>International No Diet Day</p>\r\n\r\n<p>May 6, 2022</p>', 'May 6, 2022', '2022-02-10 19:59:50', '2022-06-06 05:27:57'),
(18, 'World Asthma Day', '266331038.jpg', '<p>World Asthma Day</p>\r\n\r\n<p>May 7, 2022</p>', 'May 7, 2022', '2022-02-10 20:01:19', '2022-06-06 05:25:46'),
(19, 'World Red Cross and Crescent Day', '275421179.jpg', '<p>World Red Cross and Crescent Day</p>', 'May 8, 2022', '2022-02-10 20:04:11', '2022-06-06 05:24:08'),
(20, 'World Chronic Fatigue Syndrome Awareness Day', '299864228.jpg', '<p>World Chronic Fatigue Syndrome Awareness Day</p>', 'May 12, 2022', '2022-02-10 20:04:42', '2022-06-06 05:22:20'),
(21, 'International Nurses Day', '1415664380.jpg', '<p>International Nurses Day</p>', 'May 12, 2022', '2022-02-10 20:05:14', '2022-06-06 05:18:02'),
(22, 'World AIDS Vaccine Awareness Day', '1508844739.jpg', '<p>World AIDS Vaccine Awareness Day</p>', 'May 18, 2022', '2022-02-10 20:05:37', '2022-06-06 05:15:46'),
(23, 'World No Tobacco Day', '1290182777.jpg', '<p>World No Tobacco Day</p>', 'May 31, 2022', '2022-02-10 20:05:59', '2022-06-04 22:11:48'),
(24, 'World Brain Tumor Day', '156492583.jpg', '<p>World Brain Tumor Day</p>', 'June 8, 2022', '2022-02-10 20:06:22', '2022-06-04 22:01:06'),
(25, 'World Blood Donor Day', '1473530270.jpg', '<p>Every year countries around the world celebrate World Blood Donor Day (WBDD). The event serves to raise awareness of the need for safe blood and blood products and to thank voluntary, unpaid blood donors for their life-saving gifts of blood.</p>\r\n\r\n<p>A blood service that gives patients access to safe blood and blood products in sufficient quantity is a key component of an effective health system. The global theme of World Blood Donor Day changes each year in recognition of the selfless individuals who donate their blood for people unknown to them.</p>', 'June 14, 2022', '2022-02-10 20:06:50', '2022-06-12 04:21:55'),
(26, 'International Day against Drug Abuse', '513384434.jpg', '<p>International Day against Drug Abuse and Illicit Trafficking</p>', 'June 26, 2022', '2022-02-10 20:07:35', '2022-06-04 21:47:44'),
(27, 'World Hepatitis Day', '1627227058.jpg', '<p>World Hepatitis Day</p>', 'July 28, 2022', '2022-02-10 20:08:24', '2022-06-06 05:12:09'),
(28, 'World Suicide Prevention Day', '2132897125.jpg', '<p>World Suicide Prevention Day</p>', 'September 10, 2022', '2022-02-10 20:08:49', '2022-06-06 05:09:11'),
(29, 'World Rabies Day', '967240779.jpg', '<p>World Rabies Day</p>', 'September 28, 2022', '2022-02-10 20:09:13', '2022-06-06 04:36:55'),
(30, 'World Mental Health Day', '426437603.jpg', '<p>World Mental Health Day</p>', 'October 10, 2022', '2022-02-10 20:09:37', '2022-06-06 04:34:44'),
(31, 'Global Handwashing Day', '1726436210.jpg', '<p>Global Handwashing Day</p>', 'October 15, 2022', '2022-02-10 20:10:31', '2022-06-02 05:19:48'),
(32, 'World Food Day', '87645799.jpg', '<p>World Food Day is an international day celebrated every year worldwide on 16 October to commemorate the date of the founding of the United Nations Food and Agriculture Organization in 1945. The day is celebrated widely by many other organizations concerned with hunger and food security, including the World Food Programme, the World Health Organization and the International Fund for Agricultural Development. WFP received the Nobel Prize in Peace for 2020 for their efforts to combat hunger, contribute to peace in conflict areas, and for playing a leading role in stopping the use of hunger in the form of a weapon for war and conflict.</p>\r\n\r\n<p>The World Food Day theme for 2014 was Family Farming: &quot;Feeding the world, caring for the earth&quot;; in 2015 it was &quot;Social Protection and Agriculture: Breaking the Cycle of Rural Poverty&quot;; in 2016 it is Climate Change: &quot;Climate is changing. Food and agriculture must too&quot;, which echoes the theme of 2008, and of 2002 and 1989 before that. The theme of 2020 was &quot;Grow, nourish, sustain. Together. Our actions are our future.&quot;</p>', 'October 16, 2022', '2022-02-10 20:14:19', '2022-03-19 06:21:51'),
(33, 'World Osteoporosis Day', '765421742.jpg', '<p>World Osteoporosis Day</p>', 'October 20, 2022', '2022-02-10 20:14:40', '2022-06-06 04:32:47'),
(34, 'International Stuttering Awareness Day', '247547531.jpg', '<p><strong>International Stuttering Awareness Day</strong></p>\r\n\r\n<p><em>International Stuttering Awareness Day, also known as International Stammering Awareness Day (ISAD) is an annual event celebrated on 22nd October every year to raise awareness about stuttering. The theme for this year is &quot; A World That Understands Stuttering,&quot; which highlights the importance of educating the public and bringing hope to people who stutter. The National Stuttering Association started in 1977, dedicated to bring hope and empowerment to children and adults who stutter.</em></p>', 'October 22, 2022', '2022-02-10 20:15:02', '2022-06-02 05:13:41'),
(35, 'World Pneumonia Day', '1432542304.jpg', '<p><strong>World Pneumonia Day</strong>&nbsp;is observed across the world on&nbsp;<strong>November 12</strong>&nbsp;every year to raise awareness, promote prevention and treatment and produce action to combat the disease. World Pneumonia Day 2021 is an annual event that was first celebrated in the year&nbsp;<strong>2009.</strong></p>', 'November 12, 2022', '2022-02-10 20:15:29', '2022-06-04 21:36:40'),
(36, 'World Diabetes Day', '1275128432.jpg', '<p>World Diabetes Day is the primary global awareness campaign focusing on diabetes mellitus and is held on 14 November each year.</p>\r\n\r\n<p>Led by the International Diabetes Federation (IDF), each World Diabetes Day focuses on a theme related to diabetes; type-2 diabetes is largely preventable and treatable non-communicable disease that is rapidly increasing in numbers worldwide. Type 1 diabetes is not preventable but can be managed with insulin injections.Topics covered have included diabetes and human rights, diabetes and lifestyle, diabetes and obesity, diabetes in the disadvantaged and the vulnerable, and diabetes in children and adolescents. While the campaigns last the whole year, the day itself marks the birthday of Frederick Banting who, along with Charles Best and John Macleod, first conceived the idea which led to the discovery of insulin in 1922.</p>', 'November 14, 2022', '2022-02-10 20:15:56', '2022-06-02 04:39:44'),
(37, 'World Prematurity Day', '1905110199.jpg', '<p>World Prematurity Day is observed on 17 November each year to raise awareness of preterm birth and the concerns of preterm babies and their families worldwide. Approximately 15 million babies are born preterm each year, accounting for about one in 10 of all babies born worldwide. Premature birth is the leading cause of death in children under the age of five worldwide. Urgent action is always requested to address preterm birth given that the first country-level estimates show that globally 15 million babies are born too soon and rates are increasing in most countries with reliable time trend data. Preterm birth is critical for progress on Millennium Development Goal 4 (MDG) for child survival by 2015 and beyond, and gives added value to maternal health (MDG 5) investments also linking to non-communicable diseases. For preterm babies who survive, the additional burden of prematurity-related disability may affect families and health systems.</p>\r\n\r\n<p>November is Prematurity Awareness Month.</p>', 'November 17, 2022', '2022-02-10 20:16:20', '2022-06-02 05:12:47'),
(38, 'World AIDS Day', '1674171758.jpg', '<p>Founded in 1988, World AIDS Day was the first ever international day for global health. Every year, United Nations agencies, governments and civil society join together to campaign around specific themes related to HIV.</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>Awareness-raising activities take place around the globe.</p>\r\n\r\n<p>Many people wear a red ribbon, the universal symbol of awareness of, support for and solidarity with people living with HIV.</p>\r\n\r\n<p>People living with HIV make their voice heard on issues important in their lives.</p>\r\n\r\n<p>Groups of people living with HIV and other civil society organizations involved in the AIDS response mobilize in support of the communities they serve and to raise funds.</p>\r\n\r\n<p>Events highlight the current state of the epidemic.</p>\r\n\r\n<p>World AIDS Day remains as relevant today as it&rsquo;s always been, reminding people and governments that HIV has not gone away. There is still a critical need for increased funding for the AIDS response, to increase awareness of the impact of HIV on people&rsquo;s lives, to end stigma and discrimination and to improve the quality of life of people living with HIV.</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong>Themes</strong></p>\r\n\r\n<ul>\r\n	<li>2022&nbsp; &nbsp; End inequalities. End AIDS. End pandemics.</li>\r\n	<li>2021&nbsp;&nbsp;&nbsp; End inequalities. End AIDS. End pandemics.</li>\r\n	<li>2020&nbsp;&nbsp;&nbsp; Global solidarity, shared responsibility</li>\r\n	<li>2019&nbsp;&nbsp;&nbsp; Communities make the difference</li>\r\n	<li>2018&nbsp;&nbsp;&nbsp; Know your status</li>\r\n	<li>2017&nbsp;&nbsp;&nbsp; My health, my right</li>\r\n	<li>2016&nbsp;&nbsp;&nbsp; Hands up for HIV prevention</li>\r\n	<li>2015&nbsp; &nbsp;&nbsp;On the Fast-Track to end AIDS</li>\r\n	<li>2014&nbsp;&nbsp;&nbsp; Close the gap</li>\r\n	<li>2013&nbsp;&nbsp;&nbsp; Zero discrimination</li>\r\n	<li>2012&nbsp;&nbsp;&nbsp; Together we will end AIDS</li>\r\n	<li>2011&nbsp;&nbsp;&nbsp; Getting to zero</li>\r\n	<li>2010&nbsp;&nbsp;&nbsp; Universal access and human rights</li>\r\n	<li>2009&nbsp;&nbsp;&nbsp; Universal access and human rights</li>\r\n	<li>2008&nbsp;&nbsp;&nbsp; Stop AIDS. Keep the promise&mdash;lead, empower, deliver</li>\r\n	<li>2007&nbsp;&nbsp;&nbsp; Stop AIDS. Keep the promise&mdash;leadership</li>\r\n	<li>2006&nbsp;&nbsp;&nbsp; Stop AIDS. Keep the promise&mdash;accountability</li>\r\n	<li>2005&nbsp;&nbsp;&nbsp; Stop AIDS. Keep the promise</li>\r\n	<li>2004&nbsp;&nbsp;&nbsp; Women, girls, HIV and AIDS</li>\r\n	<li>2003&nbsp;&nbsp;&nbsp; Stigma and discrimination</li>\r\n	<li>2002&nbsp;&nbsp;&nbsp; Stigma and discrimination</li>\r\n	<li>2001&nbsp;&nbsp;&nbsp; I care, do you?</li>\r\n	<li>2000&nbsp;&nbsp;&nbsp; AIDS: men make a difference</li>\r\n	<li>1999&nbsp;&nbsp;&nbsp; Listen, learn, live! World AIDS campaign with children and young people</li>\r\n	<li>1998&nbsp;&nbsp;&nbsp; Force for change&mdash;world AIDS campaign with young people</li>\r\n	<li>1997&nbsp;&nbsp;&nbsp; Children living in a world of AIDS</li>\r\n	<li>1996&nbsp;&nbsp;&nbsp; One world, one hope</li>\r\n	<li>1995&nbsp;&nbsp;&nbsp; Shared rights, shared responsibilities</li>\r\n	<li>1994&nbsp;&nbsp;&nbsp; AIDS and the family</li>\r\n	<li>1993&nbsp;&nbsp;&nbsp; Time to act</li>\r\n	<li>1992&nbsp;&nbsp;&nbsp; AIDS&mdash;a community commitment</li>\r\n	<li>1991&nbsp;&nbsp;&nbsp; Sharing the challenge</li>\r\n	<li>1990&nbsp;&nbsp;&nbsp; Women and AIDS</li>\r\n	<li>1989&nbsp;&nbsp;&nbsp; Our lives, our world&mdash;let&rsquo;s take care of each other</li>\r\n	<li>1988&nbsp;&nbsp; &nbsp;A world united against AIDS</li>\r\n</ul>', 'December 1, 2022', '2022-02-10 20:16:41', '2022-06-04 20:52:30'),
(39, 'International Day of Persons with Disabilities', '1503838393.jpg', '<p><em><strong>International Day of Persons with Disabilities (December 3)</strong> is an international observance promoted by the United Nations since 1992. It has been observed with varying degrees of success around the planet. The observance of the Day aims to promote an understanding of disability issues and mobilize support for the dignity, rights and well-being of persons with disabilities. It also seeks to increase awareness of gains to be derived from the integration of persons with disabilities in every aspect of political, social, economic and cultural life. It was originally called &quot;International Day of Disabled Persons&quot; until 2007. Each year the day focuses on a different issue.</em></p>', 'December 3, 2022', '2022-02-10 20:17:03', '2022-06-02 04:38:14'),
(40, 'Universal Health Coverage Day', '1572000168.jpg', '<p><strong>Universal Health Coverage Day on 12 December is the annual rallying point for the growing movement for health for all. </strong></p>\r\n\r\n<p><strong>It marks the anniversary of the United Nations&rsquo; historic and unanimous endorsement of universal health coverage in 2012.</strong></p>', 'December 12, 2022', '2022-02-10 20:17:22', '2022-03-19 05:49:33'),
(41, 'World Patient Safety Day', '669809380.jpg', '<p><strong>World Patient Safety Day (WPSD), </strong>observed annually on 17 September, aims to raise global awareness about patient safety and call for solidarity and united action by all countries and international partners to reduce patient harm. Patient safety focuses on preventing and reducing risks, errors and harm that happen to patients during the provision of health care.</p>\r\n\r\n<p>World Patient Safety Day is one of 11 official global public health campaigns marked by the World Health Organization (WHO), along with World Tuberculosis Day, World Health Day, World Chagas Disease Day, World Malaria Day, World Immunization Week, World No Tobacco Day, World Blood Donor Day, World Hepatitis Day, World Antimicrobial Awareness Week and World AIDS Day.</p>\r\n\r\n<p>&nbsp;</p>', 'September 17, 2022', '2022-02-10 20:17:39', '2022-06-06 05:19:49');

-- --------------------------------------------------------

--
-- Table structure for table `maintenances`
--

CREATE TABLE `maintenances` (
  `id` bigint(20) UNSIGNED NOT NULL,
  `status` int(11) NOT NULL DEFAULT 1 COMMENT '0: In-active, 1: Active',
  `secrate_code` varchar(255) DEFAULT NULL,
  `created_at` timestamp NULL DEFAULT NULL,
  `updated_at` timestamp NULL DEFAULT NULL
) ENGINE=InnoDB DEFAULT CHARSET=utf8mb4 COLLATE=utf8mb4_unicode_ci;

--
-- Dumping data for table `maintenances`
--

INSERT INTO `maintenances` (`id`, `status`, `secrate_code`, `created_at`, `updated_at`) VALUES
(1, 1, NULL, '2022-01-16 07:40:49', '2022-02-03 07:40:12');

-- --------------------------------------------------------

--
-- Table structure for table `migrations`
--

CREATE TABLE `migrations` (
  `id` int(10) UNSIGNED NOT NULL,
  `migration` varchar(255) NOT NULL,
  `batch` int(11) NOT NULL
) ENGINE=InnoDB DEFAULT CHARSET=utf8mb4 COLLATE=utf8mb4_unicode_ci;

--
-- Dumping data for table `migrations`
--

INSERT INTO `migrations` (`id`, `migration`, `batch`) VALUES
(1, '2014_10_12_000000_create_users_table', 1),
(2, '2014_10_12_100000_create_password_resets_table', 1),
(3, '2014_10_12_200000_add_two_factor_columns_to_users_table', 1),
(4, '2019_08_19_000000_create_failed_jobs_table', 1),
(5, '2019_12_14_000001_create_personal_access_tokens_table', 1),
(6, '2021_12_27_094359_create_sessions_table', 1),
(7, '2022_01_08_093117_create_pharmaceutical_companies_table', 1),
(8, '2022_01_09_125439_create_maintenances_table', 1),
(9, '2022_01_12_111555_create_generic_categories_table', 1),
(10, '2022_01_12_123020_create_generics_table', 1),
(11, '2022_01_12_140510_create_generic_companies_table', 1),
(12, '2022_01_15_064314_create_generic_details_table', 1),
(13, '2022_01_16_092302_create_dosages_table', 2),
(14, '2022_01_17_072951_create_brands_table', 3),
(15, '2022_01_20_115951_create_post_categories_table', 4),
(16, '2022_01_27_103829_create_slide_links_table', 5),
(17, '2022_01_27_113704_create_gif_ads_table', 6),
(18, '2022_01_27_123406_create_news_table', 7),
(19, '2022_01_27_140830_create_inter_national_health_days_table', 8),
(20, '2022_01_27_150655_create_products_table', 9),
(21, '2022_01_27_234011_create_videos_table', 10),
(22, '2022_01_28_094642_create_pharpa_jobs_table', 11),
(23, '2022_01_31_063059_create_documents_table', 12),
(24, '2022_01_29_143819_create_categories_table', 13),
(25, '2022_02_06_193139_create_subscribes_table', 14);

-- --------------------------------------------------------

--
-- Table structure for table `model_pharmacies`
--

CREATE TABLE `model_pharmacies` (
  `id` bigint(20) UNSIGNED NOT NULL,
  `model_pharmacy_name` varchar(255) NOT NULL,
  `address` varchar(255) DEFAULT NULL,
  `district` varchar(255) DEFAULT NULL,
  `drug_license_no` varchar(255) DEFAULT NULL,
  `owner_name_no` text DEFAULT NULL,
  `a_grade_pharmacist` text DEFAULT NULL,
  `created_at` timestamp NULL DEFAULT NULL,
  `updated_at` timestamp NULL DEFAULT NULL
) ENGINE=InnoDB DEFAULT CHARSET=utf8mb4 COLLATE=utf8mb4_unicode_ci;

--
-- Dumping data for table `model_pharmacies`
--

INSERT INTO `model_pharmacies` (`id`, `model_pharmacy_name`, `address`, `district`, `drug_license_no`, `owner_name_no`, `a_grade_pharmacist`, `created_at`, `updated_at`) VALUES
(1, 'Tana Gallagher', 'Oren Patton', 'Thomas Benjamin', 'Phoebe Buckley', 'Nolan Bird', 'Paloma Rodgers', '2022-07-06 19:10:58', '2022-07-07 18:54:47'),
(2, 'Raymond Gonzalez', 'Risa Silva', 'Jameson Mathews', 'Brent Parks', 'Virginia Stein', 'Mark Hawkins', '2022-07-06 19:11:56', '2022-07-07 18:54:40'),
(3, 'Cora Holt', 'Graiden Reynolds', 'Caryn Nelson', 'Elijah Mcmillan', 'sdd', 'Roanna Buck', '2022-07-06 19:12:08', '2022-07-06 19:12:08'),
(5, 'Lazz Pharma', 'Bottola, Sardar Market, B/44, Dhaka 1229', 'Dhaka', 'N/A', 'N/A', 'N/A', '2022-07-07 18:09:12', '2022-07-07 18:55:05'),
(6, 'Hop Callahan', 'Zena Andrews', 'May Sanders', 'Phillip Lang', 'Ezekiel Alvarez', 'Rhonda Mccoy', '2022-07-07 18:52:51', '2022-07-07 18:52:51');

-- --------------------------------------------------------

--
-- Table structure for table `news`
--

CREATE TABLE `news` (
  `id` bigint(20) UNSIGNED NOT NULL,
  `news_title` varchar(255) NOT NULL,
  `image` varchar(255) NOT NULL,
  `description` longtext DEFAULT NULL,
  `created_at` timestamp NULL DEFAULT NULL,
  `updated_at` timestamp NULL DEFAULT NULL
) ENGINE=InnoDB DEFAULT CHARSET=utf8mb4 COLLATE=utf8mb4_unicode_ci;

--
-- Dumping data for table `news`
--

INSERT INTO `news` (`id`, `news_title`, `image`, `description`, `created_at`, `updated_at`) VALUES
(1, 'ডায়াবেটিস নিয়ন্ত্রণে ইনসেপটার নতুন ওষুধ \"Orsema\" ইনজেকশন', '1011367845.jpg', '<p>বিশ্ব ডায়াবেটিস দিবসে ডায়াবেটিস নিয়ন্ত্রণে নতুন সুখবর এনেছে ইনসেপটা ফার্মাসিউটিক্যালস লিমিটেড। ডায়াবেটিস নিয়ন্ত্রণে &#39;ওরসেমা ইনজেকশন&#39; নামের নতুন ওষুধ বাজারজাত করতে যাচ্ছে।&nbsp;<br />\r\n<br />\r\nএ উপলক্ষে রোববার ডায়াবেটিস দিবসে বিভিন্ন আনুষ্ঠানিকতার সাথে রাজধানীর বারডেমে ইনসেপ্টা ফার্মাসিউটিক্যালস-এর এই ঔষধটির মোড়ক উন্মোচন করা হয়।&nbsp;<br />\r\n<br />\r\nইনসেপটা জানিয়েছে, প্রথমবারের মত দেশে তৈরি ইঞ্জেকট্যাবল সেমাগ্লুটাইড এই ওষুধ সপ্তাহে একবার গ্রহণযোগ্য, যা প্রতিদিন ট্যাবলেট খাওয়ার ঝামেলা কমিয়ে দেবে এবং ডায়াবেটিস চিকিৎসায় সহায়ক হিসেবে কাজ করবে। এটি প্রি-ফিল্ড সিরিঞ্জ হিসেবে &#39;ওরসেমা&#39; নামে ০.২৫ মি.গ্রা. এবং ০.৫০ মি.গ্রা. এই দুই মাত্রায় বাজারে পাওয়া যাবে। ওষুধটির দামও সাধারণ মানুষের হাতের নাগালে রয়েছে। ০.২৫ মি.গ্রা. ৩৫০ টাকা এবং ০.৫০ মি.গ্রা. ৬০০ টাকা মাত্র।&nbsp;<br />\r\n<br />\r\nইনসেপটা বলছে, ডায়াবেটিস নিয়ন্ত্রণের জন্য প্রতিদিন ওষুধ গ্রহণের চিন্তা আর নয়। এই ওষুধটি সপ্তাহে শুধুমাত্র একবার গ্রহণ করলেই হবে।<br />\r\n<br />\r\nসারা বিশ্বের মত বাংলাদেশেও রোববার বিশ্ব ডায়াবেটিস দিবস পালিত হয়েছে। এইবারের প্রতিপাদ্য বিষয় &lsquo;সার্বজনীন ডায়াবেটিস চিকিৎসা নিশ্চিতকরণ।</p>', '2022-01-27 07:04:43', '2022-01-27 07:04:43'),
(3, 'কোভিড-১৯: তিন কোটি ডোজ টিকা বিনামূল্যে দেবে সরকার', '1658157216.jpg', '<p><strong>সরকারিভাবে প্রথম দফায় করোনাভাইরাসের তিন কোটি ডোজ টিকা এনে তা এই মহামারী মোকাবেলায় যারা সামনে থেকে কাজ করছেন তাদের বিনামূল্যে বিতরণ করা হবে।</strong><br />\r\n&nbsp;<br />\r\n<em>করোনাভাইরাসের দ্বিতীয় ঢেউ মোকাবেলা ও ভ্যাকসিন সংগ্রহের সর্বশেষ অগ্রগতি সম্পর্কে সোমবার মন্ত্রিসভাকে অবহিত করা হয়েছে জানিয়ে মন্ত্রিপরিষদ সচিব খন্দকার আনোয়ারুল ইসলাম সাংবাদিকদের এ কথা বলেন।<br />\r\n<br />\r\nতিনি বলেন, ভারতের সেরাম ইনস্টিটিউটে উৎপাদিত অক্সফোর্ডের ভ্যাকসিনের তিন কোটি ডোজ সংগ্রহের প্রস্তাবে গত ১৪ অক্টোবর অনুমোদন দিয়েছেন প্রধানমন্ত্রী। এরপর গত ৫ নভেম্বর সেরাম ইনস্টিটিউট অব ইন্ডিয়া এবং বাংলাদেশের বেক্সিমকো ফার্মাসিউটিক্যালস লিমিটেডের সঙ্গে সরকার চুক্তিও করেছে।<br />\r\n<br />\r\n&ldquo;ভ্যাকসিন কেনার জন্য ১৬ নভেম্বর অর্থ বিভাগ স্বাস্থ্যসেবা বিভাগকে ৭৩৫ কোটি ৭৭ লাখ ৫০ হাজার টাকা বরাদ্দ দিয়েছে। এখন ভ্যাকসিন কেনার প্রস্তাব অর্থনৈতিক ক্রয় সংক্রান্ত মন্ত্রিসভা কমিটিতে যাবে, সে প্রস্তাব চলে এসেছে।&rdquo;<br />\r\n<br />\r\nপ্রথম দফায় ভ্যাকসিন কারা পাবে- সেই প্রশ্নে মন্ত্রিপরিষদ সচিব বলেন, &ldquo;বিশ্ব স্বাস্থ্য সংস্থার একটা গাইডলাইন আছে। প্রথম কারা পাবে, দ্বিতীয় ধাপে কারা পাবে, সে অনুযায়ী তারা একটা প্রোগ্রাম ডেভেলপ করছে।<br />\r\n<br />\r\n&ldquo;ফ্রন্টলাইন ওয়ার্কার- পুলিশ, প্রশাসনের লোক যারা মাঠে চাকরি করছে, তারপর বয়স্ক লোক, বাচ্চা- এরকম একটা প্রোটোকল আছে।&rdquo;<br />\r\n<br />\r\nসচিব বলেন, &ldquo;মানুষকে এই ভ্যাকসিন বিনা পয়সায় দেওয়া হবে। টাকা সরকার পে করে দিচ্ছে। তিন কোটি ভ্যাকসিন ফ্রি দেওয়া হবে।&rdquo;<br />\r\n<br />\r\nএই টিকা বিতরণে অনিয়ম হলে কী হবে- এমন প্রশ্নে আনোয়ারুল বলেন, &ldquo;করাপশন কেউ করলে আমাদেরকে জানাবেন, উই উইল টেইক অ্যাকশন।&rdquo;<br />\r\n<br />\r\nমন্ত্রিপরিষদ সচিব জানান, এই ভ্যাকসিন কিনতে মোট কত টাকা করে খরচ হবে তা ক্রয়চুক্তি না হওয়া পর্যন্ত বলা যাচ্ছে না। বুধবার বিষয়টি অর্থনৈতিক বিষয় সংক্রান্ত মন্ত্রিসভা কমিটিতে উঠবে।<br />\r\n<br />\r\n&ldquo;আরও অনেকগুলো ভ্যাকসিনের বিষয়ে (মন্ত্রিসভায় তথ্য) উপস্থাপন করা হয়েছে, তারা বলেছে- যোগাযোগ রাখছে। এখনই বলা যাচ্ছে না কোনটা বেশি কার্যকর হবে। আমাদের এক নম্বর কন্ডিশন হল, বিশ্ব স্বাস্থ্য সংস্থার প্রটোকল মানতে হবে।<br />\r\n<br />\r\n&ldquo;যার সাথে চুক্তি করবেন, যদি মেজর কোনো সমস্যা হয়, তাহলে বিশ্ব স্বাস্থ্য সংস্থার প্রটোকলের বাইরে গেলে ওই চুক্তির কোনো মূল্য থাকবে না।&rdquo;<br />\r\n<br />\r\nবাংলাদেশে চীনা কোম্পানি সিনোভ্যাকের সম্ভাব্য টিকার ট্রায়াল আটকে থাকার বিষয়ে এক প্রশ্নে মন্ত্রিপরিষদ সচিব বলেন, &ldquo;ওরা একটা টাকা চাচ্ছে। সরকার এখনও দেয়নি বা রাজি হয়নি। আমরা ওটা এখনও বাতিলও করিনি।&rdquo;</em><br />\r\n<br />\r\n<br />\r\nSource:&nbsp;bdnews24.com</p>', '2022-01-27 08:04:21', '2022-02-12 01:41:33'),
(4, 'ডায়াবেটিস নিয়ন্ত্রণে ইনসেপটার নতুন ওষুধ \"Orsema\" ইনজেকশন', '1011367845.jpg', '<p>বিশ্ব ডায়াবেটিস দিবসে ডায়াবেটিস নিয়ন্ত্রণে নতুন সুখবর এনেছে ইনসেপটা ফার্মাসিউটিক্যালস লিমিটেড। ডায়াবেটিস নিয়ন্ত্রণে &#39;ওরসেমা ইনজেকশন&#39; নামের নতুন ওষুধ বাজারজাত করতে যাচ্ছে।&nbsp;<br />\r\n<br />\r\nএ উপলক্ষে রোববার ডায়াবেটিস দিবসে বিভিন্ন আনুষ্ঠানিকতার সাথে রাজধানীর বারডেমে ইনসেপ্টা ফার্মাসিউটিক্যালস-এর এই ঔষধটির মোড়ক উন্মোচন করা হয়।&nbsp;<br />\r\n<br />\r\nইনসেপটা জানিয়েছে, প্রথমবারের মত দেশে তৈরি ইঞ্জেকট্যাবল সেমাগ্লুটাইড এই ওষুধ সপ্তাহে একবার গ্রহণযোগ্য, যা প্রতিদিন ট্যাবলেট খাওয়ার ঝামেলা কমিয়ে দেবে এবং ডায়াবেটিস চিকিৎসায় সহায়ক হিসেবে কাজ করবে। এটি প্রি-ফিল্ড সিরিঞ্জ হিসেবে &#39;ওরসেমা&#39; নামে ০.২৫ মি.গ্রা. এবং ০.৫০ মি.গ্রা. এই দুই মাত্রায় বাজারে পাওয়া যাবে। ওষুধটির দামও সাধারণ মানুষের হাতের নাগালে রয়েছে। ০.২৫ মি.গ্রা. ৩৫০ টাকা এবং ০.৫০ মি.গ্রা. ৬০০ টাকা মাত্র।&nbsp;<br />\r\n<br />\r\nইনসেপটা বলছে, ডায়াবেটিস নিয়ন্ত্রণের জন্য প্রতিদিন ওষুধ গ্রহণের চিন্তা আর নয়। এই ওষুধটি সপ্তাহে শুধুমাত্র একবার গ্রহণ করলেই হবে।<br />\r\n<br />\r\nসারা বিশ্বের মত বাংলাদেশেও রোববার বিশ্ব ডায়াবেটিস দিবস পালিত হয়েছে। এইবারের প্রতিপাদ্য বিষয় &lsquo;সার্বজনীন ডায়াবেটিস চিকিৎসা নিশ্চিতকরণ।</p>', '2022-01-27 07:04:43', '2022-01-27 07:04:43'),
(6, 'প্যারাসিটামল: দীর্ঘদিন খেলে হৃদরোগ ও স্ট্রোকের ঝুঁকি বাড়ে - গবেষণা', '136119157.jpg', '<p><strong>উচ্চ</strong><strong> </strong><strong>রক্তচাপের</strong><strong> </strong><strong>সমস্যা</strong><strong> </strong><strong>থাকা</strong><strong> </strong><strong>যেসব</strong><strong> </strong><strong>ব্যক্তি</strong><strong> </strong><strong>ডাক্তারের</strong><strong> </strong><strong>পরামর্শ</strong><strong> </strong><strong>অনুযায়ী</strong><strong> </strong><strong>প্যারাসিটামল</strong><strong> </strong><strong>গ্রহণ</strong><strong> </strong><strong>করেন</strong><strong>, </strong><strong>তাদের</strong><strong> </strong><strong>হার্ট</strong><strong> </strong><strong>অ্যাটাক</strong><strong> </strong><strong>ও</strong><strong> </strong><strong>স্ট্রোকের</strong><strong> </strong><strong>ঝুঁকি</strong><strong> </strong><strong>বাড়তে</strong><strong> </strong><strong>পারে</strong><strong> </strong><strong>বলে</strong><strong> </strong><strong>উঠে</strong><strong> </strong><strong>এসেছে</strong><strong> </strong><strong>এক</strong><strong> </strong><strong>গবেষণায়।</strong></p>\r\n\r\n<p>এডিনবরা বিশ্ববিদ্যালয়ের গবেষকরা বলছেন, যেসব রোগী দীর্ঘসময় ধরে প্যারাসিটামল গ্রহণ করছেন তাদের স্বাস্থ্য ঝুঁকির বিষয়গুলো চিকিৎসকদের চিন্তা করা দরকার।</p>\r\n\r\n<p>গবেষকরা বলছেন, মাথা ব্যথা ও জ্বরের জন্য প্যারাসিটামল গ্রহণ করা যেতে পারে।</p>\r\n\r\n<p>তবে অন্য গবেষকরা বলছেন, এ বিষয়ে নিশ্চিতভাবে জানার জন্য আরো বেশি মানুষের ওপর বেশি সময় ধরে গবেষণা চালানো প্রয়োজন।</p>\r\n\r\n<ul>\r\n	<li><em>ভেজাল প্যারাসিটামলে শিশু মৃত্যু:আসামীরা খালাস</em></li>\r\n	<li><em>কোভিড ১৯: ঔষধ কিনে বাড়িতে মজুদ রাখলে যে বিপদ</em></li>\r\n</ul>\r\n\r\n<p>শরীরের ব্যথার জন্য সারা বিশ্বে বহুলভাবে ব্যবহৃত হয় প্যারাসিটামল। তবে দীর্ঘস্থায়ী বা পুরনো ব্যথা উপশমের জন্যও প্যারাসিটামলের পরামর্শ দিয়ে থাকেন চিকিৎসকরা।</p>\r\n\r\n<p>তবে দীর্ঘ মেয়াদে প্যারাসিটামল ব্যবহারের কোনো উপকারিতা আছে কিনা, তা নিয়ে তেমন প্রমাণ নেই।</p>\r\n\r\n<p>স্কটল্যান্ডে ২০১৮ সালে অন্তত ৫ লাখ মানুষকে প্যারাসিটামল খাওয়ার পরামর্শ দেয়া হয়েছিল। এই সংখ্যা দেশটির জনসংখ্যার দশ শতাংশ।</p>\r\n\r\n<p>রোগীদের যদি উচ্চ রক্তচাপের সমস্যা থাকে - যেই সমস্যায় যুক্তরাজ্যে প্রতি তিনজনে একজন ভুগে থাকেন - তাহলে তাদের আরো বেশি ঝুঁকি তৈরি হতে পারে বলে উঠে এসেছে গবেষণায়।</p>\r\n\r\n<p>গবেষণার ট্রায়ালে ১১০ জন স্বেচ্ছাসেবীকে নেয়া হয়, যাদের টানা দুই সপ্তাহ ধরে প্রতিদিন ৪টি করে প্যারাসিটামল (১ গ্রাম) সেবন করতে দেয়া হয়।</p>\r\n\r\n<p>এই ১১০ জন স্বেচ্ছাসেবীর দুই-তৃতীয়াংশ উচ্চ রক্তচাপ অথবা দুশ্চিন্তার কারণে প্যারাসিটামল নিচ্ছিলেন।</p>\r\n\r\n<p>ট্রায়ালে উঠে এসেছে, &#39;প্যারাসিটামলের কারণে তৈরি হওয়া উচ্চ রক্তচাপ&#39; হার্ট অ্যাটাক ও স্ট্রোকের অন্যতম প্রধান কারণ।</p>\r\n\r\n<ul>\r\n	<li><em>বাড়িতে বসে কোভিড-১৯ চিকিৎসা: যে ছয়টি বিষয় মনে রাখবেন</em></li>\r\n	<li><em>করোনাভাইরাসের এই সময়ে সর্দি-কাশি-গলাব্যথা হলে কী করবেন?</em></li>\r\n</ul>\r\n\r\n<p>সার্কুলেশন জার্নালে সম্প্রতি প্রকাশিত হওয়া গবেষণাটিতে &#39;কিছু শ্বেতাঙ্গ স্কটিশের রক্তচাপে ছোট কিন্তু তাৎপর্যপূর্ণ পরিবর্তন হয়&#39; তবে এখনো এ সম্পর্কে &#39;অনেক অজানা তথ্য&#39; রয়েছে, মন্তব্য করেন লন্ডনের সেইন্ট জর্জেস ইউনিভার্সিটির ফার্মাকোলজি ও থেরাপিউটিকসের শিক্ষক ড. দিপেন্দর গিল।</p>\r\n\r\n<p>&quot;প্রথমত, প্যারাসিটামল ব্যবহারের ফলে রক্তচাপ বাড়ার সমস্যা দীর্ঘ দিন টিকে থাকে কিনা, তা পরিষ্কার নয়&quot;, বলেন ড. গিল।</p>\r\n\r\n<p>&quot;দ্বিতীয়ত, প্যারাসিটামলের জন্য বৃদ্ধি পাওয়া রক্তচাপের কারণে হৃদরোগ তৈরি হতে পারে কিনা, তাও নিশ্চিতভাবে জানা যায়নি।&quot;</p>\r\n\r\n<p>যুক্তরাষ্ট্রের একটি ব্যাপকভিত্তিক গবেষণায় এর আগে উঠে এসেছিল যে দীর্ঘ মেয়াদে প্যারাসিটামল ব্যবহার হার্ট অ্যাটাকের ঝুঁকি বাড়ায় - তবে এই দু&#39;টির মধ্যে সরাসরি সম্পর্ক আছে কিনা, তা নিশ্চিত হওয়া যায়নি।</p>\r\n\r\n<p>এডিনবরার গবেষকরা বলছেন, প্যারাসিটামল কীভাবে রক্তচাপ বাড়ায় সে সম্পর্কে তারা পরিষ্কারভাবে ব্যখ্যা দিতে পারছেন না।</p>\r\n\r\n<p>তবে তারা আশা প্রকাশ করেছেন তাদের গবেষণা থেকে পাওয়া তথ্যের ভিত্তিতে প্যারাসিটামল প্রেসক্রাইব করার বিষয়টি নিয়ে নতুন করে গবেষণা শুরু হবে।</p>\r\n\r\n<p>গবেষণার অর্থায়ন করা সংস্থা ব্রিটিশ হার্ট ফাউন্ডেশন বলছে ডাক্তার ও রোগীদের প্রতিনিয়ত চিন্তা করা উচিত যে &#39;প্যারাসিটামলের মত অপেক্ষাকৃত ক্ষতিহীন&#39; ওষুধও আমাদের গ্রহণ করা উচিত কিনা।</p>\r\n\r\n<p>&nbsp;</p>', '2022-01-27 08:04:21', '2022-02-12 01:38:58'),
(8, 'করোনাভাইরাস সংক্রমণের তৃতীয় ঢেউয়ের চূড়া কি পার করেছে বাংলাদেশ', '847648892.jpg', '<p><strong>বাংলাদেশের বিজ্ঞানী, গবেষক ও বিশ্লেষকরা বলছেন যে তাদের ধারণা দেশটি করোনাভাইরাসের তৃতীয় ঢেউয়ের চূড়া অতিক্রম করেছে, তবে সতর্ক না হলে আবারও নতুন ঢেউয়ের আশঙ্কা আছে।</strong></p>\r\n\r\n<p>সংক্রমণ সংখ্যা, হার ও মৃত্যুর গতিপ্রকৃতি বিশ্লেষণ করে তারা বলছেন যে মূলত জানুয়ারির শেষ সপ্তাহেই চূড়া অতিক্রম করেছে বাংলাদেশে।</p>\r\n\r\n<p>তারা বলছেন যে জানুয়ারির শেষ দিকে যারা সংক্রমিত হয়েছেন তাদের অনেকের অবস্থা গুরুতর হওয়ার কারণেই এখন ২/৩ সপ্তাহ পর এসে মৃত্যুর সংখ্যা বেশি বা উর্ধ্বমুখী।</p>\r\n\r\n<p>রোগতত্ত্ব, রোগ নিয়ন্ত্রণ ও গবেষণা ইন্সটিটিউট বা আইইডিসিআরের প্রধান বৈজ্ঞানিক কর্মকর্তা এ এস এম আলমগীর বিবিসিকে বলছেন যে তারা মনে করছেন করোনাভাইরাস সংক্রমণের হার এখন নিম্মমূখী এবং পিক সময়টা পার হয়েই এসেছে বলা যায়।</p>\r\n\r\n<p>&quot;ট্রেন্ডটা এখন নিম্নমুখী তবে সতর্ক থাকতে হবে। কারণ সংক্রমণের হার এখনো অনেক কমতে হবে। শতকরা দশ শতাংশের নীচে এবং এরপর ৫ শতাংশের নীচে আসতে হবে ধারাবাহিকভাবে। সেটি হচ্ছে কিন্তু খুব ধীরগতিতে,&quot; বলছিলেন তিনি।</p>\r\n\r\n<p>অর্থাৎ আগের দু দফায় সংক্রমণের চূড়ায় উঠার পর সংক্রমণ যে গতিতে কমে এসেছিলো এবার তুলনামূলক কম গতিতে সেটি কমছে।</p>\r\n\r\n<p>প্রসঙ্গত, বাংলাদেশে স্বাস্থ্য বিভাগের তথ্য অনুযায়ী ২০২০ সালের ৮ই মার্চ থেকে এ পর্যন্ত করোনাভাইরাসে আক্রান্ত হিসেবে মোট শনাক্ত হয়েছে ১৮ লাখ ৯৪ হাজার ৫৩৫ জন। আর এ সময়ে মোট মারা গেছে ২৮ হাজার ৭৪৪ জন।</p>\r\n\r\n<p>সবশেষ আজ শুক্রবার স্বাস্থ্য বিভাগ জানিয়েছে যে গত চব্বিশ ঘণ্টায় করোনা সংক্রমণের হার ও সংখ্যা আগের দিনের তুলনায় আরও কমেছে। এ সময়ে নতুন করে ৫২৬৮ জন শনাক্ত হয়েছে এবং শনাক্তের হার ১৫ দশমিক ৪৬। তবে মারা গেছে ২৭ জন।</p>\r\n\r\n<p>source:&nbsp;https://www.bbc.com/bengali/news-60343569&nbsp;</p>', '2022-02-12 01:30:01', '2022-02-12 01:30:01'),
(9, 'আসুন ভালো রাখি আমাদের কিডনি', '1401110834.jpg', '<p><strong>আমাদের শরীর সুস্থ রাখতে যেসব অঙ্গ নিরন্তর কাজ করে, তার মধ্যে অন্যতম হলো কিডনি। আজ বিশ্ব কিডনি দিবস। দিবসটির এবারের প্রতিপাদ্য, &lsquo;সবার জন্য সুস্থ্ কিডনি&rsquo;।</strong></p>\r\n\r\n<p>স্বাস্থ্যই সম্পদ। এই বাক্যের মর্মার্থ আমরা অসুস্থ হলে খুব ভালো করেই বুঝতে পারি। আমাদের শরীরকে সুস্থ রাখতে যেসব অঙ্গ নিরন্তর কাজ করে যাচ্ছে, তার মধ্যে অন্যতম গুরুত্বপূর্ণ হলো কিডনি। কিডনি মূলত একটি ছাঁকনযন্ত্র। মানবদেহে দুটো কিডনি থাকে। এটি আমাদের রক্ত থেকে দূষিত পদার্থ দেহের বাইরে বের করে দেয়।</p>\r\n\r\n<p>কিডনির প্রধান কাজগুলো হলো&mdash;</p>\r\n\r\n<p><strong>রক্তের পরিশোধন</strong></p>\r\n\r\n<p>কিডনি দেহের বিপাকের ফলে উৎপন্ন বর্জ্য পদার্থগুলো মূত্র সৃষ্টির মাধ্যমে দেহ থেকে বের করে দেয়, ফলে রক্ত বর্জ্যমুক্ত হয়ে পরিশোধিত হয়।</p>\r\n\r\n<p><strong>দেহে পানির সমতা বজায় রাখা</strong></p>\r\n\r\n<p>দেহে পানি স্বাভাবিকের তুলনায় বেশি হলে কিডনি বেশি মূত্র তৈরি করে আবার পানির ঘাটতি থাকলে কম মূত্র সৃষ্টির মাধ্যমে কিডনি দেহে পানির সমতা বজায় রাখে।</p>\r\n\r\n<p><em>কিডনি সুস্থ রাখতে ফাস্ট ফুড, প্রক্রিয়াজাত খাবার, লবণযুক্ত খাবার, অতিরিক্ত প্রাণিজ আমিষ পরিহার করে শাকসবজি ও আঁশজাতীয় খাবার বেশি বেশি খেতে হবে। কিডনি সুস্থ রাখতে কোমল পানীয় যতটা সম্ভব পরিহার করে চলতে হবে।</em></p>\r\n\r\n<p><strong>অম্ল ও ক্ষারের সমতা বজায় রাখা</strong></p>\r\n\r\n<p>কিডনি দেহের খনিজ লবণ ও বাইকার্বনেটের মাত্রা নিয়ন্ত্রণের মাধ্যমে অম্ল&ndash;ক্ষার সমতা বজায় রাখতে সাহায্য করে।</p>\r\n\r\n<p><strong>রক্তচাপ নিয়ন্ত্রণ</strong></p>\r\n\r\n<p>দেহের পানির সমতা নিয়ন্ত্রণের মাধ্যমে, বিভিন্ন হরমোনের সাহায্যে কিডনি রক্তচাপকে নিয়ন্ত্রণ করে।</p>\r\n\r\n<p><strong>লোহিত রক্তকণিকা উৎপাদন</strong></p>\r\n\r\n<p>আমাদের দেহে লোহিত রক্তকণিকা উৎপাদনে ইরাইথ্রোপয়েটিন নামক একটি হরমোন গুরুত্বপূর্ণ ভূমিকা পালন করে।</p>\r\n\r\n<p>এই হরমোন কিডনি থেকেই উৎপন্ন হয়।</p>\r\n\r\n<p><strong>মজবুত হাড় ও দাঁতের গঠন</strong></p>\r\n\r\n<p>কিডনি ভিটামিন ডির কার্যকর রূপ তৈরিতে প্রধান ভূমিকা রাখে। ভিটামিন ডি হাড় ও দাঁতকে মজবুত করে।</p>\r\n\r\n<p><strong>কিডনি বৈকল্যের কারণ</strong></p>\r\n\r\n<p>কিডনির বৈকল্য দুইভাবে দেখা দিতে পারে। একটি হলো তাৎক্ষণিক বৈকল্য, অপরটি হলো দীর্ঘস্থায়ী বৈকল্য।</p>\r\n\r\n<p><strong>কিডনির তাৎক্ষণিক বৈকল্য</strong></p>\r\n\r\n<p>সাধারণত ৪৮ ঘণ্টার মধ্যে যখন দেহের বর্জ্য অপসারণ ও ইলেক্ট্রোলাইটের ভারসাম্য নিয়ন্ত্রণে কিডনি অক্ষম হয়, সে অবস্থাকে কিডনির তাৎক্ষণিক বৈকল্য বলে। তীব্র ডায়রিয়া, রক্তক্ষরণ, হার্ট অ্যাটাক, হার্ট ফেইলিউর, রক্তে পানি ও লবণের অভাব, ভুল রক্ত দেওয়া, তীব্র অ্যালার্জিক প্রতিক্রিয়া, ওষুধের পার্শ্বপ্রতিক্রিয়া, মারাত্মকভাবে পুড়ে যাওয়া, তীব্র সংক্রমণ&mdash;এসব কারণে কিডনি তাৎক্ষণিকভাবে বিকল হতে পারে।</p>\r\n\r\n<p><strong>কিডনির দীর্ঘস্থায়ী বৈকল্য</strong></p>\r\n\r\n<p>কোনো রোগে আক্রান্ত হয়ে কিডনির কার্যকারিতা তিন মাস বা তার অধিক সময় পর্যন্ত লোপ পেলে তাকে কিডনির দীর্ঘস্থায়ী বৈকল্য বলে।</p>\r\n\r\n<p><strong>কিডনি রোগের প্রাথমিক লক্ষণ</strong></p>\r\n\r\n<p>● প্রস্রাব কমে যাওয়া, প্রস্রাবের সময় জ্বালাপোড়া হওয়া, এমনকি প্রস্রাবের সঙ্গে রক্ত যাওয়া।</p>\r\n\r\n<p>● পাঁজর ও কোমরের মাঝামাঝি দুই পাশে ব্যথা হওয়া (Flank Pain)।</p>\r\n\r\n<p>● শরীরে ফোলাভাব তৈরি হওয়া।</p>\r\n\r\n<p>● মুখমণ্ডল, হাত&ndash;পায়ের পাতা, পা ও গোড়ালি ফুলে যাওয়া।</p>\r\n\r\n<p>● ফুসফুসে পানি জমার কারণে ঘন ঘন শ্বাস নেওয়া।</p>\r\n\r\n<p>● রক্তশূন্যতা হওয়া ও শরীর ফ্যাকাশে হয়ে যাওয়া।</p>\r\n\r\n<p>● খাবারে অরুচি, তন্দ্রাচ্ছন্নতা, অনেকক্ষণ ধরে হেঁচকি তোলা, মুখে ধাতব স্বাদ অনুভূত হওয়া।</p>\r\n\r\n<p>● রক্তে পটাশিয়ামের মাত্রা বেড়ে যাওয়ার কারণে অসারতা ও অস্বাভাবিক হৃৎস্পন্দন হওয়া।</p>\r\n\r\n<p>দেহের গুরুত্বপূর্ণ এই অঙ্গের জন্য অবশ্যই ভালোভাবে যত্ন নেওয়া উচিত। কিন্তু আমরা কতটুকু সচেতন এর যত্নের ব্যাপারে? একটু সচেতন হলেই কীভাবে আমরা সুস্থ রাখতে পারি আমাদের কিডনিকে।</p>\r\n\r\n<p>● পরিমিত পানি পান ও দীর্ঘক্ষণ প্রস্রাব আটকে না রাখা।</p>\r\n\r\n<p>● কিডনি আমাদের দেহের দূষিত বর্জ্য পদার্থ প্রস্রাবের মাধ্যমে বের করে দেয়।</p>\r\n\r\n<p>● তাই পরিমিত পানি পান ও নিয়মমতো প্রস্রাব করার অভ্যাস কিডনিকে সুস্থ রাখতে সাহায্য করে।</p>\r\n\r\n<p>এ বিষয়ে পাবনা জেনারেল হাসপাতালের ইউরোলজিস্ট ও ল্যাপারোস্কোপিক সার্জন কনসালট্যান্ট এ এস এম কুতুবউদ্দিন আওয়াল জানান, নিয়মিত দুই&ndash;তিন লিটার বিশুদ্ধ পানি পান ও প্রস্রাব আটকে না রাখার অভ্যাস কিডনির সুস্থতায় গুরুত্বপূর্ণ ভূমিকা পালন করে।</p>\r\n\r\n<p><strong>সঠিক খাদ্যাভাস</strong></p>\r\n\r\n<p>কিডনিকে সুস্থ রাখতে, সঠিক খাদ্যাভাসের গুরুত্ব অপরিসীম। এ বিষয়ে কিডনি রোগবিশেষজ্ঞ, কর্নেল মালেক মেডিকেল কলেজ, মানিকগঞ্জ, ঢাকার সহকারী অধ্যাপক ডা. মো. রোকনুজ্জামান খান বলেন, কিডনিকে সুস্থ রাখতে, ফাস্টফুড, প্রক্রিয়াজাত খাবার, লবণযুক্ত খাবার, অতিরিক্ত প্রাণীজ আমিষ পরিহার করে শাকসবজি ও আঁশজাতীয় খাবার বেশি বেশি খেতে হবে। কিডনি সুস্থ রাখতে, কোমল পানীয় যতটা সম্ভব পরিহার করে চলতে হবে।</p>\r\n\r\n<p><strong>ধূমপান ও মদ্যপান পরিহার করতে হবে</strong></p>\r\n\r\n<p>● ধূমপান রক্তনালিকে সংকুচিত করে রক্তচাপ বাড়িয়ে দেয়, যা কিডনির জন্য ভয়াবহ বিপদ ডেকে আনে।</p>\r\n\r\n<p>● ধূমপান ও মদ্যপানের ফলে কিডনির রক্তপ্রবাহ কমে যেতে পারে। এসব অভ্যাস থাকলে তা পরিহার করতে হবে।</p>\r\n\r\n<p><strong>ডায়াবেটিস রাখুন নিয়ন্ত্রণে</strong></p>\r\n\r\n<p>আপনার বয়স চল্লিশের বেশি হলে ডায়াবেটিস ও ব্লাড প্রেশার নিয়মিত পর্যবেক্ষণ করুন। কারণ, অনিয়ন্ত্রিত ডায়াবেটিস কিডনি রোগের ঝুঁকি তৈরি করে।</p>\r\n\r\n<p><strong>উচ্চ রক্তচাপে বাড়ে কিডনি রোগের ঝুঁকি</strong></p>\r\n\r\n<p>যাঁরা দীর্ঘদিন উচ্চ রক্তচাপে ভোগেন, তাঁদের কিডনি নষ্ট হওয়ার ঝুঁকি থাকে। কারণ, উচ্চরক্তচাপ কিডনির রক্তনালিগুলো ক্ষতিগ্রস্ত করে।</p>\r\n\r\n<p><strong>ওষুধ গ্রহণে বিশেষ সতর্কতা</strong></p>\r\n\r\n<p>চিকিৎসকের পরামর্শ ব্যতীত কোনো ওষুধ, বিশেষ করে ব্যথানাশক ও অ্যান্টিবায়োটিক খাওয়া যাবে না। এগুলোর অযাচিত ব্যবহার কিডনিকে ক্ষতিগ্রস্ত করে।</p>\r\n\r\n<p><strong>ওজন রাখুন নিয়ন্ত্রণে</strong></p>\r\n\r\n<p>● অতিরিক্ত স্থূলতা, ডায়াবেটিস, উচ্চরক্তচাপ নানাবিধ স্বাস্থ্যঝুঁকি তৈরি করে। এসব রোগ কিডনিকে নানাভাবে আক্রান্ত করে।</p>\r\n\r\n<p>● কিডনিকে সুস্থ রাখতে আপনার ওজন রাখুন নিয়ন্ত্রণে।</p>\r\n\r\n<p><strong>অতিরিক্ত মানসিক চাপ পরিহার করুন</strong></p>\r\n\r\n<p>অতিরিক্ত মানসিক চাপে আমাদের দেহের নানান ধরনের হরমোনের তারতম্য ঘটে, যা রক্তচাপসহ দেহের স্বাভাবিক সব প্রক্রিয়াকে ব্যাহত করে। কিডনিকে সুস্থ রাখতে যতটা সম্ভব চাপমুক্ত প্রফুল্ল জীবন যাপন করুন।</p>\r\n\r\n<p><strong>নিয়মিত শরীরচর্চা করুন</strong></p>\r\n\r\n<p>নিয়মিত শরীরচর্চার উপকারিতা অনেক। এর ফলে ওজন নিয়ন্ত্রণে থাকে। ডায়াবেটিস ও উচ্চ রক্তচাপের ঝুঁকি কমে যায়, ফলে এটি আমাদের কিডনিকে সুস্থ রাখতে সাহায্য করে।</p>\r\n\r\n<p><strong>কিডনি পরীক্ষা করুন</strong></p>\r\n\r\n<p>যাঁদের স্থূলতা, উচ্চরক্তচাপ ও ডায়াবেটিস আছে, তাঁদের চিকিৎসকের পরামর্শে নিয়মিত কিডনি পরীক্ষা করা উচিত।</p>\r\n\r\n<p><strong>সচেতন হোন, আতঙ্কিত নয়</strong></p>\r\n\r\n<p>যদি আপনার কিডনির কোনো সমস্যা হয়, তাহলে আতঙ্কিত না হয়ে দ্রুত বিশেষজ্ঞ ডাক্তারের পরামর্শ নিন।</p>\r\n\r\n<p>এ বিষয়ে বাংলাদেশ সেনাবাহিনীর সাবেক চিফ কনসালট্যান্ট সার্জন ও বর্তমান সেন্ট্রাল হাসপাতালের কনসালট্যান্ট ইউরোলজিস্ট মেজর জেনারেল প্রফেসর ড. এইচ আর হারুন বলেন, &lsquo;কিডনি রোগের প্রতিকার সম্পর্কে সচেতনতা বাড়াতে এ রোগের লক্ষণগুলো সম্পর্কে সবারই ধারণা থাকা প্রয়োজন। কিডনির রোগসমূহের মধ্যে ক্যানসার অন্যতম। কিডনির ক্যানসারের একটি গুরুত্বপূর্ণ লক্ষণ হলো পেইনলেস হেমাচুরিয়া অর্থাৎ প্রসাবে প্রদাহবিহীন রক্ত যাওয়া। অতীতে আমাদের দেশে কিডনিতে যেকোনো ধরনের ক্যানসার হলে পুরো কিডনিই ফেলে দেওয়া হতো। কিন্তু বর্তমানে শুধু টিউমার কেটে ফেলে বাকি সুস্থ কিডনিটুকু সংরক্ষণ করা যায়, যেটাকে বলা হয় নেফরন স্পেয়ারিং সার্জারি। উল্লেখ্য যে শুধু ২০ শতাংশ কিডনি নিয়েও সুস্থ জীবন যাপন করা যায়।&rsquo;</p>\r\n\r\n<p><em><strong>ডা. মো. ফরহাদ পারভেজ:</strong> সহকারী সার্জন, উপজেলা স্বাস্থ্য কমপ্লেক্স, চাটমোহর, পাবনা।</em></p>', '2022-03-17 15:35:24', '2022-03-17 15:35:24');

-- --------------------------------------------------------

--
-- Table structure for table `password_resets`
--

CREATE TABLE `password_resets` (
  `email` varchar(255) NOT NULL,
  `token` varchar(255) NOT NULL,
  `created_at` timestamp NULL DEFAULT NULL
) ENGINE=InnoDB DEFAULT CHARSET=utf8mb4 COLLATE=utf8mb4_unicode_ci;

-- --------------------------------------------------------

--
-- Table structure for table `personal_access_tokens`
--

CREATE TABLE `personal_access_tokens` (
  `id` bigint(20) UNSIGNED NOT NULL,
  `tokenable_type` varchar(255) NOT NULL,
  `tokenable_id` bigint(20) UNSIGNED NOT NULL,
  `name` varchar(255) NOT NULL,
  `token` varchar(64) NOT NULL,
  `abilities` text DEFAULT NULL,
  `last_used_at` timestamp NULL DEFAULT NULL,
  `created_at` timestamp NULL DEFAULT NULL,
  `updated_at` timestamp NULL DEFAULT NULL
) ENGINE=InnoDB DEFAULT CHARSET=utf8mb4 COLLATE=utf8mb4_unicode_ci;

-- --------------------------------------------------------

--
-- Table structure for table `pharmaceutical_companies`
--

CREATE TABLE `pharmaceutical_companies` (
  `id` bigint(20) UNSIGNED NOT NULL,
  `company_name` varchar(255) NOT NULL,
  `established` varchar(255) DEFAULT NULL,
  `market_share` varchar(255) DEFAULT NULL,
  `growth` varchar(255) DEFAULT NULL,
  `contact_details` varchar(255) DEFAULT NULL,
  `fax` varchar(255) DEFAULT NULL,
  `company_image` varchar(255) DEFAULT NULL,
  `description` text DEFAULT NULL,
  `status` int(11) NOT NULL DEFAULT 1 COMMENT '0: In-active, 1: Active',
  `created_at` timestamp NULL DEFAULT NULL,
  `updated_at` timestamp NULL DEFAULT NULL
) ENGINE=InnoDB DEFAULT CHARSET=utf8mb4 COLLATE=utf8mb4_unicode_ci;

--
-- Dumping data for table `pharmaceutical_companies`
--

INSERT INTO `pharmaceutical_companies` (`id`, `company_name`, `established`, `market_share`, `growth`, `contact_details`, `fax`, `company_image`, `description`, `status`, `created_at`, `updated_at`) VALUES
(15, 'List of Pharmaceutical Companies', 'Established', 'Market Share', 'Growth', 'Contact Details', 'Fax', NULL, '<p>Description</p>', 1, '2022-01-29 04:38:06', '2022-01-29 04:38:06'),
(18, 'ACI Limited', '1992', '3.78%', '9.69%', '(+8802) 8878603', '(+8802) 8878619, 8878626', '140778857.jpg', '<p>With almost three decades of partnering life and engendering hope, ACI is one of the top pharmaceutical companies in Bangladesh, employing more than 5,000 people all over the country. As a progressive and forward-thinking company, ACI Pharma is dedicated to improve the health of people of Bangladesh through introduction of innovative and reliable pharmaceutical products.<br />\r\n<br />\r\nOur pharmaceuticals are exported to 30 countries of 4 continents. ACI introduced the concept of quality management system by being the first company in Bangladesh to achieve ISO 9001 certification in 1995 and follows the policy of continuous improvement in all its operations.<br />\r\n<br />\r\nAligned with the concept that a pharmaceutical must ensure effective management of environment, ACI complies with standard environment management policy, thus adorned with EMS 14001 in 2000.</p>', 1, '2022-02-10 02:40:41', '2022-02-10 02:40:41'),
(19, 'ACME Laboratories', '1954', '3.65%', '11.39%', '+880-2-9004194-6, +880-2-9005620', '+880-2-9016872, +880-2-9032475, +880-2-9016515', '905539344.jpg', '<p>The ACME Laboratories Ltd. is a leading company for manufacturing world-class and top-quality pharmaceutical products in Bangladesh. We are currently producing more than 500 products in different dosage forms covering broader therapeutic categories which include anti-infective, cardiovascular, antidiabetics, gastrointestinal, CNS, respiratory disease etc. among many others. The success in local market prompted us to explore the international market and over the years we gained a firm presence in South East Asia, Africa and Central America and continuously discovering new horizons to improve the quality of life for patients, to further the success of our customers and to help meet global challenges. Through the outstanding knowledge, professionalism and commitment of more than 7000 employees, we are consistently building upon our facilities, capabilities and also portfolio to meet the growing health care needs.<br />\r\n<br />\r\nWe are united, inspired and fueled by our mission to ensure health vigour and happiness for all. Since our founding in 1954 by Mr. Hamidur Rahman Sinha, an entrepreneur and philanthropist in this region of then British divided Indian sub-continent, we have been committed to offering solutions to our most pressing health care needs. More than half a century later, we remain true to our founder&rsquo;s vision and values &ndash; to produce high quality medicines with integrity, customer focus, pro-activity, team spirit, excellence and desire to win and responding to social and environmental needs. Over the past few decades, we have seen an amazing growth and success in pharmaceutical sector. With more than 60 years of expertise in medicine and science, our company draws upon a rich legacy of high quality formulations and a robust pipeline of promising generic medicines at affordable price to meet the health care needs.<br />\r\n<br />\r\nSince 1954 ACME has been stood for quality, business success and responsible entrepreneurship. Our heritage and our values are the foundation of our mission to ensure health, vigour and happiness for mankind.</p>', 1, '2022-02-10 02:45:43', '2022-02-10 02:45:43'),
(20, 'Ad-din Pharmaceuticals Ltd.', '1996', '0.4%', '0.6%', 'info@addinpharma.com', '+88042166340, +8801732012545', '1333675347.jpg', '<p>Ad-din Pharmaceuticals Ltd. has started its humble journey since 1 August 1996. &nbsp;It is a promising company for manufacturing world-class and top-quality pharmaceutical products in Bangladesh. We are currently producing more than 70 products in different dosage forms covering broader therapeutic categories which include antiulcerants, analgesics, cardiovascular, antidiabetics, gastrointestinal, respiratory disease etc. among many others. Through the outstanding knowledge, professionalism and expertise of more than 60 employees, we are steadily building upon our facilities, competence and also portfolio to meet the growing&nbsp;health care requirement of our nation.</p>', 1, '2022-02-10 05:20:54', '2022-02-10 05:20:54'),
(21, 'Aexim Pharmaceuticals Ltd.', '1980', '0.04%', '0.03%', '880 - 2 - 8837402', '880 - 2 - 9889734', '2012766855.jpg', '<p>Aexim Pharmaceuticals Ltd.</p>', 1, '2022-02-10 05:32:54', '2022-02-10 05:32:54'),
(22, 'Al-Madina Pharmaceuticals Ltd.', '2019', 'N/A', 'N/A', '+88-02-8712019, 8834052', 'info@almadinapharma.com', '1329479036.jfif', '<p>AL-Madina Pharmaceuticals Ltd. (AMPL) stepped into 13th years of its excellence in 2020 with lots of inspiration from previous successful years. Today we become a transnational pharmaceutical company through the development and introduction of a wide portfolio of branded and generic products in key markets. We have a dedicated factory, where people are protected by ensuring the highest quality of environment &amp; we manufacture best quality based products. Our key strength is our total quality system. We have inherited the standard operating procedures and quality approach. For maintain the excellence that we strive to achieve, we use the most advanced technology &amp; we also follow GMP for quality control in each and every stage of the manufacturing process.</p>\r\n\r\n<p>AMPL has grown into a company that boosts world class products, highest production facilities &amp; quality professionals.</p>\r\n\r\n<p>AMPL is fully self-dependent for its distribution. The company has the capability to make its products available throughout the country in a short time utilizing its own manpower and own logistic and transport services. Apart from its central warehouse in Gazipur it has 12 distribution centers throughout the country. The company maintains the strategy to make its products available to the customer&rsquo;s doorstep within fastest possible time.</p>', 1, '2022-02-10 05:37:20', '2022-02-10 05:37:20'),
(23, 'Alco Pharma Ltd.', '1986', 'N/A', 'N/A', 'info@alcopharmaltd.com', '+8825336, 8826103, 9881170', '1250411090.png', '<p>Alco Pharma Ltd. is a premier pharmaceutical company in Bangladesh with nearly 2,000 dedicated employees. We at Alco work to prevent and treat the diseases we know about today, as well as those we may face tomorrow. We are committed to developing safe and effective medicines, and ensure healthy living of patients and their families.</p>\r\n\r\n<p>We, at Alco Pharma Ltd., always believe in &#39;Quality never ends&#39; and refuse to settle for anything until it exceeds the existing standard.</p>\r\n\r\n<p>Alco&#39;s activities underscore the Company&rsquo;s well-defined mission to improve the quality of care and treatment of patients by providing effective therapies, products and specialized programs.</p>\r\n\r\n<p>ALCO Pharma Ltd. and its people are working hand-in-hand to become one of the respected and leading pharmaceutical companies in Bangladesh.</p>\r\n\r\n<p>Currently, Alco employs 2000 people and markets more than 180 products and dosage strengths nationwide.</p>', 1, '2022-02-10 05:47:59', '2022-02-10 05:47:59'),
(24, 'Alien Pharma', '2008', 'N/A', 'N/A', '+88-01918-300630', NULL, '578480695.jpg', '<p>The Alien Pharma and associated group of companies have modern manufacturing plants that produce a novel range of products to the specifications and satisfaction of its customers. All products are manufactured and analyzed by a highly qualified and experienced team of chemists ensuring quality products to its valued clients all over the country. Manufacturer of herbal products created using natural ingredients. The company offers medicinal products made from environmental herbs and natural elements for various types of skin diseases enabling users to protect their health and use chemical free products.&quot;</p>', 1, '2022-02-10 06:06:02', '2022-02-10 06:06:02'),
(25, 'Alkad Laboratories Ltd', NULL, 'N/A', 'N/A', 'Tatipara Rd, Rangpur, Bangladesh', '+8801713289820', '1973196026.png', '<p>Alkad Laboratories Ltd</p>', 1, '2022-02-10 06:16:10', '2022-02-10 06:16:10'),
(26, 'Allied Pharmaceuticals Ltd.', NULL, 'N/A', 'N/A', 'Ashuganj, B.Baria,Bangladesh', NULL, '754507758.png', '<h1>Allied Pharmaceuticals Ltd.</h1>', 1, '2022-02-10 06:18:24', '2022-02-10 06:18:24'),
(27, 'Ambee Pharmaceuticals Ltd.', '1978', 'N/A', 'N/A', '84/1, Tejgaon I/A, Dhaka, Bangladesh', NULL, '90743869.jfif', '<p>Ambee Pharmaceuticals Limited was incorporated in 1976 and commenced operations in 1978. It has a joint venture with Medimpex of Hungary. It started its operation with modest 17 joint ventured products and is now running in full swing with 76 products. The company offers Tablets, Capsules, Liquids, Gel in tubes and Injectables. It is headquartered in Dhaka.</p>', 1, '2022-02-10 06:22:04', '2022-02-10 06:22:04'),
(28, 'Amico Laboratories Ltd.', '1976', 'N/A', 'N/A', '22/10, Shondhani Life Bhaban, Dhaka, Bangladesh', NULL, '679908691.jpg', '<p>Amico laboratories Limited has emerged one of the fastest growing Pharmaceutical companies in Bangladesh and dedicated towards manufacturing &amp; marketing of human health care products. In this fast paced competitive business environment, Amico focuses on quality &amp; efficacy of products. Amico Laboratories Limited strictly follows GMP (Good Manufacturing Practices). It has always been our endeavour to create an environment where in innovation of the highest order can blossom. To Keep our commitment on quality, we have worked hard to achieve ISO 9001:2000 for Quality Management System. This international recognition has enhanced out reputation with pride &amp; dignity. The company, with its clear vision, marketing policies and long-term vision on customer satisfaction, has already created a favourable image in all over Bangladesh. With moderate product range, professional attitude and focused marketing policies, the company has availed a strong track record so far. Amico Laboratories Limited, indeed, is a newborn baby in the pharmaceutical industry and still has many more to offer to serve the nation with its health care products. Its increasing growth rate indicates a promising future.</p>', 1, '2022-02-10 06:30:00', '2022-02-10 06:30:00'),
(29, 'Amulet Pharmaceuticals Ltd.', '2008', 'N/A', 'N/A', 'House-7, Road-1, Block-B, Niketan, Gulshan-1, Dhaka-1212', 'info@amuletpharma.com.bd', '1831454543.png', '<p>Amulet Pharmaceuticals Ltd. Is one of the established privately owned pharmaceutical companies in Bangladesh with its headquarter in Dhaka. It has been developing, manufacturing, selling and distributing pharmaceutical products throughout Bangladesh, a country with 165 million people. Amulet has enabled people of all income categories to live their lives to the fullest. As an integrated healthcare solutions provider the company&rsquo;s product basket covers different therapeutic areas that includes gastro-intestinal, analgesics, haematinics, anti-infectives and antibiotics, respiratory agents and non-steroidal anti-inflammatory drugs, The company is committed to providing high quality, appropriately priced products to its customers, supports doctors and consultants with detailed information on their product range and provides dedicated customer service. Amulet Pharmaceuticals has a dedicated and competent workforce with exceptional expertise and talent in the field of pharmaceutical products employed in the factory, office and the sales force.</p>\r\n\r\n<p>We have already constructed a &ldquo;<strong>State of the Art</strong>&rdquo; world class pharmaceuticals manufacturing plant at Maona, Gazipur to meet local demand and are establishing new facilities of&nbsp;<strong>UK-MHRA</strong>&nbsp;as well as&nbsp;<strong>US-FDA, WHO cGMP</strong>&nbsp;standards in order to facilitate export to western countries. Our goal is to produce high quality Pharmaceutical products for comprehensive healthcare for all.</p>', 1, '2022-02-10 06:34:55', '2022-02-10 06:34:55'),
(30, 'APC Pharma Ltd.', NULL, 'N/A', 'N/A', NULL, NULL, '1602808909.jpg', '<p>APC PHARMACEUTICALS LTD is a leading Pharmaceutical Company in Bangladesh established in the year 1951.The factory is situated in Lokhpur, Fakirhat which is 7 kilometers away from Rupsha Bridge in Khulna City. The Company produces various types of dosage forms which includes tablet, Capsule, Liquid, dry syrup. It Constructed the factory building with new concepts where the penicillin, non-penicillin Cephalosporin and general blocks are separated &amp; dedicated.</p>\r\n\r\n<p>APC quickly developed a very Competent sales team, The Company virtually covers every single corner of the rural as well as urban area of Bangladesh.</p>\r\n\r\n<p>The Company has always been Committed to serve the nation and its population with the best products and services. It has its main focus on quality and efficacy of the products. Because the company strictly follows Current Good Manufacturing Practices. (CGMP) We have adopted a well defined quality Management System and secured ISO certification.</p>\r\n\r\n<p>APC pharmaceuticals ltd is not just a great workplace, but is a great way of life.</p>', 1, '2022-02-10 06:36:42', '2022-02-10 06:36:42'),
(31, 'Apex Pharmaceuticals Ltd.', NULL, 'N/A', 'N/A', NULL, NULL, '45723209.jfif', '<p>Apex Pharma is the pharmaceutical business of one of the reputed Bangladeshi conglomerate &ndash; SYED MANZUR ELAHI ENTERPRISE, which operates in leather, footwear, retail, advertising, market research &amp; financial services (namely Apex Tannery Ltd., Gallerie Apex, Apex Adelchi Footwear Ltd., Grey Advertising Bangladesh Ltd., Quantum Market Research Bangladesh Ltd., Blue Ocean Footwear etc).</p>\r\n\r\n<p>Apex Pharma is one of the fastest growing pharmaceutical company in Bangladesh located at Shafipur, Gazipur near Dhaka City. The company is already a Bangladesh Drug Administration regulated facility (WHO cGMP standard) for tablet, capsules, injectables, semisolid, liquid and ophthalmic formulations.</p>\r\n\r\n<p>Apex Phama&#39;s purpose-built manufacturing factory has separate and dedicated Cephalosporin, Penicillin and General production facilities to produce medicines of all therapeutic groups with the highest quality, efficacy and safety.</p>\r\n\r\n<p>Apex Pharma produces medicines of wide range of therapeutic classes like antiulcerants, antibiotics, NSAIDs, antipyretics, vitamins &amp; minerals, cardiovasculars, antidiabetics, steroids, antispasmodics, antihistamines, antipsychotics, antiemetics, antiseptics and many more.</p>\r\n\r\n<p>Apex Pharma has business alliance with&nbsp;<strong>Sanofi</strong>, a leading global pharmaceutical company to market, promote and distribute their selected Brands -&nbsp;<strong>Sandom, Fiprox, Inflam D, Frisium and Lasilactone</strong>.</p>\r\n\r\n<p><strong>Our motto is &#39;HONEST GROWTH&#39;, by Committed People, with Excellent Products.</strong></p>', 1, '2022-02-10 06:38:41', '2022-02-10 06:38:41'),
(32, 'Apollo Pharmaceutical Ltd.', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 06:39:36', '2022-02-10 06:39:36'),
(33, 'Arges Life Science Ltd.', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 06:40:06', '2022-02-10 06:40:06'),
(34, 'Aristopharma Ltd.', '1986', '3.98%', '18.44%', '7 Purana Paltan Line Dhaka-1000, Bangladesh.', '880-2-8317005', '1063355235.jfif', '<p>Aristopharma Ltd. is one of the Top 10 pharmaceutical companies in Bangladesh. The company started its journey in 1986 with the honest promise to provide quality medicines at affordable prices to the countrymen.</p>\r\n\r\n<p>It started manufacturing sterile ophthalmic products in 2002 and presently is maintaining no. 1 position in ophthalmic market in Bangladesh. In 2010 Aristopharma expanded its plant &amp; started manufacturing hi-tech products like inhalers, lyophilized injections, pre-filled syringes, suppositories, insulin &amp; other bio-tech products. Recently Aristopharma has opened its new UK MHRA standard plant at Gachha, Gazipur with dedicated facility for cephalosporin products. Construction work of dedicated Ophthalmic &amp; Oncology plants are also running in full swing in this new campus.</p>\r\n\r\n<p>In Aristopharma, quality is a journey, not a goal. It continuously sets higher standards and feels passionate to achieve that.</p>\r\n\r\n<p>Aristopharma conducted bioequivalence study for its products like Omep (Omeprazole) Capsule, Metacard MR (Trimetazidine) Tablet, Lodipin-5 (Amlodipine) Tablet, AZ (Azithromycin) Capsule &amp; Suspension, Aropen (Meropenem) Injection etc. The company also conducted clinical trials on Taxetil (Cefpodoxime), Afix (Cefixime), Metacard MR (Trimetazidine), Ipec-Plus (Iron Polymaltose+Zinc+Folic Acid) etc. and the results of these studies showed that they are as effective as innovators&rsquo; brands. It may be mentioned that clinical trials on some other products are ongoing at different hospitals and universities.</p>\r\n\r\n<p>With the aim to cope with the challenges of globalization, Aristopharma ltd. stepped beyond the boundary of Bangladesh in 2000, Vietnam being the first country to export. Today Aristopharma exports it quality medicines to 30 countries of 5 continents and is moving aggressively to expand and extend its export market. As a recognition to its Quality Management System, Aristopharma achieved ISO 9001:2000 certificate in 2005.</p>\r\n\r\n<p>The certificate was issued by Orion Registrar Inc. USA, one of the prime certification bodies in the world. Later on the certificate was upgraded to ISO 9001:2008 standard. Today around 7000 employees are relentlessly working for Aristopharma in its journey to build a healthier future.</p>', 1, '2022-02-10 06:44:22', '2022-02-10 06:44:22'),
(35, 'Asiatic Laboratories Ltd.', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 06:44:52', '2022-02-10 06:44:52'),
(36, 'Astra Biopharmaceuticals Ltd.', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 06:45:06', '2022-02-10 06:45:06'),
(37, 'Aztec Pharmaceuticals Ltd.', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 06:45:25', '2022-02-10 06:45:25'),
(38, 'Bangladesh Immunity Co', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 06:46:06', '2022-02-10 06:46:06'),
(39, 'Beacon Pharmaceuticals Ltd.', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 06:46:32', '2022-02-10 06:46:32'),
(40, 'Belsen Pharmaceuticals Ltd.', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 06:46:47', '2022-02-10 06:46:47'),
(41, 'Bengal Drugs Ltd', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 06:47:10', '2022-02-10 06:47:10'),
(42, 'Benham Pharmaceuticals Ltd.', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 06:47:26', '2022-02-10 06:47:26'),
(43, 'Beximco Pharmaceuticals Ltd.', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 06:47:40', '2022-02-10 06:47:40'),
(44, 'Biogen Pharmaceuticals Ltd.', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 06:47:56', '2022-02-10 06:47:56'),
(45, 'Biopharma Laboratories Ltd.', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 06:48:09', '2022-02-10 06:48:09'),
(46, 'BioRx Limited', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 06:48:26', '2022-02-10 06:48:26'),
(47, 'BOTS Pvt. Limited', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 06:53:02', '2022-02-10 06:53:02'),
(48, 'Bristol Pharmaceuticals Ltd.', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 06:53:30', '2022-02-10 06:53:30'),
(49, 'Centeon Pharma Ltd.', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 06:54:08', '2022-02-10 06:54:08'),
(50, 'Central Pharmaceuticals Ltd.', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 06:54:23', '2022-02-10 06:54:23'),
(51, 'Chemist Laboratories Ltd.', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 06:54:40', '2022-02-10 06:54:40'),
(52, 'City Overseas Ltd.', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 06:54:56', '2022-02-10 06:54:56'),
(53, 'Concord Pharmaceuticals Ltd.', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 06:55:11', '2022-02-10 06:55:11'),
(54, 'Cosmic Pharma Ltd.', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 06:55:27', '2022-02-10 06:55:27'),
(55, 'Cosmo Pharma Ltd.', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 06:55:44', '2022-02-10 06:55:44'),
(56, 'Credence Pharmaceuticals Ltd', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 06:56:03', '2022-02-10 06:56:03'),
(57, 'Crystal Pharmaceuticals Ltd', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 06:56:18', '2022-02-10 06:56:18'),
(58, 'D16 Pharma & Biotec', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 06:57:23', '2022-02-10 06:57:23'),
(59, 'DBL Pharmaceuticals Ltd', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 06:57:43', '2022-02-10 06:57:43'),
(60, 'Decent Pharma Laboratories Ltd', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 06:57:56', '2022-02-10 06:57:56'),
(61, 'Delta Pharma Ltd', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 06:58:08', '2022-02-10 06:58:08'),
(62, 'Desh Pharmaceuticals Ltd', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 06:58:25', '2022-02-10 06:58:25'),
(63, 'Doctor TIMS Pharmaceuticals Ltd', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 06:58:39', '2022-02-10 06:58:39'),
(64, 'Doctor’s Chemical Works Ltd', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 06:58:53', '2022-02-10 06:58:53'),
(65, 'Drug International Ltd', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 06:59:07', '2022-02-10 06:59:07'),
(66, 'Eastern Pharmaceuticals Ltd', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 06:59:20', '2022-02-10 06:59:20'),
(67, 'Edruc Ltd', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 06:59:34', '2022-02-10 06:59:34'),
(68, 'Eli Lilly and Company', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:00:13', '2022-02-10 07:00:13'),
(69, 'Elixir Pharmaceuticals Ltd', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:00:28', '2022-02-10 07:00:28'),
(70, 'Empiric Laboratories Ltd', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:00:44', '2022-02-10 07:00:44'),
(71, 'Eskayef Pharmaceuticals Ltd', NULL, NULL, NULL, NULL, NULL, NULL, '<p>Eskayef Bangladesh Limited, a successor of world-renowned multinational pharmaceutical company, SmithKline &amp; French (SK&amp;F), USA was acquired by TRANSCOM Group in 1990. After the acquisition, the new company was named &lsquo;Eskayef Bangladesh Limited&rsquo; and it has subsequently culminated to become one of the leading pharmaceutical companies in Bangladesh. Rapid business growth, since its inception has propelled Eskayef to a position of eminence among the pharmaceutical companies operating in Bangladesh today. Owing to its qualified, trained and skilled professionals and through its unswerving standards of quality control, Eskayef is now one of the most respected names in the pharmaceutical industry of Bangladesh.<br />\r\n<br />\r\nMission: To manufacture &amp; supply products with quality and excellency &amp; to contribute to improving the population&rsquo;s health &amp; well-being.<br />\r\n<br />\r\nVision: To lead the national pharmaceutical market, to be recognized as a multinational conglomerate from Bangladesh and stand out as a model of efficiency &amp; trust to our collaborators, consumers, health care professionals &amp; society.</p>', 1, '2022-02-10 07:01:16', '2022-02-10 07:01:16'),
(72, 'Ethical Drug Ltd', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:01:33', '2022-02-10 07:01:33'),
(73, 'Euro Pharma Ltd.', '2003', 'N/A', 'N/A', 'Kathal Bagan Sonargaon Road, Dhaka 1205', '+88-02-9612910', '41473594.png', '<p><strong>Our Vision</strong></p>\r\n\r\n<p>Our vision is to be a leading pharmaceutical company in Bangladesh and to become a significant national player by providing high quality medicines at affordable prices, making health care accessible to all sections of the society.</p>\r\n\r\n<p><strong>Our Mission</strong></p>\r\n\r\n<p>Our mission is to render total customer satisfaction and achieve leadership in chosen markets, products and services across the country, through excellence in producing quality medicine, based on high standards of quality control and quality assurance, driven by high ethical standards.</p>\r\n\r\n<p><strong>Our core strengths are:</strong></p>\r\n\r\n<ul>\r\n	<li>Operational Excellence from conception to commercialization</li>\r\n	<li>Efficient regulatory affairs team ensuring market compliance</li>\r\n	<li>Highly motivated and devoted employees</li>\r\n	<li>Comprehensive focus on customers</li>\r\n	<li>A positive work environment</li>\r\n	<li>Efficient distribution channel</li>\r\n</ul>\r\n\r\n<p><strong>Our core philosophy is to:</strong></p>\r\n\r\n<ul>\r\n	<li>Operate in compliance with all regulatory and policy requirements providing regular audits to ensure that controls and compliances are maintained at a high standard</li>\r\n</ul>\r\n\r\n<ul>\r\n	<li>Conduct operations in a manner that is ethical and proactive</li>\r\n	<li>Committed to fostering diversity in the workplace, both in its employees and leadership team</li>\r\n	<li>Committed to the principle of equal employment opportunity for all employees and to provide employees with a work environment free of discrimination and harassment</li>\r\n</ul>\r\n\r\n<p>Board of Directors</p>\r\n\r\n<p>Chairman: Professor S.M. Ashiquzzaman (Ph.D)</p>\r\n\r\n<p>Managing Director: Professor Borhan Uddin Khan (Ph.D)</p>\r\n\r\n<p>Deputy Managing Director: Heamayet Karim (M. Pharm)</p>\r\n\r\n<p>Director : Professor Tehmina Ghafur (Ph.D)</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n</ul>', 1, '2022-02-10 07:08:34', '2022-02-10 07:08:34'),
(74, 'Everest Pharmaceuticals Ltd.', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:08:54', '2022-02-10 07:08:54'),
(75, 'Fabrique en France', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:09:10', '2022-02-10 07:09:10'),
(76, 'FnF Pharmaceuticals Ltd.', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:09:24', '2022-02-10 07:09:24'),
(77, 'Gaco Pharmaceuticals Ltd.', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:10:13', '2022-02-10 07:10:13'),
(78, 'General Pharmaceuticals Ltd.', '1987', 'N/A', 'N/A', NULL, NULL, '1582345989.jfif', '<p>General Pharmaceuticals Ltd (GPL) has stepped into 34th Years of its Excellence in 2021 with lots of inspiration from previous successful years. We are immensely pleased to announce that GPL has started its production in 2011 at the state-of-the-art factory (Unit 2) which is build in compliance with cGMP standards, where people are protected by assuring the highest quality of the products and environment. The state-of-the-art factory is having the most modern ophthalmic &amp; parenteral production facilities, dedicated steroidal &amp; non-steroidal facilities, high tech heating ventilation &amp; air conditioning system (HVAC), SVP &amp; LVP (including Amino Acid) production facilities, effluent treatment plant &amp; incineration process for waste management. Total site area is 29,792 Sqm &amp; building foot print is 14,444 Sqm.The site master plan has been developed by APC, Australia. The state-of-the-art factory is in compliance with UK MHRA, EU-GMP, TGA, ICH, PIC/S. Now GPL is able to export pharmaceutical products into the regulated countries like North America, South America, European countries and Middle East etc. and meeting the local demands.</p>', 1, '2022-02-10 07:11:23', '2022-02-10 07:11:23'),
(79, 'Genvio Pharma Ltd.', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:11:36', '2022-02-10 07:11:36'),
(80, 'Get Well Ltd.', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:11:50', '2022-02-10 07:11:50'),
(81, 'GlaxoSmithKline', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:12:06', '2022-02-10 07:12:06'),
(82, 'Globe Pharmaceuticals Ltd.', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:12:17', '2022-02-10 07:12:17'),
(83, 'Globex Pharmaceuticals Ltd.', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:12:33', '2022-02-10 07:12:33'),
(84, 'Gonoshasthaya Pharma Ltd.', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:12:46', '2022-02-10 07:12:46'),
(85, 'Goodman Pharmaceuticals Ltd.', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:12:59', '2022-02-10 07:12:59'),
(86, 'Greenland Pharmaceuticals Ltd.', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:13:13', '2022-02-10 07:13:13'),
(87, 'Guardian Healthcare Ltd.', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:13:28', '2022-02-10 07:13:28'),
(88, 'Hallmark Pharmaceuticals Ltd.', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:15:04', '2022-02-10 07:15:04'),
(89, 'Healthcare Pharmaceuticals Ltd.', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:15:24', '2022-02-10 07:15:24'),
(90, 'Hudson Pharmaceuticals Ltd.', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:15:38', '2022-02-10 07:15:38'),
(91, 'IBN SINA Pharmaceuticals Ltd.', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:16:03', '2022-02-10 07:16:03'),
(92, 'Incepta Pharmaceuticals Ltd.', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:16:18', '2022-02-10 07:16:18'),
(93, 'Indo Bangla Pharmaceuticals', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:16:34', '2022-02-10 07:16:34'),
(94, 'Innova Pharma (Albion)', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:16:48', '2022-02-10 07:16:48'),
(95, 'Institute of Public Health (IPH)', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:17:07', '2022-02-10 07:17:07'),
(96, 'International Agencies (BD) Ltd.', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:17:36', '2022-02-10 07:17:36'),
(97, 'Janata Traders', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:17:49', '2022-02-10 07:17:49'),
(98, 'Jayson Pharmaceuticals Ltd.', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:18:38', '2022-02-10 07:18:38'),
(99, 'Julphar Bangladesh Ltd.', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:18:52', '2022-02-10 07:18:52'),
(100, 'Kawsar Chemicals', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:19:07', '2022-02-10 07:19:07'),
(101, 'Kemiko Pharmaceuticals Ltd.', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:19:22', '2022-02-10 07:19:22'),
(102, 'Kumudini Pharma Ltd.', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:19:36', '2022-02-10 07:19:36'),
(103, 'Labaid Pharma Ltd.', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:22:21', '2022-02-10 07:22:21'),
(104, 'Legends Pharma', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:22:34', '2022-02-10 07:22:34'),
(105, 'Leon Pharmaceuticals Ltd.', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:22:48', '2022-02-10 07:22:48'),
(106, 'Libra Infusions Ltd.', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:23:02', '2022-02-10 07:23:02'),
(107, 'Libra Pharmaceuticls Ltd.', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:23:18', '2022-02-10 07:23:18'),
(108, 'Linde Bangladesh Ltd.', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:24:32', '2022-02-10 07:24:32'),
(109, 'Marie Stopes Bangladesh', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:24:45', '2022-02-10 07:24:45'),
(110, 'Marker Pharma Ltd.', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:25:01', '2022-02-10 07:25:01'),
(111, 'Marksman Pharmaceuticals Ltd.', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:25:16', '2022-02-10 07:25:16'),
(112, 'Medicon Pharmaceuticals Ltd.', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:25:32', '2022-02-10 07:25:32'),
(113, 'Medimet Pharmaceuticals Ltd.', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:25:46', '2022-02-10 07:25:46'),
(114, 'MedRx Life Science Ltd.', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:26:00', '2022-02-10 07:26:00'),
(115, 'MicroMed', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:26:17', '2022-02-10 07:26:17'),
(116, 'Millat Pharmaceuticals Ltd.', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:26:31', '2022-02-10 07:26:31'),
(117, 'Modern Pharmaceuticals Ltd.', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:26:45', '2022-02-10 07:26:45'),
(118, 'Momotaz Pharmaceuticals Ltd.', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:28:32', '2022-02-10 07:28:32'),
(119, 'Monicopharma Ltd.', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:28:48', '2022-02-10 07:28:48'),
(120, 'MST Pharma', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:29:18', '2022-02-10 07:29:18'),
(121, 'Mundipharma (BD) Pvt. Ltd.', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:29:33', '2022-02-10 07:29:33'),
(122, 'Mystic Pharmaceuticals Ltd.', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:29:52', '2022-02-10 07:29:52'),
(123, 'Naafco Pharma Ltd.', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:30:08', '2022-02-10 07:30:08'),
(124, 'Navana Pharmaceuticals Ltd.', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:30:24', '2022-02-10 07:30:24'),
(125, 'NEMUS Pharmaceutical Pvt. Ltd.', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:30:39', '2022-02-10 07:30:39'),
(126, 'Nipa Pharmaceuticals Ltd.', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:30:53', '2022-02-10 07:30:53'),
(127, 'NIPRO JMI Pharma Ltd.', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:31:12', '2022-02-10 07:31:12'),
(128, 'Novartis (Bangladesh) Ltd.', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:31:53', '2022-02-10 07:31:53'),
(129, 'Novelta Bestway Pharma Ltd.', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:32:10', '2022-02-10 07:32:10'),
(130, 'Novo Healthcare and Pharma Ltd.', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:32:25', '2022-02-10 07:32:25'),
(131, 'Novo Nordisk', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:32:38', '2022-02-10 07:32:38'),
(132, 'Novus Pharmaceuticals Ltd.', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:32:52', '2022-02-10 07:32:52'),
(133, 'Nuvista Pharma Ltd.', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:33:08', '2022-02-10 07:33:08'),
(134, 'One Pharma Ltd.', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:33:22', '2022-02-10 07:33:22'),
(135, 'Opso Saline Ltd.', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:33:37', '2022-02-10 07:33:37'),
(136, 'Opsonin Pharma Ltd.', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:33:49', '2022-02-10 07:33:49'),
(137, 'Orbit Pharmaceuticals Ltd.', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:34:09', '2022-02-10 07:34:09'),
(138, 'Organic Health Care', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:34:56', '2022-02-10 07:34:56'),
(139, 'Orion Infusion Ltd.', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:35:11', '2022-02-10 07:35:11'),
(140, 'Orion Pharma Ltd.', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:35:22', '2022-02-10 07:35:22'),
(141, 'Oyster Pharmaceuticals Ltd.', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:35:37', '2022-02-10 07:35:37'),
(142, 'Pacific Pharmaceuticals Ltd.', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:35:53', '2022-02-10 07:35:53'),
(143, 'Peoples Pharma Ltd.', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:36:07', '2022-02-10 07:36:07'),
(144, 'Pfizer', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:36:24', '2022-02-10 07:36:24'),
(145, 'Pharmacil Limited', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:36:42', '2022-02-10 07:36:42'),
(146, 'Pharmadesh Laboratories Ltd.', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:37:00', '2022-02-10 07:37:00'),
(147, 'Pharmasia Limited', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:37:12', '2022-02-10 07:37:12'),
(148, 'Pharmik Laboratories Ltd.', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:37:51', '2022-02-10 07:37:51'),
(149, 'Phoenix Chemical Laboratory', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:38:09', '2022-02-10 07:38:09'),
(150, 'Popular Pharmaceuticals Ltd.', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:38:21', '2022-02-10 07:38:21'),
(151, 'Premier Pharmaceuticals Ltd.', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:38:35', '2022-02-10 07:38:35'),
(152, 'Prime Pharmaceuticals Ltd.', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:38:48', '2022-02-10 07:38:48'),
(153, 'Purnava Limited', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:39:02', '2022-02-10 07:39:02'),
(154, 'Quality Pharmaceuticals Ltd.', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:39:17', '2022-02-10 07:39:17'),
(155, 'Radiant Nutraceuticals Ltd.', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:39:30', '2022-02-10 07:39:30'),
(156, 'Radiant Pharmaceuticals Ltd.', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:39:41', '2022-02-10 07:39:41'),
(157, 'Rangs Pharmaceuticals Ltd.', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:39:54', '2022-02-10 07:39:54'),
(158, 'Reckitt & Benckiser Ltd.', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:40:33', '2022-02-10 07:40:33'),
(159, 'Reliance Pharmaceuticals Ltd.', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:40:46', '2022-02-10 07:40:46'),
(160, 'Reman Drug Laboratories Ltd.', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:41:01', '2022-02-10 07:41:01'),
(161, 'Renata Limited', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:41:12', '2022-02-10 07:41:12'),
(162, 'Rephco Pharmaceuticals Ltd.', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:41:25', '2022-02-10 07:41:25'),
(163, 'RN Pharmaceuticals', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:41:38', '2022-02-10 07:41:38'),
(164, 'Roche Bangladesh Ltd.', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:41:49', '2022-02-10 07:41:49'),
(165, 'S.N. Pharmaceutical Ltd.', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:42:03', '2022-02-10 07:42:03'),
(166, 'Salton Pharmaceuticals Ltd.', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:42:16', '2022-02-10 07:42:16'),
(167, 'SANDOZ (A Novartis Division)', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:42:31', '2022-02-10 07:42:31'),
(168, 'Sanofi Bangladesh Ltd.', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:43:44', '2022-02-10 07:43:44'),
(169, 'Seba Laboratories Ltd.', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:43:58', '2022-02-10 07:43:58'),
(170, 'Seema Pharmaceuticals Ltd.', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:44:12', '2022-02-10 07:44:12'),
(171, 'Servier Bangladesh Operation', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:44:25', '2022-02-10 07:44:25'),
(172, 'Sharif Pharmaceuticals Ltd.', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:44:39', '2022-02-10 07:44:39'),
(173, 'Silco Pharmaceutical Ltd.', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:44:54', '2022-02-10 07:44:54'),
(174, 'Silva Pharmaceuticals Ltd.', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:45:06', '2022-02-10 07:45:06'),
(175, 'Skylab Pharmaceuticals Ltd.', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:45:21', '2022-02-10 07:45:21'),
(176, 'Social Marketing Company', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:45:32', '2022-02-10 07:45:32'),
(177, 'Somatec Pharmaceuticals Ltd.', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:45:44', '2022-02-10 07:45:44'),
(178, 'Sonear Laboratories Ltd.', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:46:24', '2022-02-10 07:46:24'),
(179, 'Square Pharmaceuticals Ltd.', '1985', '17.30%', '23.35%', '48, Mohakhali C/A Dhaka 1212, Bangladesh.', '+8802222283604', '114186876.jpg', '<p>SQUARE today symbolizes a name- a state of mind. But its journey to the growth and prosperity has been no bed of roses. From the inception in 1958, it has today burgeoned into one of the top line conglomerates in Bangladesh. Square Pharmaceuticals Ltd., the flagship company, is holding the strong leadership position in the pharmaceutical industry of Bangladesh since 1985 and is now on its way to becoming a high performance global player.<br />\r\n<br />\r\nSQUARE Pharmaceuticals Limited is the largest pharmaceutical company in Bangladesh and it has been continuously in the 1st position among all national and multinational companies since 1985. It was established in 1958, converted into a public limited company in 1991 and listed with stock exchanges in 1995. The turnover of Square Pharma was BDT 50.87 Billion (US$ 609.18 million) with about 16.95% market share having a growth rate of about 10.85% (July 2018&ndash; June 2019).<br />\r\n<br />\r\nSQUARE Pharmaceuticals Limited has extended its range of services towards the highway of global market. It pioneered exports of medicines from Bangladesh in 1987 and has been exporting antibiotics and other pharmaceutical products. Present export market covers 42 countries. This extension in business and services has manifested the credibility of Square Pharmaceuticals Limited.<br />\r\n<br />\r\nMission: Their Mission is to produce and provide quality &amp; innovative healthcare relief for people, maintain stringently ethical standard in business operation also ensuring benefit to the shareholders, stakeholders and the society at large.<br />\r\n<br />\r\nVision: They view business as a means to the material and social wellbeing of the investors, employees and the society at large, leading to accretion of wealth through financial and moral gains as a part of the process of the human civilization.<br />\r\n<br />\r\nObjective: Their objectives are to conduct transparent business operation based on market mechanism within the legal &amp; social framework with aims to attain the mission reflected by Their vision.</p>', 1, '2022-02-10 07:48:38', '2022-02-10 07:48:38'),
(180, 'Sun Pharmaceutical Ltd.', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:48:56', '2022-02-10 07:48:56'),
(181, 'Sunman-Birdem Pharma Ltd.', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:49:12', '2022-02-10 07:49:12'),
(182, 'Supreme Pharmaceutical Ltd.', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:49:27', '2022-02-10 07:49:27'),
(183, 'Syntho Laboratories Ltd.', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:49:42', '2022-02-10 07:49:42'),
(184, 'Team Pharmaceuticals Ltd.', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:49:56', '2022-02-10 07:49:56'),
(185, 'Techno Drugs Ltd.', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:50:11', '2022-02-10 07:50:11'),
(186, 'The White Horse Pharma', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:50:25', '2022-02-10 07:50:25'),
(187, 'Therapeutics Bangladesh Ltd.', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:50:39', '2022-02-10 07:50:39'),
(188, 'Total Natural Company', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:51:26', '2022-02-10 07:51:26'),
(189, 'Ultra Pharma Ltd.', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:51:43', '2022-02-10 07:51:43'),
(190, 'UniMed UniHealth', '1997', '2.23%', '27.27%', 'House: 6/9, Block: F, Satmosjid Road, Lalmatia, Dhaka-1207, Bangladesh', '+880-2-9129135', '148876940.png', '<p>UniMed UniHealth began its journey in the year 1997 in Bangladesh by introducing life-saving and innovative pharmaceutical products from world class pharmaceutical companies like Grunenthal, Biotest, Abbott, Janssen and Vifor.<br />\r\n<br />\r\nA team of dedicated professionals having experience in multinational and leading local pharmaceutical companies under the leadership of Mr M Mosaddek Hossain prepared the plan, determined the strategies and progressed to develop the organization. Within a short period of time, the organization could successfully introduce a number of new chemical entities (NCEs) providing improved benefits to the patients.<br />\r\n<br />\r\nThe development of manufacturing capabilities in the year 2000 allowed introduction of a large number of branded generics in a number of specialty therapeutic areas.<br />\r\n<br />\r\nUniMed UniHealth ensured highest quality products from the beginning through procurement of active ingredients and excipients from selected and controlled sources, systematically processing in well designed and equipped facilities in compliance to regulatory requirements maintaining cGMP, GLP and ISO standards.<br />\r\n<br />\r\nUniMed UniHealth organized professional marketing with focused promotion through dedicated well trained teams and supplied the products throughout the country with its own developed distribution network.<br />\r\n<br />\r\nUniMed UniHealth believes and adheres to values like Quality, Knowledge and Responsibility in all aspects of its operation and earned respect and recognition of its valued customers in the healthcare sector of Bangladesh.</p>', 1, '2022-02-10 07:53:53', '2022-02-10 07:53:53'),
(191, 'Unique Pharmaceuticals Ltd.', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:54:07', '2022-02-10 07:54:07'),
(192, 'United Pharmaceuticals Ltd.', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:54:21', '2022-02-10 07:54:21'),
(193, 'Veritas Pharmaceuticals Ltd.', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:54:35', '2022-02-10 07:54:35'),
(194, 'Virgo Pharmaceuticals Ltd.', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:54:51', '2022-02-10 07:54:51'),
(195, 'ZAS Corporation Ltd', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:55:21', '2022-02-10 07:55:21'),
(196, 'Zenith Pharmaceuticals Ltd.', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 1, '2022-02-10 07:55:42', '2022-02-10 07:55:42'),
(197, 'Ziska Pharmaceuticals Ltd.', '1993', '1.2%', '6.34%', NULL, NULL, NULL, NULL, 1, '2022-02-10 07:56:36', '2022-02-10 07:56:36'),
(198, 'Synovia Pharma PLC', '2022', 'N/A', 'N/A', '09678-000777', NULL, '74470772.jpg', '<p><strong>Sanofi Bangladesh Limited is renamed Synovia Pharma PLC. on April 01, 2022.</strong></p>\r\n\r\n<p>Sanofi Bangladesh Limited was part of global biopharmaceutical company Sanofi S.A. before the majority stake acquisition by Beximco Pharmaceuticals Limited on October 1, 2021. Sanofi Bangladesh started its operation in Bangladesh as part of the British chemical company May &amp; Baker in 1958. Following a series of mergers and acquisitions (Fisons of United Kingdom, Rh&ocirc;ne-Poulenc of France and Hoechst Marion Roussel of Germany) it became known as Sanofi-Aventis in 2004, before being renamed in 2013 as Sanofi Bangladesh Limited.</p>\r\n\r\n<p>Synovia Pharma has inherited Sanofi Bangladesh&#39;s state-of-the-art manufacturing facilities, including a PIC/s certifiable manufacturing facility for cephalosporin antibiotics, are spread over 25 acres of land, located at Tongi, Gazipur Bangladesh.</p>\r\n\r\n<p>Synovia Pharma is continuing to manufacture and market Sanofi products in Bangladesh, just as before, and in addition the new company will provide an expanded portfolio of products to address the unmet medical needs of the patients. Synovia Pharma remains committed to value creation via synergy of strengths of the two ethical entities and will continue to bring hope, health and happiness in the lives of people we touch.</p>', 1, '2022-04-15 06:37:21', '2022-04-15 06:37:21'),
(199, 'Octapharma Pharmazeutica', NULL, NULL, NULL, NULL, NULL, '1474780713.png', NULL, 1, '2022-04-21 16:14:40', '2022-04-21 16:14:40'),
(200, 'Grifols Biologicals LLC', NULL, NULL, NULL, NULL, NULL, '1340002621.png', NULL, 1, '2022-04-21 16:31:50', '2022-04-21 16:31:50'),
(201, 'Alpha Therapeutic Corporation', NULL, NULL, NULL, NULL, NULL, '1745892541.jpeg', NULL, 1, '2022-04-21 16:51:48', '2022-04-21 16:51:48'),
(202, 'Jenphar Bangladesh Ltd.', NULL, NULL, NULL, NULL, NULL, '2033534951.jpeg', NULL, 1, '2022-04-23 18:31:15', '2022-04-23 18:31:15');

-- --------------------------------------------------------

--
-- Table structure for table `pharmacists`
--

CREATE TABLE `pharmacists` (
  `id` bigint(20) UNSIGNED NOT NULL,
  `pharmacist_name` varchar(255) NOT NULL,
  `grade` varchar(255) DEFAULT NULL COMMENT 'A,B,C',
  `registration_no` varchar(255) DEFAULT NULL,
  `university` varchar(255) DEFAULT NULL,
  `company` varchar(255) DEFAULT NULL,
  `created_at` timestamp NULL DEFAULT NULL,
  `updated_at` timestamp NULL DEFAULT NULL,
  `designation` varchar(255) DEFAULT NULL
) ENGINE=InnoDB DEFAULT CHARSET=utf8mb4 COLLATE=utf8mb4_unicode_ci;

--
-- Dumping data for table `pharmacists`
--

INSERT INTO `pharmacists` (`id`, `pharmacist_name`, `grade`, `registration_no`, `university`, `company`, `created_at`, `updated_at`, `designation`) VALUES
(4, 'Haley Britt ayat', 'B', 'Meghan Merrill', 'Velma Osborne', 'Richmond and Rodriguez Traders', '2022-07-06 16:24:08', '2022-07-06 16:34:42', 'Declan Estes'),
(5, 'Haley Britt', 'B', 'Meghan Merrill', 'Velma Osborne', 'Richmond and Rodriguez Traders', '2022-07-06 16:29:28', '2022-07-06 16:29:28', 'Declan Estes'),
(7, 'Jordan Gillespie', 'B', '2d545453', 'Kelly Lowe', 'Potts Moreno Traders', '2022-07-06 16:49:38', '2022-07-06 16:49:38', 'Ginger Mcbride'),
(8, 'Unity Michael', 'C', '545853434', 'Eve Lang', 'Barry Garrett Co', '2022-07-06 16:49:54', '2022-07-06 16:49:54', 'Meghan Alvarado');

-- --------------------------------------------------------

--
-- Table structure for table `pharpa_jobs`
--

CREATE TABLE `pharpa_jobs` (
  `id` bigint(20) UNSIGNED NOT NULL,
  `company_name` varchar(255) NOT NULL,
  `company_logo` varchar(255) DEFAULT NULL,
  `position` varchar(255) DEFAULT NULL,
  `published_on` varchar(255) DEFAULT NULL,
  `deadline` varchar(255) DEFAULT NULL,
  `source` varchar(255) DEFAULT NULL,
  `vacancy` varchar(255) DEFAULT NULL,
  `job_nature` varchar(255) DEFAULT NULL,
  `job_location` varchar(255) DEFAULT NULL,
  `salary` varchar(255) DEFAULT NULL,
  `job_description` longtext DEFAULT NULL,
  `compensation_other_benefits` longtext DEFAULT NULL,
  `educational_requirement` longtext DEFAULT NULL,
  `exprience_requirement` longtext DEFAULT NULL,
  `additional_requirement` longtext DEFAULT NULL,
  `apply_instructions` longtext DEFAULT NULL,
  `apply_link` longtext DEFAULT NULL,
  `created_at` timestamp NULL DEFAULT NULL,
  `updated_at` timestamp NULL DEFAULT NULL
) ENGINE=InnoDB DEFAULT CHARSET=utf8mb4 COLLATE=utf8mb4_unicode_ci;

--
-- Dumping data for table `pharpa_jobs`
--

INSERT INTO `pharpa_jobs` (`id`, `company_name`, `company_logo`, `position`, `published_on`, `deadline`, `source`, `vacancy`, `job_nature`, `job_location`, `salary`, `job_description`, `compensation_other_benefits`, `educational_requirement`, `exprience_requirement`, `additional_requirement`, `apply_instructions`, `apply_link`, `created_at`, `updated_at`) VALUES
(1, 'Incepta Pharmaceuticals Ltd.', '449816556.png', 'Executive Officer/Sr. Executive Officer, Quality Assurance', '2022-02-08', '2022-02-13', 'Bdjobs.com online job posting', 'Unspecified', 'Full-Time', 'Anywhere in Bangladesh', 'Negotiable', '<p><strong>Job Responsibilities</strong></p>\r\n\r\n<ul>\r\n	<li><em>Act as a change control coordinator to ensure change control activities are performed in a timely and thorough manner.</em></li>\r\n	<li><em>Coordinate with cross functional team to maintain change control programs. Interpret compliance and regulatory requirements for departmental systems, procedures and documentation.</em></li>\r\n	<li><em>Review key qualification/ validation documents including qualification/ validation protocols/ report, risk assessment and traceability matrices.</em></li>\r\n</ul>', '<p><strong>As per company policy.</strong></p>', '<p>Educational Requirements</p>\r\n\r\n<ul>\r\n	<li>M.Sc in Pharmacy/Chemistry/Biochemistry from a reputed university with excellent academic background</li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n</ul>', 'At least 6 year(s)', '<p><strong>Additional Requirements</strong></p>\r\n\r\n<ul>\r\n	<li>Knowledgeable in Biotech/ Pharmaceutical Quality systems inclusive of CGMP, FDA regulations and familiarity with ICH guidelines and global regulatory.</li>\r\n	<li>Aptitude to comprehend, analyse and interpret process and systems information, technical procedures.</li>\r\n</ul>', '<h2>Apply Procedures</h2>\r\n\r\n<h3>Email: Send your CV to&nbsp;<strong>jobs@inceptapharma.com</strong></h3>\r\n\r\n<h3>Hard Copy : Click to Apply&nbsp;<a href=\"http://www.inceptapharma.com/career/\">http://www.inceptapharma.com/career/</a></h3>\r\n\r\n<p><strong>Application Deadline :&nbsp;13 Feb 2022</strong></p>', 'https://jobs.bdjobs.com/jobdetails.asp?id=1028881&fcatId=11&ln=1', '2022-01-28 06:13:38', '2022-02-11 23:33:14'),
(5, 'Labaid Pharma Ltd.', '1074644886.png', 'Assistant Manager, Deputy Manager- Quality Compliance', '2022-01-28', '2022-02-17', 'Bdjobs.com', 'Unspecified', 'Full-Time', 'Plant, Savar, Dhaka', 'Negotiable', '<ul>\r\n	<li>To ensure all operations in Production / QC/ Warehouse are performed in accordance with CGMP guidelines.</li>\r\n	<li>To review daily floor inspection report and prepare corrective action plan and ensure implementation of the recommended actions.</li>\r\n	<li>To check BMR, BPR, IPC and QC data for each batch of product and take approval for final release.</li>\r\n	<li>Perform and review Internal Audit and management of CAPA process.</li>\r\n	<li>To review SOP related with Quality Compliance activities and implementations of SOPs in accordance with CGMP.</li>\r\n	<li>Responsible for supporting quality related customer complaint investigations and trend activities.</li>\r\n	<li>Coordinate training in all aspects of Quality Management Systems and GMP including procedural updates to new entrants and existing technical staffs.</li>\r\n	<li>Planning and coordinating gap assessments of existing processes and systems using multi-functional teams.</li>\r\n	<li>To handle Change control, Deviation, Risk Management process as Issuance, Tracking, Implementation and Closing of Corrective and Preventive action.</li>\r\n</ul>', '<p>As per company policy.</p>', '<p>B. Pharm/M. Pharm from any reputed university.</p>', '7 to 8 year(s)', '<ul>\r\n	<li>7-8 years of relevant experience in the same position in any reputed Pharmaceutical Company</li>\r\n	<li>Excellent interpersonal and communication skills (verbal and written) are required.</li>\r\n	<li>Strong analytical and problem solving skills</li>\r\n	<li>A high level of computer literacy (Office Suite) and presentation skills</li>\r\n	<li>Ability to interact well with all stakeholders and work independently on assigned tasks.</li>\r\n	<li>Must be able to take ownership of and follow through on assignments.</li>\r\n	<li>The ability to work under pressure and to deadlines</li>\r\n</ul>', '<p>Candidates are requested to send CV with recent photograph to HR, Labaid Pharmaceuticals Ltd., Head Office: Bay Tower (Level 2), House: 23, Gulshan Avenue, Gulshan-1 Dhaka-1212, Bangladesh. Please mention the position on the top of the envelope.</p>', 'https://jobs.bdjobs.com/jobdetails.asp?id=1025808&fcatId=11&ln=1', '2022-01-28 06:13:38', '2022-02-01 12:40:31'),
(6, 'Navana Pharmaceuticals Limited', '1600975455.jpg', 'Brand Executive, Strategic Brand Management Department(SBMD)', '2022-02-08', '2022-02-15', 'Bdjobs.com online job posting', 'Not Specific', 'Full Time', 'Dhaka (Banani)', 'Negotiable', '<p><strong>Job Context</strong></p>\r\n\r\n<ul>\r\n	<li>Navana Pharmaceuticals Ltd. is undergoing major expansion to meet the growing need of domestic as well as export market. Hence, Navana is looking for enthusiastic, ambitious and hardworking candidate.</li>\r\n</ul>\r\n\r\n<p><strong>Job Responsibilities</strong></p>\r\n\r\n<ul>\r\n	<li>Prepare Strategic Marketing Plan for the assigned portfolio and formulate Marketing Plan for the assigned brands.</li>\r\n	<li>Design effective promotional campaigns to achieve the target of assigned products and provide promotional support timely &amp; monitor the output of promotional campaign.</li>\r\n	<li>Monitor competitors&rsquo; activities regularly and provide strategic guidelines and analytical support to Sales Forces on assigned brands.</li>\r\n	<li>Conduct training and development program for Sales Forces.</li>\r\n	<li>Propose &amp; launch new products considering market demand and business potentiality.</li>\r\n	<li>Arrange and conduct Medico-Marketing Campaigns like Clinical Meeting, Seminars etc.</li>\r\n</ul>', '<p>&nbsp;</p>\r\n\r\n<ul>\r\n	<li>Mobile bill, Tour allowance, Profit share, Provident fund, Gratuity, Weekly 2 holidays</li>\r\n	<li>Lunch Facilities: Partially Subsidize</li>\r\n	<li>Salary Review: Yearly</li>\r\n	<li>Festival Bonus: 2</li>\r\n	<li>Group life insurance.</li>\r\n</ul>', '<p>&nbsp;</p>\r\n\r\n<ul>\r\n	<li>Bachelor of Medicine and Bachelor of Surgery(MBBS)</li>\r\n	<li>M. Pharm/ B. Pharm / MBA/ BBA</li>\r\n</ul>', 'N/A', '<p>&nbsp;</p>\r\n\r\n<ul>\r\n	<li>Age at most 30 years</li>\r\n	<li>Microsoft Excel, Word &amp; Power Point skill.</li>\r\n	<li>Good English proficiency.</li>\r\n	<li>Willing to tour anywhere in Bangladesh.</li>\r\n</ul>', '<h2><strong>Read Before Apply</strong></h2>\r\n\r\n<p>Eligible candidates are invited to apply with a complete CV with recent passport size photograph, Hand written application, NID&rsquo;s photocopy, All Academic certificates&rsquo; photocopies, Experience certificates (If applicable) to Human Resource Development department of Navana Pharmaceuticals Ltd., House # 99, Road # 4, Block # B, Banani, Dhaka-1213.<br />\r\nCandidates who have applied earlier need not to apply again.</p>\r\n\r\n<div style=\"background:#eeeeee; border:1px solid #cccccc; padding:5px 10px\"><q>*Photograph&nbsp;must be enclosed with the resume.</q></div>', 'https://jobs.bdjobs.com/jobdetails.asp?id=1029297&fcatId=11&ln=1', '2022-02-11 23:42:58', '2022-02-11 23:45:45'),
(7, 'Opsonin Herbal and Nutraceuticals Limited (OHNL)', '1864200586.png', 'Group Coordinator', '2022-02-07', '2022-02-15', 'Bdjobs.com online job posting', 'Not Specific', 'Full Time', 'Dhaka', 'Negotiable', '<p><strong>Job Context</strong></p>\r\n\r\n<ul>\r\n	<li>This position is located at the head office of Opsonin Herbal and Nutraceuticals Limited (OHNL) in Dhaka</li>\r\n	<li>Formulate the marketing plan and its coordination and monitoring to achieve the set business growth.</li>\r\n</ul>\r\n\r\n<p><strong>Job Responsibilities</strong></p>\r\n\r\n<ul>\r\n	<li>This position is required to supervise Product Executives</li>\r\n	<li>Developing annual marketing plan comprising innovative strategies, ensure sustainable growth and profitable business of assigned brands</li>\r\n	<li>Transforming strategies into creative and effective promotional mix to attain brand leadership, customer loyalty &amp; team motivation</li>\r\n	<li>Developing budget for promotion materials</li>\r\n	<li>Monitoring market activities with special emphasis to competitors &amp; proposing effective strategies to gain market share</li>\r\n	<li>Training to field forces to develop them</li>\r\n</ul>', '<ul>\r\n	<li>We offer excellent work environment, exceptional training, attractive compensation package and performance-based career progression.</li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>', '<ul>\r\n	<li>M. Pharm / B. Pharm</li>\r\n</ul>', 'At least 6 year(s)', '<ul>\r\n	<li>Age at most 34 years</li>\r\n	<li>Minimum 6 years of experience in pharmaceutical marketing and 2 years of experience in supervising/ similar position</li>\r\n	<li>Proficiency in both written and spoken English</li>\r\n	<li>Good leadership skill, team player &amp; excellent interpersonal skill</li>\r\n	<li>Proficient with Microsoft Word, Power Point and Excel</li>\r\n</ul>', '<h2>Read Before Apply</h2>\r\n\r\n<p>Only short listed candidates will be invited for written test/Interview.</p>', 'https://jobs.bdjobs.com/jobdetails.asp?id=1028036&fcatId=11&ln=1', '2022-02-11 23:54:19', '2022-02-11 23:54:19'),
(8, 'Opsonin Herbal and Nutraceuticals Limited (OHNL)', '699880739.png', 'Product Executive', '2022-02-07', '2022-02-15', 'Bdjobs.com online job posting', 'Not Specific', 'Full Time', 'Dhaka', 'Negotiable', '<p>Job Context</p>\r\n\r\n<ul>\r\n	<li>This position is located at the head office of Opsonin Herbal and Nutraceuticals Limited (OHNL) in Dhaka</li>\r\n</ul>\r\n\r\n<p>Job Responsibilities</p>\r\n\r\n<ul>\r\n	<li>Undertake all activities regarding new product launching and nourishing assigned products based on market potential and prospect</li>\r\n	<li>Formulate strategies and promotional campaign to achieve the sales target</li>\r\n	<li>Formulate annual budget for assigned products</li>\r\n	<li>Develop promotional materials and define necessary promotional activities for establishing new and existing products</li>\r\n	<li>Conduct field conferences, scientific seminar/CME on regular basis at different regions</li>\r\n	<li>Train the field colleagues regarding his assigned products</li>\r\n</ul>', '<ul>\r\n	<li>We offer excellent work environment, exceptional training, attractive compensation package and performance-based career progression.</li>\r\n</ul>', '<ul>\r\n	<li>M. Pharm / B. Pharm</li>\r\n</ul>', 'N/A; Freshers are also encouraged to apply', '<ul>\r\n	<li>Age at most 30 years</li>\r\n	<li>Proficiency in both written and spoken English</li>\r\n	<li>Good leadership skill, team player &amp; excellent interpersonal skill</li>\r\n	<li>Proficient with Microsoft Word, Power Point and Excel</li>\r\n</ul>', '<h2><strong>Read Before Apply</strong></h2>\r\n\r\n<p>Only short listed candidates will be invited for written test/Interview.</p>', 'https://jobs.bdjobs.com/jobdetails.asp?id=1028031&fcatId=11&ln=1', '2022-02-12 00:03:42', '2022-02-12 00:03:42'),
(9, 'Eskayef Pharmaceuticals Ltd.', '757830329.png', 'Product Executive', '2022-02-07', '2022-02-16', 'Bdjobs.com online job posting', 'Not Specific', 'Full Time', 'Dhaka', 'Negotiable', '<p><strong>Job Responsibilities</strong></p>\r\n\r\n<ul>\r\n	<li>Formulating strategies to disseminate scientific information in an innovative manner</li>\r\n	<li>Developing and monitoring of marketing activities of the brands under assigned therapeutic segments</li>\r\n	<li>Launching newer molecules to cater the unmet medical needs</li>\r\n	<li>Organizing need based scientific seminars with different specialties of doctors</li>\r\n	<li>Organizing promotional campaign</li>\r\n</ul>', '<ul>\r\n	<li>Attractive package at the top of the industry</li>\r\n	<li>A supportive environment with world-class training &amp; international exposure to bring out the best in our people</li>\r\n	<li>Excellent work culture, team spirit &amp; performance recognition schemes</li>\r\n	<li>Rapid career advancement and personal development for all high potential individuals</li>\r\n</ul>', '<ul>\r\n	<li>M.Pharm/B.Pharm from a Reputed University.</li>\r\n</ul>', '1 to 2 year(s)', '<ul>\r\n	<li>1 to 2 years of experience in the similar position in a reputed pharmaceutical company will be an added advantage.</li>\r\n	<li>Freshers are also highly encouraged to apply.</li>\r\n</ul>', '<h2><strong>Apply Procedure</strong></h2>\r\n\r\n<p>If you think you are the person we are looking for, please submit your application through&nbsp;<a href=\"http://skfmis.com/career/hr/pmd/\">http://skfmis.com/career/hr/pmd/</a></p>', 'https://jobs.bdjobs.com/jobdetails.asp?id=1028664&fcatId=11&ln=1', '2022-02-12 00:29:20', '2022-02-12 00:32:20'),
(10, 'SMC Enterprise Ltd.', '335722464.jpg', 'National Sales Manager, Pharma', '2022-02-17', '2022-03-03', 'Bdjobs.com online job posting', 'Not Specific', 'Full Time', 'Dhaka', 'Negotiable', '<p>Job Context</p>\r\n\r\n<ul>\r\n	<li>SMC Enterprise Ltd has a vacancy for the following position for Head Office:</li>\r\n</ul>\r\n\r\n<p>Job Responsibilities</p>\r\n\r\n<ul>\r\n	<li>Achieve growth and exceed sales targets through effective management of sales team.</li>\r\n	<li>Develop annual sales plan, achieve target, control expense, and expand market as per business plan.</li>\r\n	<li>Streaming processes, policies, systems and sales administrative function.</li>\r\n	<li>Provide forecasts for each product, territory and calculate the operating costs of the sales force.</li>\r\n	<li>Establish performance monitoring tools to maximize productivity of sales team.</li>\r\n	<li>Prepare monthly/quarterly sales reports and give feedback to Head of Sales &amp; Marketing, Pharma.</li>\r\n	<li>Visit markets &amp; meet with potential customers (Doctors and Chemists) across the country frequently and exchange ideas to obtain feedback on the movement of products and business opportunity.</li>\r\n	<li>Organize and provide training to field sales forces for ensuring quality presentation/detailing in front of the customers.</li>\r\n	<li>Assist in recruiting, setting objectives and performance enhancement plan of field sales force.</li>\r\n</ul>', '<p>As per company policy</p>', '<ul>\r\n	<li>Masters in any discipline from any reputed University</li>\r\n</ul>', 'At most 12 year(s)', '<ul>\r\n	<li>Age at most 50 years</li>\r\n	<li>Masters in any discipline from any reputed University</li>\r\n	<li>Minimum 12 years of experience in pharmaceuticals sales</li>\r\n	<li>Having working experience at national level will get preference</li>\r\n	<li>Maximum 50 years of age</li>\r\n	<li>Excellent Communication skills, Planning, Development, Selling skills and Analytical thinking</li>\r\n	<li>Advanced skills in MS Office Suite (particularly in word, power point, excel)</li>\r\n	<li>Willing to travel frequently</li>\r\n</ul>', '<h2>Read Before Apply</h2>\r\n\r\n<p>Interested candidates who fulfill the above criteria are encouraged to apply online.</p>', 'https://jobs.bdjobs.com/jobdetails.asp?id=1031818&fcatId=11&ln=1', '2022-02-19 04:05:36', '2022-02-19 04:05:36'),
(11, 'Renown Pharmaceuticals Industry', '172756826.jpg', 'Asst. Manager, Marketing (PMD)', '2022-02-17', '2022-03-19', 'Bdjobs.com online job posting', 'Not Specific', 'Full Time', 'Dhaka', 'Negotiable', '<ul>\r\n	<li>Develop strategic plan for new product launch and the marketing plan for the assigned products.</li>\r\n	<li>Manage the implementation of assigned elements of marketing plan.</li>\r\n	<li>Develop &amp; implement new product launch plan and make them brand leader</li>\r\n	<li>Ensure key message development and communication for product positioning and profiling for each product.</li>\r\n	<li>To coordinate the allocation of promotional materials as well as other resources to the region (FFs) according to the sales development (trend), market potentiality and demand.</li>\r\n	<li>Translate the product related scientific findings into market messages in order to communicate to the physicians through FFs.</li>\r\n	<li>To work closely with the sales team to ensure open communication and to work in the field for joint call with the field force to understand the market, competition and customers need as well as their attitude.</li>\r\n	<li>Maintain up to date knowledge of the pharmaceutical market.</li>\r\n	<li>Coordinate with other department e.g. Production, Quality Assurance, Product development, Regulatory Affairs, MSD, PPIC, Commercial, Finance and Accounts, Audit to ensure best intra-communication for the achieving company goals and objectives.</li>\r\n	<li>Conduct any special project assigned by the supervisor for the better interest of the company,</li>\r\n	<li>To set yearly budget objectives and forecast of a product for marketing.</li>\r\n</ul>', '<ul>\r\n	<li>T/A, Mobile bill, Tour allowance, Provident fund, Weekly 2 holidays, Insurance, Gratuity</li>\r\n	<li>Salary Review: Yearly</li>\r\n	<li>Festival Bonus: 2</li>\r\n</ul>', '<ul>\r\n	<li>M. Pharm</li>\r\n</ul>', 'At least 8 year(s)', '<ul>\r\n	<li>At least 8 year(s)</li>\r\n	<li>The applicants should have experience in the following area(s):<br />\r\n	Pharmaceutical Marketing, Product Development, Sales &amp; Marketing (Pharmaceutical Products)</li>\r\n	<li>The applicants should have experience in the following business area(s):<br />\r\n	Pharmaceuticals</li>\r\n</ul>', '<h2>Read Before Apply</h2>\r\n\r\n<h2>*Photograph&nbsp;must be enclosed with the resume.</h2>', 'https://jobs.bdjobs.com/jobdetails.asp?id=1031964&fcatId=11&ln=1', '2022-02-19 04:27:15', '2022-02-19 04:27:15'),
(12, 'Renata Limited', NULL, 'Officer, Production', '2022-02-17', '2022-02-24', 'Bdjobs.com online job posting', 'Not Specific', 'Full Time', 'Mymensingh (Bhaluka)', 'Negotiable', '<ul>\r\n	<li>Monitoring the production process and adjusting schedules as needed.</li>\r\n	<li>Supervising and checking manufacturing instructions and ensuring that these are followed.</li>\r\n	<li>Supervising maintenance, premises and manufacturing equipment.</li>\r\n	<li>Ensuring that necessary validation for manufacturing procedures is carried out.</li>\r\n	<li>Ensuring that batch manufacturing records and batch packaging records are reviewed and signed by authorised person before they are passed on to QC /QA Department.</li>\r\n	<li>Participating in audits (suppliers and subcontractors) &amp; in self-inspection.</li>\r\n	<li>Helping process complaints.</li>\r\n	<li>Raising and implementing change control.</li>\r\n	<li>Ensure implementation and evaluation of safety procedure.</li>\r\n	<li>Ensuring reworking of any finished and semi-finished products that have been rejected and that have not been rejected.</li>\r\n	<li>Ensuring that required initial and continuous training of production personnel is carried out and adapted to the need and motivate subordinates accordingly.</li>\r\n	<li>Any other relevant duties assigned by higher authority as and when required.</li>\r\n	<li>Ensuring the batch manufacturing records (BMR) are filled and signed properly.</li>\r\n	<li>Address any deviation issues during process work and notifying to supervisor.</li>\r\n	<li>Ensuring the cleaning of production area and equipment are in place.</li>\r\n</ul>', '<ul>\r\n	<li>Festival &amp; Annual Bonus</li>\r\n	<li>Provident Fund</li>\r\n	<li>Gratuity</li>\r\n	<li>Group Insurance</li>\r\n	<li>Lunch &amp; Transport Facilities</li>\r\n	<li>A good &amp; healthy working environment</li>\r\n</ul>', NULL, '1 to 2 year(s)', '<ul>\r\n	<li>Age at most 30 years</li>\r\n	<li>1-2 years experience in the similar positions in a reputed pharmaceutical company will get preference.</li>\r\n	<li>Good interpersonal and communication skills.</li>\r\n	<li>Ability to work under pressure.</li>\r\n	<li>Self motivated and proactive in producing and delivering outputs.</li>\r\n	<li>Smart, energetic and innovative.</li>\r\n	<li>Computer literate.</li>\r\n</ul>', '<h2>Apply Procedure</h2>\r\n\r\n<p><a href=\"https://jobs.bdjobs.com/jobdetails.asp?id=1031846&amp;fcatId=11&amp;ln=1#appliTermsModal\" onclick=\"CreateHTMLPopup_new(\'Renata Limited\', 1, 1031846)\">Apply Online</a></p>', 'https://jobs.bdjobs.com/jobdetails.asp?id=1031846&fcatId=11&ln=1', '2022-02-19 04:32:58', '2022-02-19 04:32:58'),
(13, 'General Pharmaceuticals Ltd.', '1731235045.jfif', 'Sr. Executive/ Assistant Manager, R&D', '2022-03-06', '2022-03-19', 'Bdjobs.com online job posting', 'Not Specific', 'Full Time', 'Gajipur', 'Negotiable', '<ul>\r\n	<li>Currently we are looking for eligible candidates for the position &quot;Sr. Executive/ Assistant Manager, R&amp;D&quot; where the incumbent will be responsible for coordinating transfer of technology of new and existing finished products and manage deviation &amp; risk assessment as per requirement of new and existing products and process optimization &amp; validation related jobs of General Pharmaceuticals ltd.</li>\r\n	<li>Co-ordinate technology transfer of new as well as existing finished products.</li>\r\n	<li>Perform deviation and risk assessment as per new &amp; existing product requirement.</li>\r\n	<li>Ensure adequate necessary documents(SOP/ESP/Protocol) with current regulatory guidelines.</li>\r\n	<li>Manage document initiating form, CCR,OOT,OOS &amp; CAPA.</li>\r\n	<li>Ensure process optimization &amp; process validation protocol.</li>\r\n	<li>Ensure the stability of initiation for process optimization &amp; validation batch.</li>\r\n	<li>Develop existing product as per requirement.</li>\r\n</ul>', '<ul>\r\n	<li>Performance bonus, Provident fund, Gratuity</li>\r\n	<li>Lunch Facilities: Partially Subsidize</li>\r\n	<li>Salary Review: Yearly</li>\r\n	<li>Festival Bonus: 2</li>\r\n	<li>Transport and others fringe benefits as per company policy.</li>\r\n</ul>', '<ul>\r\n	<li>M. Pharm from any reputed public and private university.</li>\r\n</ul>', 'At least 6 year(s)', '<ul>\r\n	<li>Age at most 35 years</li>\r\n	<li>Both males and females are allowed to apply</li>\r\n</ul>', '<h2>Company Information</h2>\r\n\r\n<p>General Pharmaceuticals Ltd.Address : Head Office: Sara Aftab Tower, 29 Ring Road (Holding # 6/1/A), Shyamoli, Adabor, Dhaka-1207, Bangladesh.Web :&nbsp;<a href=\"http://www.generalpharma.com/\" target=\"_blank\">www.generalpharma.com</a></p>\r\n\r\n<p>Gusiness : GENERAL Pharmaceuticals Ltd. (GPL) is one of the leading pharmaceutical companies in Bangladesh with a mission to ensure a healthier life by producing the top-notch products one can trust in treatment of ailments.</p>', 'https://jobs.bdjobs.com/jobdetails.asp?id=1035886&fcatId=11&ln=1', '2022-03-17 05:32:01', '2022-03-17 05:32:01'),
(14, 'Popular Pharmaceuticals Ltd.', '796166467.jpg', 'Product Executive- Product Management Department', '2022-05-31', '2022-06-08', 'Bdjobs.com online job posting', 'Not Specific', 'Full Time', 'Dhaka', 'Negotiable', '<p>Job Responsibilities</p>\r\n\r\n<ul>\r\n	<li>Co-ordinate the overall activities of brand management</li>\r\n	<li>Develop &amp; implement marketing plan and take corrective actions as per market feedback</li>\r\n	<li>New product launching</li>\r\n	<li>Design promotional plan and allocate promotional materials through strong, dynamic and innovative activities for establishing new products</li>\r\n	<li>Formulate annual budget for assigned products</li>\r\n	<li>Analyze sales- Rx performance to review the marketing plan</li>\r\n	<li>Conduct monthly sales meeting/conference &amp; CME</li>\r\n	<li>Train the field forces on assigned products</li>\r\n	<li>Frequent doctor and field visit for market development</li>\r\n</ul>', '<ul>\r\n	<li>Provident Fund</li>\r\n	<li>Gratuity</li>\r\n	<li>Festival Bonus: 3 (Yearly)</li>\r\n	<li>Earn Leave Encashment</li>\r\n	<li>Leave Fair Assistance</li>\r\n	<li>Profit share</li>\r\n	<li>Weekly holiday: 2 days</li>\r\n	<li>Pick &amp; drop facility</li>\r\n	<li>Insurance</li>\r\n	<li>Subsidized lunch facility</li>\r\n</ul>', '<ul>\r\n	<li>M. Pharm/B. Pharm (5 years) from any reputed university with excellent academic records</li>\r\n</ul>', '1 to 2 year(s)', '<ul>\r\n	<li>Age at most 30 years</li>\r\n	<li>The applicants should have experience in Pharmaceutical Marketing</li>\r\n	<li>Candidate should be career focused, pro-active, team player and well proficiency in computer literacy (MS Office)</li>\r\n	<li>Excellent interpersonal skills, oral and written communication skills in English and Bengali with the ability to communicate effectively with all levels in a multi-cultural environment</li>\r\n</ul>', NULL, 'https://jobs.bdjobs.com/jobdetails.asp?id=1056723&fcatId=11&ln=1', '2022-06-04 03:34:19', '2022-06-04 03:34:19'),
(15, 'Sun Pharmaceuticals (EZ) Ltd.', '861185010.jpg', 'Sr. Officer - Quality Assurance', '2022-06-02', '2022-06-15', 'Bdjobs.com online job posting', '01', 'Full Time', 'Dhaka', 'Negotiable', '<p>Job Responsibilities</p>\r\n\r\n<ul>\r\n	<li>Perform in-process checking in granulation, compression, coating and packing area including documentation .</li>\r\n	<li>Investigation of market complaint, deviation management, product recall, reporting and documentation.</li>\r\n	<li>To prepare SOP and conduct training on the SOP.</li>\r\n	<li>Handling change control as per corporate guideline.</li>\r\n	<li>Preparing of annual product review.</li>\r\n	<li>Issuance of process validation, cleaning validation and hold time study protocol and monitoring the validation activities and preparation of validation report in timely manner.</li>\r\n	<li>Issuance of machine qualification protocol and monitoring of qualification and requalification activities and preparation of qualification report in timely manner.</li>\r\n	<li>To execute project/product transfer / Technology transfer / Pharmacopeia Change management.</li>\r\n	<li>To issue and review of all master documents (e.g. BMR/BPR, SOP, STP, Form, Checklist Template etc.) and other formats.</li>\r\n	<li>To review and investigation OOS, OOT and other lab events.</li>\r\n	<li>To perform risk assessment guideline as and when required on identified events.</li>\r\n	<li>Review of batch documents after completion of production and QC activities and release of product to market.</li>\r\n</ul>', '<ul>\r\n	<li>Tour allowance, Profit share, Provident fund, Insurance, Gratuity, Over time allowance</li>\r\n	<li>Lunch Facilities: Partially Subsidize</li>\r\n	<li>Salary Review: Yearly</li>\r\n	<li>Festival Bonus: 2</li>\r\n	<li>LTA (additional bonus)</li>\r\n</ul>', '<ul>\r\n	<li>Master of Pharmacy (M.Pharm), Master of Science (MSc) in Chemistry, Master of Science (MSc) in Applied Chemistry, Master of Science (MSc) in Biochemistry</li>\r\n	<li>Skills Required: Computer skill, Familiar with SAP ERP system, Fluent In English, Good comunication skill, Teamwork skills</li>\r\n</ul>', '4 to 6 year(s)', '<ul>\r\n	<li>Age 28 to 34 years</li>\r\n</ul>', NULL, 'https://jobs.bdjobs.com/jobdetails.asp?id=1057462&fcatId=11&ln=1', '2022-06-04 04:38:24', '2022-06-04 04:38:24'),
(16, 'Goodman Pharmaceuticals Ltd.', '691491158.png', 'Executive/ Sr. Executive, International Marketing', '2022-07-25', '2022-06-05', 'Bdjobs.com online job posting', '01', 'Full Time', 'Dhaka', 'Negotiable', '<ul>\r\n	<li>Preparation of Dossiers, Communication with foreign buyers &amp; Development of new export market.</li>\r\n	<li>Product brief as per ACTD format.</li>\r\n	<li>Preparation of export documents &amp; Product development for export market.</li>\r\n	<li>Communication/Liaison with local regulatory bodies (DGDA, Banks) for export related activities.</li>\r\n</ul>', NULL, '<p>B.Pharm and M.Pharm from any reputed University</p>', '3 to 5 year(s)', '<ul>\r\n	<li>Expertise in MS office program.</li>\r\n	<li>English proficiency is a must.</li>\r\n	<li>Should be customer service oriented and organized.</li>\r\n	<li>Should have strong communication and presentation skills and sound knowledge international cultures.</li>\r\n	<li>Must have a natural ability to engage in business relationships with individuals and groups.</li>\r\n	<li>Self-motivated and committed.</li>\r\n</ul>', '<p><a href=\"mailto:siam.hr@goodmanpharmabd.com\"><strong>siam.hr@goodmanpharmabd.com</strong></a></p>', 'https://hotjobs.bdjobs.com/jobs/goodmanph/goodmanph3.htm', '2022-06-04 04:58:54', '2022-06-04 04:58:54'),
(17, 'Desh Pharmaceuticals Ltd', '2019469652.png', 'Sales Manager', '2022-05-31', '2022-06-30', 'Bdjobs.com online job posting', 'Not Specific', 'Full Time', 'Dhaka', 'Negotiable', '<ul>\r\n	<li>DESH PHARMACEUTICALS (PVT.) LIMITED: One of the GMP Certified Leading Pharmaceuticals Company`s in Bangladesh.</li>\r\n	<li>To support our rapidly expanding Pharma business, the Company is looking for a self-motivated, hardworking and enthusiastic leader who can successfully perform to achieve business goal.</li>\r\n	<li>Job Location: Desh Pharmaceuticals Pvt. Ltd., Head Office, Mirpur, Dhaka.</li>\r\n</ul>\r\n\r\n<p>Job Responsibilities</p>\r\n\r\n<ul>\r\n	<li>Develop sales plan to achieve or exceed the annual sales objectives and supervision of National Sales.</li>\r\n	<li>Work with respective team members in order to coach and develop them for performing to the optimal level.</li>\r\n	<li>Visit markets regularly to check route coverage, competitor activity and search for new opportunities.</li>\r\n	<li>Develop and maintain an efficient distribution network to ensure the availability of products</li>\r\n	<li>Establish and ensure that all sales administration procedures are properly implemented.</li>\r\n	<li>Meet with potential customers and exchange ideas to obtain feedback on the movement of products and business.</li>\r\n	<li>Provide required training to MIOs, Area Managers so that they possess sufficient medical and technical knowledge to share information on Company products.</li>\r\n	<li>Assist in recruiting, setting objectives, coaching, performance monitoring of sales forces in assigned zone.</li>\r\n	<li>Analyze the market potentiality and explore new business opportunities.</li>\r\n	<li>Interact with other departments of the company to ensure sales requirements.</li>\r\n</ul>', '<ul>\r\n	<li>Mobile bill, Performance bonus, Profit share.</li>\r\n	<li>Festival Bonus: 2.</li>\r\n</ul>', NULL, NULL, '<ul>\r\n	<li>Age at most 45 years</li>\r\n	<li>The applicants should have experience in the Pharmaceutical Sales.</li>\r\n	<li>Skills Required: Ability to Work Under Pressure, Adaptability, Coaching, Leadership and Good Communication skills, Negotiation Skills, Target Oriented, Team work, Hard Working.</li>\r\n	<li>Willing to work in any geographical area.</li>\r\n	<li>Should have at least 03 years&#39; experience in similar position.</li>\r\n	<li>Experience may relax for most deserving candidates.</li>\r\n</ul>', '<p><strong>importexport.deshpharma@gmail.com</strong></p>', 'https://jobs.bdjobs.com/jobdetails.asp?id=1056776&fcatId=11&ln=1', '2022-06-04 05:03:46', '2022-06-04 05:03:46');

-- --------------------------------------------------------

--
-- Table structure for table `post_categories`
--

CREATE TABLE `post_categories` (
  `id` bigint(20) UNSIGNED NOT NULL,
  `category_name` varchar(255) NOT NULL,
  `category_slug` varchar(255) NOT NULL,
  `category_desc` text DEFAULT NULL,
  `created_at` timestamp NULL DEFAULT NULL,
  `updated_at` timestamp NULL DEFAULT NULL
) ENGINE=InnoDB DEFAULT CHARSET=utf8mb4 COLLATE=utf8mb4_unicode_ci;

--
-- Dumping data for table `post_categories`
--

INSERT INTO `post_categories` (`id`, `category_name`, `category_slug`, `category_desc`, `created_at`, `updated_at`) VALUES
(1, 'Test Category', 'test-category', NULL, '2022-01-20 06:41:34', '2022-01-20 06:41:34');

-- --------------------------------------------------------

--
-- Table structure for table `products`
--

CREATE TABLE `products` (
  `id` bigint(20) UNSIGNED NOT NULL,
  `cat_id` int(11) DEFAULT NULL,
  `brand_id` bigint(20) UNSIGNED DEFAULT NULL,
  `company_id` bigint(20) UNSIGNED DEFAULT NULL,
  `unit` varchar(255) DEFAULT NULL,
  `origin` varchar(255) DEFAULT NULL,
  `name` varchar(255) NOT NULL,
  `specification` varchar(255) DEFAULT NULL,
  `price` varchar(255) NOT NULL,
  `image` varchar(255) NOT NULL,
  `btn_link` varchar(255) NOT NULL,
  `desc` longtext DEFAULT NULL,
  `is_featured` tinyint(1) UNSIGNED NOT NULL DEFAULT 0,
  `created_at` timestamp NULL DEFAULT NULL,
  `updated_at` timestamp NULL DEFAULT NULL
) ENGINE=InnoDB DEFAULT CHARSET=utf8mb4 COLLATE=utf8mb4_unicode_ci;

--
-- Dumping data for table `products`
--

INSERT INTO `products` (`id`, `cat_id`, `brand_id`, `company_id`, `unit`, `origin`, `name`, `specification`, `price`, `image`, `btn_link`, `desc`, `is_featured`, `created_at`, `updated_at`) VALUES
(1, 1, 1413, 84, 'P/Pc', 'BD', 'Ephedrine Hydrochloride', '25 mg/5 ml', '25.00', '1021532858.jpg', 'https://google.com', '<p><strong>Indications</strong></p>\r\n\r\n<p>Ephedrine is indicated to reverse hypotension induced by spinal or epidural anaesthesia. It is of little value in hypotensive crisis due to shock, circulatory collapse, or haemorrhage.</p>\r\n\r\n<p><strong>Pharmacology</strong></p>\r\n\r\n<p>Ephedrine is a stimulant drug, belonging to a group of medicines known as sympathomimetics. Specifically it is both an alpha and beta adrenergic agonist. In addition, Ephedrine enhances the release of norepinephrine, a strong endogenous alpha agonist. The action of this compound is notably similar to that of the body&#39;s primary adrenergic hormone epinephrine (adrenaline), which also exhibits action toward both alpha and beta receptors. When administered, Ephedrine will notably increase the activity of the central nervous system, as well as have a stimulatory effect on other target cells.</p>\r\n\r\n<p><strong>Dosage &amp; Administration</strong></p>\r\n\r\n<p>To reverse hypotension induced by spinal or epidural anaesthesia 3 to 6 mg (or at most 9 mg) Ephedrine Hydrochloride is given by slow intravenous injection and repeated every 3 to 4 minutes as required; the maximum total dose is 30 mg. Ephedrine has also been given by intramuscular or subcutaneous injection.</p>\r\n\r\n<p><strong>Interaction</strong></p>\r\n\r\n<p>Administration of Ephedrine may cause a hypertensive crisis in patients receiving an Monoamine Oxidase Inhibitor (including an Reversible Inhibitor of Monoamine Oxidase type A). Ephedrine should be avoided or used with care in patients undergoing anaesthesia with cyclopropane, halothane, or other volatile anaesthetics. An increased risk of arrhythmias may occur if given to patients receiving cardiac glycosides, quinidine, or tricyclic antidepressants, and there is an increased risk of vasoconstrictor or pressor effects in patients receiving ergot alkaloids or oxytocin</p>\r\n\r\n<p><strong>Contraindications</strong></p>\r\n\r\n<p>The use of Ephedrine is contraindicated in the presence of coronary thrombosis. It should be used with caution in patients with organic heart disease, cardiac decompensation, hyperthyroidism, hypertension, and angina pectoris, and in patients receiving digitalis.</p>\r\n\r\n<p><strong>Side Effects</strong></p>\r\n\r\n<p>Adverse effects reported are nausea, vomiting, anorexia; tachycardia (sometimes bradycardia), arrhythmias, anginal pain, vasoconstriction with hypertension, vasodilation with hypotension, dizziness and flushing; dyspnoea; headache, anxiety, restlessness, confusion, psychoses, insomnia, tremor; difficulty in micturition, urine retention; sweating, hypersalivation; changes in blood-glucose concentration; very rarely angle-closure glaucoma.</p>\r\n\r\n<p><strong>Pregnancy &amp; Lactation</strong></p>\r\n\r\n<p><strong>Pregnancy</strong>: Category C. Either studies in animals have revealed adverse effects on the foetus (teratogenic or embryocidal or other) and there are no controlled studies in women or studies in women and animals are not available. Drugs should be given only if the potential benefit justifies the potential risk to the foetus.<br />\r\n<br />\r\n<strong>Lactation</strong>: Ephedrine Hydrochloride is distributed into breast milk, and therefore Ephedrine Hydrochloride Injection is not recommended for use during lactation because of the risk of adverse effects in the infant.</p>\r\n\r\n<p><strong>Precautions &amp; Warnings</strong></p>\r\n\r\n<p>Ephedrine should be given with care to patients with hyperthyroidism, diabetes mellitus, ischemic heart disease, hypertension, renal impairment, or angle-close glaucoma. In patients with prostatic enlargement, Ephedrine may increase difficulty with micturition. Use in pregnancy and lactation: Increased fetal heart rate reported with parenteral Ephedrine. Irritability and disturbed sleep have been reported in breast-fed infants.</p>\r\n\r\n<p><strong>Overdose Effects</strong></p>\r\n\r\n<p>When given in sufficiently large doses Ephedrine gives rise in most patients to certain minor reactions, such as giddiness, headache, nausea, vomiting, sweating, palpitations, difficulty in micturition, tremors, anxiety, restlessness and insomnia; some patients may exhibit these symptoms even with the usual therapeutic dosage.</p>\r\n\r\n<p><strong>Therapeutic Class</strong></p>\r\n\r\n<p>Other adrenoceptor stimulants, Vasoconstrictor/Venotonic</p>\r\n\r\n<p><strong>Storage Conditions</strong></p>\r\n\r\n<p>Store in a cool, dry place, protected from light. Keep all medicines out of reach of children.</p>', 1, '2022-01-27 09:19:11', '2022-06-01 04:39:31'),
(2, 1, 1412, 84, 'P/Pc', 'BD', 'Heparin Sodium', '25000 IU/5 ml', '390.00', '2133235052.jpeg', 'https://google.com', '<p><strong>Indications</strong><br />\r\nAtrial fibrillation&nbsp;with&nbsp;embolization:</p>\r\n\r\n<ul>\r\n	<li>Treatment of acute and chronic consumption coagulopathies (disseminated intravascular&nbsp;coagulation);</li>\r\n	<li>Prevention of clotting in arterial and heart surgery;</li>\r\n	<li>Anticoagulant&nbsp;therapy in&nbsp;prophylaxis&nbsp;and treatment of venous&nbsp;thrombosis&nbsp;and its&nbsp;extension;</li>\r\n	<li>(In a low-dose regimen) for prevention of postoperative deep venous thrombosis and&nbsp;pulmonary embolism&nbsp;in patients undergoing major abdomino-thoracic&nbsp;surgery or who for other reasons are at risk of developing thromboembolic disease</li>\r\n	<li>Prophylaxis and treatment of pulmonary&nbsp;embolism;&nbsp;</li>\r\n	<li>Prophylaxis and treatment of peripheral arterial embolism.</li>\r\n</ul>\r\n\r\n<p><strong>Pharmacology</strong></p>\r\n\r\n<p>Heparin&nbsp;inhibits reactions that lead to the clotting of blood and the formation of&nbsp;fibrin clots both&nbsp;in vitro&nbsp;and in vivo. Heparin acts at multiple sites in the normal coagulation system. Small amounts of heparin in combination with antithrombin III (heparin cofactor) can inhibit thrombosis by inactivating activated&nbsp;Factor X&nbsp;and inhibiting the conversion of prothrombin to&nbsp;thrombin. Once active thrombosis has developed, larger amounts of heparin can inhibit further coagulation by inactivating thrombin and preventing the conversion of fibrinogen to fibrin. Heparin also prevents the formation of a stable fibrin clot in inhibiting the activation of the fibrin stabilizing factor.<br />\r\n<br />\r\nBleeding time is usually unaffected by heparin. Clotting time is prolonged by full therapeutic doses of heparin; in most cases, it is not measurably affected by low doses of heparin.</p>\r\n\r\n<p><strong>Dosage &amp; Administration</strong></p>\r\n\r\n<p><strong>Intravenous-</strong><br />\r\nProphylaxis of re-occlusion of the coronary arteries following thrombolytic therapy in myocardial infarction</p>\r\n\r\n<ul>\r\n	<li><strong>Adult:</strong>&nbsp;60 U/kg (max: 4,000 U) or a bolus of 5,000 U if streptokinase was used, followed by 12 U/kg/hr (max: 1,000 U/hr) w/ a treatment duration of 48 hr.</li>\r\n</ul>\r\n\r\n<p><strong>Intravenous-</strong><br />\r\nPeripheral arterial embolism, Unstable angina, Venous thromboembolism</p>\r\n\r\n<ul>\r\n	<li><strong>Adult:</strong>&nbsp;75-80 U/kg or 5,000 U (10,000 U in severe pulmonary embolism) IV loading dose followed by 18 U/kg or 1,000-2,000 U/hr continuous infusion. Alternatively, intermittent inj of 5,000-10,000 U 4-6 hrly.</li>\r\n	<li><strong>Child:</strong>&nbsp;50 U/kg loading dose, followed by an infusion of 15-25 U/kg/hr.</li>\r\n	<li><strong>Elderly:</strong>&nbsp;Lower dosages may be required.</li>\r\n</ul>\r\n\r\n<p><strong>Subcutaneous-</strong><br />\r\nProphylaxis of postoperative venous thromboembolism</p>\r\n\r\n<ul>\r\n	<li><strong>Adult:</strong>&nbsp;5,000 U given 2 hr before surgery then 8-12 hrly for 7 days or until the patient is ambulant.</li>\r\n</ul>\r\n\r\n<p><strong>Subcutaneous-</strong><br />\r\nVenous thromboembolism</p>\r\n\r\n<ul>\r\n	<li><strong>Adult:</strong>&nbsp;15,000-20,000 U 12 hrly or 8,000-10,000 U 8 hrly.</li>\r\n	<li><strong>Child:</strong>&nbsp;250 U/kg bid.</li>\r\n	<li><strong>Elderly:</strong>&nbsp;Lower dosages may be required.</li>\r\n</ul>\r\n\r\n<p><strong>Interaction</strong></p>\r\n\r\n<p>Enhanced anticoagulant effect with other drugs affecting platelet function or the coagulation system (e.g. platelet aggregation inhibitors, thrombolytic agents, salicylates, NSAIDs, vit K antagonists, dextrans, activated protein C). Decreased anticoagulant effect with gyceryl trinitrate infusion. Increased risk of hyperkalaemia with ACE inhibitors or angiotensin II antagonists.</p>\r\n\r\n<p><strong>Contraindications</strong></p>\r\n\r\n<p>Current or history of heparin-induced thrombocytopenia; generalised or local haemorrhagic tendency, including uncontrolled severe HTN, severe liver insufficiency, active peptic ulcer, acute or subacute septic endocarditis, intracranial haemorrhage or injuries and operations on the CNS, eyes and ears, and in women with abortus imminens; epidural anaesth during birth; locoregional anaesth in elective surgical procedures (in patients receiving heparin for treatment rather than prophylaxis).</p>\r\n\r\n<p><strong>Side Effects</strong></p>\r\n\r\n<p>Hypersensitivity reactions (e.g. chills, fever, urticaria, asthma, rhinitis); painful, ischaemic and cyanosed limbs; osteoporosis (in long-term admin), suppression of aldosterone synthesis leading to hyperkalaemia, cutaneous necrosis, delayed transient alopecia, priapism, rebound hyperlipaemia; increased serum concentrations of AST and ALT, prolonged prothrombin time; local irritation, erythema, mild pain, haematoma or ulceration on inj site.</p>\r\n\r\n<p><strong>Pregnancy &amp; Lactation</strong></p>\r\n\r\n<p><strong>Pregnancy&nbsp;</strong>Category C.&nbsp;Either studies in animals have revealed adverse effects on the foetus (teratogenic or embryocidal or other) and there are no controlled studies in women or studies in women and animals are not available. Drugs should be given only if the potential benefit justifies the potential risk to the foetus.<br />\r\n<br />\r\n<strong>Nursing Mothers</strong>: Due to its large molecular weight, heparin is not likely to be excreted in human milk, and any heparin in milk would not be orally absorbed by a nursing infant. Benzyl alcohol present in maternal serum is likely to cross into human milk and may be orally absorbed by a nursing infant. Exercise caution when administering Heparin Sodium Injection to a nursing mother.</p>\r\n\r\n<p><strong>Precautions &amp; Warnings</strong></p>\r\n\r\n<p>Patient with increased risk of bleeding complications, HTN, DM, pre-existing metabolic acidosis. Do not use in catheter lock flushing. Hepatic and renal impairment. Elderly. Pregnancy and lactation.</p>\r\n\r\n<p><strong>Use in Special Populations</strong></p>\r\n\r\n<p><strong>Pediatric Use</strong>: There are no adequate and well controlled studies on heparin use in pediatric patients. Pediatric dosing recommendations are based on clinical experience. Carefully examine all Heparin Sodium Injection vials to confirm choice of the correct strength prior to administration of the drug. Pediatric patients, including neonates, have died as a result of medication errors in which vials have been confused with &ldquo;catheter lock flush&rdquo; vials</p>\r\n\r\n<p><strong>Overdose Effects</strong></p>\r\n\r\n<p><strong>Symptoms:</strong>&nbsp;Bleeding (nose bleeds, blood in urine or tarry stools may be noted as the 1st sign of bleeding).<br />\r\n<br />\r\n<strong>Management:</strong>&nbsp;May give protamine sulfate by slow IV infusion over 10 min to treat severe bleeding (1 mg of protamine sulfate neutralises approx 100 U of heparin). Max: 50 mg as a single dose.</p>\r\n\r\n<p><strong>Therapeutic Class</strong></p>\r\n\r\n<p>Parenteral anti-coagulants</p>\r\n\r\n<p><strong>Storage Conditions</strong></p>\r\n\r\n<p>Store between 20-25&deg; C. Protect from freezing.</p>', 1, '2022-01-27 09:19:11', '2022-06-01 04:34:24'),
(3, 1, 1710, 185, 'P/Pc', 'BD', 'Isoflurane', '100 mL Isoflurane Solution for Inhalation', '3000.00', '1839361241.png', 'https://google.com', '<p><strong>Indications</strong></p>\r\n\r\n<p>Isoflurane may be used for induction and maintenance of general anesthesia. Adequate data have not been developed to establish its application in obstetrical anesthesia.</p>\r\n\r\n<p><strong>Pharmacology</strong></p>\r\n\r\n<p>Isoflurane may be used for induction and maintenance of general anesthesia. Adequate data have not been developed to establish its application in obstetrical anesthesia.<br />\r\n<br />\r\nInduction of and recovery from Isoflurane anesthesia are rapid. Isoflurane has a mild pungency, which limits the rate of induction, although excessive salivation or tracheobronchial secretions do not appear to be stimulated. Pharyngeal and laryngeal reflexes are readily obtunded. The level of anesthesia may be changed rapidly with Isoflurane. Isoflurane is a profound respiratory depressant. Respiration must be monitored closely and supported when necessary. As anesthetic dose is increased, tidal volume decreases and respiratory rate is unchanged. This depression is partially reversed by surgical stimulation, even at deeper levels of anesthesia. Isoflurane evokes a sigh response reminiscent of that seen with diethyl ether and enflurane, although the frequency is less than with enflurane.<br />\r\n<br />\r\nBlood pressure&nbsp;decreases with induction of anesthesia but returns toward normal with surgical stimulation. Progressive increases in depth of anesthesia produce corresponding decreases in blood pressure. Nitrous oxide diminishes the inspiratory concentration of Isoflurane required to reach a desired level of anesthesia and may reduce the arterial hypotension seen with Isoflurane alone. Heart rhythm is remarkably stable. With controlled ventilation and normal PaCO2, cardiac output is maintained despite increasing depth of anesthesia, primarily through an increase in heart rate, which compensates for a reduction in stroke volume. The hypercapnia, which attends spontaneous ventilation during Isoflurane anesthesia further increases heart rate and raises cardiac output above awake levels. Isoflurane does not sensitize the myocardium to exogenously administered epinephrine in the dog. Limited data indicate that subcutaneous injection of 0.25 mg of epinephrine (50 mL of 1:200,000 solution) does not produce an increase in&nbsp;ventricular arrhythmias&nbsp;in patients anesthetized with Isoflurane.<br />\r\n<br />\r\nMuscle relaxation is often adequate for intra-abdominal operations at normal levels of anesthesia. Complete muscle paralysis can be attained with small doses of muscle relaxants. All commonly used muscle relaxants are markedly potentiated with Isoflurane, the effect being most profound with the nondepolarizing type. Neostigmine reverses the effect of nondepolarizing muscle relaxants in the presence of Isoflurane. All commonly used muscle relaxants are compatible with Isoflurane.<br />\r\n<br />\r\nIsoflurane can produce coronary vasodilation at the arteriolar level in selected animal models; the drug is probably also a coronary dilator in humans. Isoflurane, like some other coronary arteriolar dilators, has been shown to divert blood from collateral dependent myocardium to normally perfused areas in an animal model (&ldquo;coronary steal&rdquo;). Clinical studies to date evaluating myocardial ischemia, infarction and death as outcome parameters have not established that the coronary arteriolar dilation property of Isoflurane is associated with coronary steal or myocardial ischemia in patients with coronary artery disease</p>\r\n\r\n<p><strong>Dosage &amp; Administration</strong></p>\r\n\r\n<p><strong>Premedication</strong>: Premedication should be selected according to the need of the individual patient, taking into account that secretions are weakly stimulated by Isoflurane, and the heart rate tends to be increased. The use of anticholinergic drugs is a matter of choice.<br />\r\n<br />\r\n<strong>Inspired Concentration</strong>: The concentration of Isoflurane being delivered from a vaporizer during anesthesia should be known. This may be accomplished by using:<br />\r\n<br />\r\nVaporizers calibrated specifically for Isoflurane;<br />\r\nVaporizers from which delivered flows can be calculated, such as vaporizers delivering a saturated vapor, which is then diluted. The delivered concentration from such a vaporizer may be calculated using the formula:&nbsp;<strong>% Isoflurane = 100 PvFv/FT&nbsp;(PA&nbsp;- PV)</strong><br />\r\n<br />\r\nWhere:</p>\r\n\r\n<ul>\r\n	<li>PA= Pressure of atmosphere</li>\r\n	<li>PV= Vapor pressure of Isoflurane</li>\r\n	<li>FV= Flow of gas through vaporizer (mL/min)</li>\r\n	<li>FT= Total gas flow (mL/min)</li>\r\n</ul>\r\n\r\n<p>Isoflurane contains no stabilizer. Nothing in the agent alters calibration or operation of these vaporizers.<br />\r\n<br />\r\n<strong>Induction</strong>: Induction with Isoflurane in oxygen or in combination with oxygen-nitrous oxide mixtures may produce coughing, breath holding, or laryngospasm. These difficulties may be avoided by the use of a hypnotic dose of an ultra-short-acting barbiturate. Inspired concentrations of 1.5 to 3.0% Isoflurane usually produce surgical anesthesia in 7 to 10 minutes.<br />\r\n<br />\r\n<strong>Maintenance</strong>: Surgical levels of anesthesia may be sustained with a 1.0 to 2.5% concentration when nitrous oxide is used concomitantly. An additional 0.5 to 1.0% may be required when Isoflurane is given using oxygen alone. If added relaxation is required, supplemental doses of muscle relaxants may be used.<br />\r\n<br />\r\nThe level of blood pressure during maintenance is an inverse function of Isoflurane concentration in the absence of other complicating problems. Excessive decreases may be due to depth of anesthesia and in such instances may be corrected by lightening anesthesia.</p>\r\n\r\n<p><strong>Interaction</strong></p>\r\n\r\n<p>Enhances effects of neuromuscular blockers. May sensitise the myocardium to adrenaline and other sympathomimetics. Enhances hypotensive effects of ACE inhibitors, TCAs, MAOIs, antihypertensives, antipsychotics or beta-blockers. May have synergistic effects with CNS depressants.</p>\r\n\r\n<p><strong>Contraindications</strong></p>\r\n\r\n<p>Known or suspected susceptibility to malignant hyperthermia. Porphyria.</p>\r\n\r\n<p><strong>Side Effects</strong></p>\r\n\r\n<p>Nausea, Vomiting, Shivering, Dose-dependent hypotension, Arrhythmias, Malignant hyperthermia (rare), Elevations in white blood count, May decrease creatinine and increase BUN, Ileus, severe (fatal), Hepatic dysfunction (postoperative period),Respiratory depression may occur</p>\r\n\r\n<p><strong>Pregnancy &amp; Lactation</strong></p>\r\n\r\n<p><strong>Pregnancy</strong>&nbsp;Category C. Isoflurane has been shown to have a possible anesthetic-related fetotoxic effect in mice when given in doses 6 times the human dose. There are no adequate and well-controlled studies in pregnant women. Isoflurane should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.<br />\r\n<br />\r\n<strong>Nursing Mothers</strong>: It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when Isoflurane is administered to a nursing woman.</p>\r\n\r\n<p><strong>Precautions &amp; Warnings</strong></p>\r\n\r\n<p>Perioperative hyperkalaemia; raised intracranial pressure. May impair ability to drive or operate machinery. Pregnancy and lactation. Do not allow carbon dioxide absorbents in anaesthetic apparatus to dry out when delivering isoflurane to minimise the risk of developing elevated carboxyhaemoglobin levels.</p>\r\n\r\n<p><strong>Therapeutic Class</strong></p>\r\n\r\n<p>General (Inhalation) anesthetics</p>\r\n\r\n<p><strong>Storage Conditions</strong></p>\r\n\r\n<p>Store at room temperature 15&deg;-30&deg;C.&nbsp;Isoflurane contains no additives and has been demonstrated to be stable at room temperature for periods in excess of five years.</p>', 1, '2022-01-27 09:19:11', '2022-06-04 04:14:21'),
(4, 1, NULL, NULL, NULL, NULL, 'Sevoflurane', NULL, '13000.00', '1043626528.jpg', 'https://google.com', '<p><strong>Indications</strong></p>\r\n\r\n<p>Sevoflurane is indicated for induction and maintenance of general&nbsp;anesthesia&nbsp;in adult and pediatric patients for inpatient and outpatient surgery. Sevoflurane should be administered only by persons trained in the administration of general anesthesia. Facilities for maintenance of a patent&nbsp;airway, artificial&nbsp;ventilation, oxygen enrichment, and&nbsp;circulatory&nbsp;resuscitationmust be immediately available. Since level of anesthesia may be altered rapidly, only vaporizers producing predictable concentrations of sevoflurane should be used.</p>\r\n\r\n<p><strong>Pharmacology</strong></p>\r\n\r\n<p>Sevoflurane is a volatile halogenated general anaesthetic that has a minimum alveolar concentration (MAC) value ranging from 1.4% to 3.3%. It alters the activity of fast synaptic neurotransmitter receptors like nicotinic acetylcholine, GABA, and glutamate. It may depress myocardial contractility and decrease both BP and sympathetic nervous activity. Additionally, it has muscle relaxant properties w/o analgesia.</p>\r\n\r\n<p><strong>Dosage &amp; Administration</strong></p>\r\n\r\n<p>he concentration of sevoflurane being delivered from a vaporizer during anesthesia should be known. This may be accomplished by using a vaporizer calibrated specifically for sevoflurane. The administration of general anesthesia must be individualized based on the patient&#39;s response.<br />\r\n<br />\r\n<strong>Replacement Of Desiccated CO2&nbsp;Absorbents</strong>: When a clinician suspects that the CO2&nbsp;absorbent may be desiccated, it should be replaced. The exothermic reaction that occurs with sevoflurane and CO2&nbsp;absorbents is increased when the CO2&nbsp;absorbent becomes desiccated, such as after an extended period of dry gas flow through the CO2&nbsp;absorbent canisters<br />\r\n<br />\r\n<strong>Pre-anesthetic Medication</strong>: No specific premedication is either indicated or contraindicated with sevoflurane. The decision as to whether or not to premedicate and the choice of premedication is left to the discretion of the&nbsp;anesthesiologist<br />\r\n<br />\r\n<strong>Induction</strong>: Sevoflurane has a nonpungent odor and does not cause respiratory irritability; it is suitable for mask induction in&nbsp;pediatrics&nbsp;and adults<br />\r\n<br />\r\n<strong>Maintenance</strong>: Surgical levels of anesthesia can usually be achieved with concentrations of 0.5-3% sevoflurane with or without the concomitant use of&nbsp;nitrous oxide. Sevoflurane can be administered with any type of anesthesia circuit</p>\r\n\r\n<p><strong>Interaction</strong></p>\r\n\r\n<p>Increased metabolism and toxicity with drugs that induce CYP2E1 isoenzyme (e.g. isoniazid). Reduced MAC with benzodiazepines, opioids. May cause ventricular arrhythmia with &beta;-sympathomimetic agents (e.g. isoprenaline), and &alpha;- and &beta;-sympathomimetic agents (e.g. adrenaline, noradrenaline). May cause crisis during operation with nonselective MAO inhibitors. May lead to marked hypotension and risk of additive negative inotropic effect with Ca antagonists (esp dihydropyridines).</p>\r\n\r\n<p><strong>Contraindications</strong></p>\r\n\r\n<p>Sevoflurane can cause malignant hyperthermia. It should not be used in patients with known sensitivity to sevoflurane or to other halogenated agents nor in patients with known or suspected susceptibility to malignant hyperthermia.</p>\r\n\r\n<p><strong>Side Effects</strong></p>\r\n\r\n<p>Cardiorespiratory depression, hypotension, bradycardia; laryngospasm, increased cough and salivation; urinary retention, acute renal failure, changes in liver enzyme values, liver damage; nausea, vomiting, delirium, seizure; rash, urticaria, pruritus, dyspnoea, wheezing, chest discomfort, bronchospasm, anaphylactic/anaphylactoid reaction; agitation, dystonic movements (childn).</p>\r\n\r\n<p><strong>Pregnancy &amp; Lactation</strong></p>\r\n\r\n<p><strong>Pregnancy</strong>&nbsp;Category B. Reproduction studies have been performed in rats and rabbits at doses up to 1 MAC (minimum alveolar concentration) without CO2 absorbent and have revealed no evidence of impaired fertility or harm to the fetus due to sevoflurane at 0.3 MAC, the highest nontoxic dose. Developmental and reproductive toxicity studies of sevoflurane in animals in the presence of strong alkalies (i.e., degradation of sevoflurane and production of Compound A) have not been conducted. There are no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, sevoflurane should be used during pregnancy only if clearly needed.<br />\r\n<br />\r\n<strong>Labor And Delivery</strong>: Sevoflurane has been used as part of general anesthesia for elective cesarean section in 29 women. There were no untoward effects in mother or neonate (see Pharmacodynamics - Clinical Trials). The safety of sevoflurane in labor and delivery has not been demonstrated.<br />\r\n<br />\r\n<strong>Nursing Mothers</strong>: The concentrations of sevoflurane in milk are probably of no clinical importance 24 hours after anesthesia. Because of rapid washout, sevoflurane concentrations in milk are predicted to be below those found with many other volatile anesthetics.</p>\r\n\r\n<p><strong>Precautions &amp; Warnings</strong></p>\r\n\r\n<p>Patient with increased intracranial pressure, neuromuscular disease (esp Duchenne muscular dystrophy), mitochondrial disorders. Patient who are hypovolaemic, hypotensive, haemodynamically compromised, at risk of QT prolongation. Hepatic and renal impairment. Childn. Pregnancy and lactation.</p>\r\n\r\n<p><strong>Use in Special Populations</strong></p>\r\n\r\n<p><strong>Geriatric Use</strong>: MAC decreases with increasing age. The average concentration of sevoflurane to achieve MAC in an 80 year old is approximately 50% of that required in a 20 year old.<br />\r\n<br />\r\n<strong>Pediatric Use</strong>: Induction and maintenance of general anesthesia with sevoflurane have been established in controlled clinical trials in pediatric patients aged 1 to 18 years. Sevoflurane has a nonpungent odor and is suitable for mask induction in pediatric patients.<br />\r\n<br />\r\nThe concentration of sevoflurane required for maintenance of general anesthesia is age dependent. When used in combination with nitrous oxide, the MAC equivalent dose of sevoflurane should be reduced in pediatric patients. MAC in premature infants has not been determined.<br />\r\n<br />\r\nThe use of sevoflurane has been associated with seizures. The majority of these have occurred in children and young adults starting from 2 months of age, most of whom had no predisposing risk factors. Clinical judgement should be exercised when using sevoflurane in patients who may be at risk for seizures.</p>\r\n\r\n<p><strong>Overdose Effects</strong></p>\r\n\r\n<p>In the event of overdosage, or what may appear to be overdosage, the following action should be taken: discontinue administration of sevoflurane, maintain a patent airway, initiate assisted or controlled ventilation with oxygen, and maintain adequate cardiovascular function.</p>\r\n\r\n<p><strong>Therapeutic Class</strong></p>\r\n\r\n<p>General (Inhalation) anesthetics</p>\r\n\r\n<p><strong>Storage Conditions</strong></p>\r\n\r\n<p>Store between 15-30&deg; C. Protect from light.</p>', 1, '2022-01-27 09:19:11', '2022-05-28 14:37:03'),
(11, 1, NULL, NULL, NULL, NULL, 'Albumin (Human)', NULL, '3600.00 (50 mL bottle)   &           ।         ৳ 7600.00  (100 mL bottle)', '622975379.png', 'https://google.com', '<p><strong>Indications</strong></p>\r\n\r\n<p><strong>Shock:</strong>&nbsp;Albumin&nbsp;is indicated in the emergency treatment of shock and in other similar conditions where the restoration of blood volume is urgent. If there has been considerable loss of&nbsp;red blood cells,&nbsp;transfusion&nbsp;with packed red blood cells is indicated.<br />\r\n<br />\r\n<strong>Burns:</strong>&nbsp;Albumin or Albumin in either normal saline or dextrose is indicated to prevent marked hemoconcentration and to maintain appropriate&nbsp;electrolyte&nbsp;balance.<br />\r\n<br />\r\n<strong>Hypoproteinemia with or without edema:</strong>&nbsp;Albumin is indicated in those clinical situations usually associated with a low concentration of&nbsp;plasma&nbsp;protein&nbsp;and a resulting decreased circulating blood volume. Although&nbsp;diuresis&nbsp;may occur soon after albumin administration has been instituted, best results are obtained if albumin is continued until the normal serum protein level is regained.</p>\r\n\r\n<p><strong>Pharmacology</strong></p>\r\n\r\n<p>The main function of albumin results from its contribution to plasma colloid oncotic pressure and transport function. Albumin stabilizes circulating blood volume and carries hormones, enzymes, medicines, and toxins. Other physiological functions include antioxidant properties, free radical scavenging, in addition to maintenance capillary membrane integrity. Exogenously administered albumin increases the oncotic pressure of the intravascular system, moving fluids from the interstitial space, thereby decreasing edema and increasing the circulating blood volume. The increase in volume reduces the concentration and viscosity of blood in patients with decreased circulating blood volume while maintaining cardiac output in shock. In dehydrated patients, negligible effects exist on circulating blood volume. In addition to the above albumin replaces protein in patients with hypoproteinemia until the cause of the deficiency can be determined.<br />\r\n<br />\r\nThis drug has thousands of endogenous and exogenous targets. Human albumin also binds and carries a plethora of hydrophobic molecules, such as endogenous (i.e., cholesterol, fatty acids, bilirubin, thyroxine) or exogenous substances (for example, drugs and toxins), transition metal ions, as well as gas (nitric oxide [NO]), with resulting implications for their solubilisation, transport, metabolism, and detoxification.</p>\r\n\r\n<p><strong>Dosage &amp; Administration</strong></p>\r\n\r\n<p><strong>Human albumin 25%</strong>&nbsp;is for intravenous administration only. Human albumin may be diluted with 5% glucose or 0.9% sodium chloride. Concentration, dosage, and infusion-rate should be adjusted to the patient&rsquo;s individual requirements and indication.</p>\r\n\r\n<ul>\r\n	<li>Hypovolemia: Initial dose 25 g is suggested.</li>\r\n	<li>Hypoalbuminemia: 50-75 gm</li>\r\n	<li>Prevention of central volume fluid removed depletion after</li>\r\n	<li>paracentesis due to cirrhotic ascites: 6-8 gm for every 1000 mL of ascitic.</li>\r\n	<li>OHSS: 50 to 100 gm over 4 hours and repeated at 4-12 hour intervals as necessary. 10-50 gm; single infusion.</li>\r\n	<li>ARDS: 25 g over 30 minutes and repeated at 8 hours for 3 days if necessary.</li>\r\n	<li>Burns: Determined by direct observation of vital sign or measurement of either plasma oncotic pressure or protein content.</li>\r\n</ul>\r\n\r\n<p><strong>Human albumin 20%</strong>: Measures of adequacy of circulating volume and not plasma albumin levels should be used to determine the dose required. If human albumin is to be administered, haemodynamic performance should be monitored regularly; this may include:</p>\r\n\r\n<ul>\r\n	<li>arterial blood pressure and pulse rate</li>\r\n	<li>central venous pressure</li>\r\n	<li>pulmonary artery wedge pressure</li>\r\n	<li>urine output</li>\r\n	<li>electrolyte</li>\r\n	<li>haematocrit / haemoglobin</li>\r\n</ul>\r\n\r\n<p>The solution can be directly administered by the intravenous route, or it can be diluted in an isotonic solution (e.g. 0.9% sodium chloride). In plasma exchange the infusion rate should be adjusted to the rate of removal.<br />\r\n<br />\r\n<strong>Human albumin 5%</strong>&nbsp;may be given intravenously without further dilution. This concentration is approximately isotonic and iso-osmotic with citrated plasma. Albumin (Human) in this concentration provides additional fluid for plasma volume expansion. Therefore, when it is administered to patients with normal blood volume, the rate of infusion should be slow enough to prevent too rapid expansion of plasma volume.<br />\r\n<br />\r\nIn the treatment of shock in an adult patient an initial dose of 500 mL of the 5% albumin solution is given as rapidly as tolerated. If response within 30 minutes is inadequate, an additional 500 mL of 5% albumin solution may be given. The 50 mL dosage form would be appropriate for pediatric use, with a dose of 10-20 mL per kg of body weight infused intravenously at a rate up to 5-10 mL per minute. Therapy should be guided by the clinical response, blood pressure and an assessment of relative anemia. If more than 1000 mL are given, or if hemorrhage has occurred, the administration of packed red blood cells may be desirable.<br />\r\n<br />\r\nIn severe burns, immediate therapy should include large volumes of crystalloid with lesser amounts of 5% albumin solution to maintain an adequate plasma volume. After the first 24 hours, the ratio of albumin to crystalloid may be increased to establish and maintain a plasma albumin level of about 2.5 g/100 mL or a total serum protein level of about 5.2 g/100 mL. However, an optimal regimen for the use of colloids, electrolytes and water after severe burns has not been established.<br />\r\n<br />\r\nThe infusion of Albumin (Human) as a nutrient in the treatment of chronic hypoproteinemia is not recommended. In acute hypoproteinemia, 5% albumin may be used in replacing the protein lost in hypoproteinemic conditions. However, if edema is present or if large amounts of albumin are lost, Albumin (Human) 25% is preferred because of the greater amount of protein in the concentrated solution. Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit.</p>\r\n\r\n<p><strong>Interaction</strong></p>\r\n\r\n<p>Albumin solution should not be mixed by protein hydrolysates or alcoholic solutions. Risk of atypical reactions to ACE inhibitors in patients undergoing therapeutic plasma exchange with albumin human replacement.</p>\r\n\r\n<p><strong>Contraindications</strong></p>\r\n\r\n<p>Albumin (Human) may be contraindicated in patients with severe anemia or cardiac failure and in patients with a history of allergic reactions to human albumin.</p>\r\n\r\n<p><strong>Side Effects</strong></p>\r\n\r\n<p>Allergic or pyrogenic reactions are characterized primarily by fever and chills; rash, nausea, vomiting, tachycardia and hypotension have also been reported. Should an adverse reaction occur, slow or stop the infusion for a period of time which may result in the disappearance of the symptoms. If administration has been stopped and the patient requires additional Albumin (Human), material from a different lot should be used. Albumin (Human), particularly if administered rapidly, may result in vascular overload with resultant pulmonary edema.</p>\r\n\r\n<p><strong>Pregnancy &amp; Lactation</strong></p>\r\n\r\n<p>Pregnancy&nbsp;Category C.&nbsp;Either studies in animals have revealed adverse effects on the foetus (teratogenic or embryocidal or other) and there are no controlled studies in women or studies in women and animals are not available. Drugs should be given only if the potential benefit justifies the potential risk to the foetus.</p>\r\n\r\n<p><strong>Precautions &amp; Warnings</strong></p>\r\n\r\n<p>Hypertension or low cardiac reserve; additional fluids for dehydrated patients. Monitor for signs of cardiac overload in injured or postoperative patients. May carry risk of viral transmission. Volume admin and rate of infusion must always be individualised according to situation and response. Pregnancy, lactation.</p>\r\n\r\n<p><strong>Use in Special Populations</strong></p>\r\n\r\n<p>No clinical studies using Albumin (Human) have been conducted in pediatric patients. Safety and effectiveness in pediatric patients have not been established. However, extensive experience in patients suggests that children respond to Albumin (Human) in the same manner as adults.</p>\r\n\r\n<p><strong>Therapeutic Class</strong></p>\r\n\r\n<p>Plasma expanders</p>\r\n\r\n<p><strong>Storage Conditions</strong></p>\r\n\r\n<p>Store below 30&deg;C. Do not freeze.</p>', 1, '2022-01-27 09:19:11', '2022-05-28 14:37:49'),
(12, 1, NULL, NULL, NULL, NULL, 'Hexiscrub Hand Rub (Chlorhexidine Gluconate [4%])', NULL, '300 (250 ml bottle)', '671300317.jpg', 'https://google.com', '<p><strong>Indications</strong></p>\r\n\r\n<p>Chlorhexidine Gluconate (4%) is indicated in-</p>\r\n\r\n<ul>\r\n	<li>Surgical hand scrub: significantly reduces the number of microorganisms on the hands and forearms prior to surgery or patient care</li>\r\n	<li>Healthcare personnel handwash: helps reduce bacteria that potentially can cause disease</li>\r\n	<li>Patient preoperative skin preparation: for the preparation of the patient&#39;s skin prior to surgery</li>\r\n	<li>Skin wound and general skin cleansing.</li>\r\n</ul>\r\n\r\n<p><strong>Pharmacology</strong></p>\r\n\r\n<p>Chlorhexidine is a very potent cationic chemoprophylactic agent that has a broad-spectrum of activity against gm+ve and gm-ve bacteria. It is both bacteriostatic and bactericidal depending on its concentration. The bactericidal effect, which is achieved at high concentrations, is due to the binding of the cationic to negatively charged bacterial cell walls and extramicrobial complexes. Bacteriostatic effect is achieved at low concentrations which causes an alteration of bacterial cell osmotic equilibrium and leakage of potassium and phosphorus.</p>\r\n\r\n<p><strong>Dosage &amp; Administration</strong></p>\r\n\r\n<p><strong>হাত ধোয়ায়</strong>: পানিতে হাত ভিজিয়ে নিন। প্রায় ৫ মিলি Chlorhexidine নিয়ে ১ মিনিট ধরে হাত ধুতে থাকুন ; নখের প্রতি বিশেষ মনযোগ দিন। পরিষ্কার পানিতে হাত ধুয়ে ফেলুন ও শুকিয়ে নিন। দ্রুত ব্যাকটেরিয়া বিনাশী ত্বক পরিষ্কারক দ্রবণ, যা শল্য চিকিৎসার পূর্বে হাতকে সংক্রামক জীবাণুমুক্ত করে এবং হাসপাতালের ওয়ার্ডসমূহে নিয়মিত ব্যবহারে বহুমুখী সংক্রামণের ঝুঁকি কমায়।<br />\r\n<br />\r\n<strong>শল্য চিকিৎসায় অস্ত্রপচার এর পূর্বে হাত ধোয়ায়</strong>: পানিতে হাতের কুনুই পর্যন্ত ভিজিয়ে নিন। প্রায় ৫ মিলি Chlorhexidine নিয়ে ১ মিনিট ধরে হাত ধুতে থাকুন; নখ পরিষ্কারের জন্য ব্রাশ বা র্স্ক্যাপার ব্যাবহার করুন। পরিষ্কার পানিতে হাত ধুয়ে ফেলুন। একই পদ্ধতিতে ২ মিনিট ধরে পুনরায় হেক্সিস্ক্রাব ব্যাবহার করুন।</p>\r\n\r\n<p><strong>Contraindications</strong></p>\r\n\r\n<p>Do not use</p>\r\n\r\n<ul>\r\n	<li>if you are allergic to chlorhexidine gluconate or any other ingredients</li>\r\n	<li>in contact with meninges</li>\r\n	<li>in the genital area</li>\r\n	<li>as a preoperative skin preparation of the head or face.</li>\r\n</ul>\r\n\r\n<p><strong>Precautions &amp; Warnings</strong></p>\r\n\r\n<p>শিশুদের নাগালের বাইরে রাখুন। চোখ, মস্তিষ্ক, মেনিঞ্জেস ও মধ্যকর্ণ হতে দূরে রাখুন । চোখের সংপর্শে এলে তাৎক্ষনিকভাবে পর্যাপ্ত পানি দিয়ে চোখ ধুয়ে ফেলুন । আলো থেকে দূরে, ঘরে স্বাভাবিক তাপমাত্রায় রাখুন। ক্লোরহেক্সিডিন সাবান ও অন্যান্য অ্যানায়নিক এর সাথে ইনকমপিটেবল । কেবলমাত্র দেহের বহিরাংশে ব্যাবহারের জন্য ।</p>\r\n\r\n<p><strong>Therapeutic Class</strong></p>\r\n\r\n<p>Other antibacterial preparation</p>\r\n\r\n<p><strong>Storage Conditions</strong></p>\r\n\r\n<p>Store in a cool and dry place, protected from light.</p>', 1, '2022-01-27 09:19:11', '2022-05-28 14:48:56');
INSERT INTO `products` (`id`, `cat_id`, `brand_id`, `company_id`, `unit`, `origin`, `name`, `specification`, `price`, `image`, `btn_link`, `desc`, `is_featured`, `created_at`, `updated_at`) VALUES
(13, 1, NULL, NULL, NULL, NULL, 'Povidone Iodine Solution', NULL, '110.00 (100 ml bottle), 552.00 (500 ml bottle), 770.00 (1000 ml bottle)', '2027328079.jpg', 'http://127.0.0.1:8000/product/11/atash-atop---25kg', '<p><strong>Indications</strong></p>\r\n\r\n<p><strong>Cream or ointment</strong>:<br />\r\nTherapeutically: As an adjunct to systemic therapy in the following indications-</p>\r\n\r\n<ul>\r\n	<li>Primary or secondary topical infections</li>\r\n	<li>Infected surgical incisions</li>\r\n	<li>Infected decubitus or stasis ulcers</li>\r\n	<li>Pyodermas</li>\r\n	<li>Secondarily infected dermatoses</li>\r\n	<li>Infected traumatic lesions</li>\r\n</ul>\r\n\r\n<p><strong>Prophylactically:</strong></p>\r\n\r\n<ul>\r\n	<li>To prevent microbial contaminations in burns, incisions and other topical lesions</li>\r\n	<li>For degerming skin in hyperalimentation, the umbilical area or circumcision</li>\r\n	<li>Its use for abrasions, minor cuts, and wounds prevents the development of infections and permits wound healing.</li>\r\n</ul>\r\n\r\n<p><strong>Solution</strong>:</p>\r\n\r\n<ul>\r\n	<li>For the prevention and treatment of surface infections as well as to degerm the skin, mucous membrane and hyperalimentation procedures</li>\r\n	<li>For seborrhea</li>\r\n	<li>For preoperative and postoperative scrubbing and washing of hospital operating room and equipments</li>\r\n	<li>For preoperative prepping of operative site, including the vagina</li>\r\n	<li>For disinfection of wounds, burns, lacerations and abrasions</li>\r\n	<li>As a prophylactic anti-infective agent in house, hospital &amp; office procedures</li>\r\n	<li>Postoperative application to incisions to help prevent infection</li>\r\n	<li>In oral moniliasis (thrush); bacterial and mycotic skin infections, decubitus &amp; stasis ulcers</li>\r\n	<li>As a preoperative swab in the mouth &amp; throat</li>\r\n</ul>\r\n\r\n<p><strong>Gargle &amp; Mouthwash</strong>: It is a pleasantly flavoured solution which is used:</p>\r\n\r\n<ul>\r\n	<li>For the treatment of acute mucosal infections of the mouth and pharynx.</li>\r\n	<li>For oral hygiene prior to, during and after dental and oral surgery.</li>\r\n</ul>\r\n\r\n<p><strong>Surgical Scrub</strong>: It is a golden surfactant solution, forms rich, golden lather which is used: As an antiseptic skin cleanser for preoperative and postoperative scrubbing and washing by surgeons and operation theatre staff and preoperative preparation of patients&#39; skin<br />\r\n<br />\r\n<strong>Powder</strong>: It is used for topical application in the following indications: Superficial wounds, Minor cuts, Burns, Abrasions, Lacerations, In the treatment and prevention of infections.<br />\r\n<br />\r\n<strong>Ophthalmic Solution</strong>: Povidone is used for the symptomatic treatment of dry eye conditions including keratoconjunctivitis sicca. It is also given as a substitute for tear fluid in case of the unstable tear film or insufficient moistening of the eye surface.</p>\r\n\r\n<p><strong>Pharmacology</strong></p>\r\n\r\n<p>Povidone Iodine is a complex of iodine and an organic polymer, povidone. This polymerization makes Povidone Iodine superior to ordinary elemental iodine. It prolongs the germicidal activity of iodine by liberating elemental iodine slowly. Consequently it has a lower toxicity than elemental iodine. It gives rapid microbicidal activity against both Gram-positive and Gram-negative bacteria, protozoa, viruses and fungi/yeasts. It is also sporicidal. It is the only microbicide with this broad spectrum of activity. It is non-staining, exerts prolong germicidal action and is also active in the presence of soap, blood, serum, pus, mucosal secretions and water.</p>\r\n\r\n<p><strong>Dosage &amp; Administration</strong></p>\r\n\r\n<p><strong>Cream or ointment</strong>:</p>\r\n\r\n<ul>\r\n	<li>For the treatment of infection: Apply once or twice daily or at dressing changes for a maximum of 14 days.</li>\r\n	<li>For the prevention of infection: Apply once or twice a week for as long as necessary. The affected skin should be cleaned and dried and can be covered with a dressing or bandage.</li>\r\n</ul>\r\n\r\n<p><strong>Solution</strong>: Apply full strength as often as needed as paint, spray, or wet soak. Maybe bandaged (where necessary).<br />\r\n<br />\r\n<strong>Gargle &amp; Mouthwash</strong>: Adults and children over 6 years of age: Use undiluted or diluted with an equal volume of warm water. Gargle or rinse with up to 10 mL for up to 30 seconds without swallowing. Repeat up to four times daily, for up to 14 consecutive days, or as advised by the Registered Dental Surgeon/Physician.<br />\r\n<br />\r\n<strong>Surgical Scrub</strong>:</p>\r\n\r\n<ul>\r\n	<li>For Preoperative and Postoperative washing by Operating Personnel: Wet hands and forearms with water. Pour about 5 mL of Povidone Iodine Surgical Scrub on the palm of the hand and spread over both hands and forearms. Without adding more water, rub the Scrub thoroughly over all areas for about five minutes. Use a brush if desired. Clean thoroughly under fingernails. Add a little water and develop copious suds. Rinse thoroughly under running water. Complete the wash by scrubbing with another 5 mL of Povidone Iodine Surgical Scrub in the same way.</li>\r\n	<li>For Preoperative use on Patients: After the skin area is shaved, wet it with water. Apply Povidone Iodine Surgical Scrub (1 mL is sufficient to cover an area of 20-30 square inches), develop lather and scrub thoroughly for about five minutes. Rinse off by aid of sterile gauze saturated with water.</li>\r\n	<li>For use in the Physician&#39;s Office: Use for washing whenever a germicidal soap is required.</li>\r\n</ul>\r\n\r\n<p><strong>Powder</strong>: Apply a light dusting of powder to the affected area. When dry, this forms a protective antiseptic layer over the area treated. Or use as advised by the Registered Physician. There are no special dosage recommendations for children or elderly patients.<br />\r\n<br />\r\n<strong>Ophthalmic Solution</strong>: 1 drop 4 times daily or as required, depending upon the severity of the disease, to be instilled into the conjunctival sac.</p>\r\n\r\n<p><strong>Interaction</strong></p>\r\n\r\n<p>It exhibits interaction with strong alkali, sodium thiosulphate, sodium metabisulphite and thiomersal. Use with concurrent lithium therapy has been shown to exhibithypothyroidic effect.</p>\r\n\r\n<p><strong>Contraindications</strong></p>\r\n\r\n<p>It can cause hypersensitivity reactions. Regular use in patients with thyroid disorders (in particular nodular colloid goitre, endemic goitre and Hashimoto&#39;s thyroiditis) or those receiving lithium therapy is to be avoided. In severely burnt patients serum iodide levels should be assessed due to possible hepatic and renal impairment. Povidone Iodine Powder should not be used in serious cavities and in Children under the age of 2 years.</p>\r\n\r\n<p><strong>Side Effects</strong></p>\r\n\r\n<p>Povidone Iodine may cause hypersensitivity reactions and irritation of the skin and mucous membranes. The application of povidone Iodine to severe burns or to large areas otherwise denuded of skin may produce systemic adverse effects such as metabolic acidosis, hypernatraemia, and impairment of renal function. It may interfere with thyroid function tests.</p>\r\n\r\n<p><strong>Pregnancy &amp; Lactation</strong></p>\r\n\r\n<p>Povidone Iodine Cream, Solution &amp; Powder are not recommended for use during pregnancy because of the possibility of absorption of sufficient iodine to affect the fetal thyroid. American Academy of Pediatrics considers that the use of Povidone-Iodine is usually compatible with breast feeding. Consult Registered Physician. Regular use of Gargle &amp; Mouthwash and Surgical Scrub should also be avoided in pregnant and lactating women.<br />\r\n<br />\r\nThere is no experience regarding the safety of the Povidone eye drops in human pregnancy or lactation. Administration during pregnancy and lactation is therefore not recommended, except for compelling reasons.</p>\r\n\r\n<p>Precautions &amp; Warnings</p>\r\n\r\n<p><strong>Cream or ointment</strong>: In case of deep or puncture wounds or serious burns, consult Registered Physician. If redness, irritation, swelling or pain persists or increases or if infection occurs, discontinue use and consult Registered Physician.<br />\r\n<br />\r\n<strong>Solution</strong>: In preoperative prepping, avoid &#39;pooling&#39; beneath the patient. Prolonged exposure to wet solution may cause irritation or rarely, severe skin reactions. In case of deep or puncture wounds or serious burns, consult Registered Physician. If redness, irritation, swelling or pain persists or increases or if infection occurs, discontinue use and consult Registered Physician.<br />\r\n<br />\r\n<strong>Gargle &amp; Mouthwash</strong>: Regular use should be avoided as prolonged use may lead to the absorption of a significant amount of iodine. Do not use for more than 14 days. If sores or ulcers in the mouth do not heal within 14 days seek dental or medical advice. It is also not for use in children under 6 years of age. Regular use should be avoided in patients on concurrent lithium therapy.<br />\r\n<br />\r\n<strong>Surgical Scrub</strong>: Special caution is needed when regular applications to broken skin are made to patients with pre-existing renal insufficiency. Regular use should be avoided in patients on concurrent lithium therapy. It can permanently discolor white gold jewellery and it is recommended that this type of jewellery should be removed before using this product.<br />\r\n<br />\r\n<strong>Powder</strong>: Care must be taken when used on known iodine sensitivity, although do not normally react to Povidone-Iodine. Excess powder can be washed off readily with warm water. It should be used directly from the container. Not to be administered internally.<br />\r\n<br />\r\n<strong>Ophthalmic Solution</strong>: Patients, who experience blurred vision after application of the eye drops, should not drive or use machinery until their vision has cleared. Contact lenses should not be worn during the instillation of the drug. After instillation, there should be an interval of at least 30 minutes before reinsertion.</p>\r\n\r\n<p>Therapeutic Class</p>\r\n\r\n<p>Iodine compounds (Anti-septic Preparations)</p>\r\n\r\n<p>Storage Conditions</p>\r\n\r\n<p>Store below 25&deg;C. Do not freeze. Store in a cool and dry place, protected from light. Keep out of the reach of children. Do not touch the ophthalmic solution dropper tip to any surface as this may contaminate this preparation. Do not use it after one month of the first opening.</p>', 1, '2022-02-06 03:49:25', '2022-05-28 14:49:50'),
(14, 5, 1720, 43, 'P/Pc', 'Oxford (AstraZeneca)', 'Covishield (Covid Vaccine)', 'Covid-19', 'N/A', '598398032.jpg', 'www.alpha-medicare.com', '<p><strong>Indications</strong></p>\r\n\r\n<p>Increases immunity against Corona Virus.</p>\r\n\r\n<p><strong>Description</strong></p>\r\n\r\n<p>The coronavirus vaccine developed by the University of Oxford is highly effective at stopping people developing Covid-19 symptoms, a large trial shows. Interim data suggests 70% protection, but the researchers say the figure may be as high as 90% by tweaking the dose. The results will be seen as a triumph, but come after Pfizer and Moderna vaccines showed 95% protection. However, the Oxford jab is far cheaper, and is easier to store and get to every corner of the world than the other two. So the vaccine will play a significant role in tackling the pandemic, if it is approved for use by regulators. The announcement today takes us another step closer to the time when we can use vaccines to bring an end to the devastation caused by [the virus],&quot; said the vaccine&#39;s architect, Prof Sarah Gilbert. The UK government has pre-ordered 100 million doses of the Oxford vaccine, and AstraZeneca says it will make three billion doses for the world next year.<br />\r\n<br />\r\nPrime Minister Boris Johnson said it was &quot;incredibly exciting news&quot; and that while there were still safety checks to come, &quot;these are fantastic results&quot;. Speaking at a Downing Street briefing on Monday evening, Mr Johnson added that the majority of people most in need of a vaccination in the UK might be able to get one by Easter. And Prof Andrew Pollard - director of the Oxford vaccine group- said it had been &quot;a very exciting day&quot; and paid tribute to the 20,000 volunteers in the trials around the world, including more than 10,000 in the UK.</p>\r\n\r\n<p><strong>Dosage &amp; Administration</strong></p>\r\n\r\n<p>The total number of these vaccine doses, if they are approved to be utilised in the course of time, should be enough to vaccine half of the country&#39;s over 1.3 billion population given the fact that most of the vaccine candidates against the coronavirus require two doses.</p>\r\n\r\n<p><strong>Therapeutic Class</strong></p>\r\n\r\n<p>Vaccines, Anti-sera &amp; Immunoglobulin</p>', 1, '2022-02-12 00:51:18', '2022-07-02 19:44:33'),
(15, 4, 69, 127, 'P/Pc', 'BD', 'Acetic Acid Glacial', NULL, '880.00', '1820594711.jpg', 'www.alpha-medicare.com', '<p>Acetic acid, systematically named ethanoic acid, is an acidic, colourless liquid and organic compound with the chemical formula CH₃COOH. Vinegar is no less than 4% acetic acid by volume, making acetic acid the main component of vinegar apart from water and other trace elements.&nbsp;</p>', 1, '2022-02-12 00:57:44', '2022-07-02 19:45:02'),
(16, 2, 201, 127, '1', 'Bangladesh', '40-P object (Microscope-NIKON)', 'N/A', '9350.00', '1976165989.jpg', 'www.alpha-medicare.com', '<p>N/A</p>', 0, '2022-02-12 01:06:39', '2022-06-04 04:23:05'),
(17, 3, 69, 127, 'P/Pc', 'BD', 'C-Arm Fluoroscopic X-Ray Machine (Neuro Surgery Dept)', NULL, '9000000.00', '1511292653.jpg', 'www.alpha-medicare.com', '<p><strong>C-arm is an&nbsp;imaging&nbsp;scanner&nbsp;intensifier</strong>.&nbsp;The name derives&nbsp;from the C-shaped arm used to connect the&nbsp;<strong>x-ray source</strong>&nbsp;and&nbsp;<strong>x-ray detector</strong>&nbsp;to one another.&nbsp;C-arms&nbsp;have&nbsp;radiographic&nbsp;capabilities, though&nbsp;they&nbsp;are&nbsp;used&nbsp;primarily&nbsp;for&nbsp;<strong>fluoroscopic intraoperative imaging</strong>&nbsp;during&nbsp;surgical,&nbsp;orthopedic and&nbsp;emergency care&nbsp;procedures.&nbsp;The devices provide high-resolution&nbsp;X-ray images in real time, thus allowing the physician to monitor progress and immediately make any corrections.</p>', 0, '2022-02-12 01:16:20', '2022-06-04 04:25:28'),
(18, 11, NULL, NULL, NULL, NULL, 'Bed Sheet (বিছানার চাদর)', NULL, '605.00', '456023490.jpg', 'www.alpha-medicare.com', '<p>বিছানার চাদর&nbsp;</p>', 0, '2022-02-13 06:11:28', '2022-02-13 06:11:28'),
(19, 11, NULL, NULL, NULL, NULL, 'Pillow Cover (বালিশের কভার)', NULL, '154.00', '1571194946.jpg', 'www.alpha-medicare.com', '<p>বালিশের কভার</p>', 0, '2022-02-13 06:17:24', '2022-02-13 06:17:24'),
(20, 11, NULL, NULL, NULL, NULL, 'Blanket Wolen (কম্বল - উলেন)', NULL, '2420.00', '1300250060.jpg', 'www.alpha-medicare.com', '<p>কম্বল (উলেন)</p>', 0, '2022-02-13 06:23:14', '2022-02-13 06:23:14'),
(21, 11, NULL, NULL, NULL, NULL, 'Balish Made by Jute (বালিশ_জুট দ্বারা তৈরী)', NULL, '275.00', '694156321.jpg', 'www.alpha-medicare.com', '<p>বালিশ জুট দ্বারা তৈরী</p>', 0, '2022-02-13 06:28:05', '2022-02-13 06:28:05'),
(22, 11, NULL, NULL, NULL, NULL, 'Mosquito nets (white nylon cloth)_মশারী (সাদা নাইলন কাপড়)', NULL, '605.00', '751389297.jpg', 'www.alpha-medicare.com', '<p>মশারী (সাদা নাইলন কাপড়&nbsp;<br />\r\n&nbsp;</p>', 0, '2022-02-13 06:38:41', '2022-02-13 06:38:41'),
(23, 11, NULL, NULL, NULL, NULL, 'Long Cloth (লং ক্লথ কাপড়)', NULL, '104.00', '2023781252.', 'www.alpha-medicare.com', '<p>লং ক্লথ কাপড়</p>', 0, '2022-02-13 06:41:53', '2022-02-13 06:41:53'),
(24, 11, NULL, NULL, NULL, NULL, 'White Drill Cloth (সাদা ড্রিল কাপড়)', NULL, '220.00', '981894660.jpg', 'www.alpha-medicare.com', '<p>সাদা ড্রিল কাপড়</p>', 0, '2022-02-13 06:45:17', '2022-02-13 06:45:17'),
(25, 11, NULL, NULL, NULL, NULL, 'Blue Colored Drill Cloth (নীল রঙয়ের ড্রিল কাপড়)', NULL, '220.00', '425224229.jfif', 'www.alpha-medicare.com', '<p>নীল রঙয়ের ড্রিল কাপড়</p>', 0, '2022-02-13 06:49:40', '2022-02-13 06:49:40'),
(26, 11, NULL, NULL, NULL, NULL, 'Poplin Cloth (পপলিন কাপড়)', NULL, '132.00', '1984320790.jpg', 'www.alpha-medicare.com', '<p>পপলিন কাপড়</p>', 0, '2022-02-13 06:54:10', '2022-02-13 06:54:10'),
(27, 11, NULL, NULL, NULL, NULL, 'Draw Sheet Size (ড্র-সীট সাইজ)', NULL, '198.00', '1208512512.jpg', 'www.alpha-medicare.com', '<p>ড্র-সীট সাইজ</p>', 0, '2022-02-13 07:01:11', '2022-02-13 07:01:11'),
(28, 11, NULL, NULL, NULL, NULL, 'Rubber Cloth (রাবার ক্লথ)', NULL, '418.00', '1779328169.jpg', 'www.alpha-medicare.com', '<p>রাবার ক্লথ</p>', 0, '2022-02-13 07:07:44', '2022-02-13 07:07:44'),
(29, 11, NULL, NULL, NULL, NULL, 'Rexine ( রেকসিন )', NULL, '247.00', '1670160910.jpeg', 'www.alpha-medicare.com', '<p>রােকসিন</p>', 0, '2022-02-13 07:12:07', '2022-02-13 07:12:07'),
(30, 11, NULL, NULL, NULL, NULL, 'Surgeon gown (সার্জন গাউন)', NULL, '605.00', '1083794983.jpg', 'www.alpha-medicare.com', '<p>সাার্জন গাউন</p>', 0, '2022-02-13 07:13:42', '2022-02-13 07:14:48'),
(31, 11, NULL, NULL, NULL, NULL, 'Fatwa and Pajamas (ফতুয়া ও পায়জামা)', NULL, '660.00', '789192168.jpg', 'www.alpha-medicare.com', '<p>ফতুয়া ও পায়জামা</p>', 0, '2022-02-13 07:34:35', '2022-02-13 07:34:35'),
(32, 11, NULL, NULL, NULL, NULL, 'Mexi (মেক্সি)', NULL, '330.00', '872591914.jpg', 'www.alpha-medicare.com', '<p>মেক্সি</p>', 0, '2022-02-13 07:39:23', '2022-02-13 07:39:23'),
(33, 11, NULL, NULL, NULL, NULL, 'Operation Towel (Made of White Drill Cloth)-অপারেশন টাওয়াল (সাদা ড্রিল কাপড়ের তৈরী)', NULL, '275.00', '1332927464.jpg', 'www.alpha-medicare.com', '<p>অপারেশন টাওয়াল (সাদা ড্রিল কাপড়ের তৈরী)</p>', 0, '2022-02-13 07:47:08', '2022-02-13 07:47:08'),
(34, 11, NULL, NULL, NULL, NULL, 'Abdominal sheet (made of white drill cloth)-এ্যাবডোমিনাল সীট (সাদা ড্রিল কাপড়ের তৈরী)', NULL, '247.00', '1282642189.jpg', 'www.alpha-medicare.com', '<p>এ্যাবডোমিনাল সীট (সাদা ড্রিল কাপড়ের তৈরী)</p>', 0, '2022-02-13 07:48:46', '2022-02-13 07:48:46'),
(35, 11, NULL, NULL, NULL, NULL, 'Mattress (Foam)', NULL, '3850.00', '249903147.jpg', 'www.alpha-medicare.com', '<p>Mattress (Foam)</p>', 0, '2022-02-13 07:52:52', '2022-02-13 07:52:52'),
(36, 11, NULL, NULL, NULL, NULL, 'Mattress (Cover)', NULL, '770.00', '1080982271.jpg', 'www.alpha-medicare.com', '<p>Mattress (Cover)</p>', 0, '2022-02-13 07:55:42', '2022-02-13 07:55:42'),
(37, 11, NULL, NULL, NULL, NULL, 'Blanket (Cotton)', NULL, '1210.00', '228916470.jpg', 'www.alpha-medicare.com', '<p>Blanket (Cotton)</p>', 0, '2022-02-13 07:58:20', '2022-02-13 07:58:20'),
(38, 11, NULL, NULL, NULL, NULL, 'Blanket (Cover)', NULL, '550.00', '1425447432.jpeg', 'www.alpha-medicare.com', '<p>Blanket (Cover)</p>', 0, '2022-02-13 08:01:54', '2022-02-13 08:01:54'),
(39, 11, NULL, NULL, NULL, NULL, 'Tenon Cloth', NULL, '99.00', '1388369652.jpg', 'www.alpha-medicare.com', '<p>tenon cloth</p>', 0, '2022-02-13 08:03:33', '2022-02-13 08:03:33'),
(40, 11, NULL, NULL, NULL, NULL, 'Markin Cloth', NULL, '99.00', '140037923.jpg', 'www.alpha-medicare.com', '<p>Marking Cloth</p>', 0, '2022-02-13 08:04:45', '2022-02-13 08:04:45'),
(41, 11, NULL, NULL, NULL, NULL, 'Voil Cloth', NULL, '99.00', '2072344422.jpg', 'www.alpha-medicare.com', '<p>voile cloth</p>', 0, '2022-02-13 08:05:48', '2022-02-13 08:05:48'),
(42, 11, NULL, NULL, NULL, NULL, 'Trouser & Shirt (male/female doctor)', NULL, '880.00', '1224493923.jpg', 'www.alpha-medicare.com', '<p>Trouser &amp; Shirt (male/female doctor)</p>', 0, '2022-02-13 08:08:26', '2022-02-13 08:08:26'),
(43, 11, NULL, NULL, NULL, NULL, 'Maxi for Female Doctor', NULL, '660.00', '1330972595.jpg', 'www.alpha-medicare.com', '<p>Maxi for Female Doctor</p>', 0, '2022-02-13 08:10:08', '2022-02-13 08:10:08'),
(44, 11, NULL, NULL, NULL, NULL, 'Shoe Cover', NULL, '110.00', '2132499310.jpg', 'www.alpha-medicare.com', '<p>Shoe Cover</p>', 0, '2022-02-13 08:11:56', '2022-02-13 08:11:56'),
(45, 11, NULL, NULL, NULL, NULL, 'Corrugated (Rubber Sheet)', NULL, '110.00', '1551234824.jpg', 'www.alpha-medicare.com', '<p>Corrugated (Rubber Sheet)</p>', 0, '2022-02-13 08:13:02', '2022-02-13 08:13:02'),
(46, 9, NULL, NULL, NULL, NULL, 'Surgical Gauge (Absorbent)', NULL, '302.00', '1111854004.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-02-15 06:40:28', '2022-02-15 06:40:28'),
(47, 9, NULL, NULL, NULL, NULL, 'Surgical Bandage', NULL, '302.00', '49761841.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-02-15 06:40:55', '2022-02-15 06:40:55'),
(48, 9, NULL, NULL, NULL, NULL, 'Absorbent Cotton', NULL, '165.00', '1837676836.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-02-15 06:41:18', '2022-02-15 06:41:18'),
(49, 9, NULL, NULL, NULL, NULL, 'Alcohol Swab for Aseptic Cleaning (Isopropyl Alcohol 70%)', NULL, '5.50', '1022694172.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-02-15 06:41:54', '2022-02-15 06:41:54'),
(50, 9, NULL, NULL, NULL, NULL, 'Sterile Chlorhexidrine antibacterial impregnated dressing', NULL, '550.00', '1203792832.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-02-15 06:42:20', '2022-02-15 06:42:20'),
(51, 9, NULL, NULL, NULL, NULL, 'Sterile Paraffin Impregnated Dressing', NULL, '154.00', '171610546.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-02-15 06:45:04', '2022-02-15 06:45:04'),
(52, 9, NULL, NULL, NULL, NULL, 'Plaster of Paris, (4\" / 6\")', NULL, '110.00', '988316328.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-02-15 06:46:46', '2022-02-15 06:46:46'),
(53, 9, NULL, NULL, NULL, NULL, 'Micropore (Leukopor) 0.5\"/1\"/2\"/3\"', NULL, '850.00', '1778965814.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-02-15 06:49:35', '2022-02-15 06:49:35'),
(54, 9, NULL, NULL, NULL, NULL, 'Surgical adhesive plaster with non adherent pad of different Size', NULL, '77.00', '2036650149.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-02-15 06:50:10', '2022-02-15 06:50:10'),
(55, 9, NULL, NULL, NULL, NULL, 'Crepe Bandage- 3\"', NULL, '88.00', '1441305799.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-02-15 06:50:52', '2022-02-15 06:50:52'),
(56, 9, NULL, NULL, NULL, NULL, 'Crepe Bandage- 4\"', NULL, '99.00', '1750434645.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-02-15 06:51:16', '2022-02-15 06:51:16'),
(57, 9, NULL, NULL, NULL, NULL, 'Crepe Bandage- 6\"', NULL, '104.00', '1918178670.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-02-15 06:52:01', '2022-02-15 06:52:01'),
(58, 9, NULL, NULL, NULL, NULL, 'Soft-Roll 4\" & 6\" or 10 cm & 15 cm', NULL, '82.00', '1803275859.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-02-15 06:52:34', '2022-02-15 06:52:34'),
(59, 9, NULL, NULL, NULL, NULL, 'Ribbed Cotton Stockinette: Size :10 m X 7.50 CM/Roll', NULL, '330.00', '1719904326.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-02-15 06:53:06', '2022-02-15 06:53:06'),
(60, 9, NULL, NULL, NULL, NULL, 'Ribbed Cotton Stockinette: Size :1 m X 5.0 CM/Roll', NULL, '330.00', '520297677.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-02-15 06:53:31', '2022-02-15 06:53:31'),
(61, 9, NULL, NULL, NULL, NULL, 'Elastic Adhesive Bandage, Size: 1.0m X 10.0cm/Bandage', NULL, '275.00', '836329719.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-02-15 06:54:10', '2022-02-15 06:54:10'),
(62, 9, NULL, NULL, NULL, NULL, 'Elastic Adhesive Bandage, Size: 1.0m X 4/6 cm/Bandage', NULL, '275.00', '2019936937.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-02-15 06:54:33', '2022-02-15 06:54:33'),
(63, 9, NULL, NULL, NULL, NULL, 'Hypo allergic non woven tape, 9.14 m X 7.50 CM (4 Rolls with Cutter.)/pack', NULL, '275.00', '1955791448.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-02-15 07:01:16', '2022-02-15 07:01:16'),
(64, 9, NULL, NULL, NULL, NULL, 'Hypo allergic non woven tape, 9.14 m X .0 CM (6 Rolls with Cutter)/ pack', NULL, '275.00', '2137311304.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-02-15 07:01:45', '2022-02-15 07:01:45'),
(65, 9, NULL, NULL, NULL, NULL, 'Hypo allergic non woven tape, 9.14 m X 2.50 CM (12 Rolls with Cutter)/ pack', NULL, '275.00', '827123639.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-02-15 07:02:19', '2022-02-15 07:02:19'),
(66, 9, NULL, NULL, NULL, NULL, 'Latex Free Cohesive Bandage. Size:- 10 cm X 2m (Unstretched)', NULL, '600.00', '749986776.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-02-15 07:03:11', '2022-02-15 07:03:11'),
(67, 9, NULL, NULL, NULL, NULL, 'Sterile Collagen Sheets (5 cm X 5cm) Must have drug control Certificate with Authorization', NULL, '375.00', '2081736421.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-02-15 07:04:06', '2022-02-15 07:04:06'),
(68, 9, NULL, NULL, NULL, NULL, 'Sterile Collagen Sheets (10 cm X 10cm) Must have drug control Certificate with Authorization', NULL, '277.00', '1645428446.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-02-15 07:04:43', '2022-02-15 07:04:43'),
(69, 9, NULL, NULL, NULL, NULL, 'Sterile Collagen Sheets 10 cm X 20cm Must have drug control Certificate with Authorization', NULL, '277.00', '704166035.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-02-15 07:05:15', '2022-02-15 07:05:15'),
(70, 9, NULL, NULL, NULL, NULL, 'Roller bandage-1\" Size', NULL, '13.00', '1811247595.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-02-15 07:07:48', '2022-02-15 07:07:48'),
(71, 9, NULL, NULL, NULL, NULL, 'Roller bandage-2\" Size', NULL, '16.00', '490388010.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-02-15 07:08:07', '2022-02-15 07:08:07'),
(72, 9, NULL, NULL, NULL, NULL, 'Roller bandage-3\" Size', NULL, '22.00', '1887803267.', 'www.alpha-medicare.com', NULL, 0, '2022-02-15 07:08:30', '2022-02-15 07:08:30'),
(73, 9, NULL, NULL, NULL, NULL, 'Roller bandage-4\" Size', NULL, '27.00', '781756190.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-02-15 07:08:56', '2022-02-15 07:08:56'),
(74, 9, NULL, NULL, NULL, NULL, 'Roller bandage-5\" / 6\" Size', NULL, '38.00', '961318336.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-02-15 07:09:16', '2022-02-15 07:09:47'),
(75, 9, NULL, NULL, NULL, NULL, 'Micropore 1\" (Nicipore or equivalent)', NULL, '250.00', '32429488.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-02-15 07:12:38', '2022-02-15 07:12:38'),
(76, 9, NULL, NULL, NULL, NULL, 'Micropore 2\" (Nicipore or equivalent)', NULL, '280.00', '1320266465.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-02-15 07:13:37', '2022-02-15 07:13:37'),
(77, 9, NULL, NULL, NULL, NULL, 'Leucoplast (BSN Medical)- Size-2\" (Nicipore or equivalent)', NULL, '154.00', '1064090659.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-02-15 07:14:51', '2022-02-15 07:14:51'),
(78, 9, NULL, NULL, NULL, NULL, 'Leucoplast (BSN Medical)- Size-4\" (Nicipore or equivalent)', NULL, '231.00', '1809687451.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-02-15 07:16:01', '2022-02-15 07:16:01'),
(79, 9, NULL, NULL, NULL, NULL, 'Micro Pore (Lecukopor)- Size-1\" (Nicipore or equivalent)', NULL, '250.00', '1962598225.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-02-15 07:16:43', '2022-02-15 07:16:43'),
(80, 9, NULL, NULL, NULL, NULL, 'Micro Pore (Lecukopor)- Size-2\" (Nicipore or equivalent)', NULL, '121.00', '1960408163.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-02-15 07:17:12', '2022-02-15 07:17:12'),
(81, 9, NULL, NULL, NULL, NULL, 'Micro Pore (Lecukopor)- Size-3\" (Nicipore or equivalent)', NULL, '165.00', '177996951.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-02-15 07:18:14', '2022-02-15 07:18:14'),
(82, 9, NULL, NULL, NULL, NULL, 'Micro Pore (Lecukopor)- Size-4\" (Nicipore or equivalent)', NULL, '242.00', '1420634450.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-02-15 07:18:34', '2022-02-15 07:18:34'),
(83, 9, NULL, NULL, NULL, NULL, 'Micro Pore (Lecukopor)- Size-6\" (Nicipore or equivalent)', NULL, '390.00', '1367137124.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-02-15 07:19:17', '2022-02-15 07:19:17'),
(84, 9, NULL, NULL, NULL, NULL, 'Sofratullae (10 Pcs Box)', NULL, '880.00', '1717976431.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-02-15 07:21:08', '2022-02-15 07:21:08'),
(85, 10, NULL, NULL, NULL, NULL, 'Iron Cot (MS)', NULL, '10450.00', '36457823.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-02-16 05:33:08', '2022-02-16 05:33:08'),
(86, 10, NULL, NULL, NULL, NULL, 'Iron Cot (Special Type)', NULL, '12650.00', '1193286080.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-02-16 05:33:40', '2022-02-16 05:33:40'),
(87, 10, NULL, NULL, NULL, NULL, 'Bed Side Locker (3 years warranty)', NULL, '7700.00', '1164993385.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-02-16 05:34:12', '2022-02-16 05:34:12'),
(88, 10, NULL, NULL, NULL, NULL, 'Bed Side Locker (2 years warranty)', NULL, '6050.00', '2043568705.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-02-16 05:34:41', '2022-02-16 05:34:41'),
(89, 10, NULL, NULL, NULL, NULL, 'Chair for Doctor & Nurse', NULL, '770.00', '1456064764.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-02-16 05:35:40', '2022-02-16 05:35:40'),
(90, 10, NULL, NULL, NULL, NULL, 'Guest Chair (Steel)', NULL, '1650.00', '1257977279.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-02-16 05:36:57', '2022-02-16 05:36:57'),
(91, 10, NULL, NULL, NULL, NULL, '4 Drawer Steel Cabinet', NULL, '11000.00', '1347875053.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-02-16 05:40:04', '2022-02-16 05:40:04'),
(92, 10, NULL, NULL, NULL, NULL, 'Food Trolley (M.S) with big wheel', NULL, '22000.00', '1209739630.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-02-16 05:40:31', '2022-02-16 05:40:31'),
(93, 10, NULL, NULL, NULL, NULL, 'Food Trolley (S.S) with big wheel', NULL, '30000.00', '648894528.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-02-16 05:42:18', '2022-02-16 05:42:18'),
(94, 10, NULL, NULL, NULL, NULL, 'Special Tray to carry food', NULL, '9900.00', '1745482618.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-02-16 05:43:07', '2022-02-16 05:43:07'),
(95, 10, NULL, NULL, NULL, NULL, 'Steel Almira', NULL, '16500.00', '1294083161.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-02-16 05:44:41', '2022-02-16 05:44:41'),
(96, 10, NULL, NULL, NULL, NULL, 'Temperature chart holder', NULL, '605.00', '1998507003.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-02-16 05:45:08', '2022-02-16 05:45:08'),
(97, 10, NULL, NULL, NULL, NULL, 'Balti (বালতি)', NULL, '605.00', '654138921.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-02-16 05:52:11', '2022-02-16 05:52:11'),
(98, 10, NULL, NULL, NULL, NULL, 'Steel Boti (স্টীলের বটি )', NULL, '495.00', '722652192.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-02-16 05:53:21', '2022-02-16 05:53:21'),
(99, 10, NULL, NULL, NULL, NULL, 'Alumium Deski (এ্যালুমিনিয়াম ডেসকি-বড় সাইজ)', NULL, '3850.00', '1169170621.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-02-16 05:54:45', '2022-02-16 05:54:45'),
(100, 10, NULL, NULL, NULL, NULL, 'Alumium Dechki (এ্যালুমিনিয়াম ডেচকি-বড় সাইজ)', NULL, '3630.00', '659590310.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-02-16 05:55:49', '2022-02-16 05:55:49'),
(101, 10, NULL, NULL, NULL, NULL, 'Pata Puta (পাটা পুতা)', NULL, '770.00', '1017445092.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-02-16 05:59:20', '2022-02-16 05:59:20'),
(102, 10, NULL, NULL, NULL, NULL, 'Cover / Dakna (ঢাকনা -15-1/2”)', NULL, '1650.00', '804936636.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-02-16 06:01:01', '2022-02-16 06:01:01'),
(103, 10, NULL, NULL, NULL, NULL, 'Cover / Dakna (ঢাকনা -17”)', NULL, '2200.00', '1926350129.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-02-16 06:01:46', '2022-02-16 06:01:46'),
(104, 10, NULL, NULL, NULL, NULL, 'Cover / Dakna (ঢাকনা -18-1/2”)', NULL, '2750.00', '170121452.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-02-16 06:02:14', '2022-02-16 06:02:14'),
(105, 10, NULL, NULL, NULL, NULL, 'Cover / Dakna (ঢাকনা -21”)', NULL, '2750.00', '679954592.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-02-16 06:02:57', '2022-02-16 06:02:57'),
(106, 10, NULL, NULL, NULL, NULL, 'Cover / Dakna (ঢাকনা -22”)', NULL, '3850.00', '767597760.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-02-16 06:03:34', '2022-02-16 06:03:34'),
(107, 10, NULL, NULL, NULL, NULL, 'Cover / Dakna (ঢাকনা -24-1/2”)', NULL, '2200.00', '1721211400.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-02-16 06:04:24', '2022-02-16 06:04:24'),
(108, 10, NULL, NULL, NULL, NULL, 'ভাত নাড়ার কব্জী', NULL, '1430.00', '1433352889.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-02-16 06:04:54', '2022-02-16 06:04:54'),
(109, 10, NULL, NULL, NULL, NULL, 'রুটির তাওয়া', NULL, '3850.00', '1271764472.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-02-16 06:05:15', '2022-02-16 06:05:15'),
(110, 10, NULL, NULL, NULL, NULL, 'হামবুল দিস্তা (লোহার)', NULL, '2750.00', '1734759186.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-02-16 06:05:39', '2022-02-16 06:05:39'),
(111, 10, NULL, NULL, NULL, NULL, 'মাছ ভাজার কড়াই', NULL, '1980.00', '1731553963.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-02-16 06:06:17', '2022-02-16 06:06:17'),
(112, 10, NULL, NULL, NULL, NULL, 'হ্যান্ডেলসহ কড়াই', NULL, '2750.00', '641855917.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-02-16 06:07:31', '2022-02-16 06:07:31'),
(113, 10, NULL, NULL, NULL, NULL, 'এ্যালুমিনিয়ামের তৈরী সসপেন (ঢাকনাসহ) বিভিন্ন সাইজ', NULL, '880.00', '53839329.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-02-16 06:08:58', '2022-02-16 06:08:58'),
(114, 10, NULL, NULL, NULL, NULL, 'কাষ্টার হুইল, আনুসাংগিক যন্ত্রাংশসহ', NULL, '2200.00', '1778625492.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-02-16 06:09:55', '2022-02-16 06:09:55'),
(115, 10, NULL, NULL, NULL, NULL, 'Attendant Tool', NULL, '660.00', '261885820.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-02-16 06:11:22', '2022-02-16 06:11:22'),
(116, 10, NULL, NULL, NULL, NULL, 'Gamla (20 Ltr capacity)', NULL, '693.00', '1473758086.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-02-16 06:11:57', '2022-02-16 06:11:57'),
(117, 10, NULL, NULL, NULL, NULL, 'Dust Dram Carry Trolly', NULL, '16500.00', '2113662591.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-02-16 06:12:23', '2022-02-16 06:12:23'),
(118, 10, NULL, NULL, NULL, NULL, 'Patient Chair (3 seat)', NULL, '13200.00', '1279598343.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-02-16 06:13:50', '2022-02-16 06:13:50'),
(119, 10, NULL, NULL, NULL, NULL, 'Instrument Cabinet', NULL, '13860.00', '2101026352.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-02-16 06:14:17', '2022-02-16 06:14:17'),
(120, 10, NULL, NULL, NULL, NULL, 'Iron Cot (Child)', NULL, '11550.00', '1659928570.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-02-16 06:15:21', '2022-02-16 06:15:21'),
(121, 10, NULL, NULL, NULL, NULL, 'Diarrhoea Khat', NULL, '11550.00', '1869965867.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-02-16 06:16:13', '2022-02-16 06:16:13'),
(122, 10, NULL, NULL, NULL, NULL, 'Dressing Trolley', NULL, '990.00', '461182827.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-02-16 06:18:16', '2022-02-16 06:18:16'),
(123, 10, NULL, NULL, NULL, NULL, 'Medicine Trolley with Wheel SS', NULL, '9350.00', '1020660625.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-02-16 06:18:57', '2022-02-16 06:18:57'),
(124, 10, NULL, NULL, NULL, NULL, 'Chaka for Trolley (2\")', NULL, '385.00', '1642905674.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-02-16 06:20:53', '2022-02-16 06:20:53'),
(125, 10, NULL, NULL, NULL, NULL, 'Chaka for Trolley (3\")', NULL, '467.00', '693407703.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-02-16 06:21:22', '2022-02-16 06:21:22'),
(126, 10, NULL, NULL, NULL, NULL, 'Chaka for Trolley (4\")', NULL, '550.00', '653634070.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-02-16 06:21:54', '2022-02-16 06:21:54'),
(127, 10, NULL, NULL, NULL, NULL, 'Chaka for Trolley (5\")', NULL, '770.00', '2063854666.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-02-16 06:22:19', '2022-02-16 06:22:19'),
(128, 10, NULL, NULL, NULL, NULL, 'Labour Table', NULL, '13200.00', '1282304576.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-02-16 06:22:53', '2022-02-16 06:22:53'),
(129, 10, NULL, NULL, NULL, NULL, 'Bed Side Stand (3 parts with screen) Metallic)', NULL, '8250.00', '64326409.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-02-16 06:23:20', '2022-02-16 06:23:20'),
(130, 10, NULL, NULL, NULL, NULL, 'Bowl Stand (Metallic)', NULL, '1650.00', '908494802.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-02-16 06:23:45', '2022-02-16 06:23:45'),
(131, 10, NULL, NULL, NULL, NULL, 'Patient Examination Table with Foam & Rexin Cover', NULL, '9350.00', '1371826547.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-02-16 06:24:17', '2022-02-16 06:24:17'),
(132, 10, NULL, NULL, NULL, NULL, 'Stretcher (Steel)', NULL, '3850.00', '892864804.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-02-16 06:24:55', '2022-02-16 06:24:55'),
(133, 10, NULL, NULL, NULL, NULL, 'Wheel Chair (Steel)', NULL, '10780.00', '267111803.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-02-16 06:25:26', '2022-02-16 06:25:26'),
(134, 10, NULL, NULL, NULL, NULL, 'Meat Safe (Steel)', NULL, '11550.00', '1602871622.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-02-16 06:26:01', '2022-02-16 06:26:01'),
(135, 10, NULL, NULL, NULL, NULL, 'Gamla (Plastic)', NULL, '165.00', '1115135456.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-02-16 06:26:24', '2022-02-16 06:26:24'),
(136, 10, NULL, NULL, NULL, NULL, 'Mug SS (500 mL)', NULL, '385.00', '409722227.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-02-16 06:26:44', '2022-02-16 06:26:44'),
(137, 10, NULL, NULL, NULL, NULL, 'Mug SS (400 mL)', NULL, '275.00', '191185300.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-02-16 06:27:04', '2022-02-16 06:27:04'),
(138, 10, NULL, NULL, NULL, NULL, 'Jug (SS) 1.50   Ltr', NULL, '550.00', '17082512.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-02-16 06:27:44', '2022-02-16 06:27:44'),
(139, 10, NULL, NULL, NULL, NULL, 'Knife (SS) 8×10', NULL, '198.00', '1279603207.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-02-16 06:28:17', '2022-02-16 06:28:17'),
(140, 10, NULL, NULL, NULL, NULL, 'Batti SS', NULL, '550.00', '1723805952.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-02-16 06:28:39', '2022-02-16 06:28:39'),
(141, 10, NULL, NULL, NULL, NULL, 'Spoon SS (for rice, dal, curry)- Large', NULL, '275.00', '264310538.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-02-16 06:29:24', '2022-02-16 06:29:24'),
(142, 10, NULL, NULL, NULL, NULL, 'Spoon SS (for rice, dal, curry) - Medium', NULL, '198.00', '1677182270.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-02-16 06:30:02', '2022-02-16 06:30:02'),
(143, 10, NULL, NULL, NULL, NULL, 'Spoon SS (for rice, dal, curry) - Small', NULL, '110.00', '1774787455.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-02-16 06:30:35', '2022-02-16 06:30:35'),
(144, 10, NULL, NULL, NULL, NULL, 'Aluminium Saucepan (for rice, dal, curry) -Medium', NULL, '220.00', '189599011.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-02-16 06:30:59', '2022-02-16 06:30:59'),
(145, 10, NULL, NULL, NULL, NULL, 'Aluminium Saucepan (for rice, dal, curry) -Small', NULL, '117.00', '760361616.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-02-16 06:31:38', '2022-02-16 06:31:38'),
(146, 10, NULL, NULL, NULL, NULL, 'Da (Iron)', NULL, '402.00', '622207540.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-02-16 06:33:21', '2022-02-16 06:33:21'),
(147, 10, NULL, NULL, NULL, NULL, 'Hasawa (iron)', NULL, '508.00', '1980971490.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-02-16 06:33:45', '2022-02-16 06:33:45'),
(148, 10, NULL, NULL, NULL, NULL, 'Khunti (iron)', NULL, '495.00', '655850634.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-02-16 06:34:09', '2022-02-16 06:34:09'),
(149, 10, NULL, NULL, NULL, NULL, 'Hurrucane lamp', NULL, '242.00', '1804811748.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-02-16 06:34:31', '2022-02-16 06:34:31'),
(150, 10, NULL, NULL, NULL, NULL, 'Bucket (Plastic) 30 Ltr', NULL, '440.00', '732468347.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-02-16 06:34:54', '2022-02-16 06:34:54'),
(151, 10, NULL, NULL, NULL, NULL, 'Bucket (Plastic) 25 Ltr', NULL, '385.00', '1623417978.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-02-16 06:35:21', '2022-02-16 06:35:21'),
(152, 10, NULL, NULL, NULL, NULL, 'Bucket (Plastic) 20 Ltr', NULL, '330.00', '267481299.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-02-16 06:35:52', '2022-02-16 06:35:52'),
(153, 10, NULL, NULL, NULL, NULL, 'Nail Brass', NULL, '99.00', '605664616.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-02-16 06:36:14', '2022-02-16 06:36:14'),
(154, 10, NULL, NULL, NULL, NULL, 'Saline stand (SS)', NULL, '1980.00', '2094759013.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-02-16 06:36:34', '2022-02-16 06:36:34'),
(155, 4, NULL, NULL, NULL, NULL, 'Acetone (2.5 litre/bottle)', NULL, '2090.00', '611379740.png', 'www.alpha-medicare.com', NULL, 0, '2022-02-16 06:44:45', '2022-02-16 06:44:45'),
(156, 4, NULL, NULL, NULL, NULL, 'Acid wash solution for 241 (500 mL)', NULL, '19250.00', '2052402573.png', 'www.alpha-medicare.com', NULL, 0, '2022-02-16 06:45:33', '2022-02-16 06:45:33'),
(157, 4, NULL, NULL, NULL, NULL, 'Acid phosphatase kit (20x3 mL)', NULL, '7260.00', '1563773876.png', 'www.alpha-medicare.com', NULL, 0, '2022-02-16 06:46:32', '2022-02-16 06:46:32'),
(158, 4, NULL, NULL, NULL, NULL, 'Acid Wash Solution for Prestige 24i Tokyo Boeki (500 mL/bottle)', NULL, '19250.00', '1459453111.png', 'www.alpha-medicare.com', NULL, 0, '2022-02-16 06:47:18', '2022-02-16 06:47:54'),
(159, 4, NULL, NULL, NULL, NULL, 'Agar Agar Powder (500gm/pk)', NULL, '6600.00', '287909851.png', 'www.alpha-medicare.com', NULL, 0, '2022-02-16 06:48:40', '2022-02-16 06:48:40'),
(160, 4, NULL, NULL, NULL, NULL, 'Angarose, LE, Analytical grade (100gm)', NULL, '20350.00', '2049488760.png', 'www.alpha-medicare.com', NULL, 0, '2022-02-16 06:49:19', '2022-02-16 06:49:19'),
(161, 4, NULL, NULL, NULL, NULL, 'Albumin (for Manual Analyzer) [4x100ML/400 Test]', NULL, '2893.00', '725064870.png', 'www.alpha-medicare.com', NULL, 0, '2022-02-16 06:50:15', '2022-02-16 06:50:15'),
(162, 4, NULL, NULL, NULL, NULL, 'Albumin Bovine 22%- 10ml/Device [per device]', NULL, '13.00', '845613546.png', 'www.alpha-medicare.com', NULL, 0, '2022-02-16 06:50:53', '2022-02-16 06:50:53'),
(163, 4, NULL, NULL, NULL, NULL, 'Albumin for Auto Analyzer [10x40ml, (800 test)]', NULL, '7700.00', '589854871.png', 'www.alpha-medicare.com', NULL, 0, '2022-02-16 06:51:29', '2022-02-16 06:51:29'),
(164, 4, NULL, NULL, NULL, NULL, 'Albumin for Prestige 24i Tokyo Boeki [10x40ml, (800 test)]', NULL, '8250.00', '437811962.png', 'www.alpha-medicare.com', NULL, 0, '2022-02-16 06:52:12', '2022-02-16 06:52:12'),
(165, 2, NULL, NULL, NULL, NULL, 'Abdominal Relatractor (Large)', NULL, '1265.00', '16360995.jpg', 'www.alpha-medicare.com', '<p>Surgical retractors help surgeons and operating room professionals hold an incision or wound open during surgical procedures. They aid in holding back underlying organs or tissues, allowing doctors/nurses better visibility and access to the exposed area.</p>\r\n\r\n<p>The right retractor and&nbsp;medical device lighting&nbsp;will bring comfort and light directly into the surgical cavity where it is needed. If you&#39;re a physician, surgical rotation can be strenuous on your arms and if you&#39;re a patient you want the best care.&nbsp;&nbsp;</p>\r\n\r\n<p>Retractors play a crucial role in surgery. Today they come in&nbsp;different sizes, shapes and designs.&nbsp;Surgical retractor lighting could allow surgeons to better navigate in deep or minimally-open cavities. Better visibility during and at the end of surgery is beneficial to both the surgical team and patient.</p>\r\n\r\n<p><strong>Most&nbsp;surgical instruments can be classified into 4 basic types:&nbsp;</strong></p>\r\n\r\n<ol>\r\n	<li>Cutting and Dissecting</li>\r\n	<li>Clamping and Occluding</li>\r\n	<li>Retracting and Exposing&nbsp;&nbsp;</li>\r\n	<li>Grasping and Holding</li>\r\n</ol>\r\n\r\n<p>Given our expertise in self retaining retractors with integrated lighting,&nbsp;we thought it prevalent to discuss number three (Retracting and Exposing). And share some of the instruments used today with their similarities and differences.&nbsp;</p>\r\n\r\n<p>There are two broad categories of retractors:&nbsp;</p>\r\n\r\n<p>1.<strong>&nbsp;Hand Retractors</strong>&nbsp;- (Manual)&nbsp;must be held by an assistant, a robot or the surgeon during a procedure.&nbsp;</p>\r\n\r\n<p>2.<strong>&nbsp;Self Retaining Retractors</strong>&nbsp;- (Stay open on their own)&nbsp;have a screw, ratchet or some type of clamp to hold the tissue by itself. These allow the surgeon with two free hands<a href=\"https://www.wpiinc.com/product-listers/self-retaining-retractors/\">.</a></p>\r\n\r\n<p>Retractors fall under the &quot;Retracting and Exposing&quot; instruments used in the OR.&nbsp;The various types of retractors are usually named after the organ which they are used in conjunction with.&nbsp;</p>\r\n\r\n<p>For example, retractors which are used to retract an abdomen, are called<strong>&nbsp;</strong>abdominal&nbsp;retractors or<strong>&nbsp;</strong>self retaining abdominal retractors.&nbsp;If it&#39;s your skin being handled, there are specific&nbsp;skin&nbsp;retractors.&nbsp;</p>', 0, '2022-02-16 07:06:08', '2022-02-16 07:06:08'),
(166, 2, NULL, NULL, NULL, NULL, 'Abdominal Relatractor (Medium)', NULL, '1100.00', '1302380747.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-02-16 07:07:18', '2022-03-11 05:15:48'),
(167, 2, NULL, NULL, NULL, NULL, 'Adams plier with 2 rechangular beaks (Std Size)', NULL, '990.00', '113919071.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-02-16 07:07:49', '2022-03-17 05:52:21'),
(168, 2, NULL, NULL, NULL, NULL, 'Admis plier with 3 rechangular beaks (Std Size)', NULL, '1100.00', '689246386.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-02-16 07:08:19', '2022-03-17 05:51:44'),
(169, 2, NULL, NULL, NULL, NULL, 'Adenoid curette with cage- different sizes (p/pc)', NULL, '1760.00', '870501967.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-02-16 07:09:28', '2022-03-17 05:50:36'),
(170, 2, NULL, NULL, NULL, NULL, 'Air Detector for nova 4Electrolyte Analyzer', NULL, '30000.00', '965850237.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-02-16 07:09:59', '2022-03-17 05:50:13'),
(171, 2, NULL, NULL, NULL, NULL, 'Air injection canula (various size)', NULL, '126.00', '960627190.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-02-16 07:10:35', '2022-03-17 05:49:51'),
(172, 2, NULL, NULL, NULL, NULL, 'Air Motor with compressor pump (Std Size)', NULL, '20130.00', '829670903.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-02-16 07:11:07', '2022-03-17 05:48:55'),
(173, 2, NULL, NULL, NULL, NULL, 'Air Motore with contrangular hand piece (Std Size)', NULL, '12320.00', '1426444921.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-02-16 07:11:37', '2022-03-17 05:48:36'),
(174, 2, NULL, NULL, NULL, NULL, 'Air Scaler (ultrasonic) (std size)', NULL, '30000.00', '599292210.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-02-16 07:12:13', '2022-03-17 05:48:16'),
(175, 2, NULL, NULL, NULL, NULL, 'Airway Tube (Curved) (Large/Medium/Small)', NULL, '165.00', '749401708.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-03-11 05:21:13', '2022-03-17 05:48:01'),
(176, 2, NULL, NULL, NULL, NULL, 'Airway Tube (Metal) (Large/Medium/Small)', NULL, '220.00', '864063527.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-03-11 05:30:35', '2022-03-17 05:47:42'),
(177, 2, NULL, NULL, NULL, NULL, 'Airway Tube (Plastic) (Large/Medium/Small)', NULL, '110.00', '992802941.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-03-11 05:31:21', '2022-03-17 05:47:23'),
(178, 2, NULL, NULL, NULL, NULL, 'Amalgum gum (Std Size)', NULL, '605.00', '1256032819.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-03-11 05:52:19', '2022-03-17 05:47:05'),
(179, 2, NULL, NULL, NULL, NULL, 'amalgum Plugger (double ended) (Std Size)', NULL, '242.00', '2080199912.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-03-11 05:53:15', '2022-03-17 05:46:42'),
(180, 2, NULL, NULL, NULL, NULL, 'Ambu Bag (adult)', NULL, '3850.00', '157175420.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-03-11 05:53:54', '2022-03-17 05:46:15'),
(181, 2, NULL, NULL, NULL, NULL, 'Ambu Bag (child)', NULL, '6600.00', '294897162.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-03-11 05:54:41', '2022-03-17 05:45:33'),
(182, 2, NULL, NULL, NULL, NULL, 'Ambu Bag  (face mask) (Large/Medium/Small Size)', NULL, '522.00', '315220934.jpg', 'www.alpha-medicare.com', NULL, 0, '2022-03-11 05:55:45', '2022-03-17 05:43:41'),
(183, 2, NULL, NULL, NULL, NULL, 'Amplatz Catheter sterile (size-6F-R-1-Rll)', NULL, '1100.00', '180578794.jpg', 'www.alpha-medicare.com', '<p>Amplatz Catheter sterile&nbsp;</p>', 0, '2022-03-11 05:57:56', '2022-03-17 05:43:15');
INSERT INTO `products` (`id`, `cat_id`, `brand_id`, `company_id`, `unit`, `origin`, `name`, `specification`, `price`, `image`, `btn_link`, `desc`, `is_featured`, `created_at`, `updated_at`) VALUES
(184, 5, 15, 92, 'P/Pc', 'BD', 'Adsorbed Tetanus Vaccine', '40 IU/ 0.5 mL', '60.00', '1235756735.jpg', 'www.alpha-medicare.com', '<p><strong>Indication:&nbsp;</strong></p>\r\n\r\n<ul>\r\n	<li><em>For the active immunization of infants, children 7 years of age or older and adults against tetanus, wherever combined antigen preparations are not indicated.</em></li>\r\n	<li><em>For the prevention of neonatal tetanus in infants by immunizing women of childbearing age or infants bom of unvaccinated pregnant women.</em></li>\r\n	<li><em>Those who are liable to be exposed to tetanus infection and persons engaged in outdoor activities e.g. gardeners, agricultural, veterinary, athletes, industrial, sewage, road and outdoor workers, etc.</em></li>\r\n	<li><em>This vaccine is not to be used for the treatment of tetanus infection. If passive immunization is required, Tetanus Immunoglobulin (TIG) should be used.</em></li>\r\n</ul>\r\n\r\n<p><strong>Pharmacology</strong></p>\r\n\r\n<p>Tetanus toxoid adsorbed is a sterile suspension on aluminium phosphate suspended in an isotonic sodium chloride solution. The vaccine, after shaking, is a turbid liquid, whitish-gray in color. Adsorbed tetanus toxoid is prepared from tetanus toxin, produced by the growth of the bacterium Clostridium tetani in a peptone-based media. The toxin is converted to tetanus formol toxoid by treatment with formaldehyde solution. Formol tetanus toxoid is then purified, sterile, filtered and adsorbed to the aluminium phosphate.Thiomersal is added as preservative.</p>\r\n\r\n<p><strong>Dosage</strong></p>\r\n\r\n<p>Primary immunization for persons 7 years of age and older-</p>\r\n\r\n<p>A series of three doses of 0.5 ml each, of adsorbed tetanus vaccine should be given intramuscularly</p>\r\n\r\n<ul>\r\n	<li><strong>First dose</strong>: At appropriate date</li>\r\n	<li><strong>Second dose</strong>: 4 to 8 weeks after the first dose</li>\r\n	<li><strong>Third dose</strong>: 6 to 12 months after the second dose</li>\r\n</ul>\r\n\r\n<p>Children older than 7 years who did not complete primary immunization series (e.g., previously received only two doses of DTaP or DTP) need to receive only one dose of tetanus toxoid adsorbed vaccine to complete the primary series of tetanus. Interruption of the recommended schedule with a delay between doses does not interfere with the final immunity achieved with adsorbed tetanus vaccine. There is no need to start the series over again, regardless of the time elapsed between doses.<br />\r\n<strong>Routine booster injections</strong>: To maintain adequate protection, a booster dose of 0.5 ml of adsorbed tetanus vaccine every 10 years thereafter is recommended.</p>\r\n\r\n<p>Vaccination of injured persons-</p>\r\n\r\n<p>Clean and minor wound:</p>\r\n\r\n<ul>\r\n	<li>If primary immunization confirmed and receiving booster dose within previous 5 years, no need of additional vaccine.</li>\r\n	<li>If primary immunization confirmed and receiving booster dose more than previous 5 years, 1 dose of 0.5 ml required.</li>\r\n</ul>\r\n\r\n<p>All other dirty wounds (contaminated with feces, soil, and saliva):</p>\r\n\r\n<ul>\r\n	<li>If primary immunization confirmed and receiving booster dose within previous 5 years, 1 dose of 0.5 ml required.</li>\r\n	<li>If primary immunization confirmed and receiving booster dose more than previous 5 years, 1 dose of 0.5 ml along with tetanus immunoglobulin required.</li>\r\n</ul>\r\n\r\n<p>If a person has no previous vaccination or uncertain, the primary series of 3 doses of 0.5ml adsorbed tetanus vaccine should be given along with tetanus immunoglobulin with 1st dose.</p>\r\n\r\n<p><strong>Protection of neonatal tetanus-</strong></p>\r\n\r\n<p>For prevention of neonatal tetanus, adsorbed tetanus vaccine is recommended for immunization of women of childbearing age.<br />\r\n<br />\r\n<strong>Women (15-49 Years)</strong>: For pregnant woman who have not had previous immunization, 2 doses of tetanus toxoid at four weeks interval preferably during the last two trimester or at least 2 weeks before delivery should be given during pregnancy so that protective antibody would be transferred to the infant in order to prevent neonatal tetanus, e.g. 1 dose of 0.5 ml at 6th month of pregnancy and 1 dose of 0.5 ml at 7th month of pregnancy. Pregnant woman who have completed the course of tetanus, next 10 years no need of additional dose during pregnancy. Thereafter a single booster dose would be sufficient to extend immunity.</p>\r\n\r\n<p><strong>Administration</strong></p>\r\n\r\n<p><strong>Method of administration</strong>: Adsorbed Tetanus Vaccine is for intramuscular injection only. Do not inject intravenously. For adults and older children Adsorbed Tetanus Vaccine should be given intramuscularly in the deltoid muscle. For infants Adsorbed Tetanus Vaccine should be given intramuscularly in the anterolateral aspect of the upper thigh. It should not be injected into the gluteal areas as the immune response may be lower. The attending physician should determine final selection of the injection site and needle size, depending upon the patient&#39;s age and the size of the target muscle. The vaccine should be shaken well before use to obtain a homogenous turbid white suspension. Please do not shake vigorously.<br />\r\n<strong>Preparation for administration:</strong></p>\r\n\r\n<ul>\r\n	<li>The vaccine should be shaken well before use to obtain a homogenous turbid white suspension. Please do not shake vigorously.</li>\r\n	<li>The vaccine should be inspected visually for particulate matter and discoloration prior to administration. If either of these conditions exist, the vaccine should not be administered.</li>\r\n	<li>The vaccine should be used as supplied; no dilution is necessary.</li>\r\n	<li>The full recommended dose of the vaccine should be used. Any vaccine remaining in a single-dose ampoule/vial should be discarded.</li>\r\n</ul>\r\n\r\n<p><strong>Co-administration</strong>: Adsorbed tetanus vaccine can be given at the same time with other vaccine as diphtheria, tetanus, pertussis (DTP), polio (OPV), measles, mumps and rubella (MMR), Haemophilus Influenzae type b (Hib) and Meningococcal vaccines at separate sites with separate syringes. It should not be mixed with other vaccines or medicinal products in the same syringe.</p>\r\n\r\n<p><strong>Interaction</strong></p>\r\n\r\n<p>Decreased immunologic response with concurrent immunosuppressants. Neutralisation of tetanus immune globulin and tetanus toxoid adsorbed if not given at different sites using different syringes.</p>\r\n\r\n<p><strong>Contraindications</strong></p>\r\n\r\n<p>Hypersensitivity to any component of the vaccine, including thiomersal, is a contraindication. This vaccine is contraindicated in patients with previous hypersensitivity to any tetanus-containing vaccine. Tetanus toxoid vaccination should be defferred during the course of any febrile illness or acute infection. A minor febrile illness such as a mild upper respiratory infection should not preclude immunization.</p>\r\n\r\n<p><strong>Side Effects</strong></p>\r\n\r\n<p>Adsorbed tetanus vaccine is generally well tolerated. Most recipients of tetanus vaccine experience some reactions upon vaccination. These are generally moderate and short in duration. They mainly consist of local reactions at the injection site (erythema, induration and tenderness). Systemic reactions (malaise and elevated temperature) are reported less commonly.</p>\r\n\r\n<p><strong>Pregnancy &amp; Lactation</strong></p>\r\n\r\n<p>For protection of neonatal tetanus, tetanus toxoid is recommended for immunization of women of childbearing age and especially pregnant women. Tetanus toxoid may be safely administered during pregnancy and should be given to the mother at first contact or as early as possible. It is not known if tetanus toxoid is excreted in human milk. It may be administered to nursing mothers only if clearly needed.</p>\r\n\r\n<p><strong>Precautions &amp; Warnings</strong></p>\r\n\r\n<p>Do not administer IV. Use subcutaneous route in bleeding disorders. Withhold vaccination in moderate or severe febrile illness. Pregnancy, lactation, history of Guillian-Barre syndrome.</p>\r\n\r\n<p><strong>Therapeutic Class</strong></p>\r\n\r\n<p>Vaccines, Anti-sera &amp; Immunoglobulin</p>\r\n\r\n<p><strong>Storage Conditions</strong></p>\r\n\r\n<p>Keep out of the reach and sight of children. Store at +2&deg;C to +8&deg;C. Transportation should also be at +2&deg;C to +8&deg;C. Do not freeze. Discard vaccine if frozen. Protect from light.</p>\r\n\r\n<ol>\r\n	<li><strong>TT Vax 40IU/0.5ml vial (95.00 taka) = Popular Pharmaceuticals Ltd.</strong></li>\r\n	<li><strong>Vaxitet 40IU/0.5ml vial (60.00 taka) = Incepta Pharmaceuticals Ltd</strong></li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>', 0, '2022-03-19 02:53:00', '2022-06-12 05:20:41'),
(185, 5, 2868, 92, 'P/Pc', 'BD', 'Snake Venom Antiserum', '10 mL per vial', '1000.00 (10ml vial)', '863506100.jpg', 'www.alpha-medicare.com', '<p><strong>Company: Incepta Vaccines Ltd.</strong></p>\r\n\r\n<p><strong>Presentation:</strong></p>\r\n\r\n<p><strong>Antivenom :</strong> Each vial contains lyophilized preparation of Snake Venom Antiserum BP. After reconstitution each ml Snake Venom Antiserum neutralizes not less than Cobra venom (Naja naja) 0.60 mg, Common Krait venom (Bungarus caeruleus) 0.45 mg, Russell&#39;s Viper venom (Vipera russelli) 0.60 mg, Saw-scaled Viper venom (Echis carinatus) 0.45 mg.</p>\r\n\r\n<p><strong>Description:</strong></p>\r\n\r\n<p>Snake Venom Antiserum lyophilized is a refined and concentrated preparation of serum globulins for intravenous administration, containing equine immunoglobulin fragments F(ab&#39;)2, obtained from the plasma of healthy equines, hyperimmunized against venoms of above species of snakes. In addition, it also contains the anti-microbial agent: cresol.</p>\r\n\r\n<p><strong>Indications:</strong></p>\r\n\r\n<p>Antivenom is indicated for bites caused by Cobra, Common Krait, Russell&#39;s Viper and Saw-Scaled Viper, where the patient presents with one or more of fallowing visible clinical signs and symptoms of envenomation &ndash;<br />\r\n<strong>1. Local envenomation-</strong><br />\r\na) Presence of bite marks with or without oozing of blood, blistering and change in color of skin.<br />\r\nb) Rapidly progressive or massive swelling involving more than half of the bitten limb within few hours of bite (without tourniquet)<br />\r\nc) Development of enlarged tender lymph nodes draining the bitten part within couple of hours after bite<br />\r\n<strong>2. Systemic envenomation-</strong><br />\r\na) Neurotoxic syndrome- signs of neuro-paralysis like blurring of vision, double vision, and difficulty in swallowing, sleepy feeling, drooping of head, Slurring of speech and the voice may become indistinct with shallow breathing, ptosis, ataxia, respiratory paralysis and generalized flaccid paralysis.<br />\r\nb) Hemotoxic syndrome- spontaneous systemic bleeding, nausea, vomiting, abdominal pain and abdominal tenderness suggestive of gastro-intestinal or retro-peritoneal bleed and/or renal damage, coagulopathy detected by 20 min WBCT with or without external bleeding and shock.<br />\r\n<br />\r\n(It has been reported that Snake Venom Antiserum also provides para-specific neutralization of venoms of related snake species, however, the extant of protection is uncertain).<br />\r\n<br />\r\n<strong>Direction for Reconstitution:</strong><br />\r\nTo reconstitute the Snake Venom Antiserum, transfer content of supplied diluents into the vial containing lyophilized preparation. Mix the contents gently by swirling action and avoid vigorous shaking. Serum should be used as soon as possible after reconstitute.</p>\r\n\r\n<p><strong>Dosage and Administration:</strong></p>\r\n\r\n<p>As of now Antivenom is the only specific antidote for snake envenomation and prompt administration of adequate dose of Antiserum is of paramount importance for neutralization of unbound circulating snake venom components for early response to treatment. Any delay in administration may result in increased dose requirement and decreased effectiveness. As the clinical signs can vary due to many factors such as type of snake, time of reporting after bite, size of snake, amount of venom injected during bite, seasonal &amp; regional variation in venom composition etc., no accurate dosage can be recommended. However, considering the average quantity of venom injected by snake at the time of bite and degree of envenomation, it is recommended to administer initial dose of 5-10 vials of Antivenom by slow intravenous infusion either undiluted at a speed of not more than 2 ml per minute or after dilution with Normal /glucose saline at a rate of 5-10 ml/kg body weight over one hour. Children should receive the same dose as adults. Constant monitoring of the vital signs at frequent intervals during initial 1 hour is recommended. Requirement of further dosing depends on extent of reversal of coagulopathy confirmed after 6 hours of Antiserum administration by WBCT in haemotoxic bite or if symptoms persist or worsen or in respiratory failure in neurotoxic bite after 1 hour of Antiserum administration. If the blood is still in coagulable or no signs of reversal of paralysis are seen, a further dose of 5 to 10 vials of Antiserum should be administered by slow IV route only. Administration by IM or locally around the bite wound is not recommended. In the majority of cases of both neurotoxic and haemotoxic bites, total dose of 15-20 vials is adequate unless a proven recurrence of envenomation is established. In such a scenario, further doses can be given as per clinical condition of the patient. Hypersensitivity skin test has no predictability value and hence should not be used.</p>\r\n\r\n<p><strong>Side Effects:</strong></p>\r\n\r\n<p>Antivenom being derived from equines is heterologous to humans can give either early or late reaction.<br />\r\nAdrenaline should be always kept handy, before starting the dose of Antivenom.<br />\r\nReduction in adverse reactions has been reported by use of adequate dilution of Antivenom with saline and controlling rate of infusion.</p>\r\n\r\n<p><strong>Precautions:</strong></p>\r\n\r\n<p>Proper precautions are necessary while dealing with persons with a known hypersensitivity to constituents of product. Few doctors prefer to premedicate patients with Inj. Adrenaline 0.25 ml s/c to prevent possibility of adverse reactions. In haemotoxic bites, IM injections should be avoided till correction of coagulopathy to avoid formation of haematoma and oozing of blood.<br />\r\nIn patients having tourniquet, it should be released slowly only after start of Antivenom administration.</p>\r\n\r\n<p><strong>Contraindications:</strong></p>\r\n\r\n<p>There are no known contraindications for the administration of Antivenom.</p>\r\n\r\n<p><strong>Use in Pregnancy and Lactation:</strong></p>\r\n\r\n<p>Considering the risk associated with snake bite envenomation, pregnancy is not a contraindication for the administration of Snake Venom Antiserum subsequent to bite,</p>\r\n\r\n<p><strong>Storage:</strong></p>\r\n\r\n<p>Lyophilized Antivenom is stable at room temperature and does not require special storage facilities. Ideally, it should be stored in a cool &amp; dark place and do not expose to excessive heat.</p>\r\n\r\n<p><strong>Commercial Pack:</strong></p>\r\n\r\n<p>Antivenom : Each box contains 1 vial of Snake Venom Antiserum BP, 10 ml WFI ampoule and one sterile disposable syringe.</p>', 0, '2022-03-19 03:08:50', '2022-06-20 04:36:57'),
(186, 5, 2869, 92, 'P/Pc', 'BD', 'Oral Cholera Vaccine', '1.5 mL/ vial', '1000.00', '907534220.jpg', 'www.alpha-medicare.com', '<p><strong>Composition</strong></p>\r\n\r\n<p>Each 1.5 ml contains Inactivated Oral Cholera Vaccine BP as-</p>\r\n\r\n<ul>\r\n	<li>cholerae O1 Inaba Phil 6973 El Tor, Formaldehyde Inactivated 600 LEU</li>\r\n	<li>cholerae O1 Inaba Cairo 48, Heat Inactivated 300 LEU</li>\r\n	<li>cholerae O1 Ogawa Cairo 50, Formaldehyde Inactivated 300 LEU</li>\r\n	<li>cholerae O1 Ogawa Cairo 50,Heat Inactivated 300 LEU</li>\r\n	<li>cholerae O139 4260B, Formaldehyde Inactivated 600 LEU</li>\r\n</ul>\r\n\r\n<p><strong>Indications</strong></p>\r\n\r\n<p>Oral Cholera Vaccine is indicated for active immunization against Vibrio cholerae. The vaccine can be administered to anyone above the age of 1 year. Data for the safety and efficacy of the vaccine in infants (less than 1 year of age) is not available. The earliest onset of protection can be expected 7-10 days after the completion of the primary series of the vaccine. Efficacy against Vibrio cholerae serogroup O139 was not demonstrated.</p>\r\n\r\n<p><strong>Description</strong></p>\r\n\r\n<p>This Cholera Vaccine for oral use, is a turbid, white or brownish suspension free of aggregates and extraneous particles. The vaccine is formulated with required quantity of V. cholerae O139 and O1 (serotypeInaba and Ogawa) inactivated by heat and formaldehyde.</p>\r\n\r\n<p><strong>Dosage &amp; Administration</strong></p>\r\n\r\n<p>The recommended dose of the vaccine (1.5 ml) is to be administered orally. The primary immunization schedule consists of two doses given at an interval of at least two weeks. Cholera vaccine should not be administered parenterally (intramuscular, subcutaneous or intravenously). The vaccine is only recommended for oral administration.<br />\r\n<br />\r\nMethod of administration: The vaccine is presented as a suspension. After vigorous shaking of the vial, 1.5 ml should be poured into the mouth of the recipient. The vaccine administration may be optionally followed by water to facilitate ingestion, if needed. The vaccine can alternatively be administered with a disposable syringe (without needle) after removing the contents from the vial and squirted into the mouth of the recipient. The vaccine should not be administered parenterally (intramuscular, subcutaneous or intravenously). The vaccine is only recommended for oral administration.</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong>Contraindications</strong></p>\r\n\r\n<p>Cholera vaccine should not be administered to subjects with either known hypersensitivity to any component of vaccine, or having shown signs of hypersensitivity after previous administration of the vaccine. Formaldehyde is used during the manufacturing process and trace amounts may be present in the final product. Caution should be taken in subjects with known hypersensitivity to formaldehyde. CVV V.N. 02 TM As with other vaccines, immunization with the cholera vaccine should be delayed in the presence of any acute illness, including acute gastrointestinal illness or acute febrile illness. A minor illness such as mild upper respiratory tract infection is not a reason to postpone immunization</p>\r\n\r\n<p><strong>Side Effects</strong></p>\r\n\r\n<p>The following adverse events are known to occur with cholera vaccine use. Acute gastroenteritis, diarrhea, fever, vomiting, abdominal pain, itching, rash, nausea, weakness, cough, vertigo, dryness of mouth, oral ulcer (rare), sore throat (rare) and yellowing of urine (rare). It has been observed that the incidence of adverse events is less after the second dose as compared to the first.</p>\r\n\r\n<p><strong>Pregnancy &amp; Lactation</strong></p>\r\n\r\n<p>No specific clinical studies have been performed to evaluate the safety and immunogenicity of cholera vaccine in pregnant women and for the fetus. However, administration of cholera vaccine to pregnant women and nursing mother may be considered after careful evaluation of the benefits and risks in case of a medical emergency or an epidemic.</p>\r\n\r\n<p><strong>Precautions &amp; Warnings</strong></p>\r\n\r\n<p>Vaccination should be provided by a review of the medical history (especilly with regard to previous vaccination &amp; possible occurrence of the undesirable events) and a clinical examination. As with any vaccine immunization with the cholera vaccine may not protect 100% susceptible individuals. This vaccine is also not a substitute for therapy in case of individuals suspected to be suffering from cholera or showing signs and symptoms of an acute episode of gastro intestinal disease or acute watery diarrhea. Immunocompromised persons (subsequent to a disease or immunosuppressive therapy) may not obtain the expected immune response after vaccination with the cholera vaccine. If possible, in the opinion of the medical practitioner, due consideration should be given to postpone vaccination until after the completion of the immunosuppressive treatment. As with all vaccines, appropriate medical treatment should always be available in case of a rare event of anaphylactic reactions following the administration of the vaccine. For this reason, it is recommended that the vaccinee should remain under medical supervision for at least 30 minutes after vaccination.</p>\r\n\r\n<p><strong>Therapeutic Class</strong>&nbsp;: Vaccines, Anti-sera &amp; Immunoglobulin</p>\r\n\r\n<p><strong>Storage Conditions</strong></p>\r\n\r\n<p>Keep out of the reach and sight of children. Store at +2 &ordm;C to +8 &ordm;C. Transportation should also be at +2 &ordm;C to +8 &ordm;C. Do not freeze. Discard vaccine if frozen. Protect from light.</p>', 0, '2022-03-19 03:39:33', '2022-06-20 04:37:28'),
(187, 5, 4230, 150, 'P/Pc', 'BD', 'Hepatitis B Vaccine [rDNA]', '20 mcg/ml', '500', '1870070052.jpg', 'www.alpha-medicare.com', '<p><strong>Composition</strong></p>\r\n\r\n<p><em>Each 0.5 ml dose contains &gt;10 mcg of hepatitis B surface antigen adsorbed on Aluminium Hydroxide gel equivalent to Al3+&nbsp;0.25 mg.<br />\r\nEach 1 ml dose contains &gt;20 mcg of hepatitis B surface antigen adsorbed on Aluminium Hydroxide gel equivalent to Al3+&nbsp;0.5 mg.</em></p>\r\n\r\n<p><strong>Indications</strong></p>\r\n\r\n<p>Hepatitis B Vaccine is indicated for active immunization against infection caused by all known subtypes of Hepatitis B virus. As Hepatitis D (caused by the delta virus) does not occur in the absence of Hepatitis B infection, it can be expected that Hepatitis D will also be prevented by Hepatitis B vaccination.<br />\r\n<br />\r\nImmunization is recommended in persons of all ages, especially those who are, or will be, at increased risk of exposure to Hepatitis B virus, for example:<br />\r\n<br />\r\nA baby whose mother is infected can be infected at birth.<br />\r\nChildren, adolescents, and adults can become infected by:</p>\r\n\r\n<ul>\r\n	<li><em>Contact with blood and body fluids through breaks in the skin such as bites, cuts, or sores</em></li>\r\n	<li><em>Contact with objects that have blood or body fluids on them such as toothbrushes, razors or monitoring and treatment devices for diabetes</em></li>\r\n	<li><em>Having unprotected sex with an infected person</em></li>\r\n	<li><em>Sharing needles when injecting drugs</em></li>\r\n	<li><em>Being stuck with a used needle</em></li>\r\n	<li><em>Household contacts of people infected with Hepatitis B</em></li>\r\n	<li><em>Residents and staff in institutions for the developmental^ disabled</em></li>\r\n	<li><em>Kidney dialysis patients</em></li>\r\n	<li><em>People who travel to countries where Hepatitis B is common</em></li>\r\n	<li><em>People with HIV infection</em></li>\r\n	<li><em>Persons with hemophilia, thalassemia, sickle cell anemia, cirrhosis</em></li>\r\n</ul>\r\n\r\n<p>Military personnel identified as being at increased risk.<br />\r\nMorticians and Embalmers.<br />\r\nPrisoners.<br />\r\nUsers of illicit injectable drugs.<br />\r\nOthers: Police, fire department personnel, who render first aid or medical assistance, and any others who, through their work or personal life-style, may be exposed to the Hepatitis B virus.</p>\r\n\r\n<p><strong>Description</strong></p>\r\n\r\n<p>Hepatitis B Vaccine is a noninfectious recombinant DNA Hepatitis B vaccine. It is sterile suspension of purified surface antigen of hepatitis B virus obtained by culturing genetically engineered yeast cells (Saccharomyces cerevisiae cells), which carry the gene that codes for the HBsAg. The HBsAg protein expressed in Saccharomyces cerevisiae cells is purified by several physicochemical steps and formulated as a suspension of the antigen adsorbed on aluminium hydroxide. No substances of human origin are used in its manufacture.</p>\r\n\r\n<p>Dosage</p>\r\n\r\n<p><strong>Neonates, infants and children upto 19 years of age</strong>: The recommended dose of Hepatitis B vaccine (rDNA) is &gt;10 mcg of antigen protein in 0.5 ml.<br />\r\n<br />\r\n<strong>Adults 19 years of age and older</strong>: The recommended dose of Hepatitis B vaccine (rDNA) is &gt;20 mcg of antigen in 1 ml.<br />\r\n<br />\r\n<strong>Primary immunization schedule for all ages</strong>:<br />\r\nThe usual immunization schedule consists of 3 doses of vaccine-</p>\r\n\r\n<ul>\r\n	<li>First dose: at elected date</li>\r\n	<li>Second dose: 1 month after first dose</li>\r\n	<li>Third dose: 6 months after first dose</li>\r\n</ul>\r\n\r\n<p>or accelerated schedule consists of 4 doses of vaccine-</p>\r\n\r\n<ul>\r\n	<li>First dose: at elected date</li>\r\n	<li>Second dose: 1 month after first dose</li>\r\n	<li>Third dose: 2 months after first dose</li>\r\n	<li>Fourth dose: 12 months after first dose</li>\r\n</ul>\r\n\r\n<p>Accelerated schedule confer protection more quickly and is expected to provide better patient compliance.<br />\r\n<br />\r\n<strong>Neonate born to hepatitis B surface antigen-positive mother, 4 doses of 10 micrograms</strong>:</p>\r\n\r\n<ul>\r\n	<li>First dose: at birth with Hepatitis B immunoglobulin injection (separate site)</li>\r\n	<li>Second dose: 1 month after first dose</li>\r\n	<li>Third dose: 2 months after first dose</li>\r\n	<li>Fourth dose: 12 months after first dose</li>\r\n</ul>\r\n\r\n<p><strong>For travellers departing within 1 month, adult over 18 years</strong>,</p>\r\n\r\n<ul>\r\n	<li>First dose: at elected date</li>\r\n	<li>Second dose: 7 days after first dose</li>\r\n	<li>Third dose: 21 days after first dose</li>\r\n	<li>Fourth dose: 12 months after first dose</li>\r\n</ul>\r\n\r\n<p><strong>Renal insufficiency (including haemodialysis patients), adult and child over 16 years 4 doses of 40 micrograms</strong>-</p>\r\n\r\n<ul>\r\n	<li>First dose: at the appropriate date</li>\r\n	<li>Second dose: 1 month after first dose</li>\r\n	<li>Third dose: 2 months after first dose</li>\r\n	<li>Fourth dose: 6 months after first dose</li>\r\n</ul>\r\n\r\n<p>Immunization schedule and booster doses may need to be adjusted in those with low antibody concentration.<br />\r\n<br />\r\n<strong>Booster vaccinations</strong>: For persons with normal immune status who have been vaccinated, booster doses of<br />\r\nHepatitis B vaccine has not been established. However, booster doses are recommended for hemodialysis patients or other immunocompromised persons.</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong>Administration</strong></p>\r\n\r\n<p><strong>Method of administration</strong>: Hepatitis B Vaccine is for intramuscular injection only. Do not inject intravenously. Hepatitis B Vaccine should be given intramuscularly in the deltoid muscle of adult and children or in the anterolateral aspect of thigh in children under 1 year.<br />\r\n<br />\r\n<strong>Preparation for administration</strong>: The vaccine should be shaken well before use to obtain a homogenous turbid white suspension. Do not shake vigorously. The vaccine should be inspected visually for particulate matter and discoloration prior to administration. If either of these conditions exists, the vaccine should not be administered. The vaccine should be used as supplied; no dilution is necessary<br />\r\n<br />\r\n<strong>Co-administration</strong>: Hepatitis B vaccine can be given at the same time with other vaccine as Diphtheria, Tetanus, Pertussis (DTP), Polio (OPV), Measles, Mumps and Rubella (MMR), Haemophilus influenzae b, Hepatitis A and BCG vaccines at separate sites and with separate syringes. It should not be mixed with other vaccines or medicinal products in the same syringe.</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong>Contraindications</strong></p>\r\n\r\n<p>Hypersensitivity to any component of the vaccine, including yeast, is a contraindication. This vaccine is contraindicated in patients with previous hypersensitivity to any Hepatitis B virus containing vaccine.</p>\r\n\r\n<p><strong>Side Effects</strong></p>\r\n\r\n<p>Hepatitis B vaccine is generally well tolerated. Most recipients of Hepatitis B vaccine experience some reactions upon vaccination. These are generally moderate and short. They mainly consist of local reactions at the injection site (erythema, induration and tenderness). Systemic reactions (malaise, headache, diarrhea, vomiting, myalgia and elevated temperature) are reported less commonly. In very rare cases allergic type reactions (pruritus, rash, urticaria) may be observed.</p>', 1, '2022-03-19 03:43:47', '2022-07-02 19:47:56'),
(188, 5, 4231, 92, 'P/Pc', 'BD', 'Inactivated Influenza Vaccine', '0.5 ml/Prefilled Syringe', '950.00', '1913634324.jpg', 'www.alpha-medicare.com', '<p><strong>Composition</strong></p>\r\n\r\n<p>One dose (0.5 ml) contains Influenza virus surface antigens (haemagglutinin and neuraminidase), propagated in fertilized hen&rsquo;s eggs from healthy chicken flocks, and inactivated with formaldehyde, of the following strains:</p>\r\n\r\n<ul>\r\n	<li>A/California/07/2009 (H1N1)-like strain (A/California/07/2009, NYMC X-181): 15 micrograms. haemagglutinin</li>\r\n	<li>A/Perth/16/2009 (H3N2)-like strain (A/Victoria/210/2009, NYMC X-187): 15 micrograms haemagglutinin.</li>\r\n	<li>B/Brisbane/60/2008-like strain (B/Brisbane/60/2008): 15 micrograms haemagglutinin.</li>\r\n</ul>\r\n\r\n<p><strong>Indications</strong></p>\r\n\r\n<p>Prophylaxis of influenza (flu), especially in those who run an increased risk of associated complications. The use of Inactivated Influenza Vaccine should be based on official recommendations.</p>\r\n\r\n<p><strong>Dosage &amp; Administration</strong></p>\r\n\r\n<p><strong>Dosage</strong>:</p>\r\n\r\n<ul>\r\n	<li>Adults and children over 36 months of age: 0.5ml</li>\r\n	<li>Children from 6 to 35 months of age: clinical data are limited. Doses of 0.25 ml or 0.5 ml have been used.</li>\r\n</ul>\r\n\r\n<p><strong>Administrations</strong>: For children who have not previously been vaccinated, a second dose should be given after an interval of at least 4 weeks. If half a dose (0.25 ml) is to be administered, discard half the contained volume (up to the mark indicated on the syringe barrel), before injection. Immunisation should be carried out by intramuscular or deep subcutaneous injection. The vaccine should be allowed to reach room temperature before use. Shake before use. Seroprotection is generally obtained within 2 to 3 weeks. The duration of postvaccinal immunity to homologous strains or to strains closely related to the vaccine strains varies but is usually 6-12 months.</p>\r\n\r\n<p><strong>Interaction</strong></p>\r\n\r\n<p>Inactivated Influenza Vaccine may be given at the same time as other vaccines. Immunisation should be carried out on separate limbs. It should be noted that the adverse reactions may be intensified. The immunological response may be diminished if the patient is undergoing immunosuppressant treatment. Following influenza vaccination, false positive results in serology tests using the ELISA method (blood test) to detect antibodies against HIV1, Hepatitis C and especially HTLV1 have been observed. The Western Blot technique disproves the false-positive ELISA results. The transient false positive reactions could be due to the IgM response by the vaccine.</p>\r\n\r\n<p><strong>Contraindications</strong></p>\r\n\r\n<p>Hypersensitivity to the active substances, to any of the excipients and to residues, e.g. eggs, chicken proteins, such as ovalbumin. The vaccine may contain residues of the following substances, e.g. kanamycin and neomycin sulphate, formaldehyde, cetyltrimethylammonium bromide (CTAB) and polysorbate 80. Immunisation shall be postponed in patients with febrile illness or acute infection.</p>\r\n\r\n<p><strong>Pregnancy &amp; Lactation</strong></p>\r\n\r\n<p>The limited data from vaccinations in pregnant women do not indicate that adverse foetal and maternal outcomes were attributable to the vaccine. The use of this vaccine may be considered from the second trimester of pregnancy. For pregnant women with medical conditions that increase their risk of complications from influenza, administration of the vaccine is recommended, irrespective of their stage of pregnancy. Inactivated Influenza Vaccine may be used during lactation.</p>\r\n\r\n<p><strong>Precautions &amp; Warnings</strong></p>\r\n\r\n<p>Antibody response in patients with endogenous (due to illness) or iatrogenic (due to medicine) immunosuppression (poor immune response) may be insufficient. As with all injectable vaccines, appropriate medical treatment and supervision should always be readily available in case of a rare anaphylactic event following the administration of the vaccine. Inactivated Influenza Vaccine&nbsp;should under no circumstances be administered intravascularly.</p>\r\n\r\n<p><strong>Therapeutic Class :</strong> Vaccines, Anti-sera &amp; Immunoglobulin</p>\r\n\r\n<p><strong>Storage Conditions</strong></p>\r\n\r\n<p>Inactivated Influenza Vaccine must be stored in a refrigerator (2&deg;C-8&deg;C). Do not freeze. Keep the syringe in the outer carton in order to protect from light. Any unused product or waste material should be disposed of in accordance with local requirements.</p>', 0, '2022-03-19 03:46:58', '2022-06-20 04:42:41'),
(189, 5, 4380, 92, 'P/Pc', 'BD', 'Meningococcal Polysaccharide Vaccine', '0.5 ml vial', '1000.00 (0.5 ml vial)', '1149052977.jpg', 'www.alpha-medicare.com', '<p><strong>Composition</strong></p>\r\n\r\n<p>Each vial contains lyophilized preparation of Meningococcal Polysaccharide Vaccine BP containing purified polysaccharides from Neisseria meningitidis serogroups A, C, W135 and Y. After reconstitution 0.5 ml contains &ge; 50 &micro;g of each of the polysaccharide serogroups A, C, W135 and Y.</p>\r\n\r\n<p><strong>Indications</strong></p>\r\n\r\n<p>Meningococcal Polysaccharide Vaccine is indicated for the active immunization of children from 2 years of age, adolescents and adults against meningococcal disease caused by meningococci of serogroups A, C, W135 and Y. The vaccine may also be used for:</p>\r\n\r\n<ul>\r\n	<li>Subjects who are living in closed communities and close contacts of patients with disease caused by meningococci of serogroups A, C, W135 and Y.</li>\r\n	<li>Travellers to countries where the disease is epidemic or highly endemic</li>\r\n</ul>\r\n\r\n<p><strong>Pharmacology</strong></p>\r\n\r\n<p>Meningococcal Polysaccharide Vaccine is a freeze-dried preparation of the group-specific polysaccharide antigens from Neisseria meningitidis Group A, Group C, Group Y and Group W135. When reconstituted, the vaccine is a clear, colorless sterile solution for subcutaneous use.</p>\r\n\r\n<p><strong>Dosage &amp; Administration</strong></p>\r\n\r\n<p>The immunizing dose is a single injection of 0.5 ml administered subcutaneously. Primary Immunization For both adults and children from 2 years of age, vaccine is administered subcutaneously as a single 0.5 ml dose. Protective antibody levels may be achieved within 7 to 10 days after vaccination.</p>\r\n\r\n<p><strong>Contraindications</strong></p>\r\n\r\n<p>Hypersensitivity to the active substances or to any of the excipients.</p>\r\n\r\n<p><strong>Side Effects</strong></p>\r\n\r\n<p>Meningococcal polysaccharide vaccine is generally well tolerated. Adverse reactions usually occur within 48 hours following vaccination.<br />\r\n<br />\r\nMetabolism and nutrition disorders-</p>\r\n\r\n<ul>\r\n	<li>Common: appetite lost Psychiatric disorders:</li>\r\n	<li>Very common: irritability</li>\r\n</ul>\r\n\r\n<p>Nervous system disorders-</p>\r\n\r\n<ul>\r\n	<li>Very common: drowsiness, headache.</li>\r\n	<li>Uncommon: dizziness</li>\r\n</ul>\r\n\r\n<p>Gastrointestinal disorders-</p>\r\n\r\n<ul>\r\n	<li>Common: gastrointestinal symptoms e.g. nausea, vomiting and diarrhea</li>\r\n</ul>\r\n\r\n<p>Musculoskeletal and connective tissue disorders-</p>\r\n\r\n<ul>\r\n	<li>Common: myalgia</li>\r\n</ul>\r\n\r\n<p>General disorders and administration site conditions-</p>\r\n\r\n<ul>\r\n	<li>Very common: pain and redness at the injection site, fatigue</li>\r\n	<li>Common: swelling at the injection site, fever</li>\r\n	<li>\r\n	<p>Pregnancy &amp; Lactation</p>\r\n\r\n	<p><strong>Pregnancy:</strong>&nbsp;Adequate human data on use during pregnancy and adequate animal reproduction studies are not available. This vaccine should be used during pregnancy only when clearly needed and when the possible advantages outweigh the possible risks for the fetus.<br />\r\n	<br />\r\n	<strong>Lactation</strong>: Adequate data on the administration of this vaccine to women who are breast-feeding are not available. This vaccine should be administered to women who are breast-feeding when needed and the possible advantages outweigh the possible risks.</p>\r\n	</li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong>Precautions &amp; Warnings</strong></p>\r\n\r\n<p>As with other vaccines, the administration of Meningococcal polysaccharide vaccine should be postponed in subjects suffering from acute severe febrile illness. The presence of a minor infection, however, is not a contraindication for immunization. This vaccine gives no protection against meningococcal meningitis caused by meningococci belonging to serogroups other than A, C, W135 and Y. If administered to subjects with impaired immune responses, the vaccine may not induce an effective response.As with all injectable vaccines, appropriate medication (e.g. adrenaline) should always be readily available for treatment in case of anaphylactic reactions following the administration of the vaccine. Vaccination should be preceded by a review of the medical history (especially with regard to previous vaccination and possible occurrence of undesirable events) and a clinical examination.</p>\r\n\r\n<p><strong>Therapeutic Class</strong>&nbsp;: Vaccines, Anti-sera &amp; Immunoglobulin</p>\r\n\r\n<p><strong>Storage Conditions</strong></p>\r\n\r\n<p>Keep out of the reach and sight of children .Store and transport at 2&deg;C to 8&deg;C. Do not freeze Protect from light .The vaccine should be used within 30 minutes after reconstitution</p>', 0, '2022-03-19 03:49:53', '2022-06-21 05:51:46');
INSERT INTO `products` (`id`, `cat_id`, `brand_id`, `company_id`, `unit`, `origin`, `name`, `specification`, `price`, `image`, `btn_link`, `desc`, `is_featured`, `created_at`, `updated_at`) VALUES
(190, 5, 4381, 92, 'P/Pc', 'BD', 'Normoglobin (500mg/10ml)', '500mg/ 10 mL', '2800.00', '938523035.jpg', 'www.alpha-medicare.com', '<p><strong>Indications</strong></p>\r\n\r\n<p>Human immunoglobulin-G (IgG) is indicated in:</p>\r\n\r\n<ul>\r\n	<li>Treatment of primary immunodeficiency</li>\r\n	<li>For combined therapy with antibiotics in severe bacterial or viral infections</li>\r\n	<li>A-/Hypogammaglobulinemia</li>\r\n	<li>Idiopathic Thrombocytopenic Purpura</li>\r\n	<li>Guillain-Barre Syndrome</li>\r\n	<li>Kawasaki Syndrome</li>\r\n</ul>\r\n\r\n<p><strong>Description</strong></p>\r\n\r\n<p>This is a ready to use, sterile, clear or slightly opalescent and colorless to pale yellow, liquid preparation of purified immunoglobulin-G (IgG) obtained from human plasma pools. The purification processes include thawing, cold ethanol fractionation, chromatography, virus inactivation with S/D fractionation and nano-filtration and dia-filtration. The final bulk is manufactured by adding maltose (as stabilizer) to bulk product and passing through sterile filter, after this the final bulk is filled into vials.</p>\r\n\r\n<p><strong>Dosage</strong></p>\r\n\r\n<p><strong>Neonates and infants</strong>: 5 ml (250 mg)/kg body weight daily on 3 consecutive days. Further infusion may be required depending on the clinical course.<br />\r\n<br />\r\nChildren and adults:</p>\r\n\r\n<ul>\r\n	<li><strong>For combined therapy with antibiotics in severe bacterial or viral infections and A-/Hypogammaglobulinemia</strong>: The usual dosage for adults and children is 2500-5000 mg and 50-150 mg/kg respectively (as a single dose) by intravenous drip infusion or direct intravenous infusion. In case of intravenous injection, it should be injected very slowly.</li>\r\n	<li><strong>For Idiopathic Thrombocytopenic Purpura</strong>: The usual dose is 200-400 mg/kg daily given for 5 consecutive days. The additional doses are discontinued if an adequate response does not occur.</li>\r\n</ul>\r\n\r\n<p><strong>For Guillain-Barre Syndrome</strong>: The usual dosage is 400 mg/kg daily given for 5 consecutive days.<br />\r\n<br />\r\n<strong>For Kawasaki Syndrome</strong>: The usual dosage is 400 mg/kg daily given for 5 consecutive days (approximately) or 2000 mg daily by intravenous drip infusion. It is recommended that the administration start within 7 days from the onset of Kawasaki Syndrome.</p>\r\n\r\n<p><strong>Administration</strong></p>\r\n\r\n<p>The human normal immunoglobulin is for intravenous use only. For intravenous injection, it should be injected very slowly. The product should be warmed to room or body temperature before use. The human normal immunoglobulin should be infused intravenously at the following rates:<br />\r\n<br />\r\n0.01~0.02 ml/kg/min for first 30 minutes and then infusion rate can be gradually increased maximum 0.06 ml/kg/min, if no abnormal sign appears from patients. This infusion can be recalculated by hourly basis; it is 0.6~1.2 ml/kg/hr and 3.6 ml/kg/hr (maximum).<br />\r\n<br />\r\n<strong>General cautions:</strong></p>\r\n\r\n<ul>\r\n	<li>The human normal immunoglobulin is for intravenous use only.</li>\r\n	<li>When a needle is inserted through the rubber stopper, the needle should be inserted vertically and slowly. If a needle is inserted in a tilted or twisted direction, rubber fragments may be mixed with medicinal product. If there are any rubber fragments, discard the product.</li>\r\n	<li>The vial should be inspected for visible particulate matter and color prior to administration. Do not use the vial if particles are detected. Do not use if turbid.</li>\r\n	<li>Several vials may be pooled into an empty sterile solution container by using aseptic technique, if large doses are to be administered.</li>\r\n	<li>The human normal immunoglobulin cannot be diluted with intravenous fluids. Other medications cannot be injected into the intravenous tubing being used for the human normal immunoglobulin. In case of idiopathic Thrombocytopenic Purpura for children, spontaneous remission should be considered.</li>\r\n	<li>Additional administration to patients with Kawasaki Syndrome should be conducted when the effectiveness of immunoglobulin is insufficient (e.g. symptomatic remission) or additional administration is clearly necessary.(Safety and efficacy for additional administration has not been established)</li>\r\n	<li>Patients should be aware of the risk and discuss with their healthcare professionals and contact them if any signs or symptoms of thrombosis during or after receiving this product develop.</li>\r\n	<li>Healthcare professionals should be aware of the risk for thrombosis with human normal immunoglobulin products and discuss with their patients the risk of thrombosis associated with this product.</li>\r\n</ul>\r\n\r\n<p>There is a possibility that live vaccines (measles, mumps, rubella and varicella vaccine etc.) do not work for the patients who were treated with human normal immunoglobulin. Therefore vaccination should be delayed for 3 months after administration. If human normal immunoglobulin is administered within 14 days after vaccination, re-vaccination should be taken after more than 3 months post administration.<br />\r\n<br />\r\nAfter a large bolus (more than 200 mg/kg) administration for the ITP and Kawasaki disease, use of live vaccines should be delayed more than 6 months. In case of low risk of measles infection, measles vaccination can be delayed more than 11 months.</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong>Interaction</strong></p>\r\n\r\n<p>May interfere with the immune response to live measles vaccine, live mumps vaccine, live rubella vaccine and live varicella vaccine, therefore these vaccines should be given at least 3 wk before or 3 mth after the admin of the immunoglobulins.</p>\r\n\r\n<p><strong>Contraindications</strong></p>\r\n\r\n<p>Contraindicated in patients who have had a history of anaphylactic or severe systemic hypersensitivity reactions to the administration of human normal immunoglobulin.</p>\r\n\r\n<p><strong>Side Effects</strong></p>\r\n\r\n<ul>\r\n	<li>Symptoms of shock may occur. If dyspnea, wheeze, chest pain, hypotension or weak pulse are watched, administration should be discontinued and 0.1-0.5 ml epinephrine (1:1000) or the administration of cortisone should be considered.</li>\r\n	<li>Rapid administration can cause hypotension.</li>\r\n	<li>Liver function disorders or jaundice accompanying and increase in ALT or AST may occur. Caution should be taken and proper treatment should be followed if needed.</li>\r\n	<li>Renal failure may occur with the use of human normal immunoglobulin. If dehydration, hypouresis, increase of creatinine or increase of BUN etc is observed, administration should be discontinued and proper treatment should be taken.</li>\r\n	<li>Aseptic meningitis from a large volume of IVIG administration may occur.</li>\r\n	<li>Decrease in platelets may occur. Other possible undesirable effects include drowsiness, chill, chest pain, abdominal pain, gluteal pain and anxiety etc.</li>\r\n</ul>\r\n\r\n<p><strong>Pregnancy &amp; Lactation</strong></p>\r\n\r\n<p>Safety for a pregnant woman has not been established. The possibility of parvovirus B-19 infection cannot be excluded from the administration of human normal immunoglobulin. In case of parvovirus B-19 infection, fetal disturbances (Abortion, Hydrops fetalis, fetal death) may occur. Human normal immunoglobulin should be given to a pregnant woman only if the expected benefit justifies the possible risk.&nbsp;Use of this product has not been evaluated in nursing mothers.</p>\r\n\r\n<p><strong>Precautions &amp; Warnings</strong></p>\r\n\r\n<p>Human normal immunoglobulin, manufactured from human plasma, has the potential to transmit hepatitis viruses or other viruses. Accordingly, patients with hemophilia or immunodeficiency are recommended to be appropriately vaccinated (Hepatitis A vaccine, etc.), and the attending physician should monitor patients regularly to check any sign of virus infection.<br />\r\n<br />\r\nThrombosis may occur regardless of the route of administration and in the absence of known risk factors (advanced age, prolonged immobilization, hypercoagulable conditions, history of venous or arterial thrombosis, use of estrogens, indwelling central vascular catheters, hyperviscosity and cardiovascular risk factors). For patients at risk of thrombosis, administer at the minimum concentration possible and at the minimum rate of infusion practicable.<br />\r\n<br />\r\nSevere hypersensitivity reactions and anaphylactic reactions with a fall in blood pressure may occur. Patients with antibodies to IgA have a greater risk of developing potentially severe hypersensitivity and anaphylactic reactions.<br />\r\n<br />\r\nPatients with renal disorder (Renal function may deteriorate), Acute renal dysfunction/failure, acute tubular necrosis, proximal tubular nephropathy, osmotic nephrosis and death have been reported in patients receiving IVIG. It should be ensured that patients are not volume-depleted before administration of the IVIG. For patients judged to be at risk for developing renal dysfunction, including patients with any degree of pre-existing renal insufficiency, diabetes mellitus, age greater than 65, volume depletion, sepsis, paraproteinemia, or patients receiving known nephrotoxic drugs, IVIG should be administered at the minimum dose and rate of infusion practicable.<br />\r\n<br />\r\nPatients with hemolytic anemia or anemia from blood loss (Human parvovirus B19 infection may occur. In case of infection, continuous anemia may occur.) Patients with cerebrovascular and cardiovascular disorders or case history thereof for example, (Elderly patients with ischemic disease, cardiovascular disorder, cerebrovascular disorders or case of history thereof: a large bolus administration can cause thrombus or embolism such as cerebral infarction, a myocardial infarction, etc, due to blood viscosity increase.)<br />\r\nPatients with high risk of thrombus or embolism (Thrombus or embolism may occur due to an increase of blood viscosity due to large bolus administration.)<br />\r\n<br />\r\nPatients with low heart function.<br />\r\n<br />\r\nAseptic Meningitis Syndrome (AMS) has been reported to occur following high dose (e.g. over 1.0 g per kg body weight) of IVIG treatment or rapid infusion of IVIG. The symptoms of AMS usually begin within several hours to 2 days following IVIG treatment. Discontinuation of IVIG treatment has resulted in remission of AMS within several days without sequelae. AMS is characterized by the following signs and symptoms: severe headache, nuchal rigidity, drowsiness, fever, photophobia, painful eye movements, nausea and vomiting.<br />\r\n<br />\r\nPatients should take caution with IgA deficiency. (IVIG may cause anaphylaxis to patients who have anti-IgA)<br />\r\n<br />\r\nHuman normal immunoglobulin may contain blood group antibodies that may act as hemolysins and induce in vivo coating of red blood cells with immunoglobulin, causing a positive direct antiglobulin test result and hemolysis. Delayed hemolytic anemia can develop subsequent to IVIG therapy due to enhanced red blood cell sequestration and acute hemolysis, consistent with intravascular hemolysis, has been reported.<br />\r\n<br />\r\nNon-cardiogenic pulmonary edema has been reported in patients following IVIG treatment. Transfusion-related acute lung injury is characterized by severe respiratory distress, pulmonary edema, hypoxemia, normal left ventricular function, and fever. Symptoms typically appear within 1 to 6 hours after transfusion.</p>\r\n\r\n<p><strong>Therapeutic Class</strong>&nbsp;: Vaccines, Anti-sera &amp; Immunoglobulin</p>\r\n\r\n<p><strong>Storage Conditions</strong></p>\r\n\r\n<p>Store and transport at 2&deg;C to 8&deg;C. Protect from light. Do not freeze. Keep out of the reach and sight of children</p>', 1, '2022-03-19 03:54:34', '2022-07-02 19:48:32'),
(191, 5, 4381, 92, 'P/Pc', 'BD', 'Normoglobin (2.5gm/50ml)', '250mg/50 mL', '14000.00', '146511157.jpg', 'www.alpha-medicare.com', '<p><strong>Indications</strong></p>\r\n\r\n<p>Human immunoglobulin-G (IgG) is indicated in:</p>\r\n\r\n<ul>\r\n	<li>Treatment of primary immunodeficiency</li>\r\n	<li>For combined therapy with antibiotics in severe bacterial or viral infections</li>\r\n	<li>A-/Hypogammaglobulinemia</li>\r\n	<li>Idiopathic Thrombocytopenic Purpura</li>\r\n	<li>Guillain-Barre Syndrome</li>\r\n	<li>Kawasaki Syndrome</li>\r\n</ul>\r\n\r\n<p><strong>Description</strong></p>\r\n\r\n<p>This is a ready to use, sterile, clear or slightly opalescent and colorless to pale yellow, liquid preparation of purified immunoglobulin-G (IgG) obtained from human plasma pools. The purification processes include thawing, cold ethanol fractionation, chromatography, virus inactivation with S/D fractionation and nano-filtration and dia-filtration. The final bulk is manufactured by adding maltose (as stabilizer) to bulk product and passing through sterile filter, after this the final bulk is filled into vials.</p>\r\n\r\n<p><strong>Dosage</strong></p>\r\n\r\n<p><strong>Neonates and infants</strong>: 5 ml (250 mg)/kg body weight daily on 3 consecutive days. Further infusion may be required depending on the clinical course.<br />\r\n<br />\r\nChildren and adults:</p>\r\n\r\n<ul>\r\n	<li><strong>For combined therapy with antibiotics in severe bacterial or viral infections and A-/Hypogammaglobulinemia</strong>: The usual dosage for adults and children is 2500-5000 mg and 50-150 mg/kg respectively (as a single dose) by intravenous drip infusion or direct intravenous infusion. In case of intravenous injection, it should be injected very slowly.</li>\r\n	<li><strong>For Idiopathic Thrombocytopenic Purpura</strong>: The usual dose is 200-400 mg/kg daily given for 5 consecutive days. The additional doses are discontinued if an adequate response does not occur.</li>\r\n</ul>\r\n\r\n<p><strong>For Guillain-Barre Syndrome</strong>: The usual dosage is 400 mg/kg daily given for 5 consecutive days.<br />\r\n<br />\r\n<strong>For Kawasaki Syndrome</strong>: The usual dosage is 400 mg/kg daily given for 5 consecutive days (approximately) or 2000 mg daily by intravenous drip infusion. It is recommended that the administration start within 7 days from the onset of Kawasaki Syndrome.</p>\r\n\r\n<p><strong>Administration</strong></p>\r\n\r\n<p>The human normal immunoglobulin is for intravenous use only. For intravenous injection, it should be injected very slowly. The product should be warmed to room or body temperature before use. The human normal immunoglobulin should be infused intravenously at the following rates:<br />\r\n<br />\r\n0.01~0.02 ml/kg/min for first 30 minutes and then infusion rate can be gradually increased maximum 0.06 ml/kg/min, if no abnormal sign appears from patients. This infusion can be recalculated by hourly basis; it is 0.6~1.2 ml/kg/hr and 3.6 ml/kg/hr (maximum).<br />\r\n<br />\r\n<strong>General cautions:</strong></p>\r\n\r\n<ul>\r\n	<li>The human normal immunoglobulin is for intravenous use only.</li>\r\n	<li>When a needle is inserted through the rubber stopper, the needle should be inserted vertically and slowly. If a needle is inserted in a tilted or twisted direction, rubber fragments may be mixed with medicinal product. If there are any rubber fragments, discard the product.</li>\r\n	<li>The vial should be inspected for visible particulate matter and color prior to administration. Do not use the vial if particles are detected. Do not use if turbid.</li>\r\n	<li>Several vials may be pooled into an empty sterile solution container by using aseptic technique, if large doses are to be administered.</li>\r\n	<li>The human normal immunoglobulin cannot be diluted with intravenous fluids. Other medications cannot be injected into the intravenous tubing being used for the human normal immunoglobulin. In case of idiopathic Thrombocytopenic Purpura for children, spontaneous remission should be considered.</li>\r\n	<li>Additional administration to patients with Kawasaki Syndrome should be conducted when the effectiveness of immunoglobulin is insufficient (e.g. symptomatic remission) or additional administration is clearly necessary.(Safety and efficacy for additional administration has not been established)</li>\r\n	<li>Patients should be aware of the risk and discuss with their healthcare professionals and contact them if any signs or symptoms of thrombosis during or after receiving this product develop.</li>\r\n	<li>Healthcare professionals should be aware of the risk for thrombosis with human normal immunoglobulin products and discuss with their patients the risk of thrombosis associated with this product.</li>\r\n</ul>\r\n\r\n<p>There is a possibility that live vaccines (measles, mumps, rubella and varicella vaccine etc.) do not work for the patients who were treated with human normal immunoglobulin. Therefore vaccination should be delayed for 3 months after administration. If human normal immunoglobulin is administered within 14 days after vaccination, re-vaccination should be taken after more than 3 months post administration.<br />\r\n<br />\r\nAfter a large bolus (more than 200 mg/kg) administration for the ITP and Kawasaki disease, use of live vaccines should be delayed more than 6 months. In case of low risk of measles infection, measles vaccination can be delayed more than 11 months.</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong>Interaction</strong></p>\r\n\r\n<p>May interfere with the immune response to live measles vaccine, live mumps vaccine, live rubella vaccine and live varicella vaccine, therefore these vaccines should be given at least 3 wk before or 3 mth after the admin of the immunoglobulins.</p>\r\n\r\n<p><strong>Contraindications</strong></p>\r\n\r\n<p>Contraindicated in patients who have had a history of anaphylactic or severe systemic hypersensitivity reactions to the administration of human normal immunoglobulin.</p>\r\n\r\n<p><strong>Side Effects</strong></p>\r\n\r\n<ul>\r\n	<li>Symptoms of shock may occur. If dyspnea, wheeze, chest pain, hypotension or weak pulse are watched, administration should be discontinued and 0.1-0.5 ml epinephrine (1:1000) or the administration of cortisone should be considered.</li>\r\n	<li>Rapid administration can cause hypotension.</li>\r\n	<li>Liver function disorders or jaundice accompanying and increase in ALT or AST may occur. Caution should be taken and proper treatment should be followed if needed.</li>\r\n	<li>Renal failure may occur with the use of human normal immunoglobulin. If dehydration, hypouresis, increase of creatinine or increase of BUN etc is observed, administration should be discontinued and proper treatment should be taken.</li>\r\n	<li>Aseptic meningitis from a large volume of IVIG administration may occur.</li>\r\n	<li>Decrease in platelets may occur. Other possible undesirable effects include drowsiness, chill, chest pain, abdominal pain, gluteal pain and anxiety etc.</li>\r\n</ul>\r\n\r\n<p><strong>Pregnancy &amp; Lactation</strong></p>\r\n\r\n<p>Safety for a pregnant woman has not been established. The possibility of parvovirus B-19 infection cannot be excluded from the administration of human normal immunoglobulin. In case of parvovirus B-19 infection, fetal disturbances (Abortion, Hydrops fetalis, fetal death) may occur. Human normal immunoglobulin should be given to a pregnant woman only if the expected benefit justifies the possible risk.&nbsp;Use of this product has not been evaluated in nursing mothers.</p>\r\n\r\n<p><strong>Precautions &amp; Warnings</strong></p>\r\n\r\n<p>Human normal immunoglobulin, manufactured from human plasma, has the potential to transmit hepatitis viruses or other viruses. Accordingly, patients with hemophilia or immunodeficiency are recommended to be appropriately vaccinated (Hepatitis A vaccine, etc.), and the attending physician should monitor patients regularly to check any sign of virus infection.<br />\r\n<br />\r\nThrombosis may occur regardless of the route of administration and in the absence of known risk factors (advanced age, prolonged immobilization, hypercoagulable conditions, history of venous or arterial thrombosis, use of estrogens, indwelling central vascular catheters, hyperviscosity and cardiovascular risk factors). For patients at risk of thrombosis, administer at the minimum concentration possible and at the minimum rate of infusion practicable.<br />\r\n<br />\r\nSevere hypersensitivity reactions and anaphylactic reactions with a fall in blood pressure may occur. Patients with antibodies to IgA have a greater risk of developing potentially severe hypersensitivity and anaphylactic reactions.<br />\r\n<br />\r\nPatients with renal disorder (Renal function may deteriorate), Acute renal dysfunction/failure, acute tubular necrosis, proximal tubular nephropathy, osmotic nephrosis and death have been reported in patients receiving IVIG. It should be ensured that patients are not volume-depleted before administration of the IVIG. For patients judged to be at risk for developing renal dysfunction, including patients with any degree of pre-existing renal insufficiency, diabetes mellitus, age greater than 65, volume depletion, sepsis, paraproteinemia, or patients receiving known nephrotoxic drugs, IVIG should be administered at the minimum dose and rate of infusion practicable.<br />\r\n<br />\r\nPatients with hemolytic anemia or anemia from blood loss (Human parvovirus B19 infection may occur. In case of infection, continuous anemia may occur.) Patients with cerebrovascular and cardiovascular disorders or case history thereof for example, (Elderly patients with ischemic disease, cardiovascular disorder, cerebrovascular disorders or case of history thereof: a large bolus administration can cause thrombus or embolism such as cerebral infarction, a myocardial infarction, etc, due to blood viscosity increase.)<br />\r\nPatients with high risk of thrombus or embolism (Thrombus or embolism may occur due to an increase of blood viscosity due to large bolus administration.)<br />\r\n<br />\r\nPatients with low heart function.<br />\r\n<br />\r\nAseptic Meningitis Syndrome (AMS) has been reported to occur following high dose (e.g. over 1.0 g per kg body weight) of IVIG treatment or rapid infusion of IVIG. The symptoms of AMS usually begin within several hours to 2 days following IVIG treatment. Discontinuation of IVIG treatment has resulted in remission of AMS within several days without sequelae. AMS is characterized by the following signs and symptoms: severe headache, nuchal rigidity, drowsiness, fever, photophobia, painful eye movements, nausea and vomiting.<br />\r\n<br />\r\nPatients should take caution with IgA deficiency. (IVIG may cause anaphylaxis to patients who have anti-IgA)<br />\r\n<br />\r\nHuman normal immunoglobulin may contain blood group antibodies that may act as hemolysins and induce in vivo coating of red blood cells with immunoglobulin, causing a positive direct antiglobulin test result and hemolysis. Delayed hemolytic anemia can develop subsequent to IVIG therapy due to enhanced red blood cell sequestration and acute hemolysis, consistent with intravascular hemolysis, has been reported.<br />\r\n<br />\r\nNon-cardiogenic pulmonary edema has been reported in patients following IVIG treatment. Transfusion-related acute lung injury is characterized by severe respiratory distress, pulmonary edema, hypoxemia, normal left ventricular function, and fever. Symptoms typically appear within 1 to 6 hours after transfusion.</p>\r\n\r\n<p><strong>Therapeutic Class</strong>&nbsp;: Vaccines, Anti-sera &amp; Immunoglobulin</p>\r\n\r\n<p><strong>Storage Conditions</strong></p>\r\n\r\n<p>Store and transport at 2&deg;C to 8&deg;C. Protect from light. Do not freeze. Keep out of the reach and sight of children</p>', 0, '2022-03-19 03:57:20', '2022-07-03 05:37:47'),
(192, 5, 8023, 92, 'P/Pc', 'BD', 'Inactivated Hepatitis A Vaccine-child', '250 unit/0.5 mL', '600.00 (0.5 ml vial)', '1456224428.jpg', 'www.alpha-medicare.com', '<p><strong>Indications</strong></p>\r\n\r\n<p>The vaccine is indicated for the active immunization of adults and children from 12 months of age against infection caused by Hepatitis A virus.</p>\r\n\r\n<p><strong>Description</strong></p>\r\n\r\n<p>This is a purified sterile suspension of inactivated Hepatitis A vaccine derived from Hepatitis A virus cultured in human diploid cell followed by harvest, purification, inactivation by formaldehyde and Aluminium hydroxide adsorption.</p>\r\n\r\n<p><strong>Pharmacology</strong></p>\r\n\r\n<p>The hepatitis A virus belongs to the picornavirus family. It is one of several hepatitis viruses that cause systemic disease with pathology in the liver. The incubation period for hepatitis A averages 28 days (range: 15 to 50 days). The course of hepatitis A infection is extremely variable, ranging from asymptomatic infection to icteric hepatitis and death. The presence of antibodies to HAV confers protection against hepatitis A infection. However, the lowest titer needed to confer protection has not been determined.</p>\r\n\r\n<p><strong>Dosage</strong></p>\r\n\r\n<p>Hepatitis A vaccine should be given intramuscularly only. Do not inject it intravenously. The primary immunization consists of two doses, the first dose is at the selected date and the second dose will be at 6 months later.<br />\r\n<br />\r\nChildren 12 months to 15 years: The recommended dose is 0.5 ml</p>\r\n\r\n<ul>\r\n	<li><strong>First dose</strong>: At the elected date</li>\r\n	<li><strong>Second dose</strong>: 6 months after the first dose</li>\r\n</ul>\r\n\r\n<p>Children 16 years and above: The recommended dose is 1 ml</p>\r\n\r\n<ul>\r\n	<li><strong>First dose</strong>: At the elected date</li>\r\n	<li><strong>Second dose</strong>: 6 months after the first dose</li>\r\n</ul>\r\n\r\n<p><strong>Administration</strong></p>\r\n\r\n<p><strong>Method of administration</strong>: Hepatitis A vaccine should be injected intramuscularly in the deltoid region in adults and children and in the anterolateral part of the thigh in young children under 1 year. The vaccine should not be administered intramuscularly in the gluteal region or subcutaneously/intradermally since administration by these routes may result in less antibody response than optimal. Hepatitis A vaccine should be inspected visually for any foreign particulate matter and/or discoloration prior to administration. Before use, the vial should be well shaken to obtain a slightly milky-white suspension. The vaccine must be used as supplied.<br />\r\n<br />\r\n<strong>Co-administration</strong>: Since Hepatitis A vaccine is an inactivated vaccine, its concomitant use with other inactivated vaccines is unlikely to result in interference with immune responses. When concomitant administration of other vaccines is considered necessary, the vaccines must be given with different syringes and at different injection sites. Concomitant administration of Hepatitis B, typhoid, yellow fever, cholera (injectable) or tetanus vaccine does not interfere with Hepatitis A vaccine immune response. Concomitant administration of Hepatitis A vaccine and human immune globulin may be considered when a subject is at risk of being exposed to Hepatitis A before adequate antibody titre can be reached. Hepatitis A vaccine and human immune globulin should be administered at separate injection sites.</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong>Contraindications</strong></p>\r\n\r\n<p>People who are allergic to any component of the vaccine. People who suffer from serious diseases, fever, and any immune disease</p>\r\n\r\n<p><strong>Side Effects</strong></p>\r\n\r\n<p>Reactions at the site of injection are common but can be recovered within 72 hours without any treatment. Some of the mild and temporary adverse reactions are: pain and redness at the site of injection, fever after vaccination.</p>\r\n\r\n<p><strong>Pregnancy &amp; Lactation</strong></p>\r\n\r\n<p>The vaccine should be given to a pregnant woman only if clearly needed. The vaccine should be used with caution for lactating women.</p>\r\n\r\n<p><strong>Precautions &amp; Warnings</strong></p>\r\n\r\n<ul>\r\n	<li>Shake well before use</li>\r\n	<li>The product should be used with caution for people who or whose family has the history of convulsion or epilepsy, chronic diseases and allergic symptoms</li>\r\n	<li>Do not use the product if any crack of the container, foreign particulate matter, or out of expiry date</li>\r\n	<li>This product should be used immediately after opening</li>\r\n	<li>Adrenaline and other first aid medicines should be prepared at the vaccination place in serious allergic reaction. The people after vaccination should remain under medical supervision for 30 minutes</li>\r\n	<li>The vaccine must not be frozen</li>\r\n</ul>\r\n\r\n<p><strong>Therapeutic Class</strong>&nbsp;: Vaccines, Anti-sera &amp; Immunoglobulin</p>\r\n\r\n<p><strong>Storage Conditions</strong></p>\r\n\r\n<p>Keep out of the reach and sight of children Store and transport at 2&deg;C to 8&deg;C. Protect from light</p>', 0, '2022-03-19 04:03:44', '2022-07-03 05:43:21'),
(193, 5, 8023, 92, 'P/Pc', 'BD', 'Inactivated Hepatitis A Vaccine-adult', '500 unit/mL', '1000.00 (1 ml vial)', '1482030358.jpg', 'www.alpha-medicare.com', '<p><strong>Indications</strong></p>\r\n\r\n<p>The vaccine is indicated for the active immunization of adults and children from 12 months of age against infection caused by Hepatitis A virus.</p>\r\n\r\n<p><strong>Description</strong></p>\r\n\r\n<p>This is a purified sterile suspension of inactivated Hepatitis A vaccine derived from Hepatitis A virus cultured in human diploid cell followed by harvest, purification, inactivation by formaldehyde and Aluminium hydroxide adsorption.</p>\r\n\r\n<p><strong>Pharmacology</strong></p>\r\n\r\n<p>The hepatitis A virus belongs to the picornavirus family. It is one of several hepatitis viruses that cause systemic disease with pathology in the liver. The incubation period for hepatitis A averages 28 days (range: 15 to 50 days). The course of hepatitis A infection is extremely variable, ranging from asymptomatic infection to icteric hepatitis and death. The presence of antibodies to HAV confers protection against hepatitis A infection. However, the lowest titer needed to confer protection has not been determined.</p>\r\n\r\n<p><strong>Dosage</strong></p>\r\n\r\n<p>Hepatitis A vaccine should be given intramuscularly only. Do not inject it intravenously. The primary immunization consists of two doses, the first dose is at the selected date and the second dose will be at 6 months later.<br />\r\n<br />\r\nChildren 12 months to 15 years: The recommended dose is 0.5 ml</p>\r\n\r\n<ul>\r\n	<li><strong>First dose</strong>: At the elected date</li>\r\n	<li><strong>Second dose</strong>: 6 months after the first dose</li>\r\n</ul>\r\n\r\n<p>Children 16 years and above: The recommended dose is 1 ml</p>\r\n\r\n<ul>\r\n	<li><strong>First dose</strong>: At the elected date</li>\r\n	<li><strong>Second dose</strong>: 6 months after the first dose</li>\r\n</ul>\r\n\r\n<p><strong>Administration</strong></p>\r\n\r\n<p><strong>Method of administration</strong>: Hepatitis A vaccine should be injected intramuscularly in the deltoid region in adults and children and in the anterolateral part of the thigh in young children under 1 year. The vaccine should not be administered intramuscularly in the gluteal region or subcutaneously/intradermally since administration by these routes may result in less antibody response than optimal. Hepatitis A vaccine should be inspected visually for any foreign particulate matter and/or discoloration prior to administration. Before use, the vial should be well shaken to obtain a slightly milky-white suspension. The vaccine must be used as supplied.<br />\r\n<br />\r\n<strong>Co-administration</strong>: Since Hepatitis A vaccine is an inactivated vaccine, its concomitant use with other inactivated vaccines is unlikely to result in interference with immune responses. When concomitant administration of other vaccines is considered necessary, the vaccines must be given with different syringes and at different injection sites. Concomitant administration of Hepatitis B, typhoid, yellow fever, cholera (injectable) or tetanus vaccine does not interfere with Hepatitis A vaccine immune response. Concomitant administration of Hepatitis A vaccine and human immune globulin may be considered when a subject is at risk of being exposed to Hepatitis A before adequate antibody titre can be reached. Hepatitis A vaccine and human immune globulin should be administered at separate injection sites.</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong>Contraindications</strong></p>\r\n\r\n<p>People who are allergic to any component of the vaccine. People who suffer from serious diseases, fever, and any immune disease</p>\r\n\r\n<p><strong>Side Effects</strong></p>\r\n\r\n<p>Reactions at the site of injection are common but can be recovered within 72 hours without any treatment. Some of the mild and temporary adverse reactions are: pain and redness at the site of injection, fever after vaccination.</p>\r\n\r\n<p><strong>Pregnancy &amp; Lactation</strong></p>\r\n\r\n<p>The vaccine should be given to a pregnant woman only if clearly needed. The vaccine should be used with caution for lactating women.</p>\r\n\r\n<p><strong>Precautions &amp; Warnings</strong></p>\r\n\r\n<ul>\r\n	<li>Shake well before use</li>\r\n	<li>The product should be used with caution for people who or whose family has the history of convulsion or epilepsy, chronic diseases and allergic symptoms</li>\r\n	<li>Do not use the product if any crack of the container, foreign particulate matter, or out of expiry date</li>\r\n	<li>This product should be used immediately after opening</li>\r\n	<li>Adrenaline and other first aid medicines should be prepared at the vaccination place in serious allergic reaction. The people after vaccination should remain under medical supervision for 30 minutes</li>\r\n	<li>The vaccine must not be frozen</li>\r\n</ul>\r\n\r\n<p><strong>Therapeutic Class</strong>&nbsp;: Vaccines, Anti-sera &amp; Immunoglobulin</p>\r\n\r\n<p><strong>Storage Conditions</strong></p>\r\n\r\n<p>Keep out of the reach and sight of children Store and transport at 2&deg;C to 8&deg;C. Protect from light</p>', 0, '2022-03-19 04:03:50', '2022-07-03 05:44:48'),
(194, 5, 8024, 92, 'P/Pc', 'BD', 'Human Tetanus Immunoglobulin', '250 IU/mL', '975.00', '2134481575.jpg', 'www.alpha-medicare.com', '<p><strong>Indications</strong></p>\r\n\r\n<p>Indications and uses Human Tetanus Immunoglobulin is indicated for -</p>\r\n\r\n<ul>\r\n	<li>Prophylaxis of tetanus following injury in patients whose immunization is incomplete or uncertain.</li>\r\n	<li>Therapeutically in the treatment of tetanus.</li>\r\n</ul>\r\n\r\n<p>Tetanus immunoglobulin should always be administered in conjunction with an active tetanus vaccination unless there are contraindications or confirmations of adequate vaccination.</p>\r\n\r\n<p><strong>Description</strong></p>\r\n\r\n<p>Human Tetanus Immunoglobulin is a sterile solution containing human tetanus immunoglobulin which is prepared by Cohn fractionation of plasma of individuals with high titers of antibody to the tetanus antigen and heat inactivation step in manufacturing process (60&deg;C, 10 hrs) is used to inactivate infectious agents such as Hepatitis B virus, Hepatitis C virus, Human immunodeficiency virus and so on.</p>\r\n\r\n<p><strong>Pharmacology</strong></p>\r\n\r\n<p>Human clostridium tetani toxoid immune globulin prevents tetanus toxoid from damaging tissue and producing the symptoms associated with tetanus.&nbsp;The immune globulin binds to tetanus toxiod, interfering with the normal interaction of the toxoid with human tissue. This prevents the toxoid from invading the nervous system and producing painful muscle spasms as well as autonomic dysfunction. The Clostridium tetani bacterium is killed either via antibiotic treatment of the host&#39;s immune system and immune globulin-bound toxoid is likely broken down by phagocytic immune cells.</p>\r\n\r\n<p><strong>Dosage</strong></p>\r\n\r\n<p>Post-exposure prophylaxis of tetanus:</p>\r\n\r\n<ul>\r\n	<li>For adults and children single dose of 250 IU should be given. The dose may be increased to 500 IU in case of:</li>\r\n	<li>Infected wounds where surgically appropriate treatment cannot be achieved within 24 hours</li>\r\n	<li>Deep or contaminated wounds with tissue damage and reduced oxygen supply, as well as foreign body injury (e.g., bites, stings or shots)</li>\r\n	<li>Burns, congelations</li>\r\n	<li>Tissue necrosis</li>\r\n	<li>Septicaemic abortion</li>\r\n	<li>Adults weighing more than the average</li>\r\n</ul>\r\n\r\n<p>In case of extensive bums, it is advisable to administer a second injection of 250 IU human tetanus immunoglobulin after the exsudative phase of the burn has subsided (about 36 hours after onset of the bum).<br />\r\n<br />\r\nAt the same time, 0.5 ml of tetanus vaccine in a different extremity with a separate syringe and complete immunization schedule is required to be administered.<br />\r\n<br />\r\n<strong>Therapy of clinically manifest tetanus</strong>: For adults and children single doses of 3,000 to 6,000 IU (in combination with other appropriate clinical procedures).</p>\r\n\r\n<p><strong>Administration</strong></p>\r\n\r\n<p><strong>Administrations</strong>: Human Tetanus Immunoglobulin should only be administered by intramuscular injection. Human tetanus immunoglobulin should not be administered by intravenously.<br />\r\n<br />\r\nDo not use solutions which are cloudy or contain residues (deposits/particles)<br />\r\n<br />\r\nHuman tetanus immunoglobulin is a ready for use solution and should be administered at body temperature. If comparatively large total volumes are required, it is advisable to administer them in divided doses at different sites<br />\r\n<br />\r\nIn the presence of a severe coagulation disorder where intramuscular injections are contraindicated, human tetanus immunoglobulin may be given subcutaneously (under the skin) for prophylaxis. Afterwards the injection site should be compressed with a swab. However, it should be noted that there are no clinical efficacy data to support administration by the subcutaneous route<br />\r\n<br />\r\n<strong>Co-administration</strong>: Immunoglobulin administration may impair the efficacy of live, attenuated virus vaccines such as measles, rubella, mumps and varicella vaccines for a period of up to three months.<br />\r\n<br />\r\nAfter administration of human tetanus immunoglobulin an interval of at least three months should elapse before vaccination with live, attenuated virus vaccines. In the case of measles, this impairment may persist for up to five months. Therefore, patients receiving measles vaccine should have their antibody status checked.</p>\r\n\r\n<p><strong>Interaction</strong>&nbsp;: May reduce the efficacy of live vaccines.</p>\r\n\r\n<p><strong>Contraindications</strong></p>\r\n\r\n<ul>\r\n	<li>Known hypersensitivity to any of the components of the product</li>\r\n	<li>Known hypersensitivity to human immunoglobulins</li>\r\n	<li>Like any other intramuscular injections, human tetanus immunoglobulin is not advocated for patients with bleeding disorders</li>\r\n	<li>In patients with a history of immunoglobulin A (IgA) deficiency or severe anaphylactic reactions to plasma products, the risk-benefit ratio must be considered</li>\r\n</ul>\r\n\r\n<p><strong>Side Effects</strong></p>\r\n\r\n<p>Adverse reaction following administration of human tetanus immunoglobulin is infrequent and mild, but severe local and systemic reactions have occurred rarely.</p>\r\n\r\n<ul>\r\n	<li><strong>Local reactions at the injection site</strong>: Local pain, tenderness or swelling.</li>\r\n</ul>\r\n\r\n<p>In rare cases the following adverse reactions may occur:</p>\r\n\r\n<ul>\r\n	<li><strong>Immune system disorders</strong>: Allergic reactions including fall in blood pressure, dyspnoea, cutaneous reactions, in isolated cases reaching as far as anaphylactic shock, even when the patient has shown no hypersensitivity to previous administration of immunoglobulins.</li>\r\n	<li><strong>Generalized reactions</strong>: Chills, fever, headache, malaise, nausea, vomiting, arthralgia and moderate back pain.</li>\r\n	<li><strong>Heart and vascular disorders</strong>: Cardiovascular reactions particularly if the product is inadvertently injected intravascularly.</li>\r\n</ul>\r\n\r\n<p><strong>Pregnancy &amp; Lactation</strong></p>\r\n\r\n<p>The safety for use of human tetanus immunoglobulin in human pregnancy has not been established in controlled clinical trials. Long lasting clinical experience with immunoglobulins suggests that no harmful effects on the course of pregnancy, or on the fetus and the neonate are to be expected.</p>\r\n\r\n<p><strong>Precautions &amp; Warnings</strong></p>\r\n\r\n<p>Should not be administered intravenously<br />\r\n<br />\r\nA separate sterile syringe must be used for each patient to prevent the possible transmission of hepatitis B and other infectious diseases.<br />\r\n<br />\r\nShould be administered with caution to individuals who have exhibited systemic allergic reactions to immunoglobulin. Epinephrine (0.1~0.5ml, 1:1000) should be available for immediate treatment.<br />\r\n<br />\r\nIn patients who have severe thrombocytopenia or any coagulation disorder that would contra-indicated intramuscular injection, human tetanus immunoglobulin should be given only if the expected benefits out way the risks.<br />\r\n<br />\r\nWhile administering human tetanus immunoglobulin care should be taken to drawback the plunger of the syringe before injection in order to be certain that the needle is not in blood vessel.<br />\r\n<br />\r\nHuman tetanus immunoglobulin is prepared from human plasma is pasteurized in its bulk condition to reduce the risk of viruses infections but freedom from the risk of unknown viruses (Parvovirus B-19, etc) cannot be assumed. The infused patient is continuously checked for long time after injection.</p>\r\n\r\n<p><strong>Overdose Effects</strong></p>\r\n\r\n<p>Not applicable.</p>\r\n\r\n<p><strong>Therapeutic Class</strong> : Vaccines, Anti-sera &amp; Immunoglobulin</p>\r\n\r\n<p><strong>Storage Conditions</strong></p>\r\n\r\n<p>Keep out of the reach and sight of children. Store at +2 &deg;C to +8 &deg;C. Transportation should also be in designed packs to maintain the product temperature +2 &deg;C to +8 &deg;C. Do not freeze. Discard vaccine if frozen. Protect from light</p>', 0, '2022-03-19 04:13:35', '2022-07-03 06:04:59');
INSERT INTO `products` (`id`, `cat_id`, `brand_id`, `company_id`, `unit`, `origin`, `name`, `specification`, `price`, `image`, `btn_link`, `desc`, `is_featured`, `created_at`, `updated_at`) VALUES
(195, 5, 8025, 92, 'P/Pc', 'BD', 'Rabies Vaccine', '2.5 IU/mL', '500.00', '856469849.jpg', 'www.alpha-medicare.com', '<p><strong>Indications</strong></p>\r\n\r\n<p>Rabies vaccine is indicated for prophylactic immunization against rabies and treatment of patients following suspected rabies contact.<br />\r\n<br />\r\n<strong>Pre-exposure Immunization:</strong></p>\r\n\r\n<ul>\r\n	<li>Professional groups exposed to frequent contamination</li>\r\n	<li>Veterinary surgeons (including students at veterinary colleges)</li>\r\n	<li>Technical personnel working with veterinary surgeons</li>\r\n	<li>Laboratory personnel handling material contaminated with rabies vims</li>\r\n	<li>Personnel in abattoirs and knackers yards</li>\r\n	<li>Taxidermists</li>\r\n	<li>Gamekeepers, forestry workers and naturalists in enzootic areas</li>\r\n	<li>Infants particularly exposed to the risk of rabies</li>\r\n</ul>\r\n\r\n<p><strong>Post-exposure Immunization:</strong></p>\r\n\r\n<ul>\r\n	<li>Treatment of subjects bitten by rabid animals or those suspected of being so</li>\r\n	<li>Treatment of contact subjects.</li>\r\n</ul>\r\n\r\n<p><strong>Pharmacology</strong></p>\r\n\r\n<p>Rabies Vaccine for human use is a freeze-dried preparations of inactivated rabies virus produced on Vero cell. After reconstitution the vaccine is a clear, colorless sterile solution for intramuscular use.</p>\r\n\r\n<p><strong>Dosage</strong></p>\r\n\r\n<p>To reconstitute the vaccine, transfer content of supplied diluent into the vial containing freeze-dried preparation. Do not shake. After reconstitution the solution should be homogeneous, clear and free from any particles. Vaccine must be injected immediately after reconstitution and the syringe should be destroyed after use.<br />\r\n<br />\r\n<strong>Method of administration for intramuscular use</strong>: The 1 ml dose of Rabies vaccine should be given intramuscularly in the deltoid in adults and in the anterolateral aspect of the thigh muscle in children under 1 year. It should not be injected into the gluteal region. Do not inject intravenously.<br />\r\n<br />\r\n<strong>Pre-exposure immunization</strong>:</p>\r\n\r\n<ul>\r\n	<li>1 ml for children and adults.</li>\r\n	<li>Primary-vaccination: According to the WHO recommendations 1 injection by the intramuscular route on days DO, D7, D21 or D28, followed by a booster dose one year later.</li>\r\n	<li>Boosters: Thereafter, one injection every 5 years or when the titre is found to be less than 0.5 lU/ml</li>\r\n</ul>\r\n\r\n<p><strong>Post-exposure immunization</strong>:</p>\r\n\r\n<ul>\r\n	<li>Local treatment of the wound: Prompt and gentle through washing with soap or detergent and flushing the wound with running tap water for at least 15 minutes. After washing, disinfectants like either ethanol (700 ml/l) or tincture or aqueous solution of iodine or povidone iodine must be applied. Don&#39;t bandage or suture the wound.</li>\r\n	<li>Vaccination of non-immunized subjects</li>\r\n</ul>\r\n\r\n<p>Intramuscular schedules: One Intramuscular (IM) dose comprised of 1 ml.<br />\r\n<br />\r\nStandard intramuscular (1-1-1-1-1) regimen:</p>\r\n\r\n<ul>\r\n	<li>Day 0: 1 injection of 1 ml</li>\r\n	<li>Day 3: 1 injection of 1 ml</li>\r\n	<li>Day 7: 1 injection of 1 ml</li>\r\n	<li>Day 14: 1 injection of 1 ml</li>\r\n	<li>Day 28: 1 injection of 1 ml</li>\r\n</ul>\r\n\r\n<p>Or abbreviated multisite (2-1-1) regimen:</p>\r\n\r\n<ul>\r\n	<li>Day 0: 2 injections each of 1 ml at separate sites</li>\r\n	<li>Day 7: 1 injection of 1 ml</li>\r\n	<li>Day 21: 1 injection of 1 ml</li>\r\n</ul>\r\n\r\n<p>In case of severe (WHO category 3) wounds, rabies immunoglobulin should be administered as soon as possible with the first dose of rabies vaccine. The anti-rabies immunoglobulin should be used as local wound soakage injections as much as possible, with the rest part for muscle injection. The rabies vaccine should be administered in different injection site.<br />\r\n<br />\r\nVaccination of subjects already immunized: Patients had complete post exposure immunization schedule within 1 year. Bitten by suspected rabid animal, 1 dose injection is required on Day 0, Day 3, respectively. Patients had complete post-exposure immunization schedule 1 year ago, Bitten by suspected rabid animal, complete post-exposure immunization required. Patient had complete immunization schedule and booster immunization within 3 years. Bitten by suspected rabid animal, 1 dose injection is required on Day 0, Day 3, respectively. Patient had complete immunization schedule and booster immunization 3 years ago. Bitten by suspected rabid animal, complete post-exposure immunization required. Post-exposure vaccination must be administered on the basis of severity under medical supervision.</p>\r\n\r\n<p><strong>Administration</strong></p>\r\n\r\n<p>Co-administration: Corticosteroid and immunosuppressive treatment may interfere with antibody production and cause vaccination failure. In these cases, a titration of neutralizing antibodies should be performed.</p>\r\n\r\n<p><strong>Interaction</strong></p>\r\n\r\n<p>Concurrent use with immunosuppressants may reduce the efficacy of vaccines.</p>\r\n\r\n<p><strong>Contraindications</strong></p>\r\n\r\n<p>Rabies vaccine is contraindicated in the following cases:<br />\r\n<br />\r\n<strong>Pre-exposure</strong>: Severe fever, febrile infection, acute disease, progressive chronic diseases. Known hypersensitivity reactions to rabies vaccine or any of its components<br />\r\n<br />\r\n<strong>Post-exposure</strong>: No contraindication to post-exposure treatment, because rabies is lethal disease, any contraindication to exposure, treatment should be considered carefully before disqualifying an individual for anti-rabies treatment.</p>\r\n\r\n<p><strong>Side Effects</strong></p>\r\n\r\n<p>Minor local reactions like pain, erythema, oedema, pruritus and induration at the injection site and lasting to 24-48 hours. Moderate fever, shivering, fainting, asthenia, dizziness, respiratory manifestations (dyspnoea, wheezing), fever, abdominal pain, vomiting and allergic skin reactions (urticaria, rash, itching).</p>\r\n\r\n<p><strong>Pregnancy &amp; Lactation</strong></p>\r\n\r\n<p><strong>Pregnancy</strong>. The potential risk of administration of rabies vaccine during pregnancy is unknown. Due to the severity of the disease, pregnancy is not considered to be a contraindication to post-exposure prophylaxis.<br />\r\n<br />\r\n<strong>Lactation</strong>: It is not known whether the vaccine is excreted in human breast milk. Due to the severity of the disease, breast-feeding is not considered a contraindication.</p>\r\n\r\n<p><strong>Precautions &amp; Warnings</strong></p>\r\n\r\n<ul>\r\n	<li>Intravenous injection is prohibited.</li>\r\n	<li>The vaccine and anti-rabies immunoglobulin must not be administered with same syringe and in the same injection site.</li>\r\n	<li>Before use, please carefully check package, label, appearance and the validity period.</li>\r\n	<li>After reconstitution, the freeze-dried rabies vaccine should be administered as soon as possible.</li>\r\n	<li>Any reconstituted vaccine should be used as soon as possible. It must be stored in a refrigerator at 2&deg;C to 8&deg;C and used within 8 hours after reconstitution or discarded.</li>\r\n</ul>\r\n\r\n<p><strong>Therapeutic Class</strong>&nbsp;: Vaccines, Anti-sera &amp; Immunoglobulin</p>\r\n\r\n<p><strong>Storage Conditions</strong></p>\r\n\r\n<p>Keep out of the reach and sight of children. Store &amp; transport at 2&deg;C to 8&deg;C. Protect from light. Do not keep in the deep freeze.</p>', 0, '2022-03-19 04:17:02', '2022-07-03 06:11:59'),
(196, 5, 8026, 92, 'P/Pc', 'BD', 'Rabies Immunoglobulin', '1000 IU/5 mL', '1000.00', '1186907151.jpg', 'www.alpha-medicare.com', '<p><strong>Indications</strong></p>\r\n\r\n<p>For the seroprophylaxis (prevention by injecting antibodies) of rabies in subjects suspected to have been exposed to the rabies virus, particularly in the event of severe exposure e.g.:</p>\r\n\r\n<ul>\r\n	<li>Multiple transdermal bites or scratches</li>\r\n	<li>Contamination of mucous membrane with saliva</li>\r\n	<li>Severe bites located on the face, head, neck and hands</li>\r\n	<li>When the domestic or wild animal responsible cannot be examined or is infected or suspected to be infected by the rabies virus</li>\r\n	<li>Bites to young children</li>\r\n</ul>\r\n\r\n<p>Rabies Immunoglobulin provides passive immunization against rabies for prevention of rabies in patients after contact with a rabid animal or an animal presumed to be rabid. Anti rabies serum itself does not constitute an anti-rabies treatment and should always be used in conjunction with rabies vaccine.</p>\r\n\r\n<p><strong>Dosage &amp; Administration</strong></p>\r\n\r\n<p>First-aid treatment: Prompt local treatment of bite wounds and scratches that may be contaminated with rabies virus is important, whatever the time elapsed since the contact. The recommended first-aid measures consist of immediate flushing and washing of the wound with soap and water, detergent or other substance of proven lethal effect on rabies virus. The rabies immune globulin should be injected as soon as possible after exposure.<br />\r\n<br />\r\nThe recommended dose for both adults and children is 40 IU/kg of body weight. If anatomically feasible, as much as possible of the dose should be infiltrated around and into the wound(s). The remainder should be administered intramuscularly (into the gluteal region) in a single injection.<br />\r\n<br />\r\nHowever, for children, particularly in the case of multiple wounds, it has been proposed to dilute the dose 2-3 times in a 0.9% sodium chloride solution to obtain a sufficient quantity of equine rabies immune globulin to infiltrate the wound(s) correctly. Wounds in certain anatomical sites (fingertips) should be infiltrated with care so as to prevent a local increase in pressure in the tissue.<br />\r\n<br />\r\nFor prevention of rabies, combined immune globulin-vaccine treatment is recommended. The 1st dose of the rabies vaccine should be given at the same time as the Rabies immunoglobulin, but in different parts of the body. If Rabies immunoglobulin is not available when the rabies vaccine is administered, it can be administered up to the 7th or 8th day after the first dose of rabies vaccine. When indicated, begin anti-tetanus treatment and administer anti-microbial drugs to control infections other than rabies.<br />\r\n<br />\r\nThe WHO expert committee on rabies has issued the following therapeutic recommendations:<br />\r\n<br />\r\nCategory Type of contact with a suspect or confirmed rabid domestic or wild animal or animal not available for observation Recommended Treatment:</p>\r\n\r\n<ul>\r\n	<li>Touching or feeding, licks on intact skin None, if reliable case history is available</li>\r\n	<li>Nibbling of uncovered skin, minor scratches superficial bites (except on head, neck, shoulder girdle, arms or hands) or abrasions without bleeding, licks on broken skin. Administer vaccine immediately on Day 0, D3, D7, D14 and D28. Stop treatment if animal remains healthy throughout the observation period of 10 days or if animal is killed humanely and found to be negative by appropriate laboratory techniques.</li>\r\n</ul>\r\n\r\n<p>Single or multiple transdermal bites or scratches specially on head, neck, shoulder girdle,arms or hands. Contamination of mucus membrane with saliva (i.e. licks on broken skin). Administer rabies vaccine immediately on Day 0, D3, D7, D14 and D28 or D90 (optional) and rabies immune globulin on D0 immediately. Stop treatment if animal remains healthy throughout the observation period of 10 days or if animal is killed humanely and found to be negative by appropriate laboratory techniques.</p>\r\n\r\n<p><strong>Contraindications</strong></p>\r\n\r\n<p>Known history of allergic symptoms to horse proteins. Nevertheless, the lethal risk associated with rabies overcomes any potential contraindication.</p>\r\n\r\n<p><strong>Side Effects</strong></p>\r\n\r\n<p>Immediate or delayed hypersensitive type reactions may be developed on administration of rabies immune globulin. The observed immediate reactions are hypotension, dyspnoea, and urticaria. Delayed reactions consist of inflammatory reaction, fever, pruritis, rash or urticaria, adenopathy and arthralgia.</p>\r\n\r\n<p><strong>Pregnancy &amp; Lactation</strong></p>\r\n\r\n<p>The safety of rabies immune globulin when used during pregnancy has not been established in clinical trials in human beings. Considering the lethal risk associated with rabies, pregnancy may not be a contraindication to the administration of rabies immune globulin subsequent to exposure.</p>\r\n\r\n<p><strong>Precautions &amp; Warnings</strong></p>\r\n\r\n<p>Do not administer rabies immunoglobulin intravenously (due to the risk of shock i.e., sudden collapse with drop in blood pressure). Consequently, make sure that the needle has not penetrated a blood vessel. Rabies immunoglobulin should not be administered in repeated doses. Once the vaccine treatment has been started, repeating injections of rabies immunoglobulin may reduce the protective efficacy that must be guaranteed by the vaccine. Shake well before use. Do not shake vigorously.</p>\r\n\r\n<p><strong>Overdose Effects</strong></p>\r\n\r\n<p>If the recommended dosage is not strictly observed, there is a risk of immunosuppressive interference (suppression of immune defenses) with rabies vaccine.</p>\r\n\r\n<p><strong>Therapeutic Class</strong>&nbsp;: Vaccines, Anti-sera &amp; Immunoglobulin</p>\r\n\r\n<p><strong>Storage Conditions</strong></p>\r\n\r\n<p>Keep out of the reach and sight of children. Store at 2&deg;C to 8&deg;C. Transportation should also be at 2&deg;C to 8&deg;C. Protect from light. Do not freeze.</p>', 0, '2022-03-19 04:22:05', '2022-07-03 06:15:25'),
(197, 5, 8027, 92, 'P/Pc', 'BD', 'Measles and Rubella', '0.5 mL', '400.00', '1735617694.jpg', 'www.alpha-medicare.com', '<p><strong>Composition</strong></p>\r\n\r\n<p>Each vial contains lyophilized preparation of live attenuated Measles virus (Long-47 strain) grown in chicken embryo cell cultures and live attenuated Rubella virus (RA27/3 strain) grown in human diploid cell. After reconstitution each 0.5 ml contains live, attenuated measles virus USP&ge; 1000 CCID50 and live, attenuated rubella virus USP &ge;1000 CCID50.</p>\r\n\r\n<p><strong>Indications</strong></p>\r\n\r\n<p>This is indicated for simultaneous immunization against measles and rubella in persons older than 8 months.</p>\r\n\r\n<p><strong>Description</strong></p>\r\n\r\n<p>This is a live, attenuated virus vaccine for vaccination against measles (rubeola) and rubella (German measles). This is a sterile lyophilized vaccine prepared from live, attenuated strains of CAM-70 Measles virus propagated on chicken embryo fibroblast (CEF) cell substrate &amp; live, attenuated strains of Wistar RA 27/3 Rubella virus grown on human diploid cell culture. The two viruses are mixed before being lyophilized. Before reconstitution, the lyophilized vaccine is a light yellow compact crystalline plug/powder. When reconstituted as directed, can vary from clear pale yellow to pinkish yellow solution.</p>\r\n\r\n<p><strong>Dosage &amp; Administration</strong></p>\r\n\r\n<p><strong>Adults and Children</strong>: A single dose of 0.5 ml of the reconstituted vaccine given by deep subcutaneous injection. Do not give intravenously.<br />\r\n<br />\r\n<strong>EPI schedule</strong>: After completion of 9 months, 1 dose of measles-rubella vaccine should be given. After completion of 15 months, 1 dose of only measles containing vaccine should be given.</p>\r\n\r\n<p><strong>Contraindications</strong></p>\r\n\r\n<p>Allergic to any ingredient in the vaccine. Suffering from acute diseases, severe chronic diseases, acute exacerbation of chronic diseases and fever. Pregnant women. Immune deficiency, immune dysfunction or receiving immunosuppressive therapy. Suffering from encephalopathy, uncontrolled epilepsy and other progressive neurological diseases.</p>\r\n\r\n<p><strong>Side Effects</strong></p>\r\n\r\n<p><em><strong>Common side-effects:</strong></em></p>\r\n\r\n<ul>\r\n	<li>Generally pain and tenderness at the injection site may occur within 24 hours after vaccination, which usually disappear by itself within 2-3 days.</li>\r\n	<li>Generally transient fever reaction may occur within 1-2 weeks after vaccination.</li>\r\n	<li>Rash: generally mild rash may occur within 12 days after vaccination, which generally lasts for no more than 2 days.</li>\r\n</ul>\r\n\r\n<p><strong><em>Rare side-effects:</em></strong></p>\r\n\r\n<ul>\r\n	<li>Severe fever reaction: physical methods and drugs should be used for symptomatic treatment to prevent febrile seizures.</li>\r\n</ul>\r\n\r\n<p><em><strong>Very rare side-effects:</strong></em></p>\r\n\r\n<ul>\r\n	<li>Allergic rash: generally urticaria may occur within 72 hours after vaccination, and if this reaction occurs, anti-allergy treatment should be timely given.</li>\r\n	<li>Anaphylactic shock: generally occurs within 1 hour after vaccination. Injection of epinephrine and other emergency measures should be timely given for treatment.</li>\r\n	<li>Anaphylactoid purpura: medical care should be timely given if anaphylactoid purpura occurs. Cortical steroids can be given for anti-allergy treatment. Improper or not timely treatment is likely to cause anaphylatic purpura nephritis.</li>\r\n	<li>Thrombocytopenia purpura.</li>\r\n</ul>\r\n\r\n<p>Adults may develop arthritis, pain and swelling of large joints after vaccination.</p>\r\n\r\n<p><strong>Pregnancy &amp; Lactation</strong></p>\r\n\r\n<p>Pregnancy category C. Pregnancy should be avoided for 3 months following vaccination. Caution should be exercised when Measles and Rubella vaccine is administered to a nursing woman.</p>\r\n\r\n<p><strong>Precautions &amp; Warnings</strong></p>\r\n\r\n<p>The vaccine should not be used if vaccine bottle has cracks or unclear labels, the vaccine is beyond shelf life, and abnormal appearance (such as turbidity) is observed after reconstitution. The vaccine should be used immediately after opening. Epinephrine and other drugs should be prepared for emergency use in case of occasional severe allergic reaction. The people receiving vaccination should be observed at the site for at least 30 minutes after injection. The people receiving injection of immune globulin should be vaccinated with an interval of at least 3 months so as not to affect the immune effect. Other attenuated live vaccine should be vaccinated with an interval of at least 1 month from this vaccine, but this vaccine can be vaccinated simultaneously with attenuated live mumps vaccine. This product is an attenuated live vaccine and it is not recommended to be used in the epidemic season. Women of childbearing age should avoid pregnancy within at least 3 months after injection of this vaccine. Freezing is prohibited.</p>\r\n\r\n<p><strong>Therapeutic Class</strong>&nbsp;: Vaccines, Anti-sera &amp; Immunoglobulin</p>\r\n\r\n<p><strong>Storage Conditions</strong></p>\r\n\r\n<p>Keep out of the reach and sight of children. Store at +2&deg;C to +8&deg;C. Transportation should also be at +2&deg;C to +8&deg;C. Do not freeze. Discard vaccine if frozen. Protect from light.</p>', 0, '2022-03-19 04:28:10', '2022-07-03 06:18:33'),
(198, 5, 8028, 92, 'P/Pc', 'BD', 'Tetanus Antitoxin [Equine]', '3000 IU/mL', '408.00', '290933327.jpg', 'www.alpha-medicare.com', '<p><strong>Indications</strong></p>\r\n\r\n<p>To provide temporary passive immunity in the prevention and treatment of tetanus.</p>\r\n\r\n<p><strong>Pharmacology</strong></p>\r\n\r\n<p>This is a sterile clear, faintly yellow or brown liquid of tetanus antitoxin (equine) for human use. It is a preparation containing antitoxic globulins that have the power of specifically neutralizing the toxin formed by Clostridium tetani. It is obtained by fractionation from the serum of horses that have been hyperimmunized against tetanus toxin.</p>\r\n\r\n<p><strong>Dosage</strong></p>\r\n\r\n<p><strong>Prophylaxis of tetanus</strong>: Tetanus Antitoxin (equine) should not be used in the routine treatment of traumatic wounds. It is given prophylactically to persons at the risk of tetanus infection by infected wounds or severe wounds. For prophylaxis after injury, non-immune or partially immune persons may be given 3,000 to 5,000 units of tetanus antitoxin subcutaneously or intramuscularly. If 24 hours have passed since the wound occurred, the dose is 3,000 III. In crush wounds or wounds contaminated with soil or other foreign bodies, the dose is 10,000 to 20,000 III. For persons below 30 kg the dosage is 1,500 IU. Active immunization with Adsorbed Tetanus vaccine should be given simultaneously with the use of this preparation or a booster injection of Adsorbed Tetanus vaccine should be given if the patient has previously been immunized.<br />\r\n<br />\r\n<strong>Treatment</strong>: Therapy should be given as soon as possible after the appearance of symptoms of the disease. Therapeutic dose not less than 3000 IU. Depending on the severity, the dose may vary from 50,000 to 100,000 IU of tetanus antitoxin for hospitalized patients given partially by intravenous route and the rest of the dose intramuscularly.</p>\r\n\r\n<p><strong>Administration</strong></p>\r\n\r\n<p>The solution should be shaken well before use. Please do not shake vigorously. The solution should be inspected visually for particulate matter and discoloration prior to administration. If either of these conditions exists, the solution should not be administered. The solution should be used as supplied; no dilution is necessary. Once the vial is opened, the preperation must be used immediately.<br />\r\n<br />\r\n<strong>Co-administration:</strong> Immunosuppressive therapy should be interrupted when immunization is required because of a tetanus-prone wound.</p>\r\n\r\n<p><strong>Contraindications</strong></p>\r\n\r\n<p>Injection of the antitoxin to persons with a history of allergic reactions to equine protein and to allergic individuals is contraindicated.</p>\r\n\r\n<p><strong>Side Effects</strong></p>\r\n\r\n<p>Hypersensitive reactions may occur after the injection of any serum of animal origin. In rare cases hypotension, dyspnoea, urticaria may occur. It should be treated with adrenalin, possibly in association with antihistamine and corticosteroid therapy. Serum sickness may occur 7 to 10 days after injection of serum of animal origin; symptoms include fever, vomiting, diarrhoea, bronchospasm and urticaria.</p>\r\n\r\n<p><strong>Pregnancy &amp; Lactation</strong></p>\r\n\r\n<p>Tetanus antitoxin (equine) must not be administered during pregnancy.</p>\r\n\r\n<p><strong>Precautions &amp; Warnings</strong></p>\r\n\r\n<p>If there is no history of previous serum injection or allergic reaction, the dose of serum may be given intramuscularly. If the patient is subject to allergic diseases, a trial dose of 0,2 ml (diluted 1:10 if preferred) of the serum should be given subcutaneously; if no general reaction develops during an interval of 30 minutes, the main dose may be given intramuscularly. The patient must be kept under observation for at least 30 minutes after the injection and adrenaline kept in readiness for emergency use. In all urgent cases, the intravenous route is indicated, but should never be used unless a preliminary intramuscular injection, given at least 30 minutes beforehand, has been tolerated. For intravenous use, the serum should be at room temperature, the injection should be given very slowly, and the patient should be recumbent during the injection, and for at least an hour afterwards.</p>\r\n\r\n<p><strong>Overdose Effects</strong>&nbsp;: N/A</p>\r\n\r\n<p><strong>Therapeutic Class :&nbsp;</strong>Vaccines, Anti-sera &amp; Immunoglobulin</p>\r\n\r\n<p><strong>Storage Conditions</strong></p>\r\n\r\n<p>Keep out of the reach and sight of children. Store at +2&deg;C to +8&deg;C. Transportation should also be at +2&deg;C to +8 &deg;C. Do not freeze. Discard solution if frozen. Protect from light</p>', 0, '2022-03-19 04:31:55', '2022-07-03 06:22:10'),
(199, 5, 8029, 92, 'P/Pc', 'BD', 'Typhoid Polysaccharide Vaccine', '25 mcg/0.5 mL', '500.00', '181314040.jpg', 'www.alpha-medicare.com', '<p><strong>Indications</strong></p>\r\n\r\n<p>Typhoid Polysaccharide Vaccine is indicated for active immunization against typhoid fever for adults and children two years of age or older. Selective immunization with typhoid vaccine is recommended for the following:</p>\r\n\r\n<ul>\r\n	<li>Travellers to high endemic areas</li>\r\n	<li>Household contact of carriers</li>\r\n	<li>Healthcare personnel</li>\r\n	<li>Police, Armed forces and such other regimented personnel</li>\r\n	<li>Laboratory workers who work with Salmonella typhi</li>\r\n</ul>\r\n\r\n<p><strong>Description</strong></p>\r\n\r\n<p>Typhoid Polysaccharide Vaccine is a clear, colorless sterile solution for intramuscular use containing the Vi polysaccharide extracted from Salmonella typhi Ty2 strain.</p>\r\n\r\n<p><strong>Dosage &amp; Administration</strong></p>\r\n\r\n<p><strong>Dosage</strong>: A single dose of 0.5 ml is recommended for both adults and children 2 years of age or older. Subjects who remain at risk of typhoid fever should be given a single booster dose of the vaccine with an interval of not more than 3 years.<br />\r\n<br />\r\n<strong>Administration</strong>: Typhoid Polysaccharide Vaccine is for intramuscular injection only. Do not inject intravenously. This should be given intramuscularly in the deltoid and children should be injected intramuscularly either in the deltoid or the vastus lateralis. It should not be injected into the gluteal areas where there may be a nerve trunk. Typhoid Polysaccharide Vaccine injection should be administered with caution to subjects with thrombocytopenia or bleeding disorders since bleeding may occur following an intramuscular administration to these subjects. Following injection, firm pressure should be applied to the site (without rubbing) for at least two minutes.<br />\r\n<br />\r\n<strong>Co-administration</strong>: Typhoid vaccine can be co-administered with other vaccines but should not be mixed with other vaccines or medicinal products in the same syringe.</p>\r\n\r\n<p><strong>Contraindications</strong></p>\r\n\r\n<p>The vaccine protects against typhoid fever caused by Salmonella typhi. Protection is not conferred against paratyphoid fever or illness caused by non-invasive Salmonella. Typhoid vaccine should not be administered to subjects with known hypersensitivity to any component of the vaccine or to subjects having shown signs of hypersensitivity after previous Typhoid vaccine administration or after any other vaccine containing Vi polysaccharide Salmonella typhi antigens. It may be expected that in patients receiving immunosuppressive treatment or patients with immunodeficiency, an adequate response may not be achieved. The administration of Typhoid vaccine should be postponed in subjects suffering from acute severe febrile illness.</p>\r\n\r\n<p><strong>Side Effects</strong></p>\r\n\r\n<p>Most recepients of Typhoid vaccine experience some reactions upon vaccination. These are generally moderate and short in duration. They mainly consist of local reactions at the injection site (erythema, induration and tenderness). Systemic reactions (malaise, headache, diarrhea, vomiting, myalgia and elevated temperature) are reported less commonly. In very rare cases allergic type reactions (pruritus, rash, urticaria) may be observed.</p>\r\n\r\n<p><strong>Pregnancy &amp; Lactation</strong></p>\r\n\r\n<p>The effect of Typhoid vaccine on foetal development or reproduction capacity has not been evaluated. Typhoid vaccine should only be used during pregnancy when there is a high risk of infection. It is not known if Typhoid vaccine is excreted in human milk. It may be administered to nursing mothers only if clearly needed.</p>\r\n\r\n<p><strong>Therapeutic Class</strong>&nbsp;: Vaccines, Anti-sera &amp; Immunoglobulin</p>\r\n\r\n<p><strong>Storage Conditions</strong></p>\r\n\r\n<p>Keep out of the reach of children. Store at +2&deg;C to +8&deg;C. Transportation should also be at +2&deg;C to +8&deg;C. Do not freeze. Discard vaccine if frozen. Protect from light.</p>', 0, '2022-03-19 04:34:03', '2022-07-03 06:24:54'),
(200, 2, NULL, NULL, NULL, NULL, 'Amputation saw (s.s) (large/medium/small)', NULL, '1100.00', '2043667077.png', 'www.alpha-medicare.com', NULL, 0, '2022-05-08 19:28:30', '2022-05-08 19:28:30'),
(201, 2, NULL, NULL, NULL, NULL, 'Angled bipolar forceps (Std Size)', NULL, '30000.00', '1249962596.png', 'www.alpha-medicare.com', NULL, 0, '2022-05-08 19:48:59', '2022-05-08 19:48:59'),
(202, 2, NULL, NULL, NULL, NULL, 'Angular Elvator (P/Pc)', NULL, '198.00', '953297040.png', 'www.alpha-medicare.com', NULL, 0, '2022-05-08 19:49:53', '2022-05-08 19:49:53'),
(203, 2, NULL, NULL, NULL, NULL, 'Antral puncture trocker & cannula (P/Pc)', NULL, '1760.00', '577875569.png', 'www.alpha-medicare.com', NULL, 0, '2022-05-08 19:50:43', '2022-05-08 19:50:43'),
(204, 2, NULL, NULL, NULL, NULL, 'Antrum curtte straight and curved (set of 2) (p/pc)', NULL, '1540.00', '80782917.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-09 05:05:12', '2022-05-09 05:05:12'),
(205, 2, NULL, NULL, NULL, NULL, 'Antrum washing trocher with canula (std size)', NULL, '687.00', '1757602881.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-09 05:13:31', '2022-05-09 05:13:31'),
(206, 2, NULL, NULL, NULL, NULL, 'Aortic cannula (Sterile) (8F/12F/14F/20F/22F/24F)', NULL, '1870.00', '1972140565.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-10 00:06:47', '2022-05-10 00:06:47'),
(207, 2, NULL, NULL, NULL, NULL, 'Aortic root Cannula (Size-14 Gauge Edwards life seience)', NULL, '1430.00', '521378483.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-10 00:07:39', '2022-05-10 00:07:39'),
(208, 2, NULL, NULL, NULL, NULL, 'Aortic root Cannula (Size-16Guage Edwards life science)', NULL, '1320.00', '1824137371.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-10 00:08:39', '2022-05-10 00:08:39'),
(209, 2, NULL, NULL, NULL, NULL, 'Archbar (Erich Pattern) (Roll)', NULL, '275.00', '792790523.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-10 00:09:30', '2022-05-10 00:09:30'),
(210, 2, NULL, NULL, NULL, NULL, 'Articulator (dental) (P/pc)', NULL, '440.00', '684602141.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-10 00:10:22', '2022-05-10 00:10:22'),
(211, 2, NULL, NULL, NULL, NULL, 'A-sean paper (per role)', NULL, '1100.00', '400346492.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-10 00:11:21', '2022-05-10 00:11:21'),
(212, 2, NULL, NULL, NULL, NULL, 'Aschs septum forceps(Hilbro or equivatent) (p/pc)', NULL, '2530.00', '767311578.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-10 00:12:10', '2022-05-10 00:12:10'),
(213, 2, NULL, NULL, NULL, NULL, 'Ash\'s septum forceps (Do (PC))', NULL, '2585.00', '1419035575.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-10 00:13:02', '2022-05-10 00:13:02'),
(214, 2, NULL, NULL, NULL, NULL, 'Aspiration Tube for Eppendorf ECOM semi Auto Biochemistry Analyzer (3 pcs)', NULL, '21450.00', '1013248379.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-10 00:14:00', '2022-05-10 00:14:00'),
(215, 2, NULL, NULL, NULL, NULL, 'Aspiration Tube for Eppendorf ECOM semi Auto Biochemistry Analyzer (3 pcs)', NULL, '21450.00', '1382404563.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-10 00:14:53', '2022-05-10 00:14:53'),
(216, 2, NULL, NULL, NULL, NULL, 'Atraumatic chromic catgut 1/2 circle round body /cutting body (No-3/0(per Dozen))', NULL, '1430.00', '366208305.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-10 00:15:55', '2022-05-10 00:15:55'),
(217, 2, NULL, NULL, NULL, NULL, 'Atraumatic chromic catgut 1/2 circle round body /cutting body (No-2 (per Dozen))', NULL, '1815.00', '1576986590.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-10 00:16:46', '2022-05-10 00:16:46'),
(218, 2, NULL, NULL, NULL, NULL, 'Atraumatic chromic catgut 1/2 circle round body /cutting body (No-1 (per Dozen))', NULL, '1716.00', '428636869.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-10 00:17:30', '2022-05-10 00:17:30'),
(219, 2, NULL, NULL, NULL, NULL, 'Atraumatic chromic catgut 1/2 circle round body /cutting body (No-1/0 (per Dozen))', NULL, '1716.00', '1023811590.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-10 03:21:56', '2022-05-10 03:21:56'),
(220, 2, NULL, NULL, NULL, NULL, 'Atraumatic Chromic catagut 1/2 circle round body / cutting body (NO-2/0(per Dozen))', NULL, '1287.00', '935091217.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-10 03:22:57', '2022-05-10 03:22:57'),
(221, 2, NULL, NULL, NULL, NULL, 'Atraumatic Choromic catgut 1/2 circle round body / cutting body (No-6/0(per Dozen))', NULL, '4290.00', '797886518.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-10 03:24:52', '2022-05-10 03:24:52'),
(222, 2, NULL, NULL, NULL, NULL, 'Atraumatic Chromic catgut 1/2 circle round body / cutting body (No-4/0(per Dozen))', NULL, '1958.00', '243885537.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-10 03:26:10', '2022-05-10 03:26:10'),
(223, 2, NULL, NULL, NULL, NULL, 'Atraumatic Chromic catgut 1/2 circle round body / cutting body (No-5/0(per Dozen))', NULL, '1644.00', '913157670.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-10 03:27:33', '2022-05-10 03:27:33'),
(224, 2, NULL, NULL, NULL, NULL, 'Atraumatic Chromic catgut 3/8 circle round body', NULL, '2502.00', '1562696278.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-10 03:28:19', '2022-05-10 03:28:19'),
(225, 2, NULL, NULL, NULL, NULL, 'Atraumatic Chromic catgut 3/8 circle round body&cutting Needle 76cm (No-1 (per Dozen))', NULL, '2502.00', '1275950260.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-10 03:29:12', '2022-05-10 03:29:12'),
(226, 2, NULL, NULL, NULL, NULL, 'Atraumatic chromic catgut 3/8 circle round body & cutting Needle 76cm (No-1/0,2/0(per Dozen))', NULL, '1287.00', '951471637.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-10 03:30:00', '2022-05-10 03:30:00'),
(227, 2, NULL, NULL, NULL, NULL, 'Atraumatic chromic catgut 3/8 circle round body & cutting Needle 76cm (No-3/0(per Dozen))', NULL, '1500.00', '1031595123.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-10 03:30:51', '2022-05-10 03:30:51'),
(228, 2, NULL, NULL, NULL, NULL, 'Atraumatic chromic catgut 3/8 circle round body/ cutting body (No-5/0(per Dozen))', NULL, '2502.00', '2073403053.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-10 03:31:44', '2022-05-10 03:31:44'),
(229, 2, NULL, NULL, NULL, NULL, 'Atraumatic Chromic catagut 1/2 circle round body / cutting body (No-6/0(per Dozen))', NULL, '4312.00', '1502437399.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-10 04:35:36', '2022-05-10 04:35:36'),
(230, 2, NULL, NULL, NULL, NULL, 'Atraumatic Chromic catagut 1/2 circle round body / cutting body (No-4/0(per Dozen))', NULL, '1973.00', '951984755.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-10 04:36:27', '2022-05-10 04:36:27'),
(231, 2, NULL, NULL, NULL, NULL, 'Atraumatic Dexon 1/2 circle round body&cutting needle 76cm (No-1 (per Dozen))', NULL, '4290.00', '1415376393.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-10 04:37:15', '2022-05-10 04:37:15'),
(232, 2, NULL, NULL, NULL, NULL, 'Atraumatic Dexon 1/2 circle round body&cutting needle 76cm (No-1/0 (per Dozen))', NULL, '4290.00', '1543129035.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-10 04:38:07', '2022-05-10 04:38:07'),
(233, 2, NULL, NULL, NULL, NULL, 'Atraumatic Dexon 1/2 circle round body&cutting needle 76cm (No-2/0,3/0(per Dozen))', NULL, '4290.00', '493849672.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-10 04:39:05', '2022-05-10 04:39:05'),
(234, 2, NULL, NULL, NULL, NULL, 'Atraumatic Dexon 3/8 circle round body&cutting needle 76cm (No-1(per Dozen))', NULL, '4290.00', '2130536996.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-10 04:39:54', '2022-05-10 04:39:54'),
(235, 2, NULL, NULL, NULL, NULL, 'Atraumatic Dexon 3/8 circle round body&cutting needle 76cm (No-1/0 (per Dozen))', NULL, '4290.00', '68505116.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-10 04:41:00', '2022-05-10 04:41:00'),
(236, 2, NULL, NULL, NULL, NULL, 'Atraumatic Dexon 3/8 circle round body&cutting needle 76cm (No-2/0(per Dozen))', NULL, '4290.00', '1530379437.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-10 04:41:53', '2022-05-10 04:41:53'),
(237, 2, NULL, NULL, NULL, NULL, 'Atraumatic Dexon 3/8 circle round body&cutting needle 76cm (No-3/0(per Dozen))', NULL, '4290.00', '390571409.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-10 04:43:00', '2022-05-10 04:43:00'),
(238, 2, NULL, NULL, NULL, NULL, 'Atraumatic Nylon 1/2 circle round body&cutting needle 76cm (No-4/0(per Dozen))', NULL, '2860.00', '74576663.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-10 04:43:52', '2022-05-10 04:43:52'),
(239, 2, NULL, NULL, NULL, NULL, 'Atraumatic Nylon 1/2 circle round body&cutting needle 76cm (No-5/0,6/0(per Dozen))', NULL, '3080.00', '439459327.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 00:50:21', '2022-05-11 00:50:21'),
(240, 2, NULL, NULL, NULL, NULL, 'Atraumatic Nylon 3/8 circle round body&cutting needle 76cm (No-4/0(per Dozen))', NULL, '2860.00', '893315030.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 00:51:02', '2022-05-11 00:51:02'),
(241, 2, NULL, NULL, NULL, NULL, 'Atraumatic Nylon 1/2 circle round body&cutting needle 76cm (No-5/0,6/0(per Dozen))', NULL, '3080.00', '149690084.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 00:51:47', '2022-05-11 00:51:47'),
(242, 2, NULL, NULL, NULL, NULL, 'Atraumatic Pooline 1/2 circle round body&cutting needle 76cm (No-1(per Dozen))', NULL, '3575.00', '1233732193.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 00:52:54', '2022-05-11 00:52:54'),
(243, 2, NULL, NULL, NULL, NULL, 'Atraumatic Pooline 1/2 circle round body&cutting needle 76cm (No-1/0 (per Dozen))', NULL, '2860.00', '180186523.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 00:53:37', '2022-05-11 00:53:37'),
(244, 2, NULL, NULL, NULL, NULL, 'Atraumatic Pooline 1/2 circle round body&cutting needle 76cm (NO-2/0(per Dozen))', NULL, '2860.00', '447745779.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 00:54:42', '2022-05-11 00:54:42'),
(245, 2, NULL, NULL, NULL, NULL, 'Atraumatic Pooline 1/2 circle round body&cutting needle 76cm (No-3/0(per Dozen))', NULL, '3575.00', '390476199.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 00:55:23', '2022-05-11 00:55:23'),
(246, 2, NULL, NULL, NULL, NULL, 'Atraumatic Pooline 1/2 circle round body&cutting needle 76cm (No-04/0(per Dozen))', NULL, '2860.00', '319819115.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 00:56:05', '2022-05-11 00:56:05'),
(247, 2, NULL, NULL, NULL, NULL, 'Atraumatic Pooline 1/2 circle round body&cutting needle 76cm (No-5/0,6/0(per Dozen))', NULL, '3080.00', '2024682652.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 00:56:46', '2022-05-11 00:56:46'),
(248, 2, NULL, NULL, NULL, NULL, 'Atraumatic Pooline 3/8 circle round body&cutting needle 76cm (No-1(per Dozen))', NULL, '3575.00', '1410060577.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 00:57:25', '2022-05-11 00:57:25'),
(249, 2, NULL, NULL, NULL, NULL, 'Atraumatic Pooline 3/8 circle round body&cutting needle 76cm (No-1/0(per Dozen))', NULL, '2860.00', '1365609076.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 00:58:01', '2022-05-11 00:58:01'),
(250, 2, NULL, NULL, NULL, NULL, 'Atraumatic Pooline 3/8 circle round body&cutting needle 76cm (NO-2/0(per Dozen))', NULL, '2860.00', '261650558.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 00:58:41', '2022-05-11 00:58:41'),
(251, 2, NULL, NULL, NULL, NULL, 'Atraumatic Pooline 3/8 circle round body&cutting needle 76cm (No-3/0(per Dozen))', NULL, '3575.00', '1656844329.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 00:59:19', '2022-05-11 00:59:19'),
(252, 2, NULL, NULL, NULL, NULL, 'Atraumatic Pooline 3/8 circle round body&cutting needle 76cm (No-4/0(per Dozen))', NULL, '2860.00', '790479676.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 00:59:56', '2022-05-11 00:59:56'),
(253, 2, NULL, NULL, NULL, NULL, 'Atraumatic Pooline 3/8 circle round body&cutting needle 76cm (No-5/0,6/0(per Dozen))', NULL, '3080.00', '1506739801.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 01:00:38', '2022-05-11 01:00:38'),
(254, 2, NULL, NULL, NULL, NULL, 'Atraumatic silk braided mono filament½ circle round body&cutting needle 76cm (No-1/0,2/0(per Dozen))', NULL, '1115.00', '536478690.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 01:01:17', '2022-05-11 01:01:17'),
(255, 2, NULL, NULL, NULL, NULL, 'Atraumatic silk braided mono filament½ circle round body&cutting needle 76cm (No-1(per Dozen))', NULL, '1595.00', '1447618299.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 01:01:54', '2022-05-11 01:01:54'),
(256, 2, NULL, NULL, NULL, NULL, 'Atraumatic silk braided mono filament1/2 circle round body&cutting needle 76cm (No-4/0(per Dozen))', NULL, '1500.00', '1886636986.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 01:02:32', '2022-05-11 01:02:32'),
(257, 2, NULL, NULL, NULL, NULL, 'Atraumatic silk braided mono filament1/2 circle round body&cutting needle 76cm (No-5/0(per Dozen))', NULL, '1897.00', '800844942.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 01:03:08', '2022-05-11 01:03:08'),
(258, 2, NULL, NULL, NULL, NULL, 'Atraumatic silk braided mono filament1/2 circle round body&cutting needle 76cm (No-6/0(per Dozen))', NULL, '3646.00', '1894814191.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 01:03:50', '2022-05-11 01:03:50'),
(259, 2, NULL, NULL, NULL, NULL, 'Atraumatic silk braided mono filament1/2 circle round body&cutting needle 76cm (No-3/0(per Dozen))', NULL, '1072.00', '1228093709.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 01:04:28', '2022-05-11 01:04:28'),
(260, 2, NULL, NULL, NULL, NULL, 'Atraumatic silk braided mono filament3/8 circle round body&cutting needle 76cm (No-1/0,2/0(per Dozen))', NULL, '1115.00', '209811214.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 01:05:10', '2022-05-11 01:05:10'),
(261, 2, NULL, NULL, NULL, NULL, 'Atraumatic silk braided mono filament3/8 circle round body&cutting needle 76cm (No-3/0(per Dozen))', NULL, '1402.00', '1712253565.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 01:05:49', '2022-05-11 01:05:49'),
(262, 2, NULL, NULL, NULL, NULL, 'Atraumatic silk braided mono filament3/8 circle round body&cutting needle 76cm (No-4/0(per Dozen))', NULL, '1430.00', '1155598044.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 01:06:30', '2022-05-11 01:06:30'),
(263, 2, NULL, NULL, NULL, NULL, 'Atraumatic silk braided mono filament3/8 circle round body&cutting needle 76cm (No-5/0(per Dozen))', NULL, '1897.00', '4856944.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 01:07:08', '2022-05-11 01:07:08'),
(264, 2, NULL, NULL, NULL, NULL, 'Atraumatic silk braided mono filament3/8 circle round body&cutting needle 76cm (No-6/0(per Dozen))', NULL, '3646.00', '179344193.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 01:07:47', '2022-05-11 01:07:47'),
(265, 2, NULL, NULL, NULL, NULL, 'Atraumatic silk braided mono filament3/8 circle round body&cutting needle 76cm (No-1(per Dozen))', NULL, '1595.00', '1247583628.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 01:08:35', '2022-05-11 01:08:35'),
(266, 2, NULL, NULL, NULL, NULL, 'Atraumatic vicryl ½ circle round body& cutting needle 76 cm (No-1(per Dozen))', NULL, '3806.00', '1368588743.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 01:09:32', '2022-05-11 01:09:32'),
(267, 2, NULL, NULL, NULL, NULL, 'Atraumatic vicryl ½ circle round body& cutting needle 76 cm (No-1/0,2/0(per Dozen))', NULL, '3806.00', '1432694406.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 01:10:09', '2022-05-11 01:10:09'),
(268, 2, NULL, NULL, NULL, NULL, 'Atraumatic vicryl ½circle round body& cutting needle 76 cm (No-3/0(per Dozen))', NULL, '3289.00', '548865177.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 01:10:44', '2022-05-11 01:10:44'),
(269, 2, NULL, NULL, NULL, NULL, 'Atraumatic vicryl ½ circle round body& cutting needle 76 cm (No-7/0(per Dozen))', NULL, '13041.00', '610414215.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 01:11:19', '2022-05-11 01:11:19'),
(270, 2, NULL, NULL, NULL, NULL, 'Atraumatic vicryl ½ circle round body& cutting needle 76 cm (No-8/0(per Dozen))', NULL, '17160.00', '824598921.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 01:11:53', '2022-05-11 01:11:53'),
(271, 2, NULL, NULL, NULL, NULL, 'Atraumatic vicryl 1/2 circle round body& cutting needle 76 cm (No-4/0(per Dozen))', NULL, '2931.00', '1226644267.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 01:12:28', '2022-05-11 01:12:28'),
(272, 2, NULL, NULL, NULL, NULL, 'Atraumatic vicryl 1/2 circle round body& cutting needle 76 cm (No-5/0(per Dozen))', NULL, '3217.00', '1841293505.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 01:13:04', '2022-05-11 01:13:04'),
(273, 2, NULL, NULL, NULL, NULL, 'Atraumatic vicryl 1/2 circle round body& cutting needle 76 cm (No-6/0(per Dozen))', NULL, '5720.00', '1157369554.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 01:13:46', '2022-05-11 01:13:46'),
(274, 2, NULL, NULL, NULL, NULL, 'Atraumatic vicryl 3/8 circle round body& cutting needle 76 cm (No-1(per Dozen))', NULL, '3806.00', '534063945.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 01:14:23', '2022-05-11 01:14:23'),
(275, 2, NULL, NULL, NULL, NULL, 'Atraumatic vicryl 3/8 circle round body& cutting needle 76 cm (No-1/0(per Dozen))', NULL, '4862.00', '182907719.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 01:15:01', '2022-05-11 01:15:01'),
(276, 2, NULL, NULL, NULL, NULL, 'Atraumatic vicryl 3/8 circle round body& cutting needle 76 cm (No-2/0(per Dozen))', NULL, '4647.00', '633405836.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 01:15:37', '2022-05-11 01:15:37'),
(277, 2, NULL, NULL, NULL, NULL, 'Atraumatic vicryl 3/8 circle round body& cutting needle 76 cm (No-3/0(per Dozen))', NULL, '3932.00', '686917903.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 01:16:12', '2022-05-11 01:16:12'),
(278, 2, NULL, NULL, NULL, NULL, 'Atraumatic vicryl 3/8 circle round body& cutting needle 76 cm (No-1/0(per Dozen))', NULL, '4862.00', '900282363.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 01:16:46', '2022-05-11 01:16:46'),
(279, 2, NULL, NULL, NULL, NULL, 'Atraumatic vicryl 3/8 circle round body& cutting needle 76 cm (No-4/0(per Dozen))', NULL, '3217.00', '787694204.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 02:49:14', '2022-05-11 02:49:14'),
(280, 2, NULL, NULL, NULL, NULL, 'Atraumatic vicryl 3/8 circle round body& cutting needle 76 cm (No-5/0(per Dozen))', NULL, '3603.00', '975609577.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 02:50:00', '2022-05-11 02:50:00'),
(281, 2, NULL, NULL, NULL, NULL, 'Atraumatic vicryl 3/8 circle round body& cutting needle 76 cm (No-6/0(per Dozen))', NULL, '5720.00', '525232406.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 02:50:46', '2022-05-11 02:50:46'),
(282, 2, NULL, NULL, NULL, NULL, 'Atraumatic vicryl 3/8 circle round body& cutting needle 76 cm (No-7/0(per Dozen))', NULL, '13042.00', '1761731920.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 02:51:33', '2022-05-11 02:51:33'),
(283, 2, NULL, NULL, NULL, NULL, 'Atraumatic vicryl 3/8 circle round body& cutting needle 76 cm (No-8/0(per Dozen))', NULL, '17160.00', '170751993.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 02:52:16', '2022-05-11 02:52:16'),
(284, 2, NULL, NULL, NULL, NULL, 'Aural metallic speculam (Large /Medium/Small size)', NULL, '418.00', '1725029055.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 02:53:14', '2022-05-11 02:53:14'),
(285, 2, NULL, NULL, NULL, NULL, 'Auroscope with light source (std size)', NULL, '2310.00', '2069468287.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 02:53:58', '2022-05-11 02:53:58'),
(286, 2, NULL, NULL, NULL, NULL, 'Autoclave machine (Electrical) (std size)', NULL, '18590.00', '1925518469.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 02:56:26', '2022-05-11 02:56:26'),
(287, 2, NULL, NULL, NULL, NULL, 'Autoscope (std size)', NULL, '5500.00', '165414949.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 02:57:06', '2022-05-11 02:57:06'),
(288, 2, NULL, NULL, NULL, NULL, 'Autosuture Royal skin Stapler (35 Pin) (p/pc)', NULL, '1540.00', '1353032391.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 03:04:05', '2022-05-11 03:04:05'),
(289, 2, NULL, NULL, NULL, NULL, 'B.P Handle (Hilbro or equivalent) (No-3\'\'/4\'\'/7\'\'/8\'\',p/pc)', NULL, '935.00', '1472603767.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 03:04:49', '2022-05-11 03:04:49'),
(290, 2, NULL, NULL, NULL, NULL, 'B.P instrument aneroid (Do)', NULL, '1512.00', '1022719873.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 03:05:51', '2022-05-11 03:05:51'),
(291, 2, NULL, NULL, NULL, NULL, 'B.Pblade sterile (Japan/China or equivalent) (Size-10/11/12/15/20/21/22/23/24/,p/pc)', NULL, '7.70', '1714325201.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 03:06:55', '2022-05-11 03:06:55'),
(292, 2, NULL, NULL, NULL, NULL, 'B.scan paper (per roll)', NULL, '6050.00', '270151183.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 03:07:56', '2022-05-11 03:07:56');
INSERT INTO `products` (`id`, `cat_id`, `brand_id`, `company_id`, `unit`, `origin`, `name`, `specification`, `price`, `image`, `btn_link`, `desc`, `is_featured`, `created_at`, `updated_at`) VALUES
(293, 2, NULL, NULL, NULL, NULL, 'Babcock forceps (Hilbro or equibatent) (p/pc)', NULL, '440.00', '1704845808.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 03:08:39', '2022-05-11 03:08:39'),
(294, 2, NULL, NULL, NULL, NULL, 'Babcock intestinal forcep (155mm)', NULL, '385.00', '1191357785.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 03:09:21', '2022-05-11 03:09:21'),
(295, 2, NULL, NULL, NULL, NULL, 'Back flush needle with silicon tipped (std size)', NULL, '990.00', '568940097.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 03:10:07', '2022-05-11 03:10:07'),
(296, 2, NULL, NULL, NULL, NULL, 'Bain circuit (adult) (p/pc)', NULL, '2420.00', '119677371.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 03:10:54', '2022-05-11 03:10:54'),
(297, 2, NULL, NULL, NULL, NULL, 'Bain circuit (Anesthesia) (Do)', NULL, '3080.00', '1202037963.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 03:11:39', '2022-05-11 03:11:39'),
(298, 2, NULL, NULL, NULL, NULL, 'Bain circuit (child) (p/pc)', NULL, '3300.00', '2042924875.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 03:12:20', '2022-05-11 03:12:20'),
(299, 2, NULL, NULL, NULL, NULL, 'Ballon infator set adaptor (For PTCA full set)', NULL, '6600.00', '1317434193.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 03:13:05', '2022-05-11 03:13:05'),
(300, 2, NULL, NULL, NULL, NULL, 'Bandage cutting sessors (\'8,9\'\'pc)', NULL, '330.00', '1316622023.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 03:13:48', '2022-05-11 03:13:48'),
(301, 2, NULL, NULL, NULL, NULL, 'Bange erscerotion spoon (large size)', NULL, '880.00', '195452800.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 03:14:33', '2022-05-11 03:14:33'),
(302, 2, NULL, NULL, NULL, NULL, 'Bange erscerotion spoon (small size)', NULL, '770.00', '2041123505.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 03:15:17', '2022-05-11 03:15:17'),
(303, 2, NULL, NULL, NULL, NULL, 'Bathroon scale (wight Machine ) (Do)', NULL, '1320.00', '1889218792.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 03:16:10', '2022-05-11 03:16:10'),
(304, 2, NULL, NULL, NULL, NULL, 'Beaker (Glass)_ (250ml (pc))', NULL, '82.00', '427278314.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 03:17:29', '2022-05-11 03:17:29'),
(305, 2, NULL, NULL, NULL, NULL, 'Beaker (Glass)_ (1000ml (pc))', NULL, '253.00', '641464254.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 03:23:49', '2022-05-11 03:23:49'),
(306, 2, NULL, NULL, NULL, NULL, 'Beaker (Glass)_ (500ml(pc))', NULL, '143.00', '527811234.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 03:24:29', '2022-05-11 03:24:29'),
(307, 2, NULL, NULL, NULL, NULL, 'Bedpen (ss) (std size)', NULL, '550.00', '2100906405.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 03:25:11', '2022-05-11 03:25:11'),
(308, 2, NULL, NULL, NULL, NULL, 'Boinocular microscope (Do)', NULL, '26950.00', '1826426038.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 03:25:51', '2022-05-11 03:25:51'),
(309, 2, NULL, NULL, NULL, NULL, 'Biopsy forceps for cenix (Hibro or epuivalent) (p/pc)', NULL, '3410.00', '1410597490.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 03:26:30', '2022-05-11 03:26:30'),
(310, 2, NULL, NULL, NULL, NULL, 'Biopdstand (pair ) with fixation plate (std size)', NULL, '1430.00', '701341356.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 03:27:16', '2022-05-11 03:27:16'),
(311, 2, NULL, NULL, NULL, NULL, 'Bipolar cable (Disposable )_for phaco Emulsification (std size (pc))', NULL, '19932.00', '592713358.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 03:28:00', '2022-05-11 03:28:00'),
(312, 2, NULL, NULL, NULL, NULL, 'Bipolar cautery (straigh /curve) for phaco Emulsification (Do)', NULL, '19932.00', '1254404740.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 03:28:43', '2022-05-11 03:28:43'),
(313, 2, NULL, NULL, NULL, NULL, 'Bipolar cord (std size (pc))', NULL, '9900.00', '538805581.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 03:29:30', '2022-05-11 03:29:30'),
(314, 2, NULL, NULL, NULL, NULL, 'Bipolar diathermy forcep (7mm tip bayonet type (per set))', NULL, '24750.00', '1680464205.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 03:30:16', '2022-05-11 03:30:16'),
(315, 2, NULL, NULL, NULL, NULL, 'Bipolar hip prosthesis with fenestration (std size (pc))', NULL, '11000.00', '1595765141.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 03:31:00', '2022-05-11 03:31:00'),
(316, 2, NULL, NULL, NULL, NULL, 'Bipolar hip prosthesis without fenestration (std size (pc))', NULL, '9900.00', '2105965644.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 03:31:43', '2022-05-11 03:31:43'),
(317, 2, NULL, NULL, NULL, NULL, 'Bit for bone drill machine (various size)', NULL, '495.00', '24627822.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 03:32:23', '2022-05-11 03:32:23'),
(318, 2, NULL, NULL, NULL, NULL, 'Blade beader and holder (12mm long)', NULL, '935.00', '1239980742.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 03:33:03', '2022-05-11 03:33:03'),
(319, 2, NULL, NULL, NULL, NULL, 'Blexi forcep (punch forcep) (Different degrees 0.45.90) Pc)', NULL, '9020.00', '1892772908.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 03:33:46', '2022-05-11 03:33:46'),
(320, 2, NULL, NULL, NULL, NULL, 'Block needle (dental) (p/pc)', NULL, '6.60', '1528485800.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 03:34:25', '2022-05-11 03:34:25'),
(321, 2, NULL, NULL, NULL, NULL, 'Blood Bag -Double (Do)', NULL, '341.00', '944253438.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 03:35:10', '2022-05-11 03:35:10'),
(322, 2, NULL, NULL, NULL, NULL, 'Blood bag -signal (Do)', NULL, '220.00', '703170564.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 03:35:57', '2022-05-11 03:35:57'),
(323, 2, NULL, NULL, NULL, NULL, 'Blood Bag-triple (Do)', NULL, '480.00', '154719347.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 03:36:37', '2022-05-11 03:36:37'),
(324, 2, NULL, NULL, NULL, NULL, 'Blood collecting weight machine (std size)', NULL, '2400.00', '1874448898.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 03:37:25', '2022-05-11 03:37:25'),
(325, 2, NULL, NULL, NULL, NULL, 'Blood giving set (Do)', NULL, '77.00', '1391679019.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 03:38:14', '2022-05-11 03:38:14'),
(326, 2, NULL, NULL, NULL, NULL, 'Blood lancets (disposable) (100pcs/box)', NULL, '220.00', '239744116.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 03:39:07', '2022-05-11 03:39:07'),
(327, 2, NULL, NULL, NULL, NULL, 'Blood lancets (starile) (100pcs/box)', NULL, '220.00', '868532958.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 03:39:58', '2022-05-11 03:39:58'),
(328, 2, NULL, NULL, NULL, NULL, 'Blood line set (arterial and ve3nous ) universal (japanor equivalent) (p/pair)', NULL, '302.00', '87062948.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 03:40:51', '2022-05-11 03:40:51'),
(329, 2, NULL, NULL, NULL, NULL, 'Blue tips (200-1000ml) (500pes/pack)', NULL, '825.00', '2140668009.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 03:41:37', '2022-05-11 03:41:37'),
(330, 2, NULL, NULL, NULL, NULL, 'Blunt tip guide wire for interference screw fixation (Do(pc))', NULL, '1925.00', '740995644.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 03:42:20', '2022-05-11 03:42:20'),
(331, 2, NULL, NULL, NULL, NULL, 'Bone anal (std size (pc))', NULL, '2520.00', '867937556.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 03:43:04', '2022-05-11 03:43:04'),
(332, 2, NULL, NULL, NULL, NULL, 'Bone Awl (Medium)', NULL, '2520.00', '2138992273.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 03:43:50', '2022-05-11 03:43:50'),
(333, 2, NULL, NULL, NULL, NULL, 'Bone Awl (Large size)', NULL, '2625.00', '1726292803.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 03:44:39', '2022-05-11 03:44:39'),
(334, 2, NULL, NULL, NULL, NULL, 'Bone cement (std size (pc))', NULL, '7500.00', '1235008787.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 03:45:39', '2022-05-11 03:45:39'),
(335, 2, NULL, NULL, NULL, NULL, 'Bone clamp s,s (Do)', NULL, '1627.00', '1663172263.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 03:46:28', '2022-05-11 03:46:28'),
(336, 2, NULL, NULL, NULL, NULL, 'Bone curette (Do)', NULL, '420.00', '912347898.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 03:47:08', '2022-05-11 03:47:08'),
(337, 2, NULL, NULL, NULL, NULL, 'Bone cutting forceps (small,Medium )set of 2(hilbro or equivalent) (p/pc)', NULL, '2150.00', '1409876208.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 03:47:59', '2022-05-11 03:47:59'),
(338, 2, NULL, NULL, NULL, NULL, 'Bone cutting saw (std size)', NULL, '788.00', '1120359922.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 03:48:40', '2022-05-11 03:48:40'),
(339, 2, NULL, NULL, NULL, NULL, 'Bone cutting scissors double action (do)', NULL, '2400.00', '1252298336.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 03:49:23', '2022-05-11 03:49:23'),
(340, 2, NULL, NULL, NULL, NULL, 'bone drill machine (std size)', NULL, '5250.00', '1135589829.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 03:50:05', '2022-05-11 03:50:05'),
(341, 2, NULL, NULL, NULL, NULL, 'Bone file s,s (Do)', NULL, '845.00', '384505771.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 03:50:47', '2022-05-11 03:50:47'),
(342, 2, NULL, NULL, NULL, NULL, 'Bone gauze s,s (Do)', NULL, '477.00', '1959789582.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 03:51:31', '2022-05-11 03:51:31'),
(343, 2, NULL, NULL, NULL, NULL, 'Bone holding forcep (Do)', NULL, '4100.00', '2062107700.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 03:52:16', '2022-05-11 03:52:16'),
(344, 2, NULL, NULL, NULL, NULL, 'Bone holding saw s,s (Do)', NULL, '913.00', '973390806.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 03:52:57', '2022-05-11 03:52:57'),
(345, 2, NULL, NULL, NULL, NULL, 'Bone holding self retaining retractor (Large size)', NULL, '3465.00', '557619379.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 03:53:41', '2022-05-11 03:53:41'),
(346, 2, NULL, NULL, NULL, NULL, 'Bone holding self retaining retractor (small size)', NULL, '3145.00', '853513644.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 03:54:24', '2022-05-11 03:54:24'),
(347, 2, NULL, NULL, NULL, NULL, 'Bone hook (std size)', NULL, '493.00', '2010917273.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 03:55:06', '2022-05-11 03:55:06'),
(348, 2, NULL, NULL, NULL, NULL, 'Bone lever (small size)', NULL, '705.00', '1523684096.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 03:55:53', '2022-05-11 03:55:53'),
(349, 2, NULL, NULL, NULL, NULL, 'Bone lever (larze )', NULL, '945.00', '1700352333.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 03:56:40', '2022-05-11 03:56:40'),
(350, 2, NULL, NULL, NULL, NULL, 'Bone needle /pin (Do)', NULL, '420.00', '394460603.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 03:57:23', '2022-05-11 03:57:23'),
(351, 2, NULL, NULL, NULL, NULL, 'Bone nibbler (small,Medium) set of 2 (p/pc)', NULL, '840.00', '1516456795.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 03:58:05', '2022-05-11 03:58:05'),
(352, 2, NULL, NULL, NULL, NULL, 'Bone nibbler (Dubble Action) (p/pc)', NULL, '840.00', '729375567.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 03:58:48', '2022-05-11 03:58:48'),
(353, 2, NULL, NULL, NULL, NULL, 'Bone osteotme (Do (PC))', NULL, '846.00', '1518960061.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 03:59:28', '2022-05-11 03:59:28'),
(354, 2, NULL, NULL, NULL, NULL, 'Bone plate s.s (Do)', NULL, '2225.00', '970104423.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 04:00:08', '2022-05-11 04:00:08'),
(355, 2, NULL, NULL, NULL, NULL, 'Bone reduction forcep (Do)', NULL, '1050.00', '2049671123.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 04:00:54', '2022-05-11 04:00:54'),
(356, 2, NULL, NULL, NULL, NULL, 'Boone rongeur, curved (Do/pc)', NULL, '546.00', '2062014174.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 04:01:35', '2022-05-11 04:01:35'),
(357, 2, NULL, NULL, NULL, NULL, 'Bone rongeur,straight (Do/pc)', NULL, '546.00', '2083990199.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 04:02:21', '2022-05-11 04:02:21'),
(358, 2, NULL, NULL, NULL, NULL, 'Bone scoop s.s (Do)', NULL, '525.00', '1369498841.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 04:03:02', '2022-05-11 04:03:02'),
(359, 2, NULL, NULL, NULL, NULL, 'Bone screw driver (various )', NULL, '1470.00', '856462184.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 04:03:49', '2022-05-11 04:03:49'),
(360, 2, NULL, NULL, NULL, NULL, 'Bone shear (std size)', NULL, '2205.00', '608185661.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 04:04:29', '2022-05-11 04:04:29'),
(361, 2, NULL, NULL, NULL, NULL, 'Boomerang needle (Do)', NULL, '262.00', '1713707996.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 04:05:12', '2022-05-11 04:05:12'),
(362, 2, NULL, NULL, NULL, NULL, 'Bottle for sucker machine (500ml)', NULL, '241.00', '210652754.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 04:05:51', '2022-05-11 04:05:51'),
(363, 2, NULL, NULL, NULL, NULL, 'Bottle for sucker machine (1000 ml)', NULL, '620.00', '787683788.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 04:06:36', '2022-05-11 04:06:36'),
(364, 2, NULL, NULL, NULL, NULL, 'Boottle for sucker machine (2500 ml)', NULL, '1417.00', '1920485130.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 04:07:28', '2022-05-11 04:07:28'),
(365, 2, NULL, NULL, NULL, NULL, 'Boyle Davis Mouth Gag(Adult) (p/pc)', NULL, '6300.00', '691445671.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 04:08:07', '2022-05-11 04:08:07'),
(366, 2, NULL, NULL, NULL, NULL, 'Boyle Davis Mouth Gag(child) (p/pc)', NULL, '6300.00', '936606434.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 04:08:56', '2022-05-11 04:08:56'),
(367, 2, NULL, NULL, NULL, NULL, 'Boulers Davis mouth gag (Retaractor with tongue depressor) (std size)', NULL, '2205.00', '184893526.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 04:09:36', '2022-05-11 04:09:36'),
(368, 2, NULL, NULL, NULL, NULL, 'Bracuar needle holder ss (for eye) (std size (pc))', NULL, '630.00', '620282830.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 04:10:19', '2022-05-11 04:10:19'),
(369, 2, NULL, NULL, NULL, NULL, 'Brockenbrough needle (std size (pc))', NULL, '13650.00', '439088965.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 04:11:06', '2022-05-11 04:11:06'),
(370, 2, NULL, NULL, NULL, NULL, 'B scan paper , same as Ref M 986 Alcon/sany (p/ roll)', NULL, '5040.00', '1464225658.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 04:11:47', '2022-05-11 04:11:47'),
(371, 2, NULL, NULL, NULL, NULL, 'Bulb for colorimeter (p/pc)', NULL, '1155.00', '379893685.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 04:12:34', '2022-05-11 04:12:34'),
(372, 2, NULL, NULL, NULL, NULL, 'Bulb for indirect opthalmoscope (per piece all pupil killer)', NULL, '5460.00', '1852422994.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 04:13:32', '2022-05-11 04:13:32'),
(373, 2, NULL, NULL, NULL, NULL, 'Bulb for indirect opthalmoscope (Heine ventage)', NULL, '6300.00', '1554137613.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 04:14:28', '2022-05-11 04:14:28'),
(374, 2, NULL, NULL, NULL, NULL, 'Bulb for larungoscope (paedratric(pc))', NULL, '132.00', '755841962.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 04:15:16', '2022-05-11 04:15:16'),
(375, 2, NULL, NULL, NULL, NULL, 'Bulb for larungoscope (adult (pc))', NULL, '132.00', '1971511030.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 04:16:01', '2022-05-11 04:16:01'),
(376, 2, NULL, NULL, NULL, NULL, 'Bulb for operatinf Microscope (12volt /100watt Halogen)', NULL, '1785.00', '953159953.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 04:16:41', '2022-05-11 04:16:41'),
(377, 2, NULL, NULL, NULL, NULL, 'Bulb for ophthalmometer/ keratometer (6volt/2.4 amps )', NULL, '3255.00', '2094562792.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 04:17:23', '2022-05-11 04:17:23'),
(378, 2, NULL, NULL, NULL, NULL, 'Bulb for ophthalmoscope (2.5v/8v,p/pc)', NULL, '3830.00', '2110176359.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 04:18:09', '2022-05-11 04:18:09'),
(379, 2, NULL, NULL, NULL, NULL, 'Bulb for ophthalmoscope (2.5v/8v,p/pc)', NULL, '3830.00', '776740594.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 04:19:54', '2022-05-11 04:19:54'),
(380, 2, NULL, NULL, NULL, NULL, 'Bulb for ophthalmoscope Hein Beta 200 cat No Hein XHL 069 2.5v (p/pc)', NULL, '3150.00', '297500297.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 23:11:33', '2022-05-11 23:11:33'),
(381, 2, NULL, NULL, NULL, NULL, 'Bulb for ophthalmoscope keeler  vista  2.5v/2.8v (p/pc)', NULL, '3675.00', '244652025.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 23:13:07', '2022-05-11 23:13:07'),
(382, 2, NULL, NULL, NULL, NULL, 'Bulb for ophthalmoscope Hein Mirflex 2 cat Nb Heine 038/2.5v (p/pc)', NULL, '3360.00', '1453352469.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 23:13:45', '2022-05-11 23:13:45'),
(383, 2, NULL, NULL, NULL, NULL, 'Bulb for stil lamp (Hagg streit Model)6 volt 4.5amp Machine cat no 900-030 (p/pc)', NULL, '4400.00', '2094739461.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 23:14:25', '2022-05-11 23:14:25'),
(384, 2, NULL, NULL, NULL, NULL, 'Bulb Radium 24v-25W (p/pc)', NULL, '1250.00', '1373380186.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 23:14:57', '2022-05-11 23:14:57'),
(385, 2, NULL, NULL, NULL, NULL, 'Bulldog clamp (Big small) (p/pc)', NULL, '720.00', '1473168622.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 23:15:37', '2022-05-11 23:15:37'),
(386, 2, NULL, NULL, NULL, NULL, 'Bunnel hand drill (std size)', NULL, '4400.00', '1491665734.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 23:16:13', '2022-05-11 23:16:13'),
(387, 2, NULL, NULL, NULL, NULL, 'Burr diameter cutting Burr , 1.0mm 2.3mm 2.7mm 3.5mm 7.0mm (p/pc)', NULL, '787.00', '1475525286.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 23:16:48', '2022-05-11 23:16:48'),
(388, 2, NULL, NULL, NULL, NULL, 'Burr diameter Diamond pasted burr 1.2mm, 2.0mm, 3.0mm, 4.0mm (p/pc)', NULL, '315.00', '132063289.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 23:17:25', '2022-05-11 23:17:25'),
(389, 2, NULL, NULL, NULL, NULL, 'Bur diameter polishing burr 1.0mm,2.3mm, 2.7mm 3.5mm, 5.0mm (p/pc)', NULL, '537.00', '777642944.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 23:18:01', '2022-05-11 23:18:01'),
(390, 2, NULL, NULL, NULL, NULL, 'Butter fly needle (16G 18G 20G 22G 24G P/pc)', NULL, '16.00', '914734050.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 23:18:38', '2022-05-11 23:18:38'),
(391, 2, NULL, NULL, NULL, NULL, 'cable tracheostomy tube (Do)', NULL, '650.00', '1305545430.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 23:19:14', '2022-05-11 23:19:14'),
(392, 2, NULL, NULL, NULL, NULL, 'calazion clam (size large/Medium/small)', NULL, '1029.00', '551584800.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 23:19:51', '2022-05-11 23:19:51'),
(393, 2, NULL, NULL, NULL, NULL, 'cancellous screw (various size)', NULL, '493.00', '1481153570.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 23:20:27', '2022-05-11 23:20:27'),
(394, 2, NULL, NULL, NULL, NULL, 'cannula IV (vanocath or Equivalent) (20G/22G/24G,p/pc)', NULL, '38.00', '687035560.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 23:21:07', '2022-05-11 23:21:07'),
(395, 2, NULL, NULL, NULL, NULL, 'cannula suction (std size)', NULL, '34.00', '2117833874.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 23:21:45', '2022-05-11 23:21:45'),
(396, 2, NULL, NULL, NULL, NULL, 'cannulated Hip screw (various size )', NULL, '630.00', '1765291387.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 23:22:21', '2022-05-11 23:22:21'),
(397, 2, NULL, NULL, NULL, NULL, 'capsulorhexis forceps (std size)', NULL, '1250.00', '76626208.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 23:22:57', '2022-05-11 23:22:57'),
(398, 2, NULL, NULL, NULL, NULL, 'cardiac catheter 6F -3.5 (Left/ Right, p/pc)', NULL, '3150.00', '965551267.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 23:23:33', '2022-05-11 23:23:33'),
(399, 2, NULL, NULL, NULL, NULL, 'cardiac catheters connecting Tube (Different size)', NULL, '135.00', '315975470.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 23:24:08', '2022-05-11 23:24:08'),
(400, 2, NULL, NULL, NULL, NULL, 'cardiac catheters cournand (size 4F/5F)', NULL, '9500.00', '1235578612.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 23:24:42', '2022-05-11 23:24:42'),
(401, 2, NULL, NULL, NULL, NULL, 'cardiac catheters Diagostic Amplatz (size Al 1 6F/Al 2 6F/ AR -1 6F/AR-2 6F)', NULL, '9500.00', '1317993513.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 23:25:17', '2022-05-11 23:25:17'),
(402, 2, NULL, NULL, NULL, NULL, 'cardiac catheters Diagostic judkins Left (size : 5F-3.0/5F-3.5/5F-4.0/6F-3.0/6F-3.5/6F-4.0)', NULL, '2079.00', '1670303152.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 23:25:52', '2022-05-11 23:25:52'),
(403, 2, NULL, NULL, NULL, NULL, 'cardiac catheter Diagnostic judking Right (size : 5F-3.0/5F-3.5/5F-4.0/6F-3.0/6F-3.5/6F-4.0)', NULL, '2079.00', '153317723.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 23:26:30', '2022-05-11 23:26:30'),
(404, 2, NULL, NULL, NULL, NULL, 'cardiac catheters Fiagonstic Metallic guid wire (size; 32\'\'/35\'\')', NULL, '1243.00', '1561510182.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 23:27:07', '2022-05-11 23:27:07'),
(405, 2, NULL, NULL, NULL, NULL, 'cardiac catheters Diagnostic Ter4umo guide wire (size; 0.25\'\' 32\'\'/35\'\')', NULL, '1716.00', '1239103760.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 23:27:40', '2022-05-11 23:27:40'),
(406, 2, NULL, NULL, NULL, NULL, 'cardiac catheters introducing sheaths (size 5F/6F/7F)', NULL, '1859.00', '1167955833.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 23:28:13', '2022-05-11 23:28:13'),
(407, 2, NULL, NULL, NULL, NULL, 'cardiac catheters-NIH (size)', NULL, '9900.00', '425225155.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 23:28:47', '2022-05-11 23:28:47'),
(408, 2, NULL, NULL, NULL, NULL, 'cardiac catheters pig tail (size 5F/6F)', NULL, '10010.00', '1896130222.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 23:29:26', '2022-05-11 23:29:26'),
(409, 2, NULL, NULL, NULL, NULL, 'cardiac catheters - plastic manifold (std size)', NULL, '1364.00', '1389467645.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 23:30:06', '2022-05-11 23:30:06'),
(410, 2, NULL, NULL, NULL, NULL, 'cardiac catheters -PTCA balloon (1.25-6mm, 1.5-10mm)', NULL, '20900.00', '462157918.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 23:30:42', '2022-05-11 23:30:42'),
(411, 2, NULL, NULL, NULL, NULL, 'cardiac catheters -PTCA balloon (2.0-10mm,2.5-10mm)', NULL, '20900.00', '60987694.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 23:31:33', '2022-05-11 23:31:33'),
(412, 2, NULL, NULL, NULL, NULL, 'cardiac catheters -PTCA balloon (3.0-10mm,3.5-10mm)', NULL, '20900.00', '1166036240.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 23:32:08', '2022-05-11 23:32:08'),
(413, 2, NULL, NULL, NULL, NULL, 'cardiac catheters -Y connector (std size )', NULL, '143.00', '1683755090.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 23:32:52', '2022-05-11 23:32:52'),
(414, 2, NULL, NULL, NULL, NULL, 'cardiopladger Root cannula (size-5F /7F)', NULL, '2860.00', '2035320544.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 23:33:25', '2022-05-11 23:33:25'),
(415, 2, NULL, NULL, NULL, NULL, 'caroiovascular patch ptef (sneam Gran) thickness (mm) Dimension (cm) or with (06.mm x 04mm)', NULL, '24200.00', '1114839073.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 23:34:01', '2022-05-11 23:34:01'),
(416, 2, NULL, NULL, NULL, NULL, 'caroiovascular patch ptef (sneam Gran) thickness (mm) Dimension (cm) or with (0.6mm x10x15cmx0.4mmx0.6mm)', NULL, '27500.00', '1469256517.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 23:34:38', '2022-05-11 23:34:38'),
(417, 2, NULL, NULL, NULL, NULL, 'caroiovascular patch ptef (sneam Gran) thickness (mm) Dimension (cm) or with (15 x15 cm)', NULL, '27500.00', '86990627.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 23:35:13', '2022-05-11 23:35:13'),
(418, 2, NULL, NULL, NULL, NULL, 'carotid vascular patch PTFE/Dacron (Gelatin coated)', NULL, '22000.00', '1536022846.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 23:35:48', '2022-05-11 23:35:48'),
(419, 2, NULL, NULL, NULL, NULL, 'casting Machine (Dental) with all accessories (per pc)', NULL, '30000.00', '772651876.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 23:36:22', '2022-05-11 23:36:22'),
(420, 2, NULL, NULL, NULL, NULL, 'castroviejo corneal trephine (7.0mmdia same as cat No AA-2014/ Medelec+7.25mm)', NULL, '2750.00', '498966055.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 23:36:55', '2022-05-11 23:36:55'),
(421, 2, NULL, NULL, NULL, NULL, 'castroviejo corneal trephine (8.0mm dia same as cat NO AA-2016)', NULL, '2750.00', '345454076.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 23:37:30', '2022-05-11 23:37:30'),
(422, 2, NULL, NULL, NULL, NULL, 'castroviejo corneal trephine (7.5mm dia same as cat. No AA-2015)', NULL, '2750.00', '1652775566.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 23:38:05', '2022-05-11 23:38:05'),
(423, 2, NULL, NULL, NULL, NULL, 'castroviejo corneal trephine (8.5mm dia same as cat No AA-2017+8.25mm)', NULL, '4400.00', '1477356604.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 23:38:41', '2022-05-11 23:38:41'),
(424, 2, NULL, NULL, NULL, NULL, 'castroviejo corneal trephine (9.0mm dia same as cat No AA 2018)', NULL, '4812.50', '604415145.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 23:39:15', '2022-05-11 23:39:15'),
(425, 2, NULL, NULL, NULL, NULL, 'castroviejo corneal trephine (6.5mm dia same as cat No AA-2013/Medelec)', NULL, '2750.00', '822438911.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 23:39:47', '2022-05-11 23:39:47'),
(426, 2, NULL, NULL, NULL, NULL, 'castroviejo cyclodialysis spatula (Double ended with 0.25mm wide same as cat No IG -1000)', NULL, '7480.00', '521090502.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 23:40:21', '2022-05-11 23:40:21'),
(427, 2, NULL, NULL, NULL, NULL, 'castroviejo cyclodialysis spatula (Double ended with 0.25mm wide same as cat No IG -1998)', NULL, '5500.00', '2046892859.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 23:40:57', '2022-05-11 23:40:57'),
(428, 2, NULL, NULL, NULL, NULL, 'castroviejo Eye calliper (std size)', NULL, '1320.00', '1700755163.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 23:41:32', '2022-05-11 23:41:32'),
(429, 2, NULL, NULL, NULL, NULL, 'castroviejo Micro scissors (Curved same as cat No IG 4302B )', NULL, '6050.00', '215377273.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-11 23:42:08', '2022-05-11 23:42:08'),
(430, 2, NULL, NULL, NULL, NULL, 'Catheter (paediatric) (Female)', NULL, '198.00', '519528767.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-12 00:46:12', '2022-05-12 00:46:12'),
(431, 2, NULL, NULL, NULL, NULL, 'Catheter (paediatric) (Male)', NULL, '198.00', '2028063328.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-12 00:46:45', '2022-05-12 00:46:45'),
(432, 2, NULL, NULL, NULL, NULL, 'Catheter foleys 2 way (No: 6,8,10,12,14,16,18,20)', NULL, '82.00', '694847033.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-12 00:47:19', '2022-05-12 00:47:19'),
(433, 2, NULL, NULL, NULL, NULL, 'Catheter foleys 3 way (No: 16,18,20,22)', NULL, '214.00', '853423903.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-12 00:47:50', '2022-05-12 00:47:50'),
(434, 2, NULL, NULL, NULL, NULL, 'Catheter Metallic (Male) (Do)', NULL, '313.00', '2012340065.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-12 00:48:23', '2022-05-12 00:48:23'),
(435, 2, NULL, NULL, NULL, NULL, 'Catheter Metallic (female ) (Do)', NULL, '159.00', '1788508205.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-12 00:52:40', '2022-05-12 00:52:40'),
(436, 2, NULL, NULL, NULL, NULL, 'Catheter Mount with connector (p/pc)', NULL, '66.00', '617530285.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-12 00:53:11', '2022-05-12 00:53:11'),
(437, 2, NULL, NULL, NULL, NULL, 'catheter rubber (Male) (Do)', NULL, '10.00', '589117202.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-12 00:53:42', '2022-05-12 00:53:42'),
(438, 2, NULL, NULL, NULL, NULL, 'catheter rubber (Female ) (Do)', NULL, '10.00', '1246591906.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-12 00:54:14', '2022-05-12 00:54:14'),
(439, 2, NULL, NULL, NULL, NULL, 'cat\'s paw retractor (small /large size(pc))', NULL, '440.00', '173410509.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-12 01:06:55', '2022-05-12 01:06:55'),
(440, 2, NULL, NULL, NULL, NULL, 'C-clump pointed drill guide (various size)', NULL, '6820.00', '1998937576.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-12 01:07:36', '2022-05-12 01:07:36'),
(441, 2, NULL, NULL, NULL, NULL, 'cell seeker with curette (std size)', NULL, '346.00', '1122088264.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-12 01:08:16', '2022-05-12 01:08:16'),
(442, 2, NULL, NULL, NULL, NULL, 'cement lifter (Do)', NULL, '258.00', '644416367.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-12 01:08:49', '2022-05-12 01:08:49'),
(443, 2, NULL, NULL, NULL, NULL, 'cement spatula (std size(pc))', NULL, '198.00', '288256799.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-12 01:09:26', '2022-05-12 01:09:26'),
(444, 2, NULL, NULL, NULL, NULL, 'Centrifuge Machine (12 hole )', NULL, '10835.00', '812840525.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-12 01:09:59', '2022-05-12 01:09:59'),
(445, 2, NULL, NULL, NULL, NULL, 'Centrifuge Machine (6hole)', NULL, '5610.00', '445269114.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-12 01:10:33', '2022-05-12 01:10:33'),
(446, 2, NULL, NULL, NULL, NULL, 'Centrifuge tube (glass) (Do )', NULL, '13.00', '560015478.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-12 01:11:08', '2022-05-12 01:11:08'),
(447, 2, NULL, NULL, NULL, NULL, 'cervical dilators (Different size) (p/pc)', NULL, '1155.00', '1147442190.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-12 01:11:46', '2022-05-12 01:11:46'),
(448, 2, NULL, NULL, NULL, NULL, 'Chalazion Hook (Large /Medium/Small size)', NULL, '693.00', '153125016.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-12 01:12:20', '2022-05-12 01:12:20'),
(449, 2, NULL, NULL, NULL, NULL, 'cheek Relaractor (p/pc)', NULL, '825.00', '814099230.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-12 01:12:55', '2022-05-12 01:12:55'),
(450, 2, NULL, NULL, NULL, NULL, 'chest drain set (p/pc)', NULL, '88.00', '1292979192.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-12 01:13:30', '2022-05-12 01:13:30'),
(451, 2, NULL, NULL, NULL, NULL, 'china Micro Moto Unit ( Elecrtic) (p/pc)', NULL, '14850.00', '1623295567.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-12 01:14:01', '2022-05-12 01:14:01'),
(452, 2, NULL, NULL, NULL, NULL, 'chiron lamp (p/pc)', NULL, '11000.00', '1269617361.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-12 01:14:42', '2022-05-12 01:14:42'),
(453, 2, NULL, NULL, NULL, NULL, 'chissel |Assorted (p/pc)', NULL, '3245.00', '402192887.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-12 01:15:27', '2022-05-12 01:15:27'),
(454, 2, NULL, NULL, NULL, NULL, 'Chittle forceps (Lifter ) (std size)', NULL, '385.00', '1710118991.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-12 01:16:08', '2022-05-12 01:16:08'),
(455, 2, NULL, NULL, NULL, NULL, 'chloride sensor for Nova 4 Electrolyle Analyzer (4/pk)', NULL, '19800.00', '1977853270.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-12 02:25:23', '2022-05-12 02:25:23'),
(456, 2, NULL, NULL, NULL, NULL, 'Clamp Arterial (p/pc)', NULL, '357.00', '1985932578.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-12 02:26:00', '2022-05-12 02:26:00'),
(457, 2, NULL, NULL, NULL, NULL, 'Clamp E.C.G Machine (p/pc)', NULL, '3850.00', '2129738117.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-12 02:27:43', '2022-05-12 02:27:43'),
(458, 2, NULL, NULL, NULL, NULL, 'Clamp Hysterectomy (p/pc)', NULL, '286.00', '1862060860.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-12 02:28:25', '2022-05-12 02:28:25'),
(459, 2, NULL, NULL, NULL, NULL, 'Clamp Oshaugnessy (std)', NULL, '30000.00', '1823136047.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-12 02:29:06', '2022-05-12 02:29:06'),
(460, 2, NULL, NULL, NULL, NULL, 'Clamp shirodker (p/pc)', NULL, '176.00', '166708129.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-12 02:29:53', '2022-05-12 02:29:53'),
(461, 2, NULL, NULL, NULL, NULL, 'Clark Eye speculum open Bloade (same as cat No-AA-1090 Medelec)', NULL, '3025.00', '1690648450.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-12 02:31:03', '2022-05-12 02:31:03'),
(462, 2, NULL, NULL, NULL, NULL, 'Clinical thermoneter ( centigrade/Farenhit) (std size p/pc)', NULL, '22.00', '1674178271.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-12 02:32:08', '2022-05-12 02:32:08'),
(463, 2, NULL, NULL, NULL, NULL, 'Clip applicator for general surgery (std size p/pc)', NULL, '30000.00', '1251675284.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-12 02:32:47', '2022-05-12 02:32:47'),
(464, 2, NULL, NULL, NULL, NULL, 'Colibri Forceps (std size p/pc)', NULL, '660.00', '289479365.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-12 02:33:22', '2022-05-12 02:33:22'),
(465, 2, NULL, NULL, NULL, NULL, 'Color Dppler paper e Ribbon (UPC 21L YPC 22L)', NULL, '2090.00', '1982992770.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-12 02:35:53', '2022-05-12 02:35:53'),
(466, 2, NULL, NULL, NULL, NULL, 'Colorineter (std size p/pc)', NULL, '22000.00', '1272894546.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-12 02:36:33', '2022-05-12 02:36:33'),
(467, 2, NULL, NULL, NULL, NULL, 'composite filling materals (std size p/pc)', NULL, '1375.00', '159406356.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-12 02:37:10', '2022-05-12 02:37:10'),
(468, 2, NULL, NULL, NULL, NULL, 'concal Flux (500ml / pcs)', NULL, '165.00', '2006236289.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-12 02:37:50', '2022-05-12 02:37:50'),
(469, 2, NULL, NULL, NULL, NULL, 'concal Fluz (1000ml/pcs)', NULL, '308.00', '1348377051.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-12 02:38:37', '2022-05-12 02:38:37'),
(470, 2, NULL, NULL, NULL, NULL, 'Contrakes Microscope bulb Type 7023 FCRAI /215 12v-100w GY6-35 (std size p/pc )', NULL, '1925.00', '144200508.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-12 02:39:27', '2022-05-12 02:39:27'),
(471, 2, NULL, NULL, NULL, NULL, 'coplin jar (std size p/pc)', NULL, '220.00', '740429352.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-12 02:41:29', '2022-05-12 02:41:29'),
(472, 2, NULL, NULL, NULL, NULL, 'corneal scissors (ss) curve balade (std size p/pc)', NULL, '880.00', '946401107.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-12 02:42:05', '2022-05-12 02:42:05'),
(473, 2, NULL, NULL, NULL, NULL, 'Corneal punch with corneal Y trephine (various size p/pc)', NULL, '2310.00', '483189408.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-12 02:42:43', '2022-05-12 02:42:43'),
(474, 2, NULL, NULL, NULL, NULL, 'Coneal scissors (ss) long blade (various size p/pc)', NULL, '880.00', '1690899658.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-12 02:43:15', '2022-05-12 02:43:15'),
(475, 2, NULL, NULL, NULL, NULL, 'Cornel trephine (various size p/pc)', NULL, '6050.00', '1770995276.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-12 02:43:50', '2022-05-12 02:43:50'),
(476, 2, NULL, NULL, NULL, NULL, 'Cornesi cutting block made of teflon, same as cat No -Ig -2596 (p/pc)', NULL, '3850.00', '1021043866.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-12 02:44:27', '2022-05-12 02:44:27'),
(477, 2, NULL, NULL, NULL, NULL, 'Corrugated Rubber Drain sheel (per ft)', NULL, '88.00', '1245780261.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-12 02:45:55', '2022-05-12 02:45:55'),
(478, 2, NULL, NULL, NULL, NULL, 'Corrugated Rubber  sheel (1\'x1\') (p/pc)', NULL, '60.00', '687360400.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-12 02:46:30', '2022-05-12 02:46:30'),
(479, 2, NULL, NULL, NULL, NULL, 'Cortical screw (p/pc)', NULL, '313.00', '1499075213.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-12 02:47:05', '2022-05-12 02:47:05'),
(480, 2, NULL, NULL, NULL, NULL, 'Counter sink ((3.5/4.5/5.5mm))', NULL, '5720.00', '1597912193.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-12 02:47:47', '2022-05-12 02:47:47'),
(481, 2, NULL, NULL, NULL, NULL, 'Cournand catheter sterile (size -45F/5F/6F)', NULL, '11000.00', '1168983154.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-12 02:48:22', '2022-05-12 02:48:22'),
(482, 2, NULL, NULL, NULL, NULL, 'couscose (vvaginal speculam) (std size p/pc)', NULL, '275.00', '1771169075.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-12 02:51:47', '2022-05-12 02:51:47'),
(483, 2, NULL, NULL, NULL, NULL, 'Cover slip (18x18) (100pcs/Box)', NULL, '132.00', '1578232221.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-12 02:52:24', '2022-05-12 02:52:24'),
(484, 2, NULL, NULL, NULL, NULL, 'Cover slip (22x22) (100pcs/Box)', NULL, '176.00', '247322843.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-12 02:53:02', '2022-05-12 02:53:02'),
(485, 2, NULL, NULL, NULL, NULL, 'Cranio perforator (std size p/pc)', NULL, '1705.00', '855152981.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-12 02:53:39', '2022-05-12 02:53:39'),
(486, 2, NULL, NULL, NULL, NULL, 'Cranioclast (std size p/pc)', NULL, '4290.00', '119120616.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-12 02:54:18', '2022-05-12 02:54:18'),
(487, 2, NULL, NULL, NULL, NULL, 'Crocodile forcep (std size p/pc)', NULL, '1155.00', '435969911.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-12 02:54:51', '2022-05-12 02:54:51'),
(488, 2, NULL, NULL, NULL, NULL, 'Croneal enlarging scissors (Medilac )', NULL, '2200.00', '721006671.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-12 02:55:25', '2022-05-12 02:55:25'),
(489, 2, NULL, NULL, NULL, NULL, 'Croneal enlarging sessors (line) (Medilac )', NULL, '9900.00', '1637207389.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-12 02:56:07', '2022-05-12 02:56:07'),
(490, 2, NULL, NULL, NULL, NULL, 'Cross action folder forceps same as cat No f-120 lnor (p/pc)', NULL, '2530.00', '1146795934.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-12 02:56:56', '2022-05-12 02:56:56'),
(491, 2, NULL, NULL, NULL, NULL, 'Cros section forcep (std size )', NULL, '20350.00', '1129558753.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-12 02:57:32', '2022-05-12 02:57:32'),
(492, 2, NULL, NULL, NULL, NULL, 'Cunea traceneostomy Tube one set or different sizes (4.5mm, 5.0mm, 5.5mm, 6.0mm, 6.5mm, 7.0mm, 7.5mm, 8.0mm) (p/pc)', NULL, '275.00', '241482086.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-12 02:58:09', '2022-05-12 02:58:09'),
(493, 2, NULL, NULL, NULL, NULL, 'Currette spoon (p/pc)', NULL, '1100.00', '123833702.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-12 03:05:30', '2022-05-12 03:05:30'),
(494, 2, NULL, NULL, NULL, NULL, 'Curve Needle Holder (medium) Hibro or equivalent (p/pc)', NULL, '1045.00', '1580725853.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-12 03:06:11', '2022-05-12 03:06:11'),
(495, 2, NULL, NULL, NULL, NULL, 'Cuscus self retaining vaginal speculum (std size p/pc)', NULL, '440.00', '904750502.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-12 03:06:52', '2022-05-12 03:06:52'),
(496, 2, NULL, NULL, NULL, NULL, 'Cuscus self retaining vaginal speculum (std size p/pc)', NULL, '132.00', '946718287.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-12 03:07:26', '2022-05-12 03:07:26'),
(497, 2, NULL, NULL, NULL, NULL, 'Cutaneous Hooklet (9mm width , 152mm long )', NULL, '14300.00', '615986067.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-12 03:08:02', '2022-05-12 03:08:02'),
(498, 2, NULL, NULL, NULL, NULL, 'Cutter pack (vertical) (std size p/pc)', NULL, '15950.00', '1654756742.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-12 03:08:42', '2022-05-12 03:08:42'),
(499, 2, NULL, NULL, NULL, NULL, 'Cuvette support for Eppendort ECOM semi Auto Biochemistry Analyzer (1 set)', NULL, '4400.00', '242760488.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-12 03:09:19', '2022-05-12 03:09:19'),
(500, 2, NULL, NULL, NULL, NULL, 'Cyclo dialysis spatula (Double ended) (std size p/pc)', NULL, '4180.00', '1930028023.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-12 03:09:57', '2022-05-12 03:09:57'),
(501, 2, NULL, NULL, NULL, NULL, 'D&C set (std size p/pc)', NULL, '1925.00', '319603349.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-12 03:10:38', '2022-05-12 03:10:38'),
(502, 2, NULL, NULL, NULL, NULL, 'D.C.R set (eye) (std size p/pc)', NULL, '30000.00', '981658171.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-12 03:11:12', '2022-05-12 03:11:12'),
(503, 2, NULL, NULL, NULL, NULL, 'D.C.R Trifline (4,6,8,10 hole )', NULL, '1045.00', '22249065.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-12 03:11:46', '2022-05-12 03:11:46'),
(504, 2, NULL, NULL, NULL, NULL, 'D.H.S plate ( bable plate) (4,6,8,10 hole )', NULL, '3080.00', '795066160.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-12 03:12:20', '2022-05-12 03:12:20'),
(505, 2, NULL, NULL, NULL, NULL, 'Dabis boyel mouth gag (4.25/5.5)', NULL, '2750.00', '1183727298.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-12 03:12:53', '2022-05-12 03:12:53'),
(506, 2, NULL, NULL, NULL, NULL, 'Daevers liver vetractir (small&Medium) (p/pc)', NULL, '605.00', '1340615255.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-12 03:20:21', '2022-05-12 03:20:21'),
(507, 2, NULL, NULL, NULL, NULL, 'Dark room safelight box (Do)', NULL, '1210.00', '1702791405.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-12 03:21:02', '2022-05-12 03:21:02'),
(508, 2, NULL, NULL, NULL, NULL, 'DCR punch Forceps ( Hibro or equivalent) (p/pc)', NULL, '4400.00', '985499447.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-12 03:21:45', '2022-05-12 03:21:45'),
(509, 2, NULL, NULL, NULL, NULL, 'Deavers Abdominal retractor (std size)', NULL, '495.00', '290218878.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-12 03:22:26', '2022-05-12 03:22:26'),
(510, 2, NULL, NULL, NULL, NULL, 'Deavers retractor (Do)', NULL, '385.00', '1942651438.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-12 03:23:03', '2022-05-12 03:23:03'),
(511, 2, NULL, NULL, NULL, NULL, 'Debachey Forceps 6\'\' (Hibro or equivalent) (p/pc)', NULL, '7920.00', '1384922755.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-12 03:23:37', '2022-05-12 03:23:37'),
(512, 2, NULL, NULL, NULL, NULL, 'De Bakey\'s forceps (Do)', NULL, '2530.00', '658843612.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-12 03:24:15', '2022-05-12 03:24:15'),
(513, 2, NULL, NULL, NULL, NULL, 'Decapitation hook (Do)', NULL, '572.00', '1348134274.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-12 03:26:41', '2022-05-12 03:26:41'),
(514, 2, NULL, NULL, NULL, NULL, 'Delicate crushing Hook (p/pc )', NULL, '1155.00', '118803446.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-12 03:27:22', '2022-05-12 03:27:22'),
(515, 2, NULL, NULL, NULL, NULL, 'Denhardt Mouth Gag (p/pc )', NULL, '825.00', '2111451598.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-12 03:27:59', '2022-05-12 03:27:59'),
(516, 2, NULL, NULL, NULL, NULL, 'Denis Bowne Forceps (Hilbro or equivalent) (p/pc )', NULL, '935.00', '2142373863.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-12 03:28:42', '2022-05-12 03:28:42'),
(517, 2, NULL, NULL, NULL, NULL, 'Dental Elevator ( warwick james ) (std size )', NULL, '506.00', '1396982802.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-12 03:29:24', '2022-05-12 03:29:24'),
(518, 2, NULL, NULL, NULL, NULL, 'Dental Autoclave machine (Do )', NULL, '13750.00', '142043536.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-12 03:29:58', '2022-05-12 03:29:58'),
(519, 2, NULL, NULL, NULL, NULL, 'Dental Drill (Electrical) with NSK hand piece (Do)', NULL, '21450.00', '30788130.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-12 03:30:49', '2022-05-12 03:30:49'),
(520, 2, NULL, NULL, NULL, NULL, 'Dental Elevator ( Crayer ) (std size )', NULL, '231.00', '120034773.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-12 03:31:26', '2022-05-12 03:31:26'),
(521, 2, NULL, NULL, NULL, NULL, 'Dental elevator (left angular) (p/pc)', NULL, '231.00', '550326743.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-12 03:32:04', '2022-05-12 03:32:04'),
(522, 2, NULL, NULL, NULL, NULL, 'Dental elevator (Right angular) (Do)', NULL, '231.00', '677935866.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-12 03:32:41', '2022-05-12 03:32:41'),
(523, 2, NULL, NULL, NULL, NULL, 'Dental elevator (straight) (std )', NULL, '231.00', '1826290480.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-12 03:33:16', '2022-05-12 03:33:16'),
(524, 2, NULL, NULL, NULL, NULL, 'Dental Excavatore (double ended) (Do)', NULL, '187.00', '323667865.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-12 03:33:57', '2022-05-12 03:33:57'),
(525, 2, NULL, NULL, NULL, NULL, 'Dental Excavator (single ended) (Do)', NULL, '165.00', '1014635453.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-12 03:34:29', '2022-05-12 03:34:29'),
(526, 2, NULL, NULL, NULL, NULL, 'Dental flux (Do)', NULL, '110.00', '879598030.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-12 03:35:04', '2022-05-12 03:35:04'),
(527, 2, NULL, NULL, NULL, NULL, 'Dental forceps (Lower root) (Do)', NULL, '423.00', '2135423879.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-12 03:35:50', '2022-05-12 03:35:50'),
(528, 2, NULL, NULL, NULL, NULL, 'Dental forceps (baynet forceps) (Do)', NULL, '423.00', '858302586.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-12 03:36:23', '2022-05-12 03:36:23'),
(529, 2, NULL, NULL, NULL, NULL, 'Dental forceps (lower anterior) (Adult size)', NULL, '407.00', '819000611.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-12 03:37:00', '2022-05-12 03:37:00'),
(530, 2, NULL, NULL, NULL, NULL, 'Dental forceps (lower anterior) (Do)', NULL, '423.00', '172312654.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-12 23:28:08', '2022-05-12 23:28:08'),
(531, 2, NULL, NULL, NULL, NULL, 'Dental forceps (lower molar) (Children size )', NULL, '423.00', '1275799291.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-12 23:28:52', '2022-05-12 23:28:52'),
(532, 2, NULL, NULL, NULL, NULL, 'Dental forceps (Lower root) Lower anterior (Do)', NULL, '423.00', '1362037590.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-12 23:29:34', '2022-05-12 23:29:34'),
(533, 2, NULL, NULL, NULL, NULL, 'Dental forceps ( upper anterior) (Do)', NULL, '423.00', '1684876556.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-12 23:30:06', '2022-05-12 23:30:06'),
(534, 2, NULL, NULL, NULL, NULL, 'Dental forceps (upper molar ) left side (Do)', NULL, '423.00', '60044455.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-12 23:30:40', '2022-05-12 23:30:40'),
(535, 2, NULL, NULL, NULL, NULL, 'Dental forceps (upper molar ) Reft side (Do)', NULL, '423.00', '1796212956.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-12 23:31:12', '2022-05-12 23:31:12'),
(536, 2, NULL, NULL, NULL, NULL, 'Dental forceps (upper root) (Do)', NULL, '423.00', '1178474762.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-12 23:31:45', '2022-05-12 23:31:45'),
(537, 2, NULL, NULL, NULL, NULL, 'Dental light (wall bucket)_ (Do)', NULL, '9350.00', '188955551.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-12 23:32:19', '2022-05-12 23:32:19'),
(538, 2, NULL, NULL, NULL, NULL, 'Dental Mirror e handle (Metallic) (std size)', NULL, '154.00', '4665428.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-12 23:32:56', '2022-05-12 23:32:56'),
(539, 2, NULL, NULL, NULL, NULL, 'Dental Mirror e handle (plastic) (Do)', NULL, '82.00', '1979007069.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-12 23:33:30', '2022-05-12 23:33:30'),
(540, 2, NULL, NULL, NULL, NULL, 'Dental press (Do)', NULL, '572.00', '1973012123.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-12 23:34:06', '2022-05-12 23:34:06'),
(541, 2, NULL, NULL, NULL, NULL, 'Dental probe (Do)', NULL, '154.00', '1577372460.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-12 23:34:39', '2022-05-12 23:34:39'),
(542, 2, NULL, NULL, NULL, NULL, 'Dental twizer (Do)', NULL, '137.00', '781858693.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-12 23:35:19', '2022-05-12 23:35:19'),
(543, 2, NULL, NULL, NULL, NULL, 'Denucleating scssor (Do)', NULL, '22000.00', '409660953.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-12 23:35:59', '2022-05-12 23:35:59'),
(544, 2, NULL, NULL, NULL, NULL, 'Deoderm (size :2x4, 3x3, 6x6)', NULL, '275.00', '1790066206.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-12 23:36:38', '2022-05-12 23:36:38'),
(545, 2, NULL, NULL, NULL, NULL, 'Deoderm Gaze (Do)', NULL, '2585.00', '990482551.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-12 23:37:14', '2022-05-12 23:37:14'),
(546, 2, NULL, NULL, NULL, NULL, 'Deschamps needle curved (blunt) (280mm)', NULL, '30000.00', '1647402540.png', 'https://alpha-medicare.com', NULL, 0, '2022-05-12 23:37:56', '2022-05-12 23:37:56');
